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Abstract
Abstract
The original focus of the research for this thesis was concentrated on establishing 
strategies to detect chromosome imbalance as well as exploring the phenomenon of 
mosaicism and its underlying mechanisms in human preimplantation embryos. High 
levels of chromosomal mosaicism have been detected in human preimplantation 
embryos mostly by fluorescent in situ hybridisation (FISH) but also by comparative 
genomic hybridisation (CGH) and karyotyping. Mosaicism could arise through 
several mechanisms including abnormal cell divisions (mitotic non-disjunction or 
anaphase lag), failure of cytokinesis or endoreduplication. The FISH procedure has 
been criticised, as it is prone to failure. Two separate studies were developed and 
carried out in order to detect the level of mosaicism in embryos.
In the first study a FISH protocol for the use of two different probes per chromosome 
was developed. The aim was to gain information on mechanisms leading to 
aneuploidy mosaicism and its true incidence. Three colour FISH was performed in 
three sequential rounds. In the first and second round different probes were used for 
chromosomes 1, 11, 18. In the third round probes were used for chromosomes X, Y 
and 18. Each FISH procedure included a control slide to assess FISH efficiency in all 
rounds of FISH. Two groups of embryos were spread on day 5 of development; 
embryos grown in cleavage media throughout and embryos transferred to blastocyst 
media after day 3. A total of 21 embryos were analysed in each Group. The FISH 
results revealed one uniformly diploid and 20 mosaic embryos for Group I and 2 
uniformly diploid and 19 mosaic embryos for Group II. Use of 2 different probes per 
chromosome was able to detect FISH artefacts and failure of hybridisation. Post- 
zygotic chromosome loss was the predominant mechanism leading to aneuploidy 
mosaicism for both groups, followed by chromosome gain, with only a few examples 
of mitotic non-disjunction. The relatively high percentage of tetraploidy in the 
blastocyst medium group was considered to reflect normal embryonic development.
The use of CGH was investigated as an alternative strategy to detect the true level of 
mosaicism in the whole genome. The second part of the research for this thesis 
involved assessing the efficiency of CGH, improving the protocol for optimised use 
on single cells, and its application to human embryonic material. Results suggested
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that CGH is a laborious and technically demanding technique however, can provide 
extra information when used as a research tool. CGH was combined with FISH in 
order to assess chromosomal abnormalities in day 3 and day 5 embryos respectively. 
CGH was employed in 1-2 biopsied cells from a day 3 embryo, which was grown up 
to day 5 and further analysed by multi-colour FISH. The aim of this study was to 
observe the full chromosomal status of 1 -2 blastomeres biopsied at the cleavage stage 
(day 3) of development followed by FISH analysis of the rest of the embryo on day 5. 
This would allow the assessment of abnormalities in day 3 embryos by a full 
karyotype and then confirm whether the abnormality persists until day 5 using FISH 
for the chromosome(s) involved. In summary 30 embryos were fully analysed and 
only 3 (10%) were uniformly normal, while the rest were mosaic or chaotic. CGH was 
able to provide results in 83.3% of the embryos subjected to analysis. FISH and CGH 
showed either agreeing or complimentary results for all embryos analysed. The 
predominant mechanism of aneuploidy mosaicism was whole chromosome loss. 
Furthermore, partial aneuploidy was also detected, with partial chromosome loss 
being the principal mechanism.
In the final part o f the thesis the development of PGD protocols for a single gene 
disorder, namely DM, were devised using polymerase chain reaction (PCR) 
techniques. Two PGD protocols were devised and employed clinically in two patients 
undergoing PGD for DM using fluorescent PCR. Due to the extensive workup needed 
to develop the specific PCR protocols for each patient, a universal-like protocol was 
researched. Such a protocol would involve production of a sufficient amount of DNA 
through whole genome amplification techniques i.e. DOP-PCR from a single cell to 
carry out subsequent analysis with F-PCR markers as well whole chromosome 
analysis using CGH. DOP-PCR amplified DNA was subjected to amplification of five 
markers that would have been used during a PGD workup for DM and also subjected 
to CGH analysis. Initially genomic DNA was tested which produced high fidelity of 
amplification. Single cell DNA was then utilised in order to assess the amplification 
rate, allele dropout (ADO) and contamination levels. It was shown that there was 
relatively low amplification and ADO rates of the five markers at the single cell DNA 
level compared to the results obtained when the markers were amplified directly from 
single cells during the development of the two F-PCR PGD protocols. However, CGH
6
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analysis was successfully performed indicating that novel WGA methods might 
overcome the problem of low fidelity of the F-PCR markers.
In conclusion, several molecular and cytogenetic techniques were employed to 
analyse human embryos either to provide answers to phenomena such as aneuploidy 
mosaicism and chaos or to select normal embryos in a clinical setting for PGD for 
patient carrying single gene defects.
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1.1 Human Development
Humans, compared with other species, display low fecundity since the chance of 
conception in any ovulatory cycle is low, being 25% for women under 35 who are 
trying to conceive and are of proven fertility (Wilcox et al, 1988). Despite the advent 
of in vitro fertilisation (IVF) in 1978 (Steptoe and Edwards, 1978) and the major 
advances in reproductive medicine, there still remains a relatively high failure rate 
after embryo transfer (Wells and Delhanty, 2000).
1.1.1 Gametogenesis and Meiosis
Gametogenesis is the process of meiosis and cytodifferentiation that converts germ 
cells into mature male and female gametes (Larsen, 1997). During the fourth week of 
embryonic development primordial germ cells differentiate within the yolk sac and 
actively migrate to the posterior body o f the embryo. These cells populate the 
developing gonads and differentiate into the gamete precursor cells which are known 
as spermatogonia in the male and oogonia in the female. When these cells produce 
gametes, the process is known as gametogenesis (spermatogenesis in the male and 
oogenesis in the female).
Meiosis involves a single round of DNA replication followed by two successive 
chromosome segregations; meiosis I and meiosis II. Meiosis I involves chromosome 
pairing and recombination between non-sister chromatids, and yields two haploid 
daughter cells. In meiosis II the duplicated chromosomes divide, yielding four haploid 
daughter cells. The chromosome number is restored to its diploid state with the fusion 
of the male and female gametes at fertilisation. The recombination of homologous 
chromosomes during meiosis leads to exchange of material between maternally and 
paternally derived chromosomes. This process called crossing over is the source of 
new combinations of genes in the next generation.
1.1.1.1 Spermatogenesis
Spermatogenesis is a unique process of continuing differentiation since the DNA 
content of the product is half that o f the progenitor cells (Cooke et al, 1998). 
Furthermore, spermatogenesis is a non-stop process involving many mitotic divisions,
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possibly around 20-25 per annum, and is initiated at puberty. Spermatogenesis is a 
relatively rapid process with an average duration of 60-65 days and most steps are 
closely controlled by a hormone called testosterone. In the initial stages, 
spermatogonia undergo mitotic divisions, giving rise to primary and secondary 
spermatocytes, the cell type in which the first and second meiotic divisions occur. The 
haploid products o f meiosis are round spermatids, which elongate during 
spermiogenesis and with the aid o f the Sertoli cells they compact their chromatin into 
the sperm head and produce further sperm components. Spermiogenesis, a process of 
sperm cell differentiation, requires about 24 days (Metz and Monroy, 1985; Eddy and 
O'Brien, 1993). A spermatozoon consists of a head, a midpiece and a very long tail. 
The head contains the condensed nucleus and is capped by an apical vesicle filled 
with hydrolytic enzymes. This vesicle, the acrosome, plays a significant role during 
fertilisation. The midpiece contains mitochondria and is responsible for generating 
power to the spermatozoon to swim. The tail contains microtubules, which form part 
of the propulsion system of the spermatozoon. The final step o f sperm maturation is 
known as eapaeitation and it involves changes mainly in the acrosome that prepare it 
to release the enzymes required to penetrate the zona pellucida (ZP). Capacitation is 
thought to take place within the female genital tract.
The process o f spermatogenesis is defective for around 2% o f the population resulting 
in abnormally low sperm counts (<20xl 06 /ml, oligozoospermia) or total absence of 
sperm (azoospermia). The discovery that some of these men had a deletion for a 
region of Yq termed AZF (azoospermia factor) (Tiepolo and Zuffardi, 1976) lead to 
characterisation of gene families involved in spermatogenesis, with those mapped 
including Deleted AZoospermia (DAZ) (Reijo et al, 1995) and RNA-binding motif 
(RBM) (Ma et al, 1993). Moreover, a study by Mahadevaiah et al (1998) suggested 
that although in mice RBM deficiencies cause sperm abnormalities, in men deletion 
of the functional copies o f RBM is associated with meiotic arrest rather than sperm 
anomalies.
1.1.1.2 Oogenesis
Oogenesis is a discontinuous process and begins during fetal life. In the female, all 
primary oocytes that the individual will ever possess are produced during fetal life.
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An estimate of 200,000 germ cells are available for the reproductive life span at 
puberty when recruitment of some of these primordial follicles begins. However, over 
99% of follicles undergo atresia rather than ovulation, a degenerative process leading 
to cell death. Mature ova develop from oogonia by a complex series of intermediate 
steps. Oogonia originate from primordial germ cells by a process involving 20-30 
mitotic divisions early in embryonic life (Siracusa et al, 1985). Between the third and 
fifth months of intra-uterine life the oogonia mature into primary oocytes which start 
to undergo meiosis. Shortly after beginning meiosis, however, these cells enter a state 
of dormancy and meiotic arrest that will persist until after puberty (Baker, 1963). The 
primary oocytes remain suspended in the meiotic stage at dictyotene until puberty. 
After puberty, a few oocytes and their enclosing follicles resume development each 
month in response to the monthly production of pituitary gonadotrophic hormones. 
These hormones include gonadotrophin-releasing hormone (GnRH), follicle- 
stimulating hormone (FSH) and luteinizing hormone (LH). The hormones above play 
an indispensable part in controlling folliculogenesis, ovulation and the condition of 
the uterus. Only one follicle matures fully (others undergo atresia) and undergoes the 
process of ovulation, which is the expulsion of the secondary oocyte from the follicle. 
The final maturation stage of the oocyte, where the oocyte will complete meiosis, can 
be concluded only if it is fertilised by a spermatozoon.
1.1.2 In Vivo Fertilisation
Fertilisation, the process by which the male and female gametes fuse, occurs in the 
fallopian tube. This multi-step process begins with the specific recognition of 
complementary receptors on the surfaces of the two gametes. When a spermatozoon 
encounters an ovulated oocyte it forces its way through the cumulus mass. The zona 
matrix is made up of at least three major glycoproteins, ZP1, ZP2 and ZP3 where the 
sperm are able to bind (Longo, 1997; Acevedo and Smith, 2005). If the spermatozoon 
reaches the ZP, the sperm binds in a human-specific interaction with the glycoprotein 
sperm receptor molecule (ZP3) and then the sperm acrosome is induced to release 
degenerative enzymes that allow the sperm to penetrate the ZP. As soon as the 
spermatozoon penetrates the ZP and reaches the oocyte, the cell membranes of the 
two cells fuse. This causes a cascade of events including release of specific substances 
that interact with the ZP in such a way as to alter the sperm receptor molecules,
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rendering the ZP impenetrable to other spermatozoa. Moreover, the fusion of the 
spermatozoon cell membrane with the oocyte membrane causes the oocyte to resume 
meiosis where the oocyte will consequently release the second polar body.
The chromosomes of the oocyte and sperm are enclosed within female and male 
pronuclei respectively, which merge to produce the single, diploid, 2N nucleus of the 
fertilised zygote. The moment of zygote formation is taken as the beginning of 
embryonic development. The position of the chromosomes in the sperm nucleus has 
been found to be significant since location could influence paternal gene expression 
(Foster et al, 2005).
1.1.3 In Vivo Preimplantation Embryo Development
Twenty-four hours after merging of the male and female pronuclei, the zygote starts 
dividing through mitotic cell division known as cleavage. The zygote is subdivided 
into smaller daughter cells called blastomeres. The first cleavage division divides the 
zygote in line with the polar bodies, whereas subsequent divisions are asynchronous. 
The embryo should have divided into 4 cells by 48 hours and 6-8 cells by 72 hours 
(day 3) post ovulation. By day 4 embryos should reach the morula stage and by day 5- 
6 embryos form a hollow ball of about 100 cells. At this point the preimplantation 
embryo, now called a blastocyst, enters the uterine cavity and begins to implant into 
the endometrial lining of the uterine wall (Figure 1.1).
During these initial stages of embryo development (0-6 days), the zygote travels down 
the oviduct and undergoes cleavage that subdivides the zygote without increasing its 
size. In fact, with each division the resulting blastomeres are half the size of the parent 
cells, and they become increasingly tightly connected as compaction occurs to form 
the 16-32 cell embryo with an appearance of a small mulberry therefore called a 
morula (90-120h post-fertilisation) which then becomes a blastocyst (Trounson et al, 
1982; Gardner and Lane, 2005). The cells of the blastocyst are differentiated into two 
types: the inner cell mass (embryoblast), which will give rise to embryo proper and its 
attached membranes and the outer cell mass (trophoblast), which will be the main 
source of the placenta and related structures. This is a time characterised by intense 
DNA synthesis and replication.
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Figure 1.1. Demonstration of blastocyst implantation (picture taken from Larsen, 1997)
During oogenesis, a supply of maternal proteins and mRNA is produced which, 
following fertilisation, supports the initial development of the mammalian zygote 
(Daniels and Monk, 1997; Houghton and Leese, 2004). As development proceeds, 
these maternally derived proteins and mRNAs are degraded and replaced by those 
produced by the zygote itself. Several studies have tried to determine the timing at 
which the ‘switch’ from maternal to embryonic control of development occurs 
(Tesarik et al, 1986; Braude et al, 1988; Leese, 1998). Studies involving the 
incubation of human preimplantation embryos from the 1-cell stage in a medium 
containing a-amanatin, which inhibits transcription, have shown that development of 
human embryos may proceed to the 4- to 8-cell stage, presumably supported only by 
maternal transcripts (Tesarik et al, 1986). However, Braude and colleagues (1988)
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postulated that beyond this stage embryonic transcripts are required for further 
development (Gardner and Lane, 2005). This is in contrast to the earlier 2-cell stage 
embryonic genome initiation in the mouse (Flach et al, 1982) and later 16-cell stage 
in bovine embryos (Telford et al, 1990).
Preimplantation embryos in vivo develop in an undefined, complex milieu containing 
nutrients, including pyruvate, glucose, lactate and amino acids, ions and 
macromolecules (Houghton and Leese, 2004). The metabolic requirements of the 
embryo during the early preimplantation period are linked with the activation of the 
embryonic genome. Prior to embryonic genome activation lactate and pyruvate are the 
primary energy sources. However, following the activation of the embryonic genome, 
metabolism shifts to glucose (Gardner and Sutherland, 1996). The precise amino acid 
requirements of the preimplantation embryo are unknown but they certainly vary 
before and after genome activation (Gardner, 1998). Several studies have investigated 
the effect of single or small numbers of amino acids on preimplantation embryo 
development such as the positive effect of glutamine (Devreker et al, 1998) as well as 
the osmolyte effect of taurine (Dumoulin et al, 1997). Houghton and Leese (2004) 
developed an HPLC-based technique to measure non-invasively the turnover of a 
physiological mixture of 18 amino acids by single human embryos and found that 
leucine is depleted completely from the medium.
Recently, the contribution of mitochondrial activity to embryo competence has been 
investigated in the human (Jansen, 2000; Cummins, 2002; Van Blerkom, 2004). The 
mitochondrial complement size, mitochondrial DNA copy numbers and defects and 
stage-specific spatial distribution, have been found to influence the developmental 
normality and viability of preimplantation embryos (Van Blerkom, 2004).
During embryo growth and more significantly embryo differentiation two types of 
intracellular junctions have been described as communicative devices between 
blastomeres, appearing from the 8-cell stage onwards (Fleming et al, 2000). Firstly 
there are the structural tight junctions and desmosomes forming in the outer most 
cells, anchoring the cells together and forming a permeability seal isolating the 
interior of the embryo from the external environment. Tight junction construction 
initiates at compaction and is dependant upon uvomorulin adhesion (Fleming et al,
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1993). Certain integral and peripheral proteins such as occluding and cingulin (ZO-1) 
compose the tight junctions (Fleming et al, 1993). Desmosomal proteins are points of 
intercellular contact that ‘bolt’ the cells together. Secondly, there are the low 
resistance junctions known as gap junctions allowing intracellular connection between 
the cytoplasm of two cells so that small proteins and ions can be exchanged (Levin 
and Mercola, 1998; Cronier et al, 2001). Direct transfer through the gap junctions 
includes metabolites and second messangers (cAMP) (Bennet et al, 1997). In human 
embryos gap junctions are not apparently well developed until the early blastocyst 
stage when intracellular communication is clearly seen between inner cell mass (ICM) 
cells (Dale et al, 1991). Gap jucntions have also been linked with the early generation 
of left-right assymetry in Xenopus embryos (Levin and Mercola, 1998) as well as 
differentiation of the human placenta (Cronier et al, 2001)
1.1.4 In Vitro Fertilisation
The first successful birth following in vitro fertilisation (IVF) treatment was reported 
in 1978 by Steptoe and Edwards (Steptoe and Edwards, 1978). This medical 
breakthrough heralded the beginning of real hope for thousands of infertile couples. 
For almost three decades all aspects of IVF treatment have constantly been fine-tuned 
in order to improve pregnancy rates and help couples conceive their dream: a baby. 
Superovulation regimens have been changed to yield a high number of viable and 
normal oocytes; sperm preparation methods have been improved; culture techniques 
and media are continuously evolving in association with our understanding of the 
needs of the early embryo; moreover, laboratory settings have been re-designed to 
accommodate the gametes and embryos ‘normal’ growth. The pregnancy rate varies 
between centres according to the patient group treated but overall the livebirth per 
cycle or ‘take home baby’ rate is about 25%, which declines rapidly as maternal age 
increases over 36 years (HFEA Annual Report, 2004). Of all pregnancies following 
IVF, 29% are multiple with a significant proportion of triplets (5%). Obstetric and 
perinatal complications associated with IVF are largely attributable to the high 
incidence of multiple pregnancies at risk of pre-term delivery and low birthweight. 
There is no evidence that fetal abnormalities are more common in children conceived 
after assisted conception (about 2-3%), compared to their peers conceived normally. 
In longitudinal studies, child development appears normal (SART, 1992; FIVNAT,
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1995). Human births from cryopreserved/thawed embryos do not differ significantly 
from those from fresh IVF embryos or natural conceptions (Wennerholm et al, 1997).
1.1.4.1 Intracytoplasmic Sperm Injection
Micro-assisted fertilisation techniques (MAF) based on IVF technology have been 
developed since the late 1980s specifically to address the problem of male factor 
infertility. These include partial zona dissection (PZD) where a breach is made in the 
zona by mechanical dissection to facilitate sperm entry (Malter and Cohen, 1989), and 
sub-zonal insemination (SUZI) involving placement of two to five single sperm into 
the perivitelline space (Laws-King et al, 1987). Both techniques mentioned above 
have been replaced with intracytoplasmic sperm injection (ICSI). ICSI involves direct 
microinjection of a single sperm into the cytoplasm of a mature metaphase II oocyte 
that has been denuded of all surrounding cumulus and corona cells (Palermo et al, 
1992; Figure 1.2). This procedure enables men who were previously thought to be 
irreversibly infertile, the chance to have their own child. However, the clinical 
application of ICSI has evoked an intense debate on possible associated risks 
(Cummins and Jequier, 1994; Griffin et al, 2003), because bypassing natural 
mechanisms of sperm selection has been suspected to support the propagation of gene 
mutations and chromosomal abnormalities. These concerns are based on the 
assumption that the ZP stops the penetration of genetically abnormal sperm. 
Furthermore, ICSI has been widely used as the only method of fertilisation in PGD 
cases for chromosomal abnormalities and single gene defects (Harper et al, 2000). 
The underlying reason is to reduce the chance of maternal or paternal contamination 
during the biopsy procedure since only one sperm is injected into an oocyte where the 
surrounding cells i.e. cumulus and corona cells have been removed using 
hyaluronidase
33
Chapter 1 -Introduction
Figure 1.2. Illustration of an ICSI procedure.
A: 1) Suction applied by a glass holding pipette keeps the oocyte from moving during
the injection. A single sperm is picked up in a tiny micro-needle. 2) The needle has a 
sharp tip and can be gently pushed through the shell of the oocyte and into the 
cytoplasm and 3) and (B) The sperm is deposited deep inside the oocyte and the 
empty needle is withdrawn (www.google.com/images)
These concerns appeared to be somewhat confirmed with reports of an increase in sex 
chromosome aberrations in ICSI babies (Bonduelle et al., 1995; 1998; In’t Veld et al, 
1995; Toumaye et al, 1995; Scholtes et al, 1998) and the inheritance of paternal 
chromosome rearrangements (Testart et al, 1996; In’t Veld et al, 1997; Meschede et 
al, 1997) and Y deletions (Kent-First et al, 1996). However, other studies have 
concluded that the chromosomal abnormality rate is not higher in ICSI compared to 
IVF children (Palermo et al, 1996; Engel et al, 1996). These discrepancies between 
studies may be due to differences among laboratories in scoring criteria as well as 
intrinsic (e.g. age) and extrinsic (e.g. environment) factors may play a role (Griffin et 
al, 2003). Recently, Griffin et al (2003) prepared a questionnaire for IVF staff 
assessing their views whether or not to screen patients for sperm aneuploidy before 
undergoing ICSI treatment. It was found that staff was not against screening for sperm 
chromosomal abnormalities and that there would benefits in doing so, however, others 
argued that most would undergo the ICSI procedure regardless of the screening results 
(Grffin et al, 2003).
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1.2 Human Genetic Disease
1.2.1 Chromosome Abnormalities
In 1956 the human chromosome number was identified by Tijo and Levan being 46, 
and three years later Lejeune et al, (1959) connected genetic disease with deviations 
from the right number of chromosomes. Chromosomal abnormalities comprise 
cytogenetically detectable alterations in the normal karyotype, and may be either 
structural involving physical rearrangements of chromosomes, or numerical involving 
the loss or gain of individual chromosomes (aneuploidy) or whole chromosome sets 
(polyploidy). Furthermore, in cases where more than one genetically distinct cell line 
is present, if they arise from one zygote it is called mosaicism whereas if it results 
form more than one zygote it is referred as chimerism.
Chromosome abnormalities are a major category of genetic disease. They account for 
a large proportion of reproductive wastage, congenital malformations and mental 
retardation. The incidence of abnormalities of the autosomes and sex chromosomes 
are approximately the same (Jackson, 2002). Approximately 60% of spontaneous 
abortions in the first trimester and 5% of stillbirths are caused by chromosomal 
abnormalities (Hassold et al, 1986; Eiben et al, 1990). There has been a variety of 
factors linked to the high early pregnancy failures, with chromosome abnormalities, 
present or induced, being the most important (Munne et al, 1999). Embryonic 
aneuploidy, numerical chromosomal abnormality involving the gain or loss of one or 
more chromosomes, is one of the major causes of reproductive failure in women 
above 35, at least following IVF (Warburton et al, 1986; Munne et al, 1995a; Munne, 
2002). The chance of a fetus being affected with a chromosomal disorder increases 
with the age of mother from approximately 1:250 at age of 35 to 1:65 at 40 and 1:20 
at 46 years of age (Jackson, 2002). It has been postulated that the high level of early 
embryonic death must contribute significantly to the observed low fecundity (Wells 
and Delhanty, 2000). The importance of chromosome abnormalities was 
demonstrated by karyotyping aborted foetuses, which showed that >60% of 
spontaneous abortions at <12 weeks carried a chromosomal abnormality (Boue et al,
1985).
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The major type of chromosomal abnormality found at all gestational ages is 
aneuploidy, either trisomy or monosomy, for the X chromosome. Trisomies for all the 
chromosomes have been found in abortuses, including chromosome 1 (Dunn et al,
2001) but monosomies with the exception of monosomy X are extremely rare (Boue 
et al, 1985). The incidence of the most common live-born aneuploidies has been 
shown to increase with maternal age (Nicolaidis and Petersen, 1998). Trisomy 21 is 
the most common aneuploidy found at birth and the majority of cases are the result of 
non-disjunction occurring at maternal meiosis (Nicolaidis and Petersen, 1998), 
whereas only 5% are attributable to mitotic error (Yoon et al, 1996). Furthermore, it 
has been suggested that aneuploidy of gonosomes and disomy 18 by non-disjunction 
can be due to increasing paternal age (Griffin et al, 1995)
1.2.1.1 Numerical Aberrations
Aneuploidy involves the loss or gain of an extra chromosome causing monosomies, 
trisomies and tetrasomies (Griffin, 1996). The incidence of aneuploidy in humans is 
an order of magnitude greater than for other animals and most commonly leads to a 
high rate of mental retardation and pregnancy wastage between 6 and 20 weeks of 
gestation (Mahmood et al, 2000). Trisomy is the most common class of chromosome 
abnormality occurring in at least 0.3% of all newborns (Bond et al, 1983) and 25% of 
spontaneous abortions (Hassold et al, 1985). Approximately 30% of pregnancies 
result in fetal wastage due to aneuploidy (Wilcox et al, 1988). The most frequently 
surviving trisomies include trisomy 21 (Down syndrome), 13 (Patau syndrome), 18 
(Edwards’ syndrome) and aneuploidies involving the sex chromosomes such as 
monosomy X (Turner syndrome). Trisomy 21 is the most common aneuploidy among 
liveboms with an incidence of 1:800 births and increases markedly with maternal age, 
whereas trisomy 16 is the most frequent cause of pregnancy loss (Hassold et al,
1986). The incidence of trisomy 21 at conception is far higher but only 24% survive 
to term (Hassold et al, 1996). Furthermore, translocations with an emphasis on 
Robertsonian translocations, accounting for 5% of trisomy 21, are another cause of 
aneuploidy. Edwards’ syndrome has an incidence of 1:10,000 and Patau’s syndrome 
has an incident o f 1: 20,000 livebirths (Hassold et al, 1996). Sex trisomies, such as 
47XXY or 47XYY, have an incidence of 1:1100 and approximately 1 in 500 livebom 
males have either a 47XXY or a 47XYY chromosome constitution (Hassold et al,
36
Chapter 1 -Introduction
1998). The only monosomy reported to show compatibility with life is monosomy 
XO, termed Turner’s syndrome, with an incidence of 1:5,000-10,000 female births. 
This represents only a fraction of all conceptions with this condition, as 98-99% are 
spontaneously aborted and only 0.3% are bom alive (Hassold et al, 1996).
There are essentially three developmental stages when chromosomal defects, and 
especially aneuploidy, can arise: gametogenesis, fertilisation and embryogenesis 
(Delhanty et al, 1995). Errors in gametogenesis are usually considered to be meiotic 
in origin (Delhanty et al, 1995), whereas fertilisation errors are caused due to 
dispermy which occurs in 1% of spontaneous miscarriages in vivo (Jacobs et al, 
1978). Mitotic errors in embryogenesis are implicated in 5-20% of cases, but this may 
be underestimated as errors in pre-mitotic divisions during gametogenesis may also 
appear as being of meiotic origin (Antonarakis et al, 1993). Aneuploidy largely arises 
as a result of an error of chromosome segregation at cell division called 
nondisjunction (Griffin, 1996) (Figure 1.3). The classical model for the mechanism of 
nondisjunction in maternal meiosis I is the failure of homologous chromosomes to 
segregate properly to opposite poles during meiosis resulting in the production of 
gametes that have an incorrect chromosome complement (Day et al, 1998). Non­
disjunction of bivalents leading to loss or gain of dyads during meiosis I results in a 
disomic and a nullisomic gamete (Nakaoka et al, 1998). According to Angell and 
colleagues, premature division of the chromosome centromere during anaphase I 
leads to loss or gain of monads (Angell et al, 1994). Studies in oocytes have revealed 
that during anaphase I univalents can migrate either as a whole chromosome towards 
the meiotic spindle, or divide prematurely and move as separate chromatids, with 
subsequent random segregation (Angell et al, 1994). Both types of nondisjunction 
have been confirmed in subsequent studies (Cozzi et al, 1999).
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Figure 1.3. Segregation at meiosis of a single pair of chromosomes
A: Non-disjunction occurring during meiosis I at anaphase I will lead to four 
unbalanced gametes. B: Non-disjunction occurring during meiosis II at anaphase II 
will lead to two disomic gametes and two unbalanced gametes. 
(www.google.com/images)
Lamb et al, (1996) proposed a two hit system to explain the predominance of 
maternal MI errors in human trisomy. The first event establishes a susceptible pairing 
configuration in fetal meiosis whilst the second event is an age-related impairment of 
the meiotic process, such as defective spindle apparatus (Battaglia et al, 1996), which 
gives an increased risk of nondisjunction. This general interpretation is broad enough 
to encompass other factors that may contribute to spindle disturbances linked to 
aneuploidy such as hormonal imbalance and reduced intrafollicular vascularity 
(Gaulden, 1992; Van Blerkom, 1998).
There is a long list of factors known to affect the process of non-disjunction such as: 
parental age, recombination of chromosomes, chromosome mover components, 
differential chromosome susceptibility and certain chemicals. The most significant
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factor affecting nondisjunction is advanced maternal age and subsequent aberrant 
recombination (Griffin, 1996). Errors in maternal meiosis I account for 75% of 
trisomy 21 cases (Antonarakis et al, 1998) and all (100%) of trisomy 16 (Hassold et 
al, 1996). In trisomy 18 cases most arise due to errors occurring during maternal 
meiosis II (Fisher et al, 1995).
Polyploidy (multiple copies of all chromosomes) is the second most common group of 
chromosomal abnormalities resulting in a spontaneous abortion in the first or second 
trimester as progression to term is rare (Book and Santesson, 1960; Cassidy et al, 
1977). Errors in cell division can result in polyploidy. However, it is mainly due to 
polyspermic fertilisation (Hassold et al, 1980; Angell et al, 1986, Zaragoza et al 
2000), with dispermy being the most common cause of triploidy. Complete non­
disjunction at MI or Mil can also lead to triploidy. In digynic cases this meiotic 
failure can be caused by non-extrusion of a polar body which then becomes 
incorporated into the embryo (Penrose and Delhanty, 1961; Zaragoza et al, 2000). 
Following DNA replication any meiotic or post-zygotic mitotic failure in cytokinesis 
can cause tetraploidy or higher orders of ploidy
1.2.1.2 Structural Aberrations
Structural chromosomal abnormalities arise from chromosome breakage with 
subsequent reunion in a different configuration. They can be balanced, where the 
chromosome complement is complete with no loss or gain of genetic material or 
unbalanced, where the chromosome complement contains an incorrect amount of 
genetic material. Structural abnormalities include translocations (reciprocal or 
Robertsonian), deletions, inversions, insertions, ring chromosomes and 
isochromosomes (Figure 1.4). Structural chromosomal aberrations may be familial or 
de novo in nature with an estimated mutation rate of 1/lxl 0'3 (Jacobs, 1981) and are 
seen in 5% of spontaneous abortions (Hassold et al, 1986; Eiben et al, 1990) and 
between 0.2-0.6% of livebirths, the majority balanced (Hook and Hamerton, 1977; 
Nielsen and Wohlert, 1991).
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a. Reciprocal Translocation
A der(A,B) B
b. Robertsonian Translocation
(i) A derA derB B (ii) A insA 
c. Chromosomal Insertions
(iii) A insA
(i) A invA (ii) A invA
c. Chromosomal Inversions
Q
a
A iA 
b. Ring Chromosome
Figure 1.4: Eight types of balanced rearrangements are illustrated, Chromosomal 
translocations a) Reciprocal, b) Robertsonian, c) Insertions (i) interchromosomal, (ii) 
intrachromosomal between-arm and (iii) intrachromosomal within-arm. d) 
Chromosomal inversions (i) pericentric and (ii) paracentric, e) Ring chromosome.
A, B -  Normal homologue. der, ins, inv, r -  Rearranged chromosome. (Therman et 
al., 1989)
Translocations are the most common structural abnormality in man (approximately 
1.6 in 1000 newborns) and carriers of balanced translocations show an increased risk 
of having chromosomally abnormal offspring in addition to infertility and 
spontaneous abortions due to the formation of unbalanced gametes during meiosis 
(Iwarsson et al, 2000). Impaired spermatogenesis has also been frequently seen in 
male balanced translocation carriers. Most of the male translocation carriers that have 
reduced fertility are considered to be phenotypically normal (Sutton, 1980).
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Most structural anomalies are only identified if a couple presents with a history of 
chromosomally abnormal conceptions. These reproductive problems arise due to 
abnormal meiotic segregation and/or production of recombinant chromosomes at 
gametogenesis, the degree of which varies according to the chromosomes involved, 
the size and location of the rearranged segments, whether complete synapsis is 
achieved and the position of crossover events and the individual (Gardner and 
Sutherland, 1996). Furthermore, the fact that certain couples carrying a chromosomal 
rearrangement suffer only a slight reduction in fertility and others a detrimental one is 
a consequence of the multifactorial nature governing the production of viable or non- 
viable gametes as the production of unbalanced gametes of a particular type is 
influenced by the size of the imbalance (Cohen et al, 2000). In addition, it is generally 
known that infertile men have a higher incidence of de novo chromosomal 
abnormalities in sperm than fertile men.
1.2.1.2.1 Robertsonian Translocations
Robertsonian translocations occur with a prevalence of ~1 in 1000 in the general 
population (Gardner and Sutherland, 1996). Robertsonian translocations result from 
the breakage of two acrocentric chromosomes (13, 14, 15, 21 and 22) at or close to 
their centromeres, with subsequent fusion of their long arms (Figure 1.4b). The short 
arms of each chromosome are lost, which is of no clinical importance and the total 
chromosome number is reduced to 45. Since there is no loss or gain of essential 
genetic material this is a functionally balanced rearrangement (Conn et al, 1999). The 
most common forms are non-homologous, involving two different acrocentric 
chromosomes such as two chromosomes from the D or G group (13, 14 and 15 or 21 
and 22 respectively) or a D group and G group chromosome. There are three ways for 
the formation of a Robertsonian translocation: fusion at the centromere (centric 
fusion), giving a monocentric chromosome, a whole arm reciprocal translocation, 
with breakage in one short arm and one long arm giving a monocentric chromosome, 
and finally, union following breakages in both short arms giving a dicentric 
chromosome (or after the suppression of one centromere, a monocentric). The most 
common Robertsonian translocation is between chromosomes 13 and 14 and makes 
up 75% of all Robertsonian translocations (Gardner and Sutherland, 1996).
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1.2.1.2.2 Reciprocal Translocations
Reciprocal translocations are characterised by the exchange of chromosomal genetic 
material between two non-homologous chromosomes (Figure 1.4a). They are very 
common in the general population, occurring in 1 in 500 livebirths (Hook et al, 1977). 
Carriers of these translocations are nearly always phenotypically normal, as no loss or 
gain of genetic material is involved (abnormalities can arise if breakpoints disrupt 
important genes) (Scriven et al, 1998). Translocations are detected when the patient 
presents with recurrent pregnancy loss or phenotypically abnormal offspring due to 
the production of unbalanced gametes (Scriven et al, 1998; Iwarsson et al, 2000). The 
risk of miscarriages, stillbirths or chromosomally unbalanced live births with multiple 
congenital abnormalities depends on the probability of different types o f unbalanced 
gametes being produced and, after fertilisation of such gametes, on the probability of 
different types of unbalanced embryos being able to survive (Van Assche et al, 1999). 
Impaired spermatogenesis is also frequently seen in male balanced translocation 
carriers.
1.2.1.2.3 Deletions, Inversions, Insertions, Ring Chromosomes and 
Isochromosomes
Deletions involve loss of a chromosomal segment, resulting in chromosome 
imbalance. A carrier of a chromosomal deletion (with one normal homologue and one 
deleted homologue) is monosomic for the genetic information on the corresponding 
segment of the normal homologue. The clinical consequences generally reflect 
haploinsufficiency (Jackson, 2002) and appear to depend on the size of the deleted 
segment and the number and function of the genes that it contains (Gardner and 
Sutherland, 1996). Deletions have an incidence of approximately 1 in 7000 births and 
can be terminal or interstitial. Deletions may originate by chromosome breakage and 
loss of the centric fragment or due to unequal crossing over between misaligned 
homologous chromosomes or sister chromatids. Furthermore, it has been suggested 
that deletions are also derived due to abnormal segregation from a balanced 
translocation or inversion (Iwarsson et al, 2000).
Insertions or insertional translocations involve three breaks; the first two breaks 
release an interstitial segment, which is then inserted into the gap created by the third 
break (Figure 1.4c). If a single chromosome is involved, this can be described as a
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shift. In the interchromosomal insertions a segment of one chromosome is inserted 
interstitially into another chromosome. The insertion could be direct when the inserted 
segment is inserted with the same orientation with respect to the centromere, or it 
could be inverted when the orientation towards the centromere is reversed (Hamden et 
al, 1985). Interchromosomal insertions are rare chromosomal rearrangements with an 
incidence of 1:80000, of which nearly 80% are referred because of congenital 
abnormalities and mental retardation (Van Hemel and Eussen, 2000). In the case of 
intrachromosomal insertion either within or between an arm crossing over can occur 
in one or the other insertion loop following complete synapsis. The risk of having a 
child with an unbalanced karyotype when carrying an intrachromosomal insertion has 
been estimated to be 15% by Madan and Menko (1992). Insertions are amongst 
rearrangements implying the highest reproductive risk. This risk is greater for the 
small segment insertion than the large segment insertion however in the case of the 
meiotic recombination product carrying a duplication there appears to be no clear 
relationship between the phenotype and the length of the duplicated segment (Wilson 
et al, 1985).
Inversions involve a two-break rearrangement in a chromosome and the segment 
formed by the breaks is reversed. If the inverted segment includes the centromere then 
the inversion is pericentric [Figure 1.4d(i)], if however, the centromere is not involved 
the rearrangement is known as paracentric [Figure 1.4d(ii)]. Excluding the common 
inversions of heterochromatin lqh, 9qh, and 16qh generally considered normal 
variants, inversions occur in about 1 in 2-5000 births (Gardner and Sutherland, 1996). 
In pericentric inversions the smaller the inverted fragment the greater the 
chromosomal imbalance and the likelihood of miscarriage of the conception. 
Conversely, with a large inverted segment, the unbalanced regions will be small and 
offspring carrying the recombinant chromosomes may be viable (Daniel, 1981). In the 
case of paracentric inversions the crossing-over during synapsis at meiosis will lead to 
the formation of recombinant chromosomes that are either acentric, and incompatible 
with survival or dicentric and unstable during cell division and therefore are not 
compatible with life either (Worsham, 1989). Therefore, the risk of the birth of an 
abnormal child resulting from a carrier parent of a balanced paracentric inversion is 
almost non-existent.
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Ring chromosomes are formed by breakage in both arms of a chromosome, with 
fusion of the points of the fracture and loss of the distal fragments (Figure 1.4e). Thus, 
this would result in a partial monosomy for the distal short arm and the distal long 
arm. Ring chromosomes are often unable to complete mitotic division so that it is not 
unusual to find the ring chromosome in only a proportion of cells. In carriers of this 
abnormality where reproduction is an option, meiotic and mitotic disturbances 
presumably lead to high levels of gametic chromosomal imbalance and impaired 
fertility, although reports of stable familial rings show that this is not inevitable 
(McGinniss et al, 1992).
Isochromosome is a chromosome where one arm is missing and the other is 
duplicated in a mirror-image fashion, thus a person carrying an isochromosome has 
partial monosomy of one arm and partial trisomy of the other. The basis for 
isochromosome formation is not precisely known. However, the most probable 
explanation is that the centromere has divided transversely rather than longitudinally. 
The isochromosome for the long arm of the X chromosome, i(Xq), is the most 
common isochromosome and is found in some individuals with Turner’s syndrome.
1.2.1.3 Mosaicism
Mosaicism is defined as the presence in an individual or in a tissue of two or more 
cell lines, which differ in their genetic constitution but are derived from the same 
zygote. The phenomenon of mosaicism will be analysed in section 1.6
1.2.1.4 Chromosomal Abnormalities in Human Gamete Studies
1.2.1.4.1 Karyotyping Studies
Karyotypic analysis o f 710 oocytes (with or without polar bodies) revealed that 
cytogenetic abnormalities are closely associated with abnormal gametes, 
parthenogenesis, cytoplasm immaturity and division asynchrony after fertilisation 
(Benkhalifa et al, 1996). Angel (1997) after analysis of 200 oocytes by karyotyping 
postulated that there are two major factors regarding oocyte aneuploidy and maternal 
age: a) Vulnerable recombinants arise by chance distribution of recombination events 
at the pachytene stage of meiosis in fetal life and b) the physical structure of all 
chromosomes in the oocyte gradually deteriorates during the extended dictyate stage.
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1.2.1.4.2 FISH Studies
Studies on sperm have tried to approach aneuploidy and especially trisomy by 
employing FISH (Hixon et al, 1998). Sperm studies are advantageous in studying 
nondisjunction over female studies since they have: a) accessibility to the origin of 
aneuploidy, the gametes, b) limitless supply of the products of meiosis, making 
possible to detect subtle differences in nondisjunction among different individuals and 
c) examination of nondisjunction in a setting that is unaffected by the maternal age 
effect. Recently, Tempest et al (2004), was able to find an association between 
infertile male individuals (of variant infertility) and sperm disomy for the sex 
chromosomes and chromosome 21. Overall, it was concluded that oligozoospermic 
male have significantly elevated levels of sex chromosome disomy only, whereas 
asthenozoospermic males have elevated levels of disomy 21 and not the sex 
chromosomes.
Studies on metaphase II oocytes have revealed an unexpected class of chromosome 
abnormalities, which manifest as single chromatids, rather than whole chromosomes 
comprising a dyad of chromatids. Mahmood et al (2000), determined that extra 
material in 127 oocytes and 57 polar bodies (PB) was seen in chromosomes 13, 16, 
18, X and notably 21, but none were observed in chromosomes 1 and 9. Furthermore, 
the previous group found clues suggesting that an additional mechanism of maternal 
aneuploidy operating at anaphase II, might be the underlying reason of prematurely 
separated chromatids in the metaphase II oocyte Dailey et al (1996), used FISH on 
oocytes to investigate the involvement of specific chromosomes in aneuploidy, 
especially chromosomes 13, 15, 16, 18, 21, 22, X and Y. Sequential multi-probe FISH 
was employed for chromosomes 1, 9, 12, 13, 16, 18, 21 and X by Cupisti and 
colleagues (2003) to investigate the chromosomal status of unfertilised polar bodies 
and associated polar bodies. The same group found that mechanisms leading to 
aneuploidy include nondisjunction of whole univalents. In a recent study by Martini 
and co-workers (2000) on oocytes analysed by FISH, it was revealed that almost half 
(44% overall) of the material examined was aneuploid with chromosome specific 
patterns. Furthermore, Durban et al (1998) described an oocyte spreading procedure 
which was able of allowing detection of aneuploidy as well as structural chromosomal 
abnormalities during PGD using FISH.
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1.2.1.5 Chromosomal Abnormalities in Embryo Studies
1.2.1.5.1 Karyotyping Studies
Ideally, cytogenetic investigation would involve analysis of metaphase chromosomes 
from the blastomeres or polar bodies (Ruanvutilert et al, 2000b). Karyotyping 
embryos has been applied using conventional techniques including culture 
synchronisation, disruption of the mitotic spindle and G-banding (Papadopoulos et al, 
1989; Clouston et al, 1997; Clouston et al, 2002), however it is considered to be 
technically challenging.
Cytogenetic analyses of human preimplantation embryos have revealed extremely 
high levels of chromosome imbalance at this early stage of development 
(Papadopoulos et al, 1989; Clouston et al, 1997). Many embryos are karyotypically 
normal, however >50% of embryos are reported to carry a variety of chromosomal 
abnormalities including aneuploidy and chromosome breakage, polyploidy (addition 
of one or more complete haploid complements) and haploidy (one set of 
chromosomes instead of two) (Voullaire et al, 2000). These chromosome 
abnormalities arise during gametogenesis and/or fertilisation. Alternatively, they can 
be present in a proportion of nuclei due to post-zygotic errors during mitosis. This 
percentage indicates that pregnancy loss is frequently a result of natural selection 
against chromosomal aberrations
Limited, useful information can be extracted from processing intact day 2 and day 3 
embryos (Angell et al, 1986; Papadopoulos et al, 1989; Jamieson et al, 1994) after 
analysis using banding techniques. Jamieson et al (1994) published a study of 816 
embryos, however was able to karyotype only 195 (23.9%), finding 19.1% being 
aneuploid, 3.5% being tetraploid, 2.3% being triploid and only 0.6% being haploid. 
This was due to reduced quality of metaphases and G-banding and long colcemid 
exposure times resulting in highly contracted chromosomes. Clouston and colleagues 
(1997) devised a novel and inexpensive method for obtaining better quality G-banded 
metaphases from human blastocysts. They were able to provide full ploidy analysis on 
64% (55/86) o f the embryos and reported high levels of diploid embryos (67%); 
however, this percentage included uniformly abnormal karyotypes. Several studies 
reported chaotic findings while trying to detect mosaic and non-mosaic chromosome
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abnormalities (Jamieson et al, 1994; Clouston et al, 2002) and were able to show that 
mitotic non-disjunction is significant for the production of aberrations in human pre­
embryos (Papadopoulos et al, 1989). Furthermore, karyotypic studies on 
preimplantation embryos were among the first to reveal significant levels of 
tetraploidy, usually mosaic of about 19-23% (Papadopoulos et al, 1989; Clouston et 
al, 1997). Papadopoulos et al (1989) observed variable levels of structural 
chromosome damage, which was later confirmed by Clouston and co-workers (1997), 
including chromosome branching, chromosome breakage, anomalous chromatid 
pairing and apparent interchanges. However, it has been suggested that damage in 
early cell divisions may be a consequence of the ovarian stimulation stage of the IVF 
process rather than a characteristic of early preimplantation embryos per se (Eibling 
and Colot, 1985).
1.2.1.5.2 FISH Studies
Although karyotyping studies of chromosomal abnormalities on human 
preimplantation embryos had already provided important results, it was the advent of 
FISH that enabled the examination of every cell within the embryo that revealed the 
true extent of chromosomal abnormality in human development. The widespread use 
of IVF for treatment of infertility has stimulated research into chromosomal 
abnormalities in human preimplantation embryos. Most of the studies on embryos 
have been carried out using FISH. Nowadays, several FISH protocols have been 
devised for complex translocations (Simopoulou et al, 2003) as well as aneuploidy 
detection of up to 13 chromosomes (Abdelhadi et al, 2003). FISH studies have been 
able to demonstrate that the incidence of aneuploidy, haploidy, polyploidy and 
mosaicism in embryos is much higher than the incidence observed in clinically 
established pregnancies (Bielanska et al, 2002a). FISH has been carried out in 
arrested (Munne et al, 1995a; Bahce et al, 1999), frozen-thawed (Munne et al, 1997; 
Iwarsson et al, 1999) and fragmented (Munne et al, 1994a,b; 1995b) embryos, as well 
as embryos of good quality (Harper et al, 1995; Delhanty et al, 1997; Bielanska et al, 
2000).
An essential part of FISH is its ability to be carried out on the same sample 
sequentially or as it is know in the circles of FISH laboratories, re-FISHing. The need
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for sequential rounds of FISH on the same tissue/cell came about due to the lack of 
fluorescent colours of DNA probes thus the number of chromosomes that can be 
examined simultaneously e.g. in a blastomere is limited to a maximum of five 
(Gianaroli et al, 1997b) or six (Munne et al, 1998c). Liu and colleagues (1998a) were 
able to devise an accurate FISH protocol analysing more than six chromosome in 3 
consecutive FISH rounds in a clinical setting. It has been shown that by using 
centromeric or telomeric probes in all three rounds of FISH, an efficiency of 88-94% 
and 87-96% respectively can be achieved (Liu et al, 1998b).
Delhanty and co-workers (1993) showed that surprisingly even apparently normally 
developing IVF embryos were often chromosomally abnormal, in agreement with the 
original karyotyping data (see section 3.1.1). Several factors have been proposed from 
studies on embryos for this level of abnormality. These factors including maternal 
age, embryo culture conditions (Munne et al, 1995), multinucleation and freezing of 
human embryos (Laverge et al, 1998), ovarian stimulation regimes and patient 
specificity (Ruangvutilert et al, 2000a) have been shown to affect chromosomal 
constitution of embryos. Almost all studies carried out on preimplantation embryos 
regarding chromosome abnormalities have tried, through their FISH results, to explain 
the mechanisms behind these aberrations. Staessen et al (1998) whilst analysing the 
genetic constitution of multinuclear blastomeres using M-FISH, revealed that more 
than half of bi-or multinuclear blastomeres were abnormal, however, 45% of the those 
blastomeres had a diploid status.
1.2.1.5.3 CGH Studies
More recently high rates of aneuploidy have been reported whilst applying metaphase 
CGH in human preimplantation embryos (Wells and Delhanty, 2000; Voullaire et al, 
2000; Wilton et al, 2001; Malmgrem et al, 2002; Voullaire et al, 2002; Wilton et al, 
2003; Trussler et al, 2004) as well as polar bodies and Mil oocytes (Wells et al, 2002; 
Gutierez-Mateo et al, 2004). CGH on single cells from human preimplantation 
embryos has been performed and has provided the opportunity to assess the copy 
number of all chromosomes and thus the genuine abnormality and mosaicism level at 
this stage (Wells and Delhanty, 2000).
The application of single cell CGH, although being laborious, provides the 
opportunity to assess all the chromosomes and thus identify the true level of
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mosaicism (Wells and Delhanty, 2000, Voullaire et al, 2000, Wilton et al, 2001; 
Trussler et al, 2004). CGH has allowed the investigation of chromosomal aberrations 
in human preimplantation embryos generated by IVF. Wells and colleagues (1999) 
revealed a WGA protocol that was powerful enough to generate sufficient quantities 
of DNA from a single cell to perform CGH as well as >90 independent amplification 
reactions. Instantly, two published studies showed the extent of chromosomal 
abnormalities in preimplantation human embryos. Voullaire et al (1999) obtained 
results for 63 blastomeres from 12 cleavage stage embryos and found that the 
proportion of chromosomally normal embryos was 25%, lower than that found from 
FISH studies (Delhanty et al, 1997; Munne et al, 1998d). Wells and Delhanty (2000), 
in a similar study found high levels of chromosomal mosaicism, non-mosaic 
aneuploidy, and chromosome brakeage. Furthermore, it was postulated that there was 
a low number of uniformly normal embryos (normal chromosome numbers in every 
cell), which may have superior developmental potential, but their low frequency 
might explain the relatively low success rates in assisted conception in humans (Wells 
and Delhanty, 2000). In a recent study which combined CGH and FISH, the high 
numbers of abnormal embryos were thought to have arisen as a result of culture 
artefact or inadequate cell cycle surveillance, rather than meiotic error (Trussler et al, 
2004). CGH has also been performed in the context of PGD for aneuploidy screening 
(see section 1.5.2.3).
1.2.1.5.4 SKY-FISH and M-FISH
To overcome the limitations of FISH, it has been suggested that metaphase 
transformation by cell fusion would allow the differentiation between normal, 
balanced and unbalanced karyotypes (Munne and Cohen, 1998). Methods to obtain 
metaphase stage chromosomes by interphase conversion have been published by two 
teams. They are based on the fusion of blastomeres to bovine eggs or mice zygotes 
(Verlinsky and Evsikov, 1999; Willadsen et al, 1999). The Willadsen approach has 
been used for two PGD clinical cases for translocations resulting in chromosomally 
normal offspring (Willadsen et al, 1999) whereas the Verlinsky and Evsikov approach 
has been performed in the context of clinical PGD in 19 patients (Verlinsky and 
Evsikov, 1999). The methodology of Verlinsky and Evsikov (1999) was performed by 
fusing individual human blastomeres with enucleated or intact mouse zygotes. After 
blastomere-cytoplasm fusion, heterokaryons were fixed at metaphase of the first
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cleavage division or treated with okadaic acid to induce premature chromosome 
condensation. The effectiveness of the proposed technique with blastomeres from day 
3 diploid embryos was reported to be 91%, since 63 metaphases were obtained from 
69 blastomeres (Verlinsky and Evsikov, 1999). However, interphase conversion is 
extremely labour intensive and has to provide an interpretable metaphase spread from 
a single cell, which in turn will render a number of metaphases unsuitable due to poor 
chromosome morphology, overlapping chromosomes and even loss of chromosomes 
(Harper and Wells, 1999). Furthermore, this technique might cause ethical tension in 
some countries where it would be impossible to fuse human blastomeres or polar 
bodies with enucleate oocytes from other species (Harper and Wells, 1999).
Multiplex-FISH (M-FISH) (see section 1.3.2.2.2) and spectral karyotyping are whole 
genome screening techniques that have been successfully applied for cytogenetic 
diagnostics of constitutional chromosomal abnormalities (Speicher et al, 1996; 
Schrock et al, 1996; 1997). Both techniques utilise 24 chromosome-specific paint 
probes labelled with different combinations of fluorochromes, thus all chromosomes 
can be analysed at one time. Schrock et al (1996) employed a dedicated custom- 
designed imaging spectrometer system, in a method known as spectral karyotyping or 
SKY-FISH. This finely samples each pixel for all fluorescence across the spectrum 
simultaneously producing a set of interferograms, before data processing to form a 
spectral image. Analysis is based on comparison of the interference pattern for each 
pixel with stored data on chromosome interference spectra; the pixel is then allocated 
to a matching chromosome (Schrock et al, 1996). SKY-FISH has been employed to 
successfully identify particular de novo supernumerary marker chromosomes as well 
as de novo unbalanced structural rearrangements, proving to be of beneficial role for 
diagnostic and counselling purposes, due to its reliability and speed (Haddad et al,
1998). SKY-FISH has already been used to examne chromosomes from oocytes and 
polar bodies (Marquez et al., 1998). Sandalinas et al (2002), whilst carrying out SKY- 
FISH on fresh non-inseminated oocytes found increased non-disjunction, increased 
balanced and unbalanced predivision in the group of patientsars of over 35 years of 
age, Furthermore, all types of metaphase spreads, including metaphases obtained after 
nuclear conversion, can be analysed with M-FISH or SKY-FISH. Hence, SKY-FISH 
was the preferred method to analyse blastomeres and polar bodies where the nucleus
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had been converted to a metaphase (Evsikov & Verlinsky, 1999; Willadsen et al.,
1999).
However, both SKY-FISH and M-FISH require expertise and are unable to detect 
small deletions, duplications and translocations (Kirchhoff et al, 2000). Also, they are 
relatively time-consuming and fail to yield metaphase chromosomes of suitable 
quality for routine diagnostic purposes. Ultimately, a method capable of a full 
chromosome analysis in single cells without the need for metaphases has been 
devised, based on the technique known as comparative genomic hybridisation (CGH).
1.2.2 Single-Gene Defects
Analysis of syndromes with Mendelian inheritance patterns has identified over 7000 
single-gene defects. They are categorised as autosomal dominant (>3000), autosomal 
recessive (>3000) and X-linked disorders (>1000). A series of these mutations would 
be expected to affect the function of essential housekeeping genes and may therefore 
be lethal either in preimplantation development following the initiation of embryonic 
gene transcription and loss of maternally inherited products or in post-implantation 
development. Most de novo mutations causing inherited disease are paternal in origin 
(McKusick, 1992). This is thought to be related to differences between
spermatogenesis and oogenesis. Since, in the females, the mitotic expansion of
primordial germ cells continues until the late gestation when oogonia enters meiosis
and arrest at the dictyate stage of meiosis I until menstrual cycles are initiated at
puberty (see section 1.1.1.2). However, in males mitotic division of spermatogonia is 
continuous throughout life (see section 1.1.1.1). Therefore, the number of mitotic 
divisions preceding gametogenesis is much greater in the male which consequently 
may increase the risk of replication errors (Delhanty and Handyside, 1995).
An autosomal dominant trait is one which manifests in the heterozygous state, i.e. in a 
person possessing both the abnormal or mutant allele and the normal allele. 
Dominantly inherited diseases are generally caused by mutations resulting in gain of 
function protein alterations (Ranum and Day, 2002). Autosomal dominant traits can 
involve only one organ or part of the body and can have a multisystemic effect 
(pleiotropy) which has been seen in myotonic dystrophy (Ranum and Day, 2004) as
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well as tuberous sclerosis (Ess et al, 2005). During this study a triplet repeat dominant 
disorder will be discussed, namely myotonic dystrophy 1.
1.2.2.1 Myotonic Dystrophies
Steinert as well as Batten and Gibb in 1909 identified myotonic dystrophy (DM [MIM 
160900 and MIM 602668]) as a multisystemic disorder. Myotonic dystrophy (DM1) 
also know as dystrophia myotonica is the most common form of inherited muscular 
dystrophy seen in adults, with an overall incidence of approximately 1 in 8000 (Shaw 
and Harper, 1989). DM1 shows autosomal dominant inheritance with anticipation 
and an early onset form with rather different clinical features. The clinical picture of 
DM1 is well established but exceptionally variable (Harper, 1989). One of the striking 
features of this disorder is the variability of phenotype both within and between 
families (Harper, 1989).
Shortly after genetic testing became available, a second multisystemic disorder was 
identified referred to as either proximal myotonic myopathy (PROMM) or myotonic 
dystrophy type 2 (DM2) (Ricker et al, 1994; Thornton et al, 1994). The DM2 
mutation was linked to a 3cM region of the 3q21 and it is caused by a transcribed but 
untranslated CCTG repeat expansion located in intron 1 of the zinc finger protein 9 
(ZINF9) gene (Ranum et al, 1998; Liquori et al, 2001).
During this study only DM1 was investigated therefore for simplicity DM1 will be 
referred to as DM.
1.2.2.1.1 Clinical Pathology of DM
In contrast to most forms of muscular dystrophy, in individuals suffering from DM 
the clinical features are not limited exclusively to the neuromuscular system. Patients 
with DM have been found to suffer in other organs in addition to myopathy i.e. bone, 
skin, eyes, gastrointestinal organs and the endocrine system. Most commonly persons 
with DM present in their adult life with slowly progressive weakness and myotonia. 
The latter term refers to tonic muscle spasm with prolonged relaxation, which can 
manifest as a delay in releasing the grip of shaking hands. Other clinical abnormalities 
can include cataract, cardiac conduction defects, disturbed gastrointestinal peristalsis,
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frontal balding and testicular atrophy. The age of onset can be very variable and the 
disorder usually runs a benign course. In the congenital form affected babies present 
at birth with hypotonia, talipes and respiratory distress, which can prove life 
threatening (Harper, 1975). Children who survive tend to show a lack of facial 
expression with delayed motor development and mild retardation. The congenital 
form of DM is mostly maternally transmitted (Brook et al, 1992; Zeesman et al,
2002). The phenomenon of anticipation in which the disease symptoms become more 
severe and age at onset earlier in successive generations, is often manifested in a 
family producing a congenitally affected child (Brook et al, 1992).
Early diagnosis is based on clinical symptoms including myotonia, muscular 
weakness and atrophy, cataract and hypogonadism. In contrast to other dystrophies, 
DM attacks the distal and then proximal muscles of extremities. Originally the 
diagnosis of DM patients was based on electromyography, which has now been 
superseded by mutation analysis (Shaw and Harper, 1989).
1.2.2.1.2 Genetics of DM
Initial biochemical studies failed to identify the defective protein in DM, although 
some have highlighted a link with abnormalities in calcium transport (Seiler and 
Kuhn, 1970), membrane fluidity (Butterfield et al, 1974) as well as apamin receptor 
expression (Renaud et al, 1986). It was Brook and colleagues (1992) that employed 
positional cloning strategies in order to identify the CTG triplet repeat that undergoes 
expansion in DM patients.
The molecular genetic defect of DM involves an unstable expansion of a CTG repeat 
at the 3’ untranslated region (exon 15) of the DM gene on the long arm of 
chromosome 19 (19q 13.3) (Brook et al, 1992; Fu et al, 1992). The number of repeats 
relates to the age of onset and the severity of the disease (Harley et al, 1993). Normal 
individuals possesses 5-35 repeat copies, patients with 36-49 copies are said to have 
the premutation, patients with 50-150 copies are mildly affected, patients with 100- 
1,000 copies are severely affected and the most severe or neonatal form have 2,000 
copies or more [The International Myotonic Dystrophy Consortium (IDMC), 2000]. 
The mutant gene is almost always transmitted from the mother; however, paternal 
transmission cases have been reported (Nakagawa et al, 1994; de Die-Smulders et al,
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1997). Variation in the DM triplet repeat has been observed in sperm and somatic 
cells of the same individual (Jansen et al, 1994), between muscle and lymphocyte 
cells (Anvret et al, 1993) as well as in affected identical twins (Dubel et al, 1992). 
The length of the expanded CTG repeat remains fairly homogenous in different 
tissues during embryonic development (Mankodi and Thornton, 2002). However, 
during postnatal life a marked variability of repeat length emerges in different cells 
and tissues of an individual (Thornton et al, 1994). This somatic heterogeneity has 
been found to increase with age (Thornton et al 1994). During PGD cases for DM 
significant increases have been found in the number of repeats in embryos from 
affected female patients and in their immature and mature oocytes, whereas, in 
spermatozoa and embryos from affected male patients, smaller increases have been 
detected (De Temmerman et al, 2004).
The estimated risk of any heterozygous woman with DM to have a congenitally 
affected child is 4-9%, though the risk is significantly increased during conception of 
a second child to 20-37% (Koch et al, 1991). Another feature of DM is the reported 
tendency for healthy individuals who are heterozygous for DM alleles in the normal 
size range to preferentially transmit alleles which are greater than 19 CTG repeats in 
size (Magge and Hughes, 1998). Such phenomenon might help maintain the mutant 
DM alleles in the population. However, recently Zunz et al (2004) found no evidence 
of statistically significant deviation of the frequency of transmission of the mutated 
alleles from the 50% expected in autosomal dominant disorders and suggested that 
previous studies showed ascertainment bias.
1.2.2.1.3 The Myotonin-Protein Kinase
The myotonin-protein kinase (DMPK) gene, which consists of 15 exons occupying 
over 13,000 bases of genomic DNA, encodes a polypeptide of 624 amino acids that 
functions as a member of a protein kinase family (Shaw et al, 1993). At present it is 
not known how or indeed if the DMPK gene causes muscular weakness or other 
clinical problems. This is due to the fact that the expanded repeat lies in the 3’ 
untranslated region of the DMPK gene, a region that is transcribed into RNA, but not 
translated into protein. Rather surprisingly it has been demonstrated in mice that the 
over-expression and under-expression of the DMPK gene does not display the typical 
features of DM (Harris et al, 1996). However, it has been suggested that the RNA
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produced by the mutant DMPK gene may influence the cellular processing of RNA 
produced by other genes i.e. the gene encoding DM locus-associated homeodomain 
protein (DMAHP) which is located immediately downstream to the CTG repeat 
(Harris et al, 1996). It has been recently proposed that the RNA produced from the 
mutant DMPK gene has a toxic effect on muscle cells (Mankodi et al, 2000). Cell 
culture models have been used to demonstrate that mutant DM mRNA takes on a 
gain-of-function and inhibits myoblast differentiation (Amack et al, 1999). Although 
the molecular mechanism(s) by which this mutant mRNA disrupts myogenesis is not 
fully understood, recent findings suggest that anomalous RNA-protein interactions 
have downstream consequences that compromise key myogenic factors (Amack and 
Mahadevan, 2004). Several studies have attempted to determine the effects of the 
expansion in nearby genes. Fillipova et al (2001) suggested that changes in chromatin 
structure, and the resulting misregulation of genes in the vicinity could be relevant to 
the defects of muscle and brain development that occur in congenital DM patients.
1.2.2.1.4 Mechanisms of DM Pathogenesis
Most dominant disorders are caused by the expression of an abnormal protein with an 
altered function, it has not been clear how the multisystemic clinical features of 
dominantly inherited DM could be caused by a trinucleotide repeat that did not affect 
the protein coding portion of a gene (Tapscott, 2000). Four different mechanisms have 
been proposed for the explanation of the DM pathogenesis (Ranum and Day, 2004):
1. Haploinsuffiency o f DMPK; Earlier studies suggested that alteration of the DMPK 
expression might cause the multisystemic features of the disease (Fu et al, 1992), 
however, studies in DMPK knockout mice showed only a very mild, late-onset 
myopathy (Jansen et al, 1996).
2. Haploinsuffiency o f SIX5 and Neighboring genes: A second mechanism is that the 
expanded repeat affects the expression of multiple genes in the region. It has been 
proposed that the mutation interferes with expression of multiple genes in the DM1 
region, possibly through regional effects produced by repeat-induced alterations in 
chromatic structure (Otten and Tapscott, 1995). Studies using Six5 knockout mice 
provided some support to this mechanism (Klesert et al, 2000) however was not 
conclusive.
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3. RNA pathogenesis: Another proposed mechanism has been that the enlarged CUG- 
containing transcripts accumulate as intranuclear foci and disrupt cellular function 
which came from a transgenic mouse model (Mancodi et al, 2000).
4. Additive model: This model of DM1 has been suggested where all the above 
mechanisms contribute to disease pathogenesis (Larkin and Fardaei, 2001).
1.3 Molecular Cytogenetic Techniques
Extensive research in the field of chromosome analysis has lead to constant 
development of laboratory techniques available to detect abnormalities. Nowadays, 
scientists demand techniques to be powerful, accurate, reproducible and able to 
provide results in the shortest amount of time possible. Clinical cytogenetics is the 
study of chromosome structure and behaviour in relationship to clinical syndromes. 
Karyotyping was the first technique allowing analysis and identification of all 23 pairs 
of chromosomes with respect to number and morphological structure. Karyotyping is 
still considered the most widely applicable technique in clinical and research 
cytogenetics. Fluorescent in situ hybridisation (FISH) is a relatively novel technique, 
which combines cytogenetics and molecular technology. FISH combines DNA 
hybridisation techniques with fluorescent microscopy, allowing direct visualisation of 
a specific DNA sequence onto metaphase chromosomes, interphase nuclei or DNA 
strands. The combination of FISH and karyotyping has lead to the development of 
innovative techniques such as spectral karyotyping (SKY-FISH) (Schrock et al, 1996) 
and multi-fluorochrome karyotyping (M-FISH) (Speicher et al, 1996) (see section 
4.1). The Polymerase Chain Reaction (PCR) using oligonucleotide primers and a 
thermostable DNA polymerase (Saiki et al, 1985), is another key technique designed 
to enrich a DNA sample for a specific fragment, amplifying it to a level at which it 
can be visualised and subjected to further genetic analysis. However, the most novel 
technique which has united traditional cytogenetics and modem molecular techniques 
is comparative genomic hybridisation (CGH). CGH allows in a single hybridisation 
the copy number of all 23 pairs of chromosomes to be assessed in situations that do 
not allow standard methods of chromosomal analysis to be used (Kallionemi et al, 
1992).
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1.3.1 Karyotyping
1.3.1.1 Karyotyping Principles
Tijo and Levan in 1956 discovered that the normal human somatic cell contains 46 
chromosomes rather than 48. The methods they used, with certain modifications, are 
now employed in all cytogenetic laboratories to analyse the chromosome constitution 
of an individual, known as a karyotype. Any tissue with living nucleated cells which 
undergoes division can be used to study human chromosomes. These cells are 
cultured with nutrients for 3 days to stimulate the T lymphocytes (for whole blood), 
chorionic villi (for CVS) and amniotic fluid cells to divide e.g. phytohaemogglutinin. 
While in culture, colchicine is added to prevent the formation of the spindle, thus 
arresting cell division during metaphase. During metaphase the chromosomes are 
maximally condensed and therefore more easily visible.
There are several different staining methods that can be utilised to identify individual 
chromosomes: 1) G or Giemsa banding is the most common method used. The 
chromosomes are treated with trypsin, denaturing their protein content and giving 
each chromosome a characteristic pattern of light and dark bands. 2) Q or Quinacrine 
banding gives a similar banding pattern to G-banding and requires examination of the 
chromosomes under ultraviolet fluorescence. 3) R or Reverse banding shows reverse 
light and dark banding patterns to G-banding since the chromosomes are heated 
before staining. 4) C or Centromeric Heterochromatin banding preferentially stains 
highly repetitive DNA sequences such as centromeres and heterochromatic regions, 
by treatment of chromosomes with acid followed by alkali prior to G-banding.
1.3.1.2 Karyotyping Applications
Karyotyping has been widely used in prenatal diagnosis for genetic analysis of 
amniocentesis and chorionic villus sampling (CVS) in high risk women. Karyotyping 
is widely in the analysis of different types of cancers e.g. sarcoma (Ravi and Wong, 
2006), leukaemia (Scandura, 2005) and myelomas (Schilling et al, 2005) 
Furthermore, it has been used for research purposes on oocytes, polar-bodies, 
spermatozoa and embryos (Martin et al, 1986; Plachot et al, 1988; Zenzes et al, 1991; 
Jamieson et al, 1994; Clouston et al, 1997; 2002). Karyotyping was amongst the first
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technique to be used for embryo analysis. Karyotyping has been used extensively for 
investigating the mechanisms of nondisjunction in human oocytes and polar bodies.
1.3.1.3 Technical Limitations of Karyotyping
Karyotyping provides valuable information at the research and diagnostic level. 
Karyotyping has been considered the ‘mother of all techniques’. However, technical 
difficulties have created the need to develop newer and superior techniques. 
Problematic fixation methods resulting in loss of chromosomes and over dispersed or 
poorly spread cells which are not in a single focal lane restricting the potential of 
analysis are the main disadvantages (Martin et al, 1996). Moreover, long colcemid 
exposure times are able to increase the mitotic index but this produces highly 
contracted chromosomes that exhibit chromatid separation and G-band poorly 
compromising the information obtained (Jackson et al, 2002). Furthermore, 
karyotyping for prenatal diagnosis requires the isolation of metaphase chromosomes 
and takes 7-10 days for a final result (Reid et al, 1992), which can increase the 
emotional burden on the patient (Goel et al, 1998). The most important limitation 
during G-banding is that only a few metaphases can be obtained hence only a small 
proportion of the cells can be analysed. In the study of preimplantation embryos basic 
technical difficulties of handling individual embryos compromises the potential 
quality of preparations and hence limits the amount of information that can be gained 
(Harper et al, 1995).
1.3.2 FISH
1.3.2.1. FISH Principles
The combination of chromosome banding techniques with the revolutionary technique 
of in situ hybridisation has aided in the research and diagnosis of structural 
abnormalities not previously possible. In situ hybridisation was first introduced in 
1969 using radiolabelling detection (Pardue and Gall, 1969; John et al, 1969). In 
1986, Pinkel et al and Cremer et al reported FISH using non-radioactively labelled 
probes. Fluorescent in situ hybridisation (FISH) is a molecular cytogenetic technique 
for enumerating chromosomes combining DNA hybridisation techniques with 
fluorescent microscopy. FISH utilises fluorescently labelled DNA probes, which are 
essentially single stranded DNA fragments capable of binding to their complementary
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sequences in an interphase nucleus or a metaphase spread that are fixed and located 
on a microscope slide (Pinkel et al, 1986; Tonnies, 2002) (Figure 1.5).
Figure 1.5. Illustration of a FISH probe
FISH probes are quite sensitive DNA molecules being able to detect regions as small 
as 0.5 kb on metaphase chromosomes (McNeil and Ried, 2000). Cloned DNA 
fragments are usually the constitution of FISH chromosomal probes, which are 
characterised by the ability to anneal only to their complementary DNA sequences 
(Pinkel et al, 1986). Probes employed for FISH can be directly or indirectly labelled. 
The indirectly-labelled probes are labelled with a hapten such as biotin and 
digoxygenin, which are detected using affinity reagents labelled with fluorophore- 
linked immunoglobin reagents. This immunocytochemical detection of ‘indirectly- 
labelled’ probes allows the flexibility to amplify a weak FISH signal, necessary by 
sequential applications and is especially useful for visualising smaller probes. 
However, indirect labelling is a time-consuming process with non-specific 
background fluorescence potentially making interpretation difficult. The development 
of directly labelled probes, where the fluorochrome is attached to the probe itself, 
reduced the time-frame of the FISH experiments and further improved the specificity 
of the fluorescent detection (Wiegant et al, 1993). The most common fluorophores 
include those based on fluorescein (green) or rhodamine (red), although this selection 
has widened considerably in the last few years with the introduction of a new 
generation of commercial fluorophores such as the Cyanine, Blue, and Gold dyes 
(Yurov et al, 1996).
A single-stranded DNA fragment, 
tagged with fluorescent molecules, 
which is able to bind to its 
complementary sequence on a 
chromosome
(www.google.com/images)
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There are three types of probes that are used in FISH with respect to their size,
location and how they bind onto the chromosome.
a. Locus specific probes (Figure 1.6a), are probes able to bind to a unique sequence 
of a particular chromosome. Often called band-specific, they require more than six 
hours to hybridise and can be used in interphase and metaphase nuclei. Depending 
on the type of clone, these probes may range from small cDNA fragments in 
plasmids, to much larger blocks of genomic DNA in YACs. When using probes 
containing unique DNA sequences (as well as repetitive non-specific sequences) 
suppression of the hybridisation of the non-chromosome specific repetitive DNA 
is accomplished by chromosome in situ suppression (CISS) using co-hybridisation 
with labelled probe and unlabelled repetitive sequences (Lichter et al, 1988). 
Currently, CoT-1 [coefficient of temperature (Ekong and Wolfe, 1998)] DNA is 
added to the probe DNA, binding and blocking the repeat sequences and 
consequently allowing the probe to bind to the unique sequence that it targets.
b. Repetitive probes (Figure 1.6b&c), bind to repetitive sequences located in the 
centromeric, heterochromatic and telomeric regions of a chromosome. These 
include the widely used a-satellite/centromeric probes (b), which hybridise 
specifically to the centromeres of individual chromosomes (Willard, 1985). 
Heterochromatic probes include those binding to the heterochromatin usually 
situated below the centromere, seen in chromosomes 1, 9 and Y. Telomeric probes 
specifically recognize the repetitive sequence TTAGGG, and can be used for the 
simultaneous identification of all telomeres. They can be used in interphase and 
metaphase chromosomes and require only one hour to hybridise. The signals 
obtained are very bright and the whole FISH procedure can be performed within 
two hours (Harper et al, 1994c)
c. Chromosome paints (Figure 1.6d), paint the whole chromosome and can only be 
used in metaphase preparations. They contain a cocktail of DNA sequences 
hybridising to an entire chromosome or chromosome arm and are derived either 
from a pool of clones picked from a chromosome specific library (Fuscoe et al, 
1989) or from flow-sorted chromosomes amplified by PCR (Vooijs et al, 1993).
d. Whole genome probes. Label the whole chromosome whilst the cells are in 
metaphase in one fluorescent colour either red or green. These types of probes are 
widely used whilst carrying out CGH on metaphase chromosomes.
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Figure 1.6. Different types of FISH probes.
(a) Locus-specific 
probe
J i
Us
»
* %
(b) Centromeric 
probe
(c) Sub-telomeric 
probe
(d) Chromosome paint 
probe
(a) Illustration of a locus-specific probe labelled in Spectrum Green; (b) Illustration of 
a centromeric probe labelled in Spectrum Orange. Illustration of two sub-telomeric 
probes; one for the short arm and one for the long arm, labelled in Spectrum Green 
and Spectrum Orange respectively and (c) Illustration of chromosome paint. (Harper, 
etal, 2000)
FISH protocols vary between laboratories; however the same basic principles apply. 
The tissue/cells are obtained and placed on a microscope slide by some sort of 
fixation, either by methanol/acetic acid fixation or by applying adhesive agents on the 
actual slide prior to fixation. The slide with the tissue/cells is pre-treated with 
proteolytic enzymes and /or RNase digestion which render the nucleus of the sample 
accessible to the DNA probe. Denaturation of the slide and probe follows, causing the 
double DNA strands to separate. The sample is then left to re-anneal under optimal 
conditions, the length of time depending on probe type. The stringency with which the 
probe binds is controlled during post-hybridisation treatment by varying the 
temperature, ionic strength and concentration of formamide washes to destabilise and 
remove imperfectly base-paired probe/target duplexes. In this way only probe bound 
stably to its complementary target remains. After hybridization the slide is observed 
under ultraviolet light of the proper wavelength, and any region where the labeled 
DNA fragment has bound fluoresces. The scoring criteria that are most frequently 
applied are adopted from Hopman et al (1991) which state that signals must be a 
minimum of a signal’s width apart in order to be scored as 2 individual signals.
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1.3.2.2. FISH Applications
1.3.2.2.1 Interphase FISH applications
FISH has allowed chromosome enumeration to be performed on interphase nuclei 
without the need for culturing cells or preparing metaphase spreads. Therefore, the 
FISH technique has overcome the problems that have arisen during karyotypic 
analysis and it has been possible to investigate the presence of specific numerical and 
structural abnormalities in sperm, oocytes, and embryos as well as prenatal samples 
(chorionic villi and amniotic fluid). FISH has allowed the study of the level of 
chromosomal abnormalities and understanding of the mechanisms of chromosomal 
mosaicism in human preimplantation embryos (see section 1.6), a phenomenon 
whereby two or more cell lines are present in a tissue, which differ in their genetic 
constitution but are derived from the same zygote.
The growing availability of commercially produced probes and probe-cocktails has 
enabled FISH to become an outstanding routine diagnostic tool in the cytogenetic 
laboratory. The wide selection of existing centromeric probes allows determination of 
chromosome-specific ploidy on solid tumours, fresh or archived biopsy specimens, 
and on cultured and uncultured preimplantation, prenatal, postnatal and hematologic 
samples. In malignant solid tumors, genomic imbalances resulting from either gains 
or losses of whole chromosomes or segments of chromosomes are frequently 
observed using FISH. FISH has enabled the observation and further understanding of 
how the presence of the large genomic abnormalities are believed to contribute to the 
disease phenotype by alteration of normal patterns of gene expression. Examples of 
these genomic aberrations include the aneuploidy seen using FISH in breast, bladder 
and prostate tumors (Hopman et al, 1991; Comelisse et al, 1992) as well as 
chromosomal rearrangements seen in hematopoietic cancers (Hilgenfeld et al, 1999).
In gynaecology and fetal medicine, multicolour FISH has assisted in investigating 
fertility for example in women with endometriosis (Shin et al, 1997) and men 
suffering from Klinefelter’s syndrome (Guttenbach et al, 1997) where both conditions 
cause infertility. The chromosomal constitutions of these patients were analysed by 
FISH in an attempt to attain causes of the infertile status o f these patients. 
Furthermore, the effects of clinical treatment such as chemotherapy or radiotherapy
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on chromosomes has been examined by FISH, whereby a sperm sample was taken 
before and after treatment and its effects of studied (Monteil et al, 1997).
The FISH technique has been found to be highly effective for rapidly determining the 
number of specified chromosomes in interphase cells. FISH thus seemed to be 
especially appealing for the prenatal detection of chromosomal aberrations. The first 
developed probes were derived from DNA of flow-sorted whole chromosomes and 
used for prenatal diagnosis of trisomy 13, 18 or 21 by Kuo et al (1991) on uncultured 
amniotic fluid cell nuclei. Interphase FISH with a specific probe set for familial 
rearrangements also allows rapid exclusion of an unbalanced translocation in the fetus 
of a balanced translocation carrier (Kilby et al, 2001).
Aneuploidy and chromosomal rearrangements diagnosed by FISH can be performed 
on preparations made from around 1.0-1.5ml of amniotic fluid or chorionic villus 
samples (sections 1.4.1 and 1.4.2). Many prospective studies have been carried out 
examining the efficacy and accuracy of the FISH probes and subsequently the FISH 
technique and have revealed more than 90% accuracy (Hulten et al, 2003). The most 
significant point of doing this is a rapid diagnosis without having to wait for culture 
and karyotype. It has also been shown the risk of over- or under-diagnosis of 
aneuploidy for the target chromosomes is limited by interphase FISH compared to the 
‘gold standard’ o f karyotyping. FISH on uncultured interphase amniocytes and 
chorionic villus cells, might aid diagnosis of constitutional mosaicism (Feldman et al, 
2000). Quilter et al (2001) stipulated that interphase FISH may be of special 
advantage with respect to the problem of confined placental mosaicism in chorionic 
villus sample.
1.3.2.2.2 Metaphase FISH applications
Speicher et al, (1996) attempted combinatorial labelling of twenty-four chromosome 
paints using five fluorophores, reporting the first study of Multiplex-FISH (M-FISH). 
Following hybridisation, a monochrome CCD camera with multiple optical filters was 
used to capture each channel sequentially before merger to form a final image. The 
basis for M-FISH analysis depends on the presence or absence of probe signal for 
each fluorophore at each pixel that is then compared to the labelling strategy to 
identify the chromosome (Speicher et al, 1996). However, many groups have tried to
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maximise the number of probes that can be used employing combinatorial or Boolean 
labelling i.e. combining labelled probes in different proportions much earlier that 
1996. Nederlof and colleagues (1990) attempted FISH utilising three fluorophores to 
detect four chromosomes and Wiegant et al (1993) developed combinatorial labelling, 
to the detection of six loci on a single chromosome. Combinatorial labelling remains a 
strategy that although in theory many combinations are possible, in practice the 
number of combinations is dependent on the sensitivity of the imaging system.
Chromosomal microdeletions are associated with a number of syndromes including 
Di-George and Williams syndromes. Microdeletion probes consist of a probe specific 
for the locus or region of deletion associated with the microdeletion syndrome, as well 
as a control probe for accurate identification of the chromosome of interest. Their use 
has proved very useful for the detection of a range of microdeletion syndromes, 
providing rapid same-day results (Ligon et al, 1997). Idiopathic mental retardation 
accounts for approximately 36% of the moderately to severe handicapped population 
and are associated with subtle subtelomeric chromosomal rearrangements (Raynham 
et al, 1996). Although these abnormalities remain undetected by traditional 
cytogenetics, they can be readily detected using a panel of FISH probes specific for 
the subtelomeric regions of all non-acrocentric chromosomal arms (Knight et al, 
1999)
I.3.2.3. Technical Limitations of FISH
FISH has been hailed as one of the most robust and efficient techniques however, it 
has certain limitations. There are conflicting reports as to the true sensitivity and 
specificity of FISH diagnoses with ranges of diagnostic accuracy reported between 
70-98% (Christensen et al, 1993; Ward et al, 1993; Pergament et al, 2000). The 
availability of FISH probes has increased in recent years but it is still not possible to 
obtain probes that cover all different parts of chromosomes rendering some specific 
chromosomal rearrangements impossible to diagnose. FISH is unable to distinguish 
between samples of balanced and normal chromosomal complements in structural 
aberrations in interphase nuclei (Warburton, 1991; Conn et al, 1998). The lack of 
fluorescent dyes also limits the scope of diagnosis since not many different 
chromosomes can be analysed simultaneously.
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1.3.3 Polymerase Chain Reaction
1.3.3.1 PCR Principles
In 1983, Dr Kary Mulis conceived a novel concept of performing a test-tube process 
of repetitive DNA synthesis, termed polymerase chain reaction (Mulis et al, 1986; 
Mulis, 1990). The polymerase chain reaction (PCR) is used to amplify a sequence of 
DNA using a pair of oligonucleotide primers each complementary to one end of the 
DNA target sequence. These are primers extended towards each other by a 
thermostable DNA polymerase in a reaction cycle of three steps: denaturation, primer 
annealing and polymerisation or primer extension. PCR is a powerful molecular 
technique for quickly amplifying a particular DNA fragment to a stage that can be 
further analysed by other methods (Saiki et al, 1985). The success of PCR in 
achieving this objective has enabled it to become one of the most important methods 
in genetic testing having numerous applications in basic research and medicine.
The first step, denaturation, is able to separate the two strands. The temperature is 
then reduced depending on the primer length and sequence to allow the specific 
primers to anneal. After annealing, the temperature is increased for optimal 
polymerisation which uses a mix of deoxynucleoside 5’-triphospates (dNTP’s) and a 
polymerase, which are substrates for DNA synthesis and Mg2+. In the first 
polymerisation step, the target is copied from the primer site for various distances on 
each target molecule until the beginning of cycle 2, when the reaction is heated up 
again in order to denature the newly synthesized molecules. In the second annealing 
step, the other primer can bind to the newly synthesized strand and during 
polymerisation can only copy till it reaches the end of the first primer. Therefore, at 
the end of cycle 2, some newly synthesized molecules of the correct length exist. The 
successive cycles of DNA synthesis result in an exponential amplification of the 
target DNA sequence leading to a 105-106-fold increase in the amount of target DNA. 
If the PCR technique is 100% efficient, one target molecule would become 2n after n 
cycles. In practice, 20-30 cycles are carried out for a PCR experiment, however, 
during single-cell PCR up to 50 cycles have been reported (Piyamongkol et al, 
2001a).
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PCR primers usually need to be about 18-30 base pair long (bp) and to have similar 
G+C contents in order to anneal to their complementary sequences at similar 
temperatures. The primers are designed to anneal on opposite strands of the target 
sequence so that they will extend towards each other by addition of nucleotides to 
their 3’-ends. Short target sequences amplify more easily, so often this distance is less 
than 500bp, however, with optimisation, PCR can amplify fragments over lOkb in 
length (Reiss and Cooper, 1990).
Thermostable DNA polymerases have been mostly isolated and cloned from a number 
of thermophilic bacteria. The most common is Taq polymerase, which is isolated from 
Thermus Aquaticus. It survives the high temperature denaturation step, usually 95°C, 
having a half-life of more than two hours at this temperature. However, Taq 
polymerase is known to introduce errors when it copies DNA since it does not have 
associated 3’ to 5’ proofreading exonuclease activity. Therefore, other thermostable 
DNA polymerases have been introduced with greater accuracy including 
AmpliTaq™.
1.3.3.1.1 Multiplex PCR
The technique of amplifying multiple loci concurrently is termed multiplex PCR 
(Findlay et al, 1995a, b; Peril et al, 1996; Sherlock et al, 1998). This can facilitate the 
diagnosis of a specific genetic disease or of multiple diseases since it provides 
information for multiple loci at the same time. One example of multiplex PCR in a 
non-single-cell PCR is the amplification of nine regions of the DMD gene in a single 
reaction (Chamberlain et al, 1988). Each multiplex PCR needs to be optimised for the 
combination of primers involved with regard to primer concentrations, annealing 
temperature, the reaction buffer utilised and number of cycles carried out. Multiplex 
PCR is usually achieved using F-PCR, as several primers can be multiplexed together 
employing different fluorescent dyes even if the product ranges overlap each other 
(Kimpton et al, 1993). Strategies for multiplex PCR reactions have been widely 
reported in prenatal (see section 1.4.5) and PGD (see section 1.5.3) setups.
1.3.3.1.2 Whole Genome Amplification
An alternative method to multiplex PCR that can be used for amplification of low 
copy numbers of the entire genome is whole genome amplification (WGA) (Zhang et
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al, 1992; Snabes et al, 1994). With WGA a single genome can be amplified numerous 
times, thus providing sufficient DNA templates for many independent PCR 
amplifications (Wells and Sherlock, 1998). There are three types of WGA described:
Primer Extension Preamplification (PEP) is a WGA technique whereby at least 70% 
and 90% of the genome is amplified more than 30 times according to Zhang et al, 
(1992), and Wells et al (1998) respectively. PEP can be viewed as essentially a pre­
diagnostic PCR treatment, since the PEP product can be subsequently used in a 
further PCR to diagnose a specific disorder. It has been suggested that PEP is 
unsuitable for clinical PGD (Findlay, 2000) (see section 1.6.3.3).
Degenerate Oligonucleotide Primed PCR (DOP-PCR) has also been considered as a 
valuable WGA technique (Telenius et al, 1992). DOP-PCR amplifies a similar 
proportion of the genome to PEP, but to a much more significant level. DOP-PCR 
followed by comparative genomic hybridization (CGH) analysis of tumour DNA has 
been described by several investigators (Speicher et al, 1993; James and Varley, 
1996). A significant drawback of DOP-PCR and of other WGA techniques is that 
amplification of repetitive DNA sequences, such as short tandem repeats is error- 
prone when performed on WGA products (Wells et al, 1998). In some studies over 
50% of fragments amplified are found to differ from their expected size, presumably 
due to slippage of the DNA chain during product generation (Wells and Sherlock,
1998). The low annealing temperatures that characterize all WGA protocols may 
underlie this problem (Wells et al, 1998).
Multiple Displacement Amplification (MDA) is a rolling-circle amplification (Lizardi 
et al, 1998) method that was developed for amplifying large circular DNA templates 
such as plasmid and bacteriophage DNA (Dean et al, 2002). Using <p29 DNA 
polymerase and random exonluclease-resistant primers, DNA is amplified in a 30°C 
reaction not requiring thermal cycling. This is made possible in part by the great 
processivity of (p29 DNA polymerase, which synthesises DNA strands 70kb in length 
(Blanco et al, 1989). Dean and colleagues (2002) showed that MDA-generated DNA 
product is >10kb, and its performance can be demonstrated for a variety of 
applications including single nucleotide polymorphism (SNP) analysis, restriction 
fragment length polymorphism (RFLP), Southern blotting, DNA sequencing as well
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as comparative genomic hybridisation (CGH). However, in the same study the 
capability of MDA was not assessed on single cells. More recently Spits et al (2006), 
was able to carry out 22 locus-specific PCR’s from minute quantities of DNA.
1.3.3.2 Methods of Detection
PCR is designed to enrich a DNA sample for one specific fragment, amplifying it to a 
level where it can be visualised and subjected to further genetic analysis (Wells and 
Sherlock, 1998). The methods of mutation analyses most commonly used are referred 
to as the ‘scanning’ methods, which can be used for diagnostic purposes and applied 
for searching of uncharacterised mutations. Scanning methodologies are optimal for 
diagnosis of inherited disorders caused by a heterogeneous spectrum of mutations.
1.3.3.2.1 Fluorescent PCR
The traditional methods for visualizing PCR products following electrophoresis 
include ethidium bromide or silver staining. Both techniques benefit from nested PCR 
to ensure sufficient amplified fragments for visualization. The utilisation of 
radioactively labelled primers or nucleotides can be employed for visualization for 
greater sensitivity however it has been characterised as a time consuming technique as 
well as harmful. Furthermore, all of the above techniques are limited by their 
qualitative nature, with quantities of DNA as well as products of a similar size being 
indistinguishable (Wells and Sherlock, 1998). The advent of fluorescent PCR 
technology (Hattori et al, 1992) has enabled more far reaching diagnostic applications 
to be considered especially at the single cell level. Fluorescent-PCR (F-PCR) is a 
modification of PCR technology using fluorescent primers and an automated DNA 
sequencer and has improved both PCR accuracy and sensitivity (Ziegle et al, 1992). 
The application of oligonucleotide primers attached to fluorescent molecules gives 
rise to amplified products labelled with a fluorescent dye. When these F-PCR 
products migrate under electrophoresis to the position where the laser bisects the 
products, the fluorescent molecules are activated by the laser and give a signal of a 
specific wavelength, subsequently detected by a CCD detector and analyzed by 
computer software. The fluorescence dye is detected at a much lower threshold level 
than conventional agarose or acrylamide gel analysis. The size analysis is as precise 
as a single base pair difference. It is of major importance that fluorescent PCR is
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compatible with heteroduplex analysis (Rommens et al, 1990; section 1.3.3.2.3), 
single strand conformational polymorphism (SSCP) (Ellison et al, 1993; section 
1.3.3.2.4) as well as amplification refractory mutation system (ARMS) (Sherlock et 
al, 1998; section 1.3.3.2.5).
The main advantage of fluorescent PCR is its sensitivity compared to conventional 
PCR techniques. F-PCR is able to detect minute amounts of the fluorescent product 
such that for a single cell only 35-40 cycles of PCR are required. This in turn 
eliminates the need for nested PCR, so with one round of PCR amplification products 
even from a single cell can be analysed. F-PCR has been used extensively for prenatal 
(Hulten et al, 2003) and preimplantation genetic diagnosis worldwide (Sermon et al, 
1998a; Piyamongkol et al, 2001a and b; Dean et al, 2001). It has been postulated that 
F-PCR assays are powerful adjuncts to conventional cytogenetic techniques and can 
be applied for the rapid and accurate prenatal diagnosis of the most frequent 
aneuploidies (Pertl et al, 1999). Fluorescent PCR has been used for analysis of 
amniotic fluid and chorionic villus sampling (see section 1.4.5) as well as multiple 
single gene defects in the context of PGD (see section 1.5.3)
1.3.3.2.2 Denaturing Gradient Gel Electrophoresis
Denaturing gradient gel electrophoresis (DGGE), involves mixing a radiolabelled 
single stranded DNA probe with double stranded DNA being screened, which has 
been previously heated to make it single stranded. The mixture is electrophoresed on a 
denaturing gradient gel. The differences in DNA are detected by virtue of altered 
melting characteristics, which affect the DNA strand as it passes through the 
polyacrylamide gel with an increasing concentration of a denaturant. Recently, DGGE 
has been used for the detection of the major histocompatibility complex (Knapp, 
2005).
1.3.3.2.3 Restriction Endonuclease Digestion
Differences in DNA sequence e.g. caused by mutation can be shown using restriction 
endonucleases to digest the DNA. The restriction endonucleases are bacterial 
enzymes which recognise specific DNA sequences and cleave the DNA strand near 
the recognition site. Therefore, if the mutation and DNA sequence are known, a
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restriction endonuclease will be chosen and will cleave the normal strand, whereas the 
mutant will remain undigested. The results are visible after electrophoresis.
1.3.3.2.4 Heteroduplex Analysis
Heteroduplex analysis (HA) is based on the ability of heterozygous DNA to anneal, 
after denaturation, to its complementary strands which will associate recreating the 
original homoduplexes. Hybrid molecules will form generated by the association of 
partially complimentary strands from mutant and normal alleles. The latter 
heteroduplexes have an area of mismatch, since at the site of mutation the two alleles 
differ in DNA sequence. The area of mismatch does not anneal and retards 
heteroduplex migration during electrophoresis. Hence, heterozygocity of a sample can 
be established by the existence of homoduplexes and heteroduplexes (White et al, 
1992). Recently, sensitivity has been improved by 97% by combining a high- 
resolution sieving matrix and nucleosides as additives (Weber et al, 2006)
1.3.3.2.5 Single Strand Conformational Polymorphism
Single strand conformational polymorphism (SSCP) is able to detect point mutations 
as well as DNA polymorphisms in DNA fragments ranging in size from 100-500bp 
(Orita et al, 1989). This is accomplished by denaturing double stranded PCR products 
into single strands of DNA. These single strands will form stable, sequence-specific 
conformations and alterations in base sequences (e.g. different alleles) will give 
distinct conformations, which will subsequently migrate in different rates to non­
denaturing electrophoresis gel. Hence, different alleles can be distinguished (see 
section 1.3.3.1.1). However, SSCP is inefficient at detecting mutations with 
increasing size of the PCR product tested which limits its ability to analyses PCR 
products >300bp (Frayling, 2002)
1.3.3.2.6 Amplification Refractory Mutation System
Amplification refractory mutation system (ARMS) is based on the annealing of three 
different allele-specific oligonucleotides. With ARMS these oligonucleotides serve as 
primers for PCR and are not directly detectable. For example in a nested PCR reaction 
one of the primers can be designed to contain the mutation site during the outer 
reaction. The other two primers can be part of two different inner amplifications, one 
containing the normal and the other the mutant allele. By amplifying both normal and
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mutant alleles a ‘safety net’ is created in case one of the inner reaction does not 
amplify (see section 1.3.3.1.1).
1.3.3.3 PCR Applications
PCR has become an essential tool in molecular biology as an aid to cloning and gene 
analysis. A variety of PCR-modified techniques have been developed for different 
purposes, including forensic analysis, PND and PGD of single gene disorders. More 
sophisticated and modem techniques have been devised to better suit the needs of its 
applications.
The advent of PCR has helped in the genetic linkage of genes and diseases. For 
example, a tetranucleotide repeat region around the gene for myelin basic protein, 
after amplification, demonstrated the presence of eight different alleles among 14 
multiple sclerosis families and was used to exclude a linkage between this candidate 
gene and the disease (Rose et al, 1993). The usefulness of PCR in the elucidation and 
understanding of genetic diseases can be measured by the number of diseases that 
have been identified and diagnosed by utilising the PCR technology including 
myotonic dystrophy (Caskey et al, 1992), cystic fibrosis (Collins, 1992) as well as 
inherited colorectal cancer (Lunch et al, 1994) and breast cancer (Mikki et al, 1994). 
Furthermore, PCR can facilitate the diagnosis of infectious diseases caused by viral, 
bacterial, fungal, protozoal and other infectious agents. Using PCR on peripheral 
blood mononuclear cells from HIV affected individuals, HIV-1 sequences were 
detected in 100% of specimens that contained discernible virus by culture (Ou et al, 
1988). However, PCR has provided extreme aid in the identification and diagnosis of 
genetic diseases including P-thalassaemia, Tay-Sach’s disease, Duchenne muscular 
dystrophy in addition to deducing and cloning of cancer-causing genes such as the Rb 
gene associated with retinoblastoma, APC gene associated with adenomatous 
polyposis coli and mismatch repair genes for nonpolyposis colorectial cancer.
PCR has an advantage over FISH in prenatal diagnosis of aneuploidies, since it can 
accommodate smaller sized samples (Hulten et al, 2003). Quantitative Fluorescent 
PCR (QF-PCR) has been described as more amenable to automation, and a large 
number of samples can be handled simultaneously, allowing substantial economy of
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scale (Grimshaw et al, 2003). It has been postulated that it is less time consuming and 
labour intensive compared to FISH in a prenatal or preimplantation diagnostic setup 
(Findlay, 2000).
1.3.3.4 Technical Limitations of PCR
Because of the extremely sensitive nature of the PCR process, contamination from 
carrying over of previously amplified PCR products in the same laboratory can lead to 
significant problems. The problem of contamination affects both the diagnostic and 
quantitative PCR and may be the most formidable obstacle in PCR application. 
Contamination can occur either by intersample contamination during sample 
processing and reagent contamination from carryover (section 1.5.3.5.1). 
Precautionary measures are required such as a separate work bench, pipettes, sterile 
tips and diligent practice of aliquoting all PCR primers and reagents beforehand to 
reduce carryover contamination. Furthermore, it has been suggested that use of 
ultraviolet light (254+300nm) to inactivate as much as 30ng of contaminating double­
stranded DNA can alleviate the problem (Sarkar and Sommer, 1993). Nested-PCR has 
also been found to significantly reduce contamination (Wells and Sherlock, 1998) 
whereas the utilisation of polymorphic markers can detect contamination (Ma, 1995). 
The human genome contains many dispersed tandem-repetitive DNA sequences that 
are polymorphic due to variation in the copy number of tandem repeats. Those with 
longer motifs are called minisatellites (Jeffreys and Thein, 1985), while those with 
shorter motifs are called microsatellites (Weber et al, 1989). These polymorphic 
markers can act as contamination markers whilst examining a genetic disease in 
prenatal and preimplantation diagnosis. An important limitation of PCR and 
specifically single cell PCR is termed allele dropout (ADO) and poses a serious threat 
of false positive or false negative results (section 1.5.3.5.3)
1.3.4. Comparative Genomic Hybridisation
CGH has been described as an alternative method to interphase FISH or G-banding 
(Kallioniemi et al, 1992). It was originally applied for the detection of chromosome 
copy number changes in tumours and has further identified a variety of unbalanced 
chromosome complements. As a result quantitative fluorescent analysis using a digital 
imaging system is able to detect duplications or deletions in the sample DNA mapped
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to a target metaphase; ploidy abnormalities and balanced rearrangements however 
remain undetected.
1.3.4.1 CGH Principles
CGH is a powerful technique that utilises the advantages of the FISH and karyotyping 
techniques. Even when DNA quantities are minute CGH is able to merge karyotyping, 
FISH and PCR to view its chromosome complement under a fluorescent microscope. 
The tissue is tested against a control DNA sample, either a single cell or genomic 
DNA from a normal individual. The “control” DNA is labelled in spectrum Red and 
the “test” DNA (tissue under investigation) is labelled in spectrum Green. The test 
and control samples are mixed and co-hybridised on a target metaphase slide of a 
normal male individual. The slide is viewed under a fluorescent microscope. Several 
metaphases are captured, which are analysed using specific software able to give a 
ratio of the green and red spectra (test and control samples respectively) of the 
chromosomes therefore, allowing detection and examination for all the chromosome 
complement. Equal hybridisation of red and green DNA produces a yellow colour. 
However, if the test sample contains an excess of chromosomal material, trisomy 21 
for example, then green DNA fragments for this chromosome will be more abundant 
than their red equivalents and will out compete the red DNA fragments for 
hybridisation sites. This effect is only seen on the over-represented chromosome and 
results in a greenish coloration. Conversely if the test sample has a deficiency of 
chromosomal material, such as a monosomy, then a predominantly red coloration is 
seen on the chromosome in question (Figure 1.7).
73
Chapter 1 -Introduction
Figure 1.7: Comparative genomic hybridisation on tumours.
Sample DNA (labelled green) and 46,XY reference DNA (labelled red) are 
simultaneously hybridised to normal chromosome spreads. The ratio of red:green 
fluorescence along the axis of each chromosome is calculated by computer. An excess 
of red fluorescence indicates a deficiency in the sample for the chromosome under 
analysis, while an excess of green reveals regions of the genome that are over­
represented. (www.bu.us: University of Boston)
In Figure 1.7, it can be observed that the ratio of red:green fluorescence along the axis 
of each chromosome is calculated by a computer. Equal quantities of any loci 
(disomy) are assigned a profile ratio of 1.0. Changes in the copy number will deviate 
from this by a factor of 0.5 X n (where n is the number of copies of any locus). 
Therefore, chromosome gain (trisomy) will produce a ratio of 1.5 and a loss 
(monosomy), a ratio of 0.5 (Chang and Mark, 1997). The standard resolution of this 
technique is in the range of 10-40Mb but varies according to the regions analysed and 
degree of amplification (Kallioniemi et al, 1992; 1994; Voullaire et al, 1999). 
However, recent studies have reported sensitivity of their CGH protocols detecting 
deletions of <10Mb (Kirchhoff et al, 1999; Tonnies et al, 2001) by averaging CGH 
profiles. Since the smallest autosome is in excess of 50Mb, CGH analysis provides a 
very powerful and sensitive method for detecting duplications and deletions of 
significant size (Wells and Levy, 2003). However, certain regions of the karyotype 
including centromeres and heterochromatic segments show variation in the profile and 
these regions are normally excluded from CGH (Kallionemi et al, 1994). Certain 
chromosomes (lp, 17, 19 and 22) are prone to show frequent enhancement of the test 
signal and are also excluded from the analysis (Moore et al, 1997).
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1.3.4.2 Single Cell CGH
Most genomic DNA CGH protocols utilise between 100 ng and 1 pg of test DNA, 
equivalent to more than 10,000 cells. CGH can be applicable when only a single cell, 
or a few cells are available for analysis such as in the case of PGD when a single 
blastomere is analysed (Griffin et al, 1993) as well as for non-invasive prenatal 
diagnosis using fetal cells obtained from the maternal circulation (Simpson and Elias,
1995). In these cases universal amplification, using specific PCR, of the minute 
amount of starting template DNA is required to produce a sufficiently large DNA 
sample for CGH. Amplification of the whole genome from single cells or a few cells 
has been reported by performing PEP, DOP, Alu PCR and MDA (Snabes et al, 1994; 
Wells et al, 1999; Dean et al, 2002; Lasken and Egholm, 2003; Handyside et al, 2004; 
see section 1.6.3.3).
It has been shown that between PEP, DOP, and Alu PCR the most reliable WGA 
technique is DOP since it provides the most complete coverage of the genome (Wells 
et al, 1999). Wells et al (1999) reported successful application of DOP-CGH for 
diagnosing chromosome imbalance in single cells, which was the first reliable 
application of CGH in a research context on single cells from fibroblasts, buccal cells, 
amniocytes, and blastomeres from human preimplantation embryos. Similar results 
from single fibroblasts and amniocytes were described by Voullaire et al (1999) 
where it was demonstrated that diagnosis of chromosomal aneuploidy in single cells is 
feasible using CGH with DOP-PCR amplified DNA (see section 1.6.2.3). Single cell 
CGH has also been successfully employed to assess clonal evolution of genetic 
variants in complex populations, by subjecting single micrometastatic cells isolated 
from bone marrow of cancer patients to CGH (Klein et al, 1999). Since the first report 
of successful application of single cell CGH, continuous investigations aim to 
improve the technique’s fidelity. Huang et al (2000) conducted a comparative study 
aiming to define the optimal protocol for single cell CGH. The study employed 
differently labelled probes and hybridisation combinations and concluded that DOP- 
PCR-CGH homo-hybridisation (amplified test DNA vs. amplified reference DNA), 
especially when combined with labelling by nick translation is reliable and 
reproducible. However, the most important product of the first successful single cell 
CGH application was the potential use of CGH as a diagnostic tool for detecting
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chromosomal abnormalities in human preimplantation embryos (see section 1.6.4). 
DOP-PCR has been successfully employed as a means to amplify single human 
blastomere DNA allowing comparative genomic hybridisation to be undertaken by 
groups worldwide (Wells and Delhanty, 2000; Voullaire et al, 2000; Malmgren et al, 
2002).
1.3.4.3 CGH Applications
CGH was originally developed as a cancer research tool (Figure 1.5), the initial 
application of CGH involved direct analysis of genomic DNA from tumour 
specimens. Rising above the usual problems encountered with the use of 
conventional cytogenetics, CGH did not require time-consuming and laborious 
techniques of cell culture, or obtaining poor quality metaphase spreads consisting of 
short chromosomes of low mitotic index unsuitable for G- banding analysis. 
Therefore, the major advantage of CGH to highlight chromosomal regions of 
amplification or deletion is that it can be applied to any sample from which DNA can 
be extracted in a rapid single step, without reliance on the cytogenetic preparations 
needed for standard FISH or karyotyping..
1.3.4.3.1 Cancer Studies
The use of CGH for the analysis of tumours revealed a number of new recurring 
chromosomal gains, amplifications, losses and deletion sites. There have been over 
1400 articles published that have employed CGH to delineate cytogenetic changes in 
cancer specimens (Wells and Levy, 2003). A number of groups have employed CGH 
to show previously unrecorded areas of presumed tumour suppresser gene deletion 
and oncogene amplification in cell lines and solid tumours (Kallioniemi et a l, 1994; 
Kokkola et al., 1997; Van Roy et al., 1997). Some of the tumours studied included; 
Uveal melanomas (Becher et al, 1997), small-cell lung carcinomas (Ried et al, 1994; 
Levin et al., 1995) and breast cancer (Kallionemi et al, 1994). CGH has also shown 
its prognostic value by detecting chromosomal alterations in neoplasms including 
node-negative breast cancer (Isola et al, 1995), renal cell carcinomas (Moch et al,
1996), Uveal and cutaneous melanomas (Prescher et al, 1996; Wiltshire et al, 1995) 
and bladder cancer (Kallionemi, et al, 1995). CGH has also been applied to neoplastic 
samples relevant to reproductive medicine, such as: prostate cancer (Joos et al, 1995;
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Visakorpi et al, 1995), testicular germ cell tumours (Korn et al, 1996) and ovarian 
tumours (Kiechle et al, 2001).
1.3.4.3.2 Prenatal Studies
Similarly in clinical cytogenetics CGH has been applied to prenatal and paediatric 
samples as well as mitotically inactive cells derived from products of conception 
(Bryndorf et al, 1995; Levy et al, 1997; Wells and Levy, 2003) to characterise marker 
chromosomes, cryptic deletions and complex rearrangements, and the origin of 
intrachromosomal duplications (Benzaken et al, 1998; Daniely et al., 1999; Kirchhoff 
et al, 2001). Lapierre and co-workers (2000) carried out the first prospective study of 
CGH on uncultured amniocytes and concluded that CGH is a valuable alternative to 
interphase FISH for the rapid detection of unbalanced chromosomal aberrations. CGH 
has also been applied to material from spontaneous abortions (Daniely et al, 1998), 
where it was able to detect 48% of the abnormalities usually detected by conventional 
karyotyping including trisomies, monosomies and partial gains and losses. Tabet et al 
(2001) used CGH to analyse trophoblast cells from spontaneous abortions, 
intrauterine fetal death, and malformed fetuses, circumventing the need for culture. 
The investigations suggested that the contribution of chromosome aberrations to first 
trimester pregnancy loss is nearly 70%.
1.3.4.3.3 Embryo Studies
Recently PGS has been carried out on using CGH (Wilton et al, 2001; Wells et al, 
2002). The application of CGH for PGS is not straightforward as after embryo biopsy 
there is only a narrow window of time for the diagnosis to be made. As most 
protocols for CGH require 72 hours for hybridisation alone, two strategies have been 
proposed. Embryos can be frozen following biopsy and thawed after the CGH 
analysis has been completed (Wilton et al, 2001) or alternatively Wells et al (2002) 
tried an accelerated protocol following polar body biopsy on the day o f fertilisation. 
Both studies suggested that the major limitation of CGH for PGS is the investigation 
takes time due to the laborious analysis of template chromosomes. These difficulties 
will be overcome when the template chromosomes are replaced by microarrays where 
hundreds or thousands of chromosome specific probes are spotted onto a glass slide 
(Wilton, 2002). In the study carried out by Wilton et al (2001), the need for 
cryopreservation reduces embryo viability and implantation potential by 30% (Edgar
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et al, 2000), whereas in the study by Wells et al (2002), post-zygotic abnormalities, 
which account for more than half of abnormalities, as well as paternally derived 
aneuploidies are not detected
1.3.4.3 Technical Limitations of CGH
One of the few limitations of CGH is that it only detects relative alterations of 
chromosome copy number and cannot detect changes that involve the entire set of 
chromosomes, therefore it is unable to detect abnormalities of ploidy (Wells and 
Delhanty, 2000). Although providing information on imbalances of all chromosomes, 
unlike conventional karyotyping, CGH fails to provide information on chromosomal 
architecture. Furthermore, CGH analysis is suboptimal for both telomeric and 
pericentromeric regions, because of low fluorescence intensities and highly 
polymorphic regions that are blocked by COT-1 DNA (Daniely et al, 1998). The most 
significant limitation in utilizing CGH in a clinical setting and especially in IVF, 
relates to the technical complexities of the technique, as the method has been 
described as time consuming, labour intensive, and requiring expertise with several 
cytogenetic and molecular genetic techniques (Wells and Levy, 2003).
1.4 Prenatal Diagnosis
Prenatal diagnosis with a view to identifying fetal genetic disorders started in the 
early 1970’s. Prenatal tests can be divided into two groups: a) screening techniques 
such as those involving measurements of chemicals in maternal blood and imaging 
the fetus and b) diagnostic techniques including invasive tests to remove tissues of 
fetal origin. Women who are at known risk e.g. carrying a translocation or a single 
gene disorder and women who are found to be at risk due to abnormal screening 
results undergo invasive tests, which will allow karyotyping or identification of the 
single gene defect. The appropriate technique is selected based on the evaluation of 
gestational age, the urgency to obtain a result, the risk of the procedures and the a 
priori risk for a disorder in the fetus. Fetal cells for chromosome diagnosis are 
obtained invasively either by chorionic villus sampling (CVS) at about 9-11 weeks 
gestation or amniocentesis at about 15-20 weeks of gestation. Both procedures are 
invasive and carry an associated risk for induced abortion of 0.5-2% of women tested 
(Hulten et al, 2003).
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1.4.1 Chorionic Villus Sampling
CVS can be carried out from 9-11 weeks of gestation. The timing of diagnosis can be 
crucial in minimising the trauma of an elective abortion caused to the patient when 
unbalanced chromosomal abnormalities as well as single gene defects are diagnosed. 
The procedure is done either transcervically or transabdominally. For transcervical 
sampling different catheters are used including curved biopsy forceps as well as the 
catheter originally designed by Ward and colleagues (1983). For the transcervical 
approach, a bendable polyethylene catheter with a metal obturator is introduced 
through the cervix and guided to the chorionic frondosum under ultrasound 
surveillance. With an attached syringe (partly filled with medium) a vacuum is 
applied and approximately 10-50mg are aspirated and rinsed into a Petri dish (Rodeck 
and Whittle, 1999). The transabdominal technique was initially developed in 
Denmark by Smid-Jensen and Hahnemann (1984). It can be carried out either as a 
free-hand ultrasound-guided fine-needle aspiration or with a needle guide ultrasound 
transducer. In CVS, some fetal cells are spontaneously dividing and cells at 
metaphase can be obtained. However, the resolution, which is of great importance for 
the detection of structural abnormalities, may be low due to the condensed nature of 
the dividing cells, hence cells are cultured.
Two major problems are encountered in fetal karyotyping using cultured cells from 
chorionic villi: the relatively slow growth of these cells in culture, which subsequently 
delays the diagnosis and the occurrence of maternal cell contamination (MCC) 
(Goumy et al, 2004). However, chorionic villi are considered an excellent source of 
DNA supplying sufficient amounts for most molecular genetic techniques without 
prior culture. Thus, CVS is the method of first choice in pregnancies at risk for 
monogenic diseases (Stranc et al, 1997). Biochemical testing after CVS is possible for 
most metabolic disorders and is advantageous over amniotic fluid cells due to the high 
recurrence risks and the usually feasible use of fresh uncultured villi (Holzgreve et al, 
1999). Confined placental mosaicism (Section 1.4.7.1) has been detected in 2% of 
viable pregnancies (Kalousek and Vekemans, 1996; Grati et al, 2006) and can give 
false positive results which need to be confirmed by amniocentesis (Lacroute et al, 
2004)
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1.4.2 Amniocentesis
Amniocentesis can be carried out at gestational ages between about 14 weeks and 
term. Traditionally this test is offered between 15-17 weeks of gestational age when 
the total amount of amniotic fluid is approximately 200ml and the uterus can be 
reached transabdominally without major risks of transversing the bladder or bowel. 
Nowadays, the correct line of insertion of the needle is chosen by ultrasound and 
subsequently the puncture and aspiration are performed under continuous ultrasound 
surveillance (Holzgreve et al, 1999). In most cases, culture of amniotic fluid cells is 
required for prenatal diagnosis and this takes a further 1-4 weeks, depending on the 
number of cells required and individual variations in the speed of cell growth. This is 
due to the fact that amniotic fluid samples do not contain any fetal cells in division 
and have to be grown in vitro to obtain cells at the metaphase stage
Three problems can occur during analysis of amniocentesis samples including 
complete failure of culture, maternal cell contamination leading to false-negative 
results and the incidence of mosaicism. Several studies have been carried out trying to 
determine the risk of spontaneous abortion after amniocentesis and it is found to be 
0.5-1.5% (Tabor et al, 1986; Kapel et al, 1987).
1.4.3 Fetal Blood Sampling
Fetal blood sampling is usually obtained antenatally by fetoscopy, however, this 
procedure has been almost abandoned in favour of cordocentesis. Cordocentesis is a 
sampling technique whereby fetal blood is obtained by direct puncture of the 
umbilical vein.
1.4.4 Maternal Cells and DNA in the Fetal Circulation
During pregnancy, the fetal and maternal circulations are separated by the placental 
membranes. However, a variety of evidence has pointed towards the incompleteness 
of this barrier of cellular trafficking. Fetal nucleated cells were first demonstrated in 
the maternal circulation by Walknowska et al (1969) and have now been widely 
pursued as potential substrates for non-invasive prenatal diagnosis (Bianchi, 1999). 
The isolation and analysis of fetal cells in maternal blood for genetic diagnosis has 
been a matter of great interest in the world of prenatal diagnosis. Attention is being
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directed on choice of the best fetal cell type, selection of optimal cell enrichment, 
consistency and reproducibility of cell recovery and analysis.
1.4.5 Cytogenetics and Prenatal Diagnosis
Prenatal diagnosis of chromosomal abnormalities is routinely accomplished by 
standard cytogenetic techniques. The major disadvantage of these procedures is the 
fetal cells must be cultured for up to two weeks (for amniocentesis) before analysis 
and that cultivation must be prolonged in advanced stages of pregnancy (Pertl et al,
1999). This time interval between sampling and diagnosis places a considerable 
emotional burden on the prospective parents (Tercyak et al, 2001). A rapid diagnosis 
is essential when an ultrasound examination suggests an abnormal fetus. The two 
most common types of rapid molecular method for prenatal diagnosis of chromosome 
disorders are fluorescent in situ hybridisation (FISH) and quantitative fluorescent 
polymerase chain reaction (QF-PCR). Both methods are used, but, QF-PCR is applied 
routinely for rapid and simple diagnosis of aneuploidy (numerical chromosome 
abnormalities) including trisomies 21, 13 and 18 which give rise to Down, Patau and 
Edward syndromes respectively and sex chromosome abnormalities.
In studies where either FISH or QF-PCR have been compared to karyotyping it has 
been postulated that both rapid techniques are more economical, rapid and easier to 
perform, however, they cannot be carried out independently (Eiben et al, 1998; Billi 
et al, 2002). Eiben et al (1998) concluded that all FISH analysis should be followed 
by karyotyping in order to cover the 35% of aberrations which cannot be detected by 
FISH. In a recent study on uncultured chorionic villus samples using FISH for 
chromosomes 13, 18, 21, X and Y showed that FISH is able to minimize maternal cell 
contamination and provide rapid diagnosis which reduces parent anxiety (Goumy et 
al, 2004). Feldman et al (2000) found 100% sensitivity, specificity and predictive 
values for their routine FISH analysis as a method to detect aneuploidies of 
chromosomes 13, 18, 21, X and Y in amniocytes. The same group, however, quoted 
that even with 100% accuracy of their test, routine FISH analysis will miss about 25- 
30% of the abnormalities detected by standard cytogenetic techniques, therefore, the 
latter must always act as a backup to FISH. Several studies have shown a variety of 
detection percentages whilst using FISH in normal uncultured amniotic fluid and
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uncultured CVS, such as 70-100% (van Opstal et al, 1995; Bryndorf et al, 1997) and 
36-100% (Bryndorf et al, 1996) respectively. This substantial range of FISH 
efficiency is probably due to: maternal cell contamination; true low level mosaicism; 
the types of probes used; error in scoring’ and the efficiency of hybridisation, 
especially in nuclei interphase (Ruangvutilert et al, 2000b).
Pertl and co-workers (1999) after carrying out QF-PCR analyses on 247 chorionic 
villus samples concluded that the QF-PCR assay provides a fast and economical 
method for the prenatal diagnosis of major chromosome defects, but it is not a 
substitute for conventional cytogenetic analysis. Billi et al (2002), found no 
discordance between the results of QF-PCR and karyotyping after CVS where only 
4/1100 cases were missed by QF-PCR, indicating the reliability of QF-PCR as a 
supporting prenatal diagnostic method. Furthermore, it has been shown that QF-PCR 
is a valuable tool for prenatal diagnosis of multiple pregnancies since it allows the 
detection of all aneuploid fetuses in just a few hours after sampling, as well as the 
determination of fetal zygocity in all cases (independently of chorionicity and fetal 
sex) (Cirigliano et al, 2003).
1,4.6 Prenatal Diagnosis of DM
The development of a reliable molecular diagnostic test for DM has meant that pre- 
symptomatic testing, prenatal testing as well as PGD for DM can be offered to those 
families for whom it is appropriate and acceptable. The severe congenital form of DM 
has a prevalence of 2.5-5.5 per 100,000 live births (Geifman-Holtzman and Fay, 
1998).
In congenital DM affected pregnancies polyhydramnios, decreased fetal movement 
and prematurirty often complicate the pregnancies. Since the triplet repeat is 
expanded to hundreds or even thousands of copies, standard PCR protocols are unable 
to amplify such long products (Monckton et al, 1995). Therefore, the CTG expansion 
is detected by Southern blot performed from extracted DNA of CVS and amniotic 
fluid samples digested with the appropriate enzyme using a radioactive probe 
(Geifman-Holtzman and Fay, 1998). More recently several groups have reported the 
development of non-radioactive methods to determine the CTG repeat expansion in
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DM patients involving the use of fluorescein-labelled probes (Brugnoni et al, 1998; 
Zuhlke et al, 2000). The combination of PCR and hybridisation reduces the time 
required for prenatal diagnosis from 10 days to 2-3 days (Zuhlke et al, 2000). 
Furthermore, smaller amounts of DNA are required compared to conventional 
Southern blot analysis (Brugnoni et al, 1998). Moreover, Amincucci and co-workers 
(2000) attempted to isolate fetal cells from maternal plasma for PND of DM of an 
unaffected woman whose husband was affected by DM and concluded that this non- 
invasive method allowing first-trimester PND, can become an alternative procedure 
in selected cases.
1.4.7 Prenatal Diagnosis and Mosaicism
Mosaicism, defined as the presence of two or more cell lines with different 
chromosome constitution in an individual, presents a prognostic dilemma since it 
influences the postnatal phenotype. Mosaicism has been found present in amniotic 
cells as well as chorionic villus samples (Eisenberg and Wapner, 2002). In order to 
identify samples with mosaicism the minimal demand is:
a) Two or more identical aberrant cells in villi analysed by the direct (short term 
culture) method (CVS)
b) At least one identical aberrant cell in each of the two or more independent culture 
dishes (CVS/amniotic cells)
c) At least one identical cell found both by the direct and the culture methods 
(CVS+amniotice cells) (Phillip and Bryndoff, 1998).
The confirmation or exclusion of mosaicism detected prenatally by CVS requires 
repeat sampling of fetal cells (amniotic fluid or fetal blood) (Pergament, 2000). The 
phenomenon of mosaicism in prenatal diagnosis has also been linked to intrauterine 
growth retardation (IUGR), uniparental disomy as well as confined placental 
mosaicism.
1.4.7.1 Confined Placental Mosaicism
In most pregnancies the chromosomal complement detected in the fetus is also present 
in the placenta. The detection of an identical chromosomal complement in both the 
fetus and its placenta has always been expected as both develop from the same 
zygote. However, in approximately 2% of viable pregnancies studied by chorionic
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villus sampling (CVS) at 9 to 11 weeks of gestation, the cytogenetic abnormality, 
most often trisomy, is confined to the placenta (Kalousek and Vekemans, 1996). This 
phenomenon is known as confined placental mosaicism (CPM). It was first described 
by Kalousek et al (1991) in term placentas of infants bom with unexplained 
intrauterine growth restriction (IUGR). Contrary to generalised mosaicism, which is 
characterised by the presence of two or more karyotypically different cell lines within 
both the fetus and its placenta, CPM may be due to a postzygotic nondisjunction event 
generating a trisomic cell line in an initially normal conceptus (mitotic origin) or the 
postzygotic loss of one chromosome in an initially trisomic conceptus (meiotic origin 
and trisomy rescue) (Grati et al, 2006).
Cytogenetically, CPM can assume three different forms. In type I the trophoblast is 
aneuploid, in type II aneuploidy is present in chorionic stroma and in type III both 
trophoblast and chorion are aneuploid. In trisomic zygote rescue, either reverse type I 
CPM, when trophoblast is diploid and the rest of the placenta and the fetus are 
nonmosaic trisomic, or type III are seen (Kalousek, 2000). It has been shown that the 
effects of CPM on development depend on the origin of the extra chromosome in the 
placenta as well as the specific chromosome involved. Meiotic origin is highly 
correlated with type III CPM and increased risk of pregnancy complications, whereas 
mitotic origin, more frequently found in types I and II, shows a lower risk of 
pregnancy complications (Robinson et al, 1997).
Specific chromosomal trisomies have been observed in CPM more frequently than 
others, with trisomy of chromosomes 7, 16, and 18 being the most prevalent 
(Wolstenholm, 1996). Previous studies have shown that the majority of the CPM for 
autosomes 9, 16, and 22 are meiotic in origin, whereas CPM for autosomes 2, 7, 8, 10, 
and 12 are predominantly somatic in origin (Robinson et al, 1997)
Uniparental disomy (UPD), the inheritance of the two copies of a chromosome from 
the same parent, may sometimes be associated with CPM. UPD can result from 
gamete complementation, chromosome loss in trisomy, or duplication in monosomy 
(with or without residual mosaicism) and somatic recombination (Engel, 1993). In 
isodisomy, the uniparental pair is a duplicate of a same chromosome DNA template 
and causes an increased risk of recessive disorder by reduction to homozygosity. In
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heterodisomy, the pair remains heterozygous, made up of 2 non-recombinant 
homologous segments. But both iso- and heterodisomy may also cause disruption of 
the genomic imprints needed for differential expression of some maternal and paternal 
genes crucial to growth and development (Engel, 1997).
Conventional cytogenetic methods for detection of CPM depend on the availability of 
dividing cells and analysis of a large number of metaphase cells (Lestou et al, 1999). 
FISH has been established as a molecular cytogenetic technique for the detection of 
chromosomal aneuploidy and mosaicism in placental tissues (Lomax et al, 1994). 
More recently, it has been shown that CGH can be reliably performed on DNA 
obtained form placental (either trophoblast or stroma cells) and fetal tissues in order 
to detect aneuploidy (Lestou et al, 1999; Lestou et al, 2000; Barrett et al, 2001).
1.4.7.2 Uniparental Disomy
Uniparental disomy (UPD) is the occurrence of both homologous chromosomes from 
one parent. If an individual inherits two copies from one parent, through an error in 
meiosis II this is named uniparental isodisomy. If, however, the individual inherits 
two different homologues from one parent through an error in meiosis I, this is termed 
uniparental heterodisomy. Recent insights have revealed that the molecular basis for 
the clinical features of UPD are specific human genes that are only monoallelically 
active, depending on whether they are located on the paternal or maternal 
chromosome. UPD will lead to an imbalanced expression of these imprinted genes 
and cause abnormal development (Eggermann et al, 2002). Specific syndromes have 
been found to be associated with UPD, these include Prader-Willi syndrome (maternal 
UPD15/mUPD15), Angelman syndrome (paternal UPD15/pUPD15), (transient) 
neonatal diabetes mellitus (pUPD6), Silver-Russell syndrome (mUPD7), Beckwith- 
Wiedemann syndrome (pUPDl 1) and the mUPD14 syndrome.
The Prader-Willi (PWS) and Angelman (AS) syndromes are two clinically distinct 
syndromes which result from lack of expression of imprinted genes within 
chromosome 15qll-ql3. These two syndromes result from 15q 11 -q 13 deletions, 
chromosome 15 uniparental disomy (UPD), imprinting centre mutations and, for AS, 
probable mutations in a single gene. The differential phenotype results from a paternal
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genetic deficiency in PWS patients and a maternal genetic deficiency in AS patients. 
Within 15ql 1 -q l3, four genes (SNRPN, IPW, ZNF127, FNZ127) and two expressed 
sequence tags (PARI and PAR5) have been found to be expressed only from the 
paternally inherited chromosome, and therefore all must be considered candidate 
genes involved in the pathogenesis of PWS (Glenn et al, 1997; Liehr et al, 2005)The 
mechanisms of imprinted gene expression are not yet understood, but it is clear that 
DNA methylation is involved in both somatic cell expression and inheritance of the 
imprint
Maternal UPD(16) is the most often reported UPD other than UPD(15); almost all 
cases are associated with confined placental mosaicism (CPM). Most of maternal 
UPD(16) cases are characterised by intrauterine growth retardation (IUGR) and 
different congenital malformations. Maternal UPD(16) has therefore been suspected 
to have clinical effects: however, the lack of uniqueness and specificity of the birth 
defects observed suggests that the phenotype may be related in parts to placental 
insufficiency (Eggermann et al, 2004)
1.5 Preimplantation Genetic Diagnosis
It has been 15 years since the first PGD baby was bom (Handyside et al, 1989). PGD 
has been offered for a variety of single gene defects (Verlinksy et al, 1994; Sermon et 
al, 1997; Abou-Sleiman et al, 1999; Sermon et al, 2004), chromosomal abnormalities 
(Munne et al, 1998e; Conn et al, 1999; Scriven et al, 2001; Braude et al, 2002) and 
sexing (Griffin et al, 1991; 1992; 1994; Staessen et al, 1994; Handyside and 
Delhanty, 1997) and offers an alternative to traditional methods o f prenatal genetic 
testing (CVS and amniocentesis), and allows genetic analysis to be performed on 
early embryos prior to implantation and pregnancy. This provides couples at a risk for 
certain genetic diseases the opportunity to know that any pregnancy they achieve 
should be unaffected (Handyside, 1998). Patients requesting PGD undergo in vitro 
fertilisation (IVF) treatment because in this way multiple embryos can be generated in 
vitro giving an increased probability that a disease free embryo will be identified 
(Wells and Delhanty, 2001).
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FISH and PCR, following extensive groundwork for their suitability in clinical 
application, are the methods of choice and now form the basis of most PGD strategies 
used today for a spectrum of genetic defects ranging from gross chromosomal 
aberrations to single base-pair mutations. Although classical cytogenetic techniques 
can also be successfully applied to single blastomeres with a view to PGD, the 
efficiency with which analysable metaphase preparations can be produced per 
biopsied cell is notoriously low (Kola and Wilton, 1991; Wells and Levy, 2003).
The scope of PGD has been widened and apart from the diagnosis of genetic diseases 
(Handyside, 1998) and the detection of chromosomal abnormalities, it has been used 
to try and improve pregnancy rates for certain groups of IVF patients (Munne et al, 
2000; 2005). Preimplantation genetic screening (PGS) is offered to couples with 
recurrent IVF failure, recurrent abortions and screening for aneuploidy in older aged 
women (Egozcue et al, 2000; Abelhadi et al, 2003).
PGD is a clinical diagnostic procedure that has evolved from the substantial advances 
both in assisted reproduction technology and molecular genetic analysis. Patients 
undergo routine IVF procedures which will produce multiple embryos. Polar bodies 
(first and second) and day 3 or day 5 embryos are biopsied (section 1.5.1) and are 
analysed either by FISH (section 1.5.2), or PCR (section 1.5.3) or CGH depending on 
the nature of the aberration. Embryos free of the specific inherited disorder are 
replaced in the uterus, which will give the parents the chance o f starting a ‘normal’ 
pregnancy. As the embryos subjected to PGD must be IVF generated, certain 
difficulties are encountered. Significant limitations are presented involving the 
number and the subsequent quality of the embryos provided, that have a direct effect 
on the success rate of PGD. Thus, the success rate of PGD is relative to the highest 
possible success rate of IVF (Egozcue et al, 2000).
1.5.1 Sampling Strategies for PGD
Genetic analysis of preimplantation developmental embryos prior to replacement into 
the uterus inevitably involves removal of some embryonic cellular material from one 
of these stages.
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1.5.1.1 Polar Body Biopsy
Biopsy of the first polar body has been carried out when the carrier of the mutation or 
the chromosomal aberration is the female partner (Verlinsky et al, 1990; 1997; Munne 
et al, 2000; Strom et al, 1997). The first polar body (PB) is biopsied within six hours 
of oocyte retrieval to preserve optimum chromosome morphology (Verlinsky et al, 
1990). PB biopsy involves a breech in the zona which can be performed by 
mechanical (Verlinsky et al, 1997) or laser (Montag et al, 1998) drilling followed by 
polar body aspiration. Direct penetration through the ZP is mainly performed using a 
bevelled pipette (Roudebush et al, 1990; Verlinksy and Cieslak, 1993). The bevelled 
pipette allows mechanical perforation of the ZP, and once inside the perivitilline 
space, the first and second PB can be aspirated (Gianarolli, 2000).
First PB removal does not seem to interfere with normal fertilisation and the 
percentage of the embryos entering cleavage (Verlinsky et al, 1992). No effect on the 
viability of the resulting embryos was observed in a mouse model when both polar 
bodies were removed (Kaplan et al, 1995). Moreover, Strom et al (2000a and b) did 
not observe any deleterious effect in a follow-up study of 109 children bom after first 
and second PB biopsy. The previous studies were reassuring for the clinical 
application and genetic evaluation of human oocytes, which has resulted in clinical 
pregnancies and livebirths (Verlinsky and Kuliev, 1996b). Munne et al used PB 
biopsy for translocations of female origin, significantly reducing spontaneous abortion 
rate (Munne et al., 1998a; 1998b; 2000).
However, the main disadvantage of PB sampling is that the paternal contribution 
cannot be evaluated. Furthermore, the presence of post-zygotic mitotic errors cannot 
not be detected. Furthermore, this technique is extremely laborious (Wells and 
Delhanty, 2001), there is a risk of misdiagnosis in case of crossing over during 
meiosis I when only the first polar body is analysed and there is no information about 
the paternally derived genetic make-up of the embryo (Ruangvutilert et al, 2000b). 
First and second maternal meiotic errors can be excluded only if information on both 
polar bodies is obtained (Angell, 1994b). In cases where the paternal contribution 
needs to be evaluated, biopsy at post fertilisation stages will be required.
88
Chapter 1 -Introduction
1.5.1.2 Cleavage-Stage Biopsy
At present, most of PGD analyses are performed by employing cleavage-stage biopsy, 
where 1-2 cells are extracted from each embryo (ESHRE PGD Consortium, 1999; 
2000; 2001; 2002). The biopsy procedure involves making an opening in the ZP 
through which a cell can be removed. This can be accomplished either mechanically 
involving partial zona dissection (PZD) by direct piercing or cutting with a 
micropipette (Grifo et al, 1990; Cieslak et al, 1999), chemically by the localised 
application of acid Tyrode’s solution (pH 2.3) (Hardy et al, 1990; Inzunza et al, 1998) 
or by employing an extremely precise laser system to puncture a hole into the zona 
(Palanker et al, 1991; Veiga et al, 1997; Montag et al, 1998; Joris et al, 2003). The 
latter two techniques, using Acid Tyrode’s solution and laser, are the most commonly 
used methods for cleavage or blastocyst stage biopsy (Figure 1.8). Chemical zona 
drilling followed by blastomere aspiration is normally performed with separate 
pipettes (one drilling pipette with inner diameter ±5-7 pm, and one aspiration or 
biopsy pipette with inner diameter ±40 pm) using a double-holder setup (de Vos and 
Steirteghem, 2001). The resultant local acidification can cause subtle damage to the 
embryos and may interfere with further embryo development. Hence, Cohen et al 
(1992) suggested immediate washing of micromanipulated embryos. The use of a 
laser for zona drilling in cases of PGD is an easier procedure and results in more 
intact blastomeres (Veiga et al, 1997). Zona opening by laser drilling is performed by 
exposing the ZP to laser light. The hole size can be chosen precisely by varying the 
irradiation time, however extra care should be taken not to harm the embryonic cells 
with the laser shot. Since similar pregnancy rates are obtained from studies comparing 
laser and the acid Tyrodes technique (De Vos and Van Steirteghem, 2001). Recently, 
it was shown that there was no diference in blastomere viability, level of chromosome 
abnormalities and cytoskeleton damage when comparing embryos biopsied either by 
acid tyrodes or laser (Chatzimeletiou et al, 2005).
Figure 1.8. Illustrating cleavage stage embryo biopsy, (a): Embryo attached to holding 
pipette and positioned, (b): Acid Tyrodes is used to create a hole in the zona
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pellucida. (c): A single blastomere is carefully removed, (d): The embryo following 
the biopsy. (Harper and Doshi, 2000)
2 +  2 “bPrior to cleavage-stage biopsy, embryos are placed into Ca /Mg -free medium to 
reduce the tight junctions that occur between human blastomeres at compaction (Dale 
et al, 1991). Blastomeres at the 6-8 cell stage show a strong tendency to adhere to 
each other, which in turn might cause a high rate of cell lysis whilst performing the
2~ b  2 “bbiopsy. Hence, Santalo and colleagues (1996) used Ca /Mg -free medium to loosen 
the tight junctions of preimplantation mouse embryos, which allowed easier removal
9  4- 9 +of the blastomeres and reduced the biopsy time. The use of Ca /Mg -free medium 
thus allows for an easier biopsy procedure during pre-implantation genetic diagnosis, 
while it does not result in a loss of developmental potential of the embryo to the 
blastocyst stage (Dumoulin et al, 1998).
Early studies focused on measuring the effect of biopsy on human embryonic 
development revealed that two cells could be removed from 8-cell embryos on day 
three post-insemination without reducing the number blastulating or disturbing 
cleavage rates (Hardy et al, 1990). De Vos and Van Steirteghem (2001) suggested 
that at day 3 of embryo development the blastomeres are totipotent and embryo 
biopsy could be carried out even if the embryo was compacting. Unfortunately, not all 
embryos reach the 7- or 8-cell stage by the morning of day 3. Six cell embryos might 
also be included for one or two cell removal. However, biopsies performed at the 4- 
cell stage may alter the ratio of inner cell mass to trophectoderm cells, if  more than 
one cell is removed, which may be detrimental to embryo development (Tarin et al, 
1992). Consequently two-cell biopsy procedures should only be carried out on day 
three post-insemination at the 6-8 cell stage, when up to a quarter of the blastomeres 
can be removed without disturbing subsequent development (Handyside, 1991; Hardy 
et al, 1990), as the biopsied cells are still undifferentiated (Harper et al, 1996).
The decision as to whether one or two cells should be removed from a cleavage stage 
embryo is controversial. It has been suggested that the removal of two cells reduces 
the cellular mass and could potentially reduce its developmental capacity (Braude et 
al, 2002). However, diagnosis of inherited diseases can suffer from technical 
limitations. Single cell FISH and PCR are not 100% accurate and can give false
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positives and negatives. Furthermore, the phenomenon of mosaicism, poses a serious 
threat of misdiagnosis for PGD of chromosome abnormalities (see section 3.1.1). 
Hence it has been postulated that the accuracy of the diagnosis can be enhanced if 
embryos are replaced when results from two cells are concordant (Van de Velde et al, 
2000). For this reason many groups prefer to base their diagnosis on the result of two 
biopsied cells, particularly for chromosomal analysis and dominant disorders 
(Delhanty et al, 1994; Delhanty and Handyside, 1995; Kuo et al, 1998; Van de Velde 
et al, 2000; Simopoulou et al, 2003).
1.5.1.3 Blastocyst Biopsy
The limited amount of tissue available in PB and cleavage-stage sampling could be 
overcome with the use of blastocyst biopsy. Trophectoderm biopsy from blastocyst 
stage embryos has been attempted in animal models (mouse, Gardner, 1971; cattle, 
Betteridge et al, 1981; monkey, Summers et al, 1988), as well as humans (Dokras et 
al, 1990) showing no adverse effect on further development. The technique of zona 
slitting (similar to PZD) is used to open the ZP with a microneedle (Dokras et al, 
1990), however, laser zona opening has also been performed (Veiga et al, 1997). This 
will allow a generous amount of embryonic material in order to provide a reliable 
genetic analysis, overcoming the lack of material made available when carrying out 
cleavage stage biopsy. As these cells are from the trophectoderm there is no decrease 
in the ICM and therefore in the embryo proper. De Boer et al (2004) showed that 
blastocyst biopsy permits up to five or six cells to be genetically tested, leaving the 
inner cell mass intact and enabling embryos to be electively transferred one at a time 
without diminishing the chance of pregnancy compared with cleavage-stage biopsy 
and testing. The main drawback of this approach is the limited number of embryos 
available for biopsy and diagnosis, since only half or fewer of the IVF generated 
embryos are able to reach the blastocyst stage (Jones et al, 1998). Moreover, the time 
for diagnosis will be severely limited if the biopsy is postponed to this later 
preimplantation stage, posing serious restrictions in the time available for genetic 
analysis (De Vos and Van Steirteghem, 2001).
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1.5.2 Chromosomal Abnormalities
Chromosomal analysis of embryos is one of the most important research fields in the 
area of preimplantation development. It has been suggested that fewer than 50% of 
naturally conceived embryos reach full term with most lost before or shortly after 
implantation (Edwards an Gardner, 1967). With the advent o f IVF and more recently 
PGD studies to confirm chromosomal abnormalities by analysing embryos at early 
stages have revealed similar rates of embryonic mortality, where a significant portion 
of embryos arrest in development during the first days after fertilisation. 
Chromosomal abnormalities especially in the form of aneuploidy, usually have an 
adverse effect on the developing embryo by altering the dosage of hundreds of 
expresses genes (Wells and Levy, 2003). Chromosome analysis of human embryos 
has shown higher rates of aneuploidy than those reported for prenatal testing 
(Jamieson et al, 1994), suggesting that considerable numbers of chromosomally 
abnormal embryos are eliminated early in development (Wells and Delhanty, 2000; 
Sandalinas et al, 2001).
1.5.2.1 X-Linked Disorders
Sexing the embryo to avoid X-linked disease was the first application of FISH in this 
context (Griffin et al, 1991; 1992; 1994) and is one of the major indications for PGD 
(ESHRE PGD Consortium, 1999, 2000 and 2002, 2004). X-linked recessive diseases 
account for 6-7% of single gene defects and include conditions such as Duchenne 
muscular dystrophy (DMD), haemophilia, and various metal retardation syndromes. 
The first application of PGD was to avoid X-linked disease carried by the mother by 
the selection of female embryos for transfer following diagnosis of embryo sex by 
employing PCR (Handyside et al, 1990). Primers specific for a sequence derived from 
the long arm of the Y chromosome were designed and diagnosis was performed by 
negative selection i.e. the embryos for which no amplification was present were 
diagnosed as female and recommended for transfer. In the second series, of seven 
fetuses tested following sexing by PCR amplification, one singleton was male and the 
pregnancy was terminated (Handyside and Delhanty, 1993). This error presumably 
arose from amplification failure of a XY blastomere, subsequently shown to occur in 
15% of cells tested, although biopsy of an anucleate or haploid blastomere would give 
the same result (Kontogianni et al, 1996). Following this, protocols were developed
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for the simultaneous detection of both X and Y chromosomes, using either 
combinations of specific primers (Kontogianni et al, 1991; Grifo et al, 1992) or more 
reliably common primers for homologous sex chromosome sequence such as 
amelogenin (Nakahori et al, 1991) steroid sulphatase (Liu et al, 1994) or ZFX/ZFY 
(C hongs al, 1993).
FISH with biotinylated probes was introduced Griffin et al (1991). Moreover, the 
same group simultaneously hybridised a biotinylated X probe and two digoxigenin 
labelled Y probes using FISH to establish dual-colour FISH as the preferred method 
of for embryo sexing (Griffin et al, 1992; 1994). Indirectly labelled probes originally 
employed were soon replaced by directly labelled probes reducing the time of the 
FISH procedure from 7 to 2 hours (Harper et al, 1994a; Harper and Delhanty, 1996). 
Nowadays, to misdiagnose a normal male embryo as a normal female embryo two 
errors must occur; the signal for chromosome Y must be lost and an extra signal for 
chromosome X must be generated. A further possibility for misdiagnosis can arise in 
the case when the embryo analysed is chaotic or grossly mosaic and the cells biopsied 
are not representative of the whole embryo (Kuo et al, 1998). However, only one 
FISH misdiagnosis occurred among 78 cycles of social sexing as reported to the 
ESHRE PGD consortium (2002).
1.5.2.2 Structural Aberrations
Structurally abnormal chromosomes are formed from the rearrangement, deletion or 
duplication of chromosomal segments leaving the karyotype either genetically 
balanced or unbalanced. Structural abnormalities include translocations (reciprocal or 
Robertsonian), deletions, inversions, insertions, ring chromosomes and 
isochromosomes (see Figure 1.6; section 1.2.1.2). Balanced translocations occur in
0.2% of the neonatal population, however are at a higher rate among infertile couples 
and patients with recurrent abortions (Munne, 2002). In a study, it was reported that 
balanced translocations were found in 0.6% of infertile couples, 3.2% of couples that 
had failed over 10 IVF cycles and 9.2% among fertile couples experiencing three or 
more consecutive first trimester abortions (Stem et al, 1999).
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With the advent of PGD, carriers of balanced translocations can circumvent repeated 
miscarriages or prenatal diagnosis and termination of pregnancy (TOP) of unbalanced 
fetuses and opt for PGD. The aim of PGD for translocations is to reduce the rate of 
spontaneous abortions and to minimise the risk of conceiving an unbalanced 
offspring. PGD for structural aberrations has been attempted using a variety of 
approaches with the aid of FISH. A number of reports concerning PGD have been 
published involving Robertsonian and reciprocal translocations, inversions, insertions, 
microdeletion syndromes and gonadal mosaicism (Conn et al, 1998, 1999; Iwarsson 
et al, 1998; Reubinoff et al, 1998; Scriven et al, 1998, 2001; Van Assche et al, 1999; 
Simopoulou et al, 2003).
Different approaches have been tried to identify structural chromosomal abnormalities 
including: a) probes spanning the breakpoints of each translocation or inversion 
(Cassel et al, 1997; Munne et al, 1998a and b) use of probes distal to the breakpoints 
or telomeric probes in combination with proximal or centromeric probes (Conn et al, 
1998; 1999; Munne et al, 1998g). Munne et al (1998a) employed FISH in polar 
bodies in order to identify the translocations using chromosome painting probes for 
the chromosomes involved in the translocation. This technique was later modified by 
the same group using telomeric probes to further enhance the regions not covered by 
the chromosome-paint probes (Munne et al, 1998b). Furthermore, spectral imaging 
has been applied in polar bodies to identify all 23 chromosomes, though it was found 
to be laborious and needed well-spread chromosomes in order to distinguish each one 
(Marquez et al, 1998). The drawback of polar body analysis for translocations is the 
occurrence of crossing over and predivision of chromatids (Munne et al, 1998a, b and 
f; Marquez et al, 1998). The result of the second meiotic division in both cases is 
unclear and either the second polar body or the blastomeres should be analysed. 
Moreover, Munne et al (1998f) detected interstitial crossover with subsequent 
segregation of balanced and unbalanced sets of chromosomes during the second 
meiotic division, which might cause problems during diagnosis.
1.5.2.2.1 Robertsonian Translocations
PGD for Robertsonian translocations has been carried out on biopsied polar bodies as 
well as blastomeres (Conn et al, 1998; Munne et al, 1998g; Scriven et al, 2001; 
Ogilvie and Scriven, 2004; Sermon et al, 2004). To detect Robertsonian translocations
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chromosome enumerator probes are used to count the chromosomes in the interphase 
nuclei in the cases of cleavage blastomere biopsy (Conn et al, 1998; Munne et al, 
1998g). Probes can be chosen which bind to any point on the long arm of each 
chromosome involved in the translocation. Studying infertile couples carrying 
Robertsonian translocations using FISH revealed two factors leading to infertility in 
some of these cases. Firstly the aneuploid segregation of Robertsonian translocations 
carried by the parent and secondly a factor acting at the post-zygotic level provoking 
an uncontrolled chromosome distribution in early cleavage stages giving rise to 
chaotic embryos (Conn et al, 1998). However, this latter factor was not supported by 
a recent study by Scriven et al (2001), which concluded that Robertsonian 
translocations do not predispose to embryos with abnormal cleavage division. 
Nevertheless all studies on Robertsonian translocation carriers have reported a high 
incidence of mosaicism on their resulting blastomeres of >60%. It has been shown 
that the most common mode of segregation is the alternate (85%) (Iwarsson et al, 
2000). This finding is in line with studies of meiotic segregation in sperm of male 
carriers of a Robertsonian translocation which displayed an incidence of 91% 
(Pellestor et al, 1987). However, recent data has shown that the pregnancy rates for 
maternal or paternal reciprocal or Robertsonian translocations are similar (Sermon et 
al, 2004)
1.5.2.2.2 Reciprocal Translocations
PGD is appropriate for those at high reproductive risk. Due to the complex nature of 
reciprocal translocations, each case is usually unique, hence difficult to treat by PGD 
(Harper and Bui, 2002). For reciprocal translocations the prevalence of unbalanced 
gametes is estimated to be between 50-70% (Gardner & Sutherland, 1996).
As mentioned above (see section 1.5.2.2) two types of FISH protocols have been 
devised for the investigation of reciprocal translocations; the use of spanning (Munne 
et al, 1998g) or flanking probes (Conn et al, 1998; Munne et al, 1998e). Breakpoint 
spanning probes used in interphase nuclei can detect normal, balanced or unbalanced 
karyotypes resulting from a reciprocal translocation (can also be used for inversions, 
deletions and duplications). The disadvantage with spanning probes and their seldom 
use in PGD is due to laborious, time-consuming and expensive probe development 
required for each breakpoint for each translocation. Methods used to produce these
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probes have been described by Fung et al (1998). For the flanking-probe approach, 
two probes would be used flanking the breakpoint of one chromosome and the third 
probe would be specific for the other chromosome. Conn and co-workers (1998) 
employed this strategy for studying a reciprocal translocation involving chromosomes 
6 and 21, being able to detect all segregation patterns apart from free trisomy and 
monosomy of chromosome 6, which is not viable. The disadvantage of using flanking 
probes is that balanced and normal embryos cannot be distinguished. This approach 
however, is the simplest owing to the commercialisation of sub-telomeric probes for 
most p  and q arms. Scriven et al (1998), suggested a generalized strategy involving 
chromosome specific sub-telomeric probes specific for the subtelomeric regions of the 
translocated segments, combined with proximal probes in order to provide a fast and 
reliable approach to PGD for cases of reciprocal, Robertsonian translocations, 
inversions and other complex chromosomal rearrangements.
Malmgrem et al (2002) performed CGH on embryos diagnosed as abnormal after 
PGD for two Robertsonian and four reciprocal translocations. The group was able to 
confirm the results of CGH supported by the PGD results in 11 out of 15 embryos. It 
was revealed that all the embryos (100%) were mosaic and it was further observed 
that some couples were more prone to generate chaotic embryos than others as shown 
previously by Delhanty et al (1997). However, imbalances involving a translocation 
with a very distal breakpoint could be missed as CGH resolution was limited and 
unreliable ratio changes appeared at the telomeric regions.
Several groups have revealed high rate of mosaicism and chaos during PGD for 
reciprocal translocations. Van Assche et al (1999) after analyzing 35 embryos from 
carriers of the most common reciprocal translocation, involving chromosomes 11 and 
22 (see section 1.3.1.2.2), revealed that use of four-colour FISH analysis allowed the 
identification of all the possible segregation modes using commercially available 
probes. The most common segregation pattern in reciprocal translocations is alternate, 
although considerable variations in the proportions of segregants in reports of male 
carriers exist (Iwarsson et al, 2000). Estop et al (1995) reported an average of 47% of 
alternate segregation mode and a very low rate of adjacent-2 segregation.
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It has been postulated that two mechanisms exist giving rise to the production of 
unbalanced gametes in patients with reciprocal translocations: a) one from meiotic 
crossing over involving the critical region between the centromere and the breakpoint 
and b) the other from abnormal meiotic segregation (Brandriff et al, 1986; Scriven et 
al, 1998). By contrast, Robertsonian translocations result in unbalanced gametes only 
as a consequence of abnormal meiotic segregation because there is no critical region 
(Munne et al, 2000).
1.5.2.2.3 Inversions and Insertions.
The majority of patients requesting PGD for inversions carry a pericentric inversion 
with a very large inverted segment. The FISH protocol devised for inversions utilises 
breakpoint spanning probes and were originally presented by Cassel and co-workers 
(1997) whilst performing PGD for inversions. The probe strategy devised for such 
cases involves a probe for one of the distal segments of the chromosome involved, 
which can then detect chromosome imbalance from either of the two possible 
recombinant chromosomes. Additional probes, with different fluorophores, on the 
same or different chromosomes can be added as a control as reported by Iwarsson et 
al (1998b).
PGD for insertions can be rather problematic since depending on whether synapsis 
takes place or not, several types of meiotic behaviour are possible that have to be 
taken into consideration while devising a strategy. The complexity of such cases is 
increased as the orientation of the inverted segment is often impossible to detect. 
Therefore, the use of a subtelomeric probe along with a locus specific for the inserted 
segment is essential.
1.5.2.3 Numerical Aberrations
The major causes of the decline in implantation observed with increased maternal age 
and embryo incompetence is aneuploidy. Navot et al (1994), transferred embryos 
from younger women to women >40years of age and observed a high implantation 
rate suggesting that the latter group’s ability to become pregnant is largely unaffected, 
whereas their oocyte quality is compromised. Altered oocyte metabolism such as ATP 
production (Van Blerkom et al, 1995) and excessive deposition of ZP glycoproteins
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(Garside et al, 1997) have also been linked with advanced maternal age. The increase 
in aneuploidy and maternal age seen in spontaneous abortions and live offspring after 
genetic analysis (Antonarakis et al, 1991; Fisher et al, 1991) has also been observed 
in unfertilised oocytes (Dailey et al, 1996) as well as human cleavage-stage embryos 
(Munne et al, 1995a and b). However, in the case of preimplantation embryos and 
oocytes, the rate of chromosomal abnormalities was significantly higher, suggesting 
that a proportion of chromosomally abnormal embryos are eliminated before any 
prenatal diagnosis (Munne et al, 1999). Close correlation between aneuploidy and 
declining implantation rates, prompted the hypothesis by Munne and co-workers 
(1993b) that selection of chromosomally normal embryos could reverse this trend. 
However, while some research groups have shown a positive attitude towards this 
kind of selection (Verlinsky and Kuliev, 1996b; Gianaroli et al, 1997a; 1999) other 
have doubted its value and feasibility (Egozcue, 1996; Reubinoff and Sushan, 1996). 
As well as being labour intensive PGD reduces the number of embryos available for 
transfer and the error rate is estimated to be 9-15% (Munne et al, 1998c). Clear 
benefits of this technique in terms of live birth rate per initiated cycle have yet to be 
shown in any large-scale prospective controlled study that would properly evaluate 
this technology and its effects (Braude et al, 2002). An international clinical trial is 
needed, with a suitably matched control group to determine if this procedure benefits 
older-aged IVF patients. Such trial would involve clinical settings with similar 
(identical if possible) stimulation protocols, IVF media, diagnostic procedures in 
different laboratories. The trial would consist of three groups of patients: women <35 
years of afe, women >35 years of age and the last “blind” group would have a mixture 
of ages. All patients should be assessed for the type of infertility and should be 
“healthy” individuals.
Couples opting for PGD of aneuploidy are mainly infertile and undergoing IVF/ICSI 
to overcome their infertility. There are three main indications for aneuploidy 
screening: 1) advanced maternal age (AMA), 2) recurrent miscarriage (RM) and 3) 
recurrent implantation failure (RIF). These patients are thought to be predisposed to 
producing aneuploid embryos which would die at or before the time of implantation 
(Wilton, 2002).
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1) Patients >39 years of age show the highest increase of aneuploidy (Marquez et al,
2000), however more recent data has suggested that PGD for aneuploidy can display 
an increase in implantation even for women between 35-39 years of age (though, not 
shown to be statistically significant) (Munne et al, 2003). Staessen et al (2004) in 
clinical randomised study showed that PGD-AS does not improve clinical outcome 
per initiated cycle in patients with AMA when there are no restrictions in the number 
of embryos to be transferred.
2) RM in patients with a normal karyotype is defined as three or more consecutive 
spontaneous abortions of less than 20-28 weeks’ gestation (Stephenson, 1996). PGD- 
AS has been performed in this category of patients (Pellicer et al, 1999; Rubio et al, 
2003), however, no differences in pregnancy or implantation have been observed.
3) RIF is defined as three or more failed IVF attempts or implantation failure after the 
replacement of more than 10 embryos (Munne et al, 2002). A study by the ESHRE 
PGD Consortium Steering Committee (2004) which covers cases from 25 centres, 
reported a pregnancy rate for RIF of only 7% per retrieval, compared to 28% for PGD 
of aneuploidy cases with the indication of AMA or RM. Gianaroli et al (2001b) 
reported results on 66 PGD cycles of RIF patients, which did not find any statistical 
significance between the implantation rate of the PGD group (17%) and the control 
group (10%). From those studies it can be postulated that there is no clear indication 
that RIF patients have benefited from PGD for aneuploidy.
FISH allows enumeration of chromosomes on preimplantation embryos of common 
aneuploidies (13, 14, 15, 16, 18, 21, 22, X and Y) testing either blastomeres from 
cleavage-stage embryos or oocyte polar bodies (Munne et al, 1993b; 1995a,b; 
1998c,e; Verlinsky et al, 1996b; Gianaroli et al, 1997a). Currently, probes for 
chromosomes 13, 14, 15, 16, 18, 21, 22, X and Y are being used simultaneously (with 
re-probing)(Bah9e et al, 2000), with the potential of detecting 70% of the 
aneuploidies detected in spontaneous abortions. Inclusion of probes for chromosomes 
16 and 22 is of particular importance as trisomies of these two chromosomes are the 
two most common autosomal aneuploidies observed in spontaneous abortions 
(Wilton, 2002). Thus far, more than 2000 cases of PGS have been performed, 
resulting in >400 chromosomally normal babies (Sermon et al, 2004).
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Misdiagnoses have been reported after PGD for aneuploidy (Munne et al, 1998c; 
Gianaroli et al, 2001; PGD Consortium 2005). In all of those cases, reanalysis of the 
misdiagnosed cells with probes binding to a different locus confirmed prior results, 
indicating that the errors were probably caused by mosaicism (Munne, 2003; see 
section 3.1.1). Other sources where misdiagnosis can occur include false monosomies 
produced by signal overlaps due to the failure of the FISH technique to display the 
remaining signals (Ruangvutilert et al, 2000a and b). Causes of reduced FISH 
hybridisation efficiency can be attributed to loss of DNA during denaturation or 
fixation, poor probe penetration, insufficient binding of detection reagents or overlap 
of chromosome-specific signals when multiple probes are used (Ruangvutilert et al, 
2000b; Munne et al, 2002)
Munne and colleagues (1999) revealed that couples undergoing PGD for common 
aneuploidies showed a significant decrease in cases of spontaneous abortions (from 
23% to 9%), whereas the ongoing pregnancies and deliveries in the PGD group of 
patients increased from 10.5% to 16.1%. Furthermore, several studies have displayed 
that after PGS, the incidence of multiple embryos being transferred has been 
significantly reduced (Munne et al, 2003; Werlin et al, 2003). However, this might be 
due to the fact that there are fewer chromosomally normal embryos to select after 
PGD. After 10 years of PGS, only recently has it been shown that PGS can increase 
implantation rates, when nine chromosomes were screened using FISH (Munne et al, 
2003 a). In this study the PGD group showed a 20% implantation rate compared to a 
10% rate in the control group in women with an average age of 40 years (Munne et al, 
2003).
Recently PGS has been carried out on using CGH (Wilton et al, 2001; Wells et al, 
2002; section 1.4.1.2).
1.5.2.4 Single Cell FISH Limitations
FISH has been hailed as one of the most robust and efficient techniques however, it 
has certain limitations. When using FISH to analyse chromosome constitutions, 
several obstacles emerge, including failure of hybridisation, probe inefficiency, signal 
overlapping yielding false negative results and split/diffused/patchy signals (Munne et
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al, 1998a; Ruangvutilert et al, 2000a). Most importantly FISH is limited by the 
number of probes that can be simultaneously applied due to an increasing chance of 
FISH artefacts and FISH failure and lack of colours, since it is not possible to look at 
all chromosomes in one interphase (Ruangvutilert et al, 2000b). However, as many as 
six different chromosomes have been simultaneously analysed by Munne et al 
(1998c) and Gianaroli and colleagues (1999), achieving a total of nine chromosomes 
studied per cell with a second sequential hybridisation.
1.5.3 Single Gene Disorders
Almost any source that contains one or more intact target DNA molecules can, in 
theory, be amplified by PCR, providing appropriate primers can be designed. This has 
been of great interest to researchers as well as clinical geneticists, forensic scientists 
and even scientists involved in archaeological biological findings. Single cell PCR has 
enabled geneticists to carry out PGD. By employing PCR, the 5-10pg of DNA in a 
single blastomere is amplified in order to make the DNA amenable to conventional 
forms of mutation analysis (Wells and Delhanty, 2001). Over 8,000 disorders caused 
by single gene defects have been described. The first autosomal single gene disorder 
to be analysed by PGD was cystic fibrosis more than ten years ago (Handyside et al, 
1992). Since then, methods and procedures have improved, allowing more and more 
PGD protocols to be devised for monogenic diseases. To date many single gene defect 
diseases can be treated with PGD. Fluorescent dyes, multiplex reactions as well whole 
genome amplification techniques have been employed during PGD with PCR (see 
sections 1.5.3.1-3). Several inherent difficulties that are associated with single cell 
DNA amplification have become evident. These include potential sample 
contamination, total PCR failure, allelic dropout and preferential amplification, all of 
which should be minimised for any PGD PCR protocol before clinical application 
(see section 1.5.3.4). In addition, the chosen method must reliably and accurately 
characterise the genotype of the embryo relative to the disorder under investigation.
Initial work to develop PGD for single gene diseases began with the common 
disorders for which mutation profiles and prenatal diagnostic tests were already well 
established such as CF and the haemoglobinopathies (Monk et al, 1988; Monk and 
Holding, 1990; Liu et al, 1992). The first single gene defect to be diagnosed was
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cystic fibrosis which was accomplished using simple heteroduplex analysis to identify 
unaffected homozygous normal and heterozygous embryos for transfer (Handyside et 
al, 1992). Since then increasingly sophisticated PCR-based protocols have been 
developed and applied for many single gene defects on a list which is growing 
steadily along with patient demand and technological advances (Wells and Delhanty,
2001). These include Tay-Sachs disease (Gibbons et al, 1995), Duchenne muscular 
dystrophy (Lui et al, 1995), Marfan syndrome, (Harton et al., 1996), spinal muscular 
atrophy (Dreesen et al., 1998), Lesch-Nyhan syndrome (Ray et al., 1999), sickle cell 
anaemia (Xu et al., 1999) as well as the triplet repeat expansion disorders Huntingtons 
disease (Sermon et al, 1999), myotonic dystrophy (Sermon et al., 1998a,b; 
Piyamonkol et al., 2001), Fragile X (Sermon et al, 1999; Apessos et al., 2001) and 
inherited cancer syndromes, familial adenomatous polyposis coli (FAPC) (Ao et al., 
1998), Li-Fraumeni syndrome (Verlinsky et al., 2001) and neurofibromatosis type-1 
and type-2 (NF-1 and NF-2) (Abou Sleiman et al., 2002).
PGD on the 1st polar body (PB) was first introduced by Verlinsky et al (1992). 
However, this analysis was not sufficient since the genotype of embryos resulting 
from diagnosed heterozygous oocytes was not predictable and testing of the 2nd PB 
was required. Therefore, Verlinsky and co-workers (1997) carried out 1st and 2nd PB 
analysis for PGD of sickle cell disease, haemophilia B and cystic fibrosis. 
Furthermore, the same technique was later performed on patients at risk of producing 
offspring affected with Neurofibromatosis type-I (NF-1) (Verlinsky et al, 2002). The 
same group have continued using the ‘two-step PB analysis of oocytes’ as their 
preferred method for PGD of single gene disorders, because they have reported that 
ADO is at least half as frequent in PB’s than in blastomeres (Rechitsky et al, 1998), 
which has not been by corroborated by any other study. Dean and co-workers (2003) 
introduced the prospect of PGD for heritable mitochondrial diseases on polar bodies 
using PCR. The group studied the levels of heteroplasmy on polar bodies, oocytes and 
embryos from a heteroplasmic mouse model to assess the relative proportions of each 
of the two mitochondrial DNA genotypes in gametes and early cleavage stage 
embryos. They concluded that PGD for mitochondrial DNA diseases is feasible, 
although it should be approached with caution (Dean et al, 2003). Currently, most
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PGD cases involving single gene defects are performed on blastomeres of cleavage- 
stage human embryos, thus making PB analysis at the single gene level scarce.
1.5.3.1 Microsatellite DNA (STR’s)
Microsatellite DNA is a subclass of tandemly repeat DNA found throughout the 
human genome mostly in non-encoding loci and is also referred to as short tandem 
repeats (STR’s) (Ellegren, 2004). The most common type of microsatellite DNA are 
dinucleotide repeats, comprising 0.5% of the genome, whilst the total microsatellite 
DNA comprises approximately 2-3% of the genome (IHGSC, 2001). Other types of 
microsatellite DNA include mono-, tri- and tetra-nucleotide repeats. A significant 
feature of microsatellite DNA is that its polymorphic nature i.e. the variability in 
repetitive DNA is in the number of repeat units, which confers variability in length 
rather than sequence. STR’s have been used extensively for PGD of single gene 
disorders to overcome the problems of ADO and contamination (Sermon et al, 2001; 
Piyamongkol et al, 2001a and b). This has been achieved by carrying out multiplex 
reactions incorporating one to two STR’s in addition to the mutation marker 
(Piyamongkol et al, 2001a)
During STR amplification, the incidence of so-called ‘shadow bands’ have been 
reported by many groups especially during single cell PCR. It has been suggested that 
such bands, termed stutter bands, represent mutations in the repeat sequence and are 
thought to have arisen due to replication slippage (Hauge and Litt, 1993). Replication 
slippage occurs due to mispairing between two complementary DNA strands during 
DNA replication. One strand dissociates from its complementary strand during 
replication, only to re-associate to its complementary strand incorrectly, causing an 
increase or a decrease in one repeat unit length. It has been noticed that stutter bands 
are more prominent in amplification of mono- and dinucleotide repeats and are 
usually one repeat unit length shorter than the main allele (Ellegren, 2004). Stutter 
bands usually cause problems when allele scoring of heterozygote individuals whose 
alleles are close in size.
Multiplex PCR reactions during single cell work are designed to alleviate the problem 
of ADO and contamination. The need to design protocols which include amplification
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of more than one (singleplex) primer has mostly been the case during PGD cases. 
Incorporation of STR’s linked to the disease gene or unlinked i.e. located in another 
chromosome require alterations in the PCR protocol. Laborious and time-consuming 
testing is required especially whilst performing on single cell DNA in order to acquire 
analysable results from more than 2 primers when multiplexing. Primers must be 
designed, ideally, to have similar annealing temperatures and must not be competing 
for reagents such as the dNTP’s or the Mg+2. Furthermore, when designing PCR 
protocols for single gene disorders, a variety of STR’s may be informative for 
different families. Thus, the need to develop several multiplex protocols according to 
each family and in single cell DNA can be time consuming and not cost-effective.
1.5.3.2 Single Cell F-PCR
The introduction of F-PCR (see section 1.3.3.2.1) has boosted single cell analysis 
driving scientists to achieve analysis as well as diagnosis of single gene mutations 
accurately. It has been concluded that F-PCR was an efficient tool for PGD of 
Steinert’s disease (myotonic dystrophy) (Sermon et al, 1997; Piyamongkol et al, 
2001a). Currently, most diagnoses before implantation for inherited monogenic 
diseases are carried out using multiplex F-PCR (see section 1.5.3.2). In this type of 
diagnosis it amplifies, short tandem repeat (STR) markers which are highly 
polymorphic loci of differing numbers of a 2-5 base pair repeated unit. The 
polymorphic nature of STR markers allows the determination of the origin and purity 
of DNA amplified e.g. from single cells. Flence, if the STR allele sizes are known, 
any impurities or unexplained sizes can be distinguished. Furthermore, in extreme 
cases of preferential amplification, with conventional PCR product detection 
techniques it may seem as ADO, whereas F-PCR may still demonstrate the presence 
of both alleles with one greatly amplified relative to the other (Sherlock et al, 1998).
1.5.3.3 Single Cell Multiplex PCR
Single-cell PCR has the disadvantage that just one amplification reaction can be 
undertaken. When several different primers are combined within a single PCR assay, 
each can multiply independently and sufficiently, allowing simultaneous diagnoses to 
be performed. Furthermore, multiplex PCR can alleviate problems caused by ADO 
(Kuliev et al, 1998). When a disease-causing mutation marker and an informative
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polymorphism for the respective mutation are multiplexed, there are two chances of 
for the detection of a chromosome carrying a mutant gene. Thus, if one primer does 
not amplify due to ADO, there is another primer for backup. It has been postulated 
that ADO is independent for each fragment amplified in a multiplex PCR assay and 
the probability of ADO affecting both the mutation site and the linked polymorphism 
are very low (Ao et al, 1998). Lewis et al (2001), developed a a mathematical model 
to explore accuracy of PGD using PCR by including both extrinsic technical errors 
and intrinsic errors related to nuclear and chromosomal abnormalities. It was 
suggested in that study that a linked marker or a second biopsied cell reduces the 
probability of replacing an affected embryo (Lewis et al, 2001)
1.5.3.4 Single Cell WGA
WGA can be used for amplification of low copy numbers of the entire genome 
(Zhang et al, 1992) and provide sufficient DNA templates for many independent PCR 
amplifications (Wells and Sherlock, 1998). Hence several studies have been 
performed assessing the use of WGA in the context of PGD.
Ao et al (1998) was able to perform PGD for familial adenomatous polyposis coli 
(FAPC), after amplifying two biopsied blastomeres from each embryo with PEP and 
subsequently carrying out nested PCR to amplify two APC fragments. Following PEP 
the APC mutation and the linked polymorphism achieved 87.5% and 75% 
amplification respectively.
Applying DOP-PCR to single fibroblasts, buccal cells, amniocytes and human 
blastomeres, Wells et al (1999) showed that it could provide DNA sufficient for 
performing 100 subsequent PCR amplifications as well as CGH analysis. Voullaire 
and colleagues (1999) showed that DOP-PCR was able to successfully amplify single 
cells in such quantities able to provide diagnosis of aneuploidy using CGH. Despite 
hopes that WGA strategies might reduce the incidence of allele drop out, Wells and 
Sherlock (1998) found ADO rates after PEP and DOP-PCR to be comparable to those 
obtained by direct amplification of single cell loci.
105
Chapter I -Introduction
MDA is a method of whole genome amplification that utilises the bacteriophage (p29 
DNA polymerase for isothermal displacement amplification (Dean et al, 2001; see 
section 1.3.3.1.3). Recently, Handyside et al (2004) reported that isothermal WGA 
from single and small numbers of lymphocytes and blastomeres isolated from 
cleavage stage embryos yielded microgram quantities of amplified DNA. 20 different 
loci were successfully analysed, but a relatively high ADO of 31 % at heterozygous 
loci was found (Handyside et al, 2004).
1.5.3.5 WGA and STR’s
Whole genome amplification (WGA) has been reported by Wells and colleagues 
(1999), as an efficient means to generate sufficient quantities of DNA for as many as 
90 independent amplification reactions from a single cell. Thus, numerous specific 
loci and subsequently copy number of every chromosome (using comparative 
genomic hybridisation, CGH) can be assessed in a single cell.
WGA may be defined as the non-specific amplification of all sequences in the 
genome (Wells and Sherlock, 1998). There are different types of WGA, with three 
techniques being the most notable in context of embryo research and PGD, namely 
PEP, DOP-PCR and MDA (sections 1.3.3.1.3 and 1.6.3.3). PEP has been used 
clinically in the context of PGD of familial adenomatous polyposis coli (Ao et al, 
1998). DOP-PCR has been found to be the choice of method, especially for CGH 
since it results in larger amounts of DNA being produced (Wells et al, 1999; Chapter
4). It has been proposed that WGA would be beneficial for patients undergoing PGD 
for single gene disorders who are also of advanced maternal age since detection of the 
single gene disorder as well as chromosome complement of the embryos can be 
performed (Wells, 2004). WGA could reduce the significance of the risks of ADO 
and achieve enhanced detection of contamination without the need to perform 
multiplex reactions. However, this is based on the assumption that a single cell can be 
amplified in full, without bias, such that one could rely on subsequent tests performed 
on the DOP-PCR product. By performing microsatellite marker genotyping of the 
DOP-PCR amplified product, this would allow testing for coverage of the genome.
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Cheung and Nelson (1996) first attempted to amplify different types of STR’s after 
WGA with DOP-PCR. The study was carried out on genomic DNA and it was 
concluded that DOP-PCR provides relatively good coverage of the genome, however, 
is dependant on the amount of starting DNA. Wells and co-workers (1999) studied 
DOP-PCR on single cells, in addition to other WGA techniques, in order to 
investigate the most suitable WGA protocol for CGH analysis. The idea of producing 
enough DNA from a single cell and then perform separate PCR reactions would be 
ideal for PGD of single gene disorders.
1.5.3.6 Single Cell Mini-Sequencing
The amount of time and resources required for the design and validation of a novel 
PGD strategy limits the number of protocols that a laboratory can develop. 
Furthermore, developing a PGD strategy is not cost-effective especially for rare 
mutations which can only be used for a handful of families; hence, a universal 
methodology applicable to several mutations would accelerate the rate of which new 
methods can be developed and reduce the cost (Bermudez et al, 2003). Mini­
sequencing has recently been proposed as an alternative technique able to tackle 
disease involving a heterogeneous spectrum of mutations, such as cystic fibrosis, p- 
thalassaemia or haemophilia A in PGD (Fiorentino et al, 2003). The basis of mini­
sequencing is similar to that of sequencing apart from the fact that the nucleotides 
added to the reaction are of the labelled dideoxy type (ddNTP) i.e. only a single 
nucleotide can be added to the primer thus preventing further extension. The primers 
designed for mini-sequencing anneal to the template at the 3’ end, one nucleotide 
upstream of a known mutation/polymorphism. The ddNTP added to the primer is able 
to reveal the identity of the base of this site. Bermudez et al (2003) assessed mini­
sequencing as a method for single cell analysis and concluded that although expensive 
compared to established methods, it is rapid and accurate in diagnosing disease- 
causing mutations in single cells and the near-universal applicability of this method 
could shorten the time required for devising PGD protocols. Fiorentino and co­
workers (2003) were able to interpret results from 96.5% of the 887 blastomeres 
tested, including 55 PGD cases. This technique may be particularly useful in cases 
where the mutation involved is difficult to assess by restriction analysis or other 
commonly used methods.
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1.5.3.7 Single Cell PCR Limitations
1.5.3.7.1 Contamination
Single cell PCR assays usually employ a large number of cycles to be carried, 
especially for sufficient amplification of a single cell. Contamination can be caused 
by cumulus cells of maternal origin, sperm, culture media and the PCR products 
present in the laboratory environment (Delhanty, 1998). To improve the PCR 
technique the protocol has changed over the years to reduce contamination. The 
introduction of ICSI, where the oocyte is fertilised by the injection of a single sperm 
into the cytoplasm, thus avoiding excess sperm often left embedded in the zona 
pellucida following IVF, reduces paternal contamination (Wells and Delhanty, 2001). 
In addition some PGD protocols attempt to detect contaminants by amplifying a 
highly polymorphic locus for DNA fingerprinting (Findlay, 2000; Piyamongkol et al, 
2001a). Single-cell PCR should be set up in a DNA-ffee environment away from the 
analysis area, which can reduce the chance of ‘carry over’ contamination.
Nested PCR was developed to increase sensitivity and specificity (Monk and Holding, 
1990) addressing the problem of “carry over” contamination. Nested PCR is widely 
used in PGD and is based on the use of two sequential amplification reactions in order 
to enhance the specificity of PCR and reduce the risk of contamination caused by the 
accidental amplification of DNA fragments (Wells and Sherlock, 1998). The use of 
nested PCR by aliquoting the first amplified products for use as the target template in 
a second reaction using another set of primers (markers) situated internally to those 
used in the first reaction was suggested to prevent carry over contamination (Wells 
and Sherlock, 1998). Furthermore, Multiplex-PCR may substantially decrease the 
possibility of misdiagnosis (Lewis et al, 2001), by providing the added assurance of a 
partial “fingerprint” of the embryo, and confirming that the amplified fragment is of 
embryonic origin (Findlay et al, 1995). Piyamongkol et al (2000a) showed that the 
use of DNA fingerprinting can increase the detection of the contaminants. Ideally 
linked (Rechitsky et al, 1998; Dressen et al, 2000; Piyamongkol et al, 2001a and b) or 
unlinked polymorphic markers, which are informative for the family undergoing PGD 
should be employed (Kuliev et al, 1998; Ioulianos et al, 2000; Harper et al, 2002). 
For these markers the parents should have four different alleles e.g. A and B (mother), 
C and D (father); hence, during analysis of the embryo it should have one allele from
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each parent e.g. AC, AD, BC or BD. Any other pattern e.g. ABD or ACD would 
indicate presence of contaminants. Moreover, multiplex F-PCR is considered 
approximately 1000-fold more sensitive than conventional agarose or acrylamide gel 
analysis (Findlay, 2002). Despite all efforts, paternal and maternal contamination has 
caused misdiagnosis (Sermon et al, 1998; Harper and Delhanty, 2000).
1.5.3.7.2 Amplification Failure
The problem of AF of single cell PCR emerged when a misdiagnosis from the first 
series of PGD for X-linked disorders was reported (Hardy and Handyside, 1992). 
Whilst amplifying single cells, even an experienced PCR practitioner might face the 
obstacle of total failure of amplification. AF can between 10-20% (Kontogianni et al, 
1996; Wells and Sherlock, 1998; Piyamongkol et al, 2003) and the underlying reasons 
of this relatively high incidence are difficult to determine. The cause of AF cannot be 
distinguished empirically. However the loss of the isolated single cell during transfer 
into the PCR tube or the chance that the cell is anucleate or in the process of 
degeneration have been considered as likely candidates. Furthermore, DNA in the cell 
nucleus might not have been made accessible to the PCR reagents due to failure of 
cell lysis (Piyamongkol et al, 2003).
1.5.3.7.3 Allele Dropout
ADO is the amplification of only one of the two parental alleles present in the single 
cell, which is usually caused due to sub-optimal PCR conditions and rapid 
degradation of the target DNA during thermocycling (Handyside et al, 1997). Several 
factors have been linked with the struggle against ADO including increased 
denaturation temperature (Ray et al, 1996; Lissens and Sermon, 1997), different lysis 
methods (Sermon et al, 1995) and F-PCR (Findlay et al, 1995a). When ADO is 
encountered it gives the perception that the cell is homozygous which can lead to 
misdiagnosis when applying PCR for PGD analyses in dominant disorders. If the 
affected allele does not amplify, the embryo will be diagnosed as normal, when 
actually it is affected. For autosomal recessive diseases in couples carrying the same 
mutation, the consequences of ADO are minimal; the loss of the normal allele in 
carrier embryos will result in an apparently affected embryo that will not be replaced. 
In the case where the affected allele is lost, this will lead to diagnosis of a 
homozygous normal embryo instead of a carrier (Fasouliotis and Schenker, 1998). In
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a recent large study of single blastomeres and single buccal cells all possible aspects 
of PCR were investigated regarding their effect on allele drop-out. It was revealed that 
ADO is affected by amplicon size, amount of DNA degradation, freezing and 
thawing, the PCR programme and the number of cells simultaneously amplified 
(Piyamongkol et al, 2003). In the same study, factors which had little or no affect on 
ADO were local DNA sequence, denaturing temperature (94°C or 96°C) and type of 
cell (buccal or blastomere). Fluorescent PCR technology (See section 1.2.3.1.2) is 
having a wide impact on the PGD of single gene disorders proving to be more 
sensitive, reliable, accurate, and fewer cycles are required, thereby reducing the time 
taken to reach diagnosis (Findlay et al, 1996; Sermon et al, 1998). Furthermore, F- 
PCR technology has been found to be amenable to automation.
A different approach, which involves the combination of FISH and PCR techniques, 
has been reported by Thornhill and colleagues (1994) termed cell recycling. Cell 
recycling is performed by fixing a cell onto a glass slide and initially carrying out 
PCR and then FISH. These combined analyses can serve independently for sexing for 
X-linked diseases or for PGD of single gene defects. The combined efficiency of both 
techniques ranges from 65-85% (Monk and Thornhill, 1996; Rechitsky et al, 1996). 
However, the ADO rates were reported to be considerably higher than in conventional 
single cell PCR, in both studies above.
1.5.4 PGD for DM
Sermon and colleagues (1997) were the first group to develop a single cell PCR assay 
able to detect DM affected embryos during clinical application of PGD. It was 
reported, in this first attempt of PGD for DM, that ADO affected 24% of the biopsied 
cells in the clinical setting and 21% of the cells in the research setting (Sermon et al, 
1997). Although, these figures are considered high, there was no use of multiplex or 
fluorescence PCR techniques. The same group was able to increase their amplification 
efficiency from 87% to 95% during another study where F-PCR and automated 
fragment analysis was performed and significantly decrease their ADO rate (4.5%) in 
a clinical setting (Sermon et al, 1998a). However, the same group reported a 
misdiagnosis case during the latter study (Sermon et al, 1999). Piyamongkol et al 
(2001a) was among the first to carry out PGD on DM patients using the combination
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of multiplex and fluorescent PCR. By incorporating informative polymorphic markers 
(single tandem repeats), which are linked to the disease gene and a marker for the 
mutation, affected embryos can be distinguished thus reducing ADO and AF rates. 
Furthermore, polymorphic markers, which not linked to the disease gene, can act as 
contamination markers able to detect contamination of any sort. In an ideal PCR 
protocol a mutation marker, a linked marker and a contamination marker should be 
multiplexed (as long as they are informative for the respective patients) to minimise 
the risks associated with single cell PCR. Dean et al (2001) were able to reduce the 
ADO rates (during clinical PGD) using a hemi-nested multiplex F-PCR protocol to 
0% for the DM locus and 18% for the linked polymorphic marker.
1.6 Mosaicism in Human Preimplantation Embryos
The advent of IVF as a treatment for infertility has created the opportunity to study 
the chromosomal constitution of surplus human preimplantation embryos. An 
increasing body of evidence suggests that the incidence of chromosomal 
abnormalities in embryos is extremely high (Wilton, 2002) and even good embryo 
morphology does not necessarily exclude an abnormal chromosome constitution 
(Magli et al, 2000).
Mosaicism is defined as the presence in an individual or in a tissue of two or more 
cell lines, which differ in their genetic constitution but are derived from the same 
zygote. Little is known about the mechanisms of mosaicism. Sometimes mosaicism is 
described for chromosomal trisomy and diploidy however, the abnormal cell line may 
be represented by other chromosomal abnormalities such as sex chromosome 
monosomy, triploidy or structural rearrangement (Kalousek, 2000).
Delhanty et al (1993) first noted the presence of mosaicism as a common feature in 
preimplantation embryos whilst analysing the X and Y chromosomes using interphase 
FISH. A high degree of mosaicism has been detected in several FISH studies 
(Delhanty et al, 1993, 1997 (Table 1.1); Harper et al, 1994, 1995; Munne and Weier, 
1996 (Table 1.2); Munne et al, 1998c, d, e; Iwarsson et al, 1999; Ruangvutilert et al, 
2000a), karyotyping studies (Jamieson et a l, 1994; Clouston et al, 1997, 2002) and 
CGH studies (Wells and Delhanty, 2000; Voullaire et al, 2000; Malmgrem et al,
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2002). The frequency of chromosomal abnormality in early cleavage embryos has 
also made a major impact in IVF and human reproductive biology. It is well known 
that in routine IVF, at the cleavage stage, each transferred embryo has only about a 1 
in 5 chance of implantation (Delhanty and Harper, 2000).
Table 1.1 Classification of human embryonic mosaicism adapted from Delhanty et al 
(1997)
Classification Explanation
Uniformly Normal Embryo uniformly normal for the
chromosomes tested
m N M K h m w h n H B H  tf IfSjji
Embryo uniformly abnormal for theUniformly Abnormal
chromosomes tested
Diploid Mosaic
Aneuploid or Polyploid Mosaic
Chaotic
Majority of embryo euploid but one or a 
few cells differ (i.e. aneuploid, polyploid 
or haploid).
Majority of embryo uniformly aneuploid 
or polyploid but one or a few cells differ 
Chromosome constitution varies 
randomly from cell to cell and status of 
original zygote cannot usually be 
determined
Table 1.2. Chromosomal patterns in cleavage stage embryos as described by Munne 
and Weier (1996)
(i) Normal -  Embryos whose chromosome constitution is >90% either 
normal or aneuploidy or haploid or polyploidy.
(ii) Mosaic embryos containing a majority of diploid cells*
a. Diploid mosaics
i. Majority of diploid embryos with few being aneuploid, haploid 
or teraploid
ii. Embryos which contain a diploid and a polyploid cell line 
(2n/4n)
b. Polyploid mosaics -  embryos with a polyploid cell line
c. Haploid mosaics -  embryos with a haploid cell line
(iii) Mosaic
a. Extensive -  embryos with >38% of abnormal cells
b. Limited -  embryos with <38% of abnormal cells
(iv) Chaotic - nuclei showing randomly different chromosome complements
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*This category includes mosaic embryos that contain a majority of abnormal cells 
(e.g. due to presumptive meiotic error and also embryos in which the majority of cells 
are normal).
It has been suggested that all types of mosaicism have the same impact on embryo 
development (Sandalinas et al, 2000). Delhanty et al (1997) classified the 
chromosome patterns in cleavage stage embryos into four groups: uniformly normal, 
uniformly abnormal, mosaic and chaotic (Table 1.1). These observations were 
confirmed by Clouston et al, (1997), who karyotyped nuclei from 6- to 8-day human 
blastocysts and proposed that all four groups were also observed at that stage. 
Furthermore, the same patterns have been observed in human blastocysts 
(Ruangvutilert et al 2000a).
The delineation of the extent and nature of mosaic and non-mosaic chromosome 
abnormalities in early human preimplantation embryos is important for understanding 
the origins and selective processes leading to the anomalies seen later in gestation. 
Therefore it is important to try to understand the underlying mechanisms responsible 
for mosaic cell lines. The different types of mosaicism and their underlying 
mechanisms are better understood by reviewing the different types of analysis that 
have been used to investigate embryos
1.6.1 Mosaicism and Karyotyping
Karyotyping was amongst the first technique to be used for embryo analysis. It is a 
robust staining technique using a variety of dyes including DAPI (4, 6-diamino-2- 
phenylindole) and Giemsa to produce characteristic bands along each chromosome in 
order to carry out chromosome enumeration and structural analysis (Ronne et al, 
1990; Glassman, 1997; section 1.3.1).
Angell et al (1983) whilst examining 8-cell stage embryos revealed a high incidence 
of chromosomal abnormalities which she suggested was contributing to early 
embryonic loss and to the high failure rate after embryo transfer. This was the first 
report on haploid human embryos with an incidence of 20% suggesting parthenogenic 
activation of the oocyte, which was later confirmed by Plachot (1985). Angell et al
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(1986) carried out another karyotyping study trying to assess the contribution of lethal 
chromosome abnormalities to implantation failure and found non-disjunction giving 
rise to trisomy, monosomy, nullisomy, as well as structural abnormalities, haploidy 
and triploidy. In the same study it was revealed that chromosomally abnormal 
embryos could not be distinguished on morphological criteria from embryos of 
normal chromosomal constitution based on similar cleavage rates, which was also 
supported by Jamieson et al (1994). However, it was later concluded that only the 
embryos which were very fragmented and degenerated were shown to display a 
higher rate of chromosomal abnormalities (78%) when compared with 
morphologically healthy embryos (Plachot et al, 1989). Similar findings were 
observed by Pellestor et a l (1995) which showed that the rate of abnormalities were 
significantly higher in dysmorphic embryos (86.6%) than in good quality embryos 
(36.6%). Hence, these findings confirm the prognostic value of the grading system as 
a means of eliminating a large proportion of chromosomally abnormal embryos 
(Pellestor et al, 1995). The most significant findings whilst carrying out cytogenetic 
analysis on human preimplantation embryos was the correlation of chromosomal 
aberrations and maternal age. Maternal age was found to be directly proportional to 
aneuploidy frequency (Angell et al, 1986; Plachot et al, 1987; 1989), particularly 
affecting aneuploidies of the small satellited chromosomes of Group G (Zenzes and 
Casper, 1991).
Chromosomal abnormalities on human preimplantation embryos have also been 
linked to certain parameters of IVF such as oocyte retrieval and constitution of culture 
media (Angell et al, 1983; Pellestor et al, 1995). Ovarian hyperstimulation might be 
involved in the immaturity or overmaturity of the oocytes retrieved having a serious 
effect on the fertilization process (Testart et al, 1989) as well as delayed IVF might 
also lead to triploidy, abnormal cleavage, and fragmentation (Plachot et al, 1988). 
Moreover, delay in gamete fusion could also lead to asynchronisation of both 
formation and migration of the male and female pronuclei, resulting in cleavage 
disturbance and chromosome set fragmentation (Ron-El et al, 1991).
Several karyotyping studies reported chaotic findings while trying to detect mosaic 
and non-mosaic chromosome abnormalities (Angell et al, 1986; Plachot et al, 1989; 
Papadopoulos et al, 1989; Jamieson et al, 1994; Clouston et al, 1997; Clouston et al,
114
Chapter 1 -Introduction
2002) (Table 1.3). It has been proposed that hypodiploidy, hyperdiploidy and 
structural chromosome damage reflect the same basic phenomenon, termed 
uncontrolled or chaotic division (Clouston et al, 1997), predicted by FISH studies 
(Harper et al, 1995). Studies have shown significant levels of tetraploidy, usually 
mosaic, whilst karyotyping of about 19-23% (Angell et al, 1987; Jamieson et al, 
1994; Clouston et al, 1997). From karyotypic analysis of human blastocysts it was 
suggested that mosaic tetraploidy might result due to failure of cytokinesis (Hardy et 
al, 1993). The production of mosaic tetraploidy as a common event in early 
embryogenesis was also confirmed by a recent study on blastocysts (Clouston et al, 
2002). Mosaic monosomy was not detected in a study by Clouston et al (2002), due to 
technical difficulties and haploid cells were completely lacking in the same study
Table 1.3. Frequency of mosaicism in human preimplantation embryos after 
karyotypic analysis
Papadopoulos 
et al, 1989
Jamieson et 
al, 1994
Clouston et al, 
1997
Clouston et al, 
2002
No. of embryos 
observed
35 178 73 (blastocysts) 182(blastocysts)
Diploid
(including abnormal 
cells)
40% 22.5% 67% 68%
Mosaic polyploid 
(mainly tetraploidy)
3% 2.2% 18% 28%
Mosaic aneuploid 
(mainly trisomies)
9% 19% 7% 5%
Chaotic cells 5/35 6/178 1/73 -
Structural
chromosome damage
26% 1.1% 26% %
* Some of the studies do not add up to 100%. This is due to the presence of 
abnormalities that cannot be classified
Although results observed from karyotypic analysis have shown that a certain level of 
mosaicism exists, several technical difficulties have limited the conclusion that can be 
drawn from these studies. These technical difficulties include problematic fixation
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methods resulting in loss of chromosomes and over dispersed or poorly spread cells 
which are not in a single focal lane restricting the potential of analysis (Harper et al, 
1995). Also, long colcemid exposure times are able to increase the mitotic index but 
this produces highly contracted chromosomes that exhibit chromatid separation and 
G-band poorly compromising the information obtained (Jamieson et al, 1995). The 
most important limitation during G-banding is that only a few metaphases can be 
obtained hence only a small proportion of the cells can be analysed.
Spectral karyotyping (SKY) is a technique which employs 24 chromosome specific 
probes and has been considered an alternative to conventional cytogenetic analysis 
(Schrock et al, 1996). Each probe is labelled with different proportions of five 
separate fluorochromes and observed by spectral imaging, providing a different 
colour for each human chromosome. It has been applied to human oocytes and polar 
bodies, being able to simultaneously detect specific aneuploidies as well as de novo 
structural abnormalities, such as acentric fragments, translocations and marker 
chromosomes (Marquez et al, 1998). The analysis on first polar bodies provided 
useful data for polar body genetic diagnosis (Marquez et al, 1998). However, 
currently the technique is known to be fairly unreliable especially as it requires good 
quality chromosome spreads (Wells and Levy, 2003). Therefore, it would be more 
suitably employed in a research rather than in a clinical setting
1.6.2 Mosaicism and FISH
FISH has been widely applied in studies of oocytes, polar bodies, spermatozoa, 
blastomeres and blastocysts (sections 1.3.2.2). High levels of mosaicism and chaotic 
embryos have been reported in all embryonic stages (Delhanty et al, 1997; Clouston 
et al, 1997). Chaotics or those with a majority of abnormal cells are unlikely to 
survive beyond implantation (Harper and Delhanty, 2000; Table 1.1). Chromosomal 
abnormalities and mosaicism have been described in arrested and morphologically 
abnormal embryos (Munne and Cohen, 1998) as well as in normally developing 
embryos (Harper et al, 1995; Delhanty et al, 1997). Different types of mosaicism have 
been reported through FISH analysis including aneuploid mosaics, olyploidy and 
haploid mosaics, chaotic mosaics and multinucleation. Thus each type should be 
explored individually to understand their underlying mechanisms. Each type of
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mosaicism observed in human preimplantation embryos using FISH is explored in 
section 3.1.4, in order to fully understand the different forms of mosaic embryos and 
explain the mechanisms that various FISH studies have revealed. In Table 1.4, the 
data obtained from several studies carrying out FISH in human cleavage stage 
embryos and blastocysts is summarised. The table reveals high levels of mosaicism 
found in several studies both on cleavage stage embryos and human blastocysts.
Table 1.4. Summary of studies carried out on normally developing human cleavage-
stage embryos by applying FISH to investigate the extent of mosaicism
Study/Chromosomes
observed
No. of 
embryos Normal
Abnormal Mosaic
Diploid
Mosaic 
Abnormal§ Chaotic
Delhanty et al (1993) / X, Y 4 50% 25% 25% - 0
Munne et al (1994) / 
18, X & Y
67 0 2% 52%# 40% 6%
Coonen et al (1994) / 
1,7, X and Y
37 38% 8% 55% - -
Harper et al {1995) / 1, 7 35 54% 9% 23% 0 14%
Kligman et al (1996) / 
13, 18, 21, X and Y
47 23% 21% 51% 4%
Delhanty et al {1997) / 
1,7, X and Y
93 48% 2% 19% 4% 26%
Munne et al (1997) / 
13, 18, 21, X and Y
138 66% 9% 12%# - 14%
Laverge et al (\ 997) / 
1,X and Y
97 40% 25% 23% 12%
Munne et al (\ 998d) / 
13, 16, 18, 21, X, Y
381 36% 12% 40%* 12%
Laverge et al (1998) / 
1, Xand Y*
60 20% 45% 15% - 20%
Evsikov & Verlinsky (1998) / 
13, 18,21 *
86 ** 4% 86% 7% 3%
Iwarsson et al (1999) / 
15, 16, 17, 18, Xand Y
40 28% 2% 45% 10% 15%
Staessen et al (1999) / 
18, X and Y
94 35% 11% 40% 3% 11%
Veiga et al 
(1999)/
13, 18, 21, X, 
and Y *
Blastocysts 8 12.5% 0 75% 12.5% 0
Arrested
Embryos
8 37.5% 0 25% 0% 37.5%
Ruangvutilert 
et al (2000a) 
/13, 18, 21, X 
and Y *
Blastocysts 19 10.5% - 68.5% 10.5% 10.5%
Arrested
Embryos
20 20% “ 70% - 10%
Harrison et al, (2000) / 1, 4, 
7, 8, 9, 13, 16, 18, 21, X, Y
6 0% 17% 50% 17% 17%
Sandalinas et al, (2001) /
1, 13, 15, 16, 18,21,22, X, Y
216 15% 47%* 15%* 23%
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Gonzalez-Merino et al, 
(2003)/ 13, 18, 21, X and Y
50 10% 68% 20% 2%
Baart et al, (2004) / 1 ,7 , 13, 
15, 16, 18 ,21 ,22 , X, Y
22 45% 5% 45% - 5%
Coonen et al, (2004) / 
18, Xand Y*
295 25% - 26% 31% 17%(fl!
* These studies were carried out on human blastocysts
The embryos were analysed after the freezing and thawing process 
+ No diploid/euploid nuclei present with no evidence of chaotic division 
 ^Major cell line has an abnormal chromosome complement but diploid cells present 
** The study did not distinguish between the normal and diploid mosaic
# Diploid mosaics are embryos with >38% of abnormal cells (Table 3.2)
& Including the 2n/aneuploid cell
® Including embryos classified as unexplained
When using FISH to analyse chromosome constitutions, several obstacles emerge, 
including failure of hybridisation, probe inefficiency, signal overlapping yielding 
false negative results and split/diffused/patchy signals (Munne et al, 1998; 
Ruangvutilert et al, 2000a, b). Most importantly FISH is limited by the number of 
probes that can be simultaneously applied due to an increasing chance of FISH 
artefacts and FISH failure and lack of colours, since it is not possible to look at all 
chromosomes in one interphase (Ruangvutilert et al, 2000b). As many as six different 
chromosomes have been simultaneously analysed by Munne et al (1998c) achieving a 
total of nine chromosome studied per cell with a second sequential hybridisation. 
However, by analysing many chromosomes simultaneously the efficiency of the FISH 
technique drops (Conn et al, 1998; Ruangvutilert et al, 2000b) thus producing false 
negative and positive results. Conn et al (1999) proposed that double locus analysis 
might decrease the number of chromosomes analysed per FISH analysis will however, 
provide true information about the extent of mosaicism present in human 
preimplantation embryos. Magli and co-workers (2001) carried out double locus 
analysis of chromosome 21 for PGD to reduce any false positives and/or negatives 
and thus the risk of misdiagnosis
1.6.3 Mosaicism and CGH
To date only a small number of embryos have been studied using CGH to analyse 
every cell (Table 1.5). Two studies were carried out on a series of good quality 
cleavage stage embryos. Both studies aimed to reveal the true extent of chromosomal 
abnormalities. Combining the results of the two similar studies conducted by Wells
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and Delhanty (2000) and Voullaire et al (2000), the most striking finding was that 
mosaicism was found to be extremely common affecting 67% and 64.6% 
respectively. However, Trussler et al (2004) observed a lower incidence of mosaicism 
of 50% whilst analysing 40 embryos. It was concluded in the latter study that the 
difference in normality in the three studies might be due to variations in maternal age, 
embryo quality, stimulation protocols and culture (Trussler et al, 2004).
Table 1.5. Summary of CGH data carried out on human preimplantation embryos 
revealing the level of mosaicism.
Study No. of 
embryos
Normal Abnormal8 Mosaic
Diploid
Partial
Aneuploidyb
Chaotic
Wells & Delhanty (2000) 12 25% 8% 50% - 17%
Voullaire et al, (2000) 12 25% 8.3% 58.3% - 8.3%
Wilton et al, (2001) 5 20% 40% - - 40%
Malmgrem et al, (2002) 28 0% - 14%° 54%d 32%
Voullaire et al, (2002) 126 40% 25%a - 6% 29%
Trussler et al, (2004) 40 42.5% 7.5% 37.5% 5% 7.5%
a Including mosaic aneuploid complements
b Partial aneuploidies or structural damage induced by chromosome breakage 
c The embryos were mosaic diploid or mosaic aneuploid but balanced regarding the 
chromosomal rearrangement
d The embryos were mosaic diploid or mosaic aneuploid but unbalanced regarding the 
chromosomal rearrangement
However, all three CGH studies have confirmed the FISH and karyotyping studies 
performed on cleavage embryos. In the study by Wells and Delhanty (2000) only one 
embryo (8.3%) was completely aneuploid where all six cells were trisomic for 
chromosome 21 and monosomic for the X chromosome and was thought to have 
arisen due to meiotic errors. The same results were obtained from Voullaire et al 
(2000), though Trussler and co-workers found slightly lower (7.5%) consistent 
abnormality resulting from a meiotic error. In both early studies 3/24 (12.5%) 
embryos revealed evidence of chromosome breakage resulting in imbalance of 
specific regions, rather than whole chromosomes, were detected, with one embryo 
showing reciprocal gains and losses of regions of chromosomes 2 and 7 in sibling 
blastomeres (Wells and Delhanty, 2000). In the recent study of Trussler et al (2004) 
chromosome breakage was again reported (7.5%). Furthermore, such chromosome
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breakage has also been recorded in karyotyping studies (Papadopoulos et a l,  1989; 
Zenzes and Casper, 1992; Clouston et al., 1997).
Voullaire et al (2002) used CGH for aneuploidy screening and detected chromosome 
abnormality in 60% of single blastomeres biopsied prior to implantation from 20 
women with repeated implantation failure. The abnormalities included aneuploidy for 
one or two chromosomes (25%) and complex chromosomal abnormality (29%). 
Mosaicism involving a complex abnormality (i.e. chaotic) is a more frequent 
occurrence in these patients than in the previously studied cohort of surplus embryos 
(Voullaire et al, 2000), and is therefore likely to be related to the history of recurrent 
implantation failure. This study supports the observation that some individuals are 
more prone to chaotic embryos than others as suggested by previous FISH studies 
(Delhanty et al, 1997; Harrison et al, 2000). In addition, the complex abnormality 
seen in morphologically normal and actively dividing embryos supports the idea that 
mitotic checkpoints may not function in the cleavage embryo (Delhanty and 
Handyside, 1995; Wells and Delhanty, 2000; Harrison et al, 2000), and it suggests 
that disturbance of the normal early embryonic cell cycle might be a pathology 
associated with infertility and implantation failure (Wilton et al, 2003). Recently, 
Wells et a l (2005), after carrying out gene expression studies on human oocytes and 
embryos found that BUB1, MAD2 and APC genes were expressed in low quantities 
in 2-4cell stage embryos. These findings prompted the author to suggest that this 
might be significant for the level of mosaicism since these genes are involved in 
producing proteins that interact in the spindle assembly checkpoint which ensures 
accurate chromosome segregation.
A recent study by Malmgren et al (2002) analysed 94 blastomeres from 28 embryos 
generated from 13 couples carrying a balanced chromosomal rearrangement 
undergoing PGD. The single cell CGH confirmed most of the unbalanced 
translocations detected by PGD. As the embryos made available for this study were 
previously diagnosed as unbalanced regarding the chromosomes involved in the 
translocation or were considered unsuitable for transfer for other reasons a higher 
degree of mosaicism was expected in comparison to the other CGH studies (Wells 
and Delhanty, 2000; Voullaire et al, 2000). Indeed all of the embryos (100%) were 
classified as mosaic (containing more than one chromosomally uniform cell line) or
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chaotic. In this study, a tendency for some couples to be more prone to generate 
chaotic embryos than others was also seen, as previously described by Delhanty et al 
(1997). In the study by Malmgrem et al (2002) there was a significant reduction in the 
efficiency of the CGH technique, compared to the previous studies (Wells and 
Delhanty, 2000; Voullaire et al, 2000) from 98% and 97% respectively to 70%. 
However, the dissimilarity was attributed to the fact that normal IVF generated 
embryos were used in the earlier studies in contrast to the unbalanced or not suitable 
for transfer embryos analysed in the Malmgrem study (Malmgrem et al, 2002). 
However, it is more likely the underlying reason was the use of different CGH 
techniques between the Malmgrem study (Malmgrem et al, 2002) and the other two 
early CGH studies (Wells and Delhanty, 2000; Voullaire et al, 2000).
Following the application of CGH on single blastomeres, concerns about the 
reliability of PGD using FISH to identify chromosomally normal from abnormal 
embryos were raised. In the case of FISH, probes target a defined region on a 
chromosome so the status of the rest of the chromosomes is simply assumed to be 
normal, but lacking conclusive proof. This fact strengthens the argument for the 
adaptation of CGH for clinical screening of embryos (Wells and Levy, 2003). 
However, hypothetically more than half of the abnormalities found in the CGH 
embryo studies could have been excluded using a limited FISH probe set (13, 18, 21, 
X and Y). Recently, in a study carried out by Trussler et al (2004) the combination of 
CGH and FISH was assessed in cleavage stage embryos. A total of 1-4 cells were 
biopsied from 40 embryos and analysed with CGH and their sibling blastomeres were 
examined by FISH. From the forty embryos investigated FISH results were in 
agreement with the CGH results in all 22 embryos where both tests were informative 
(Trussler et al, 2004).
1.6.4 Types and Mechanisms of Mosaicism
Different types of mosaicism have been reported in preimplantation embryos 
including aneuploid mosaics, polyploid and haploid mosaics, chaotic mosaics and 
multinucleation. Thus each type should be explored individually to understand their 
underlying mechanisms.
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1.6.4.1 Aneuploidy Mosaicism
Aneuploid mosaicism is considered to be the most frequent form of mosaicism 
observed in human embryos (Munne et al, 1994b). Aneuploid mosaicism arises as a 
somatic postzygotic event. However molecular studies of the origin of the extra 
chromosome in the trisomic cell line indicate it is of two types: meiotic and somatic 
(Kalousek, 2000). Hence aneuploid mosaicism is of two types. Meiotic mosaicism is 
where a loss of the trisomic chromosome occurs in a trisomic fetus producing a 
diploid cell line as well as the trisomic cell line, whereas somatic mosaicism is where 
a trisomic/monosomic cell line arises in a normal diploid embryo, giving two or three 
cell lines.
Munne et al (1997) analysed 138 normally fertilised human cleavage-stage embryos 
and found that 14% were chaotic suggesting that there maybe a relationship between 
embryo abnormalities and different drug regimes and embryo culture conditions. 
Furthermore, the same group reported that mosaicism due to aneuploid cells interfered 
with embryo development for some unknown reason (Sandalinas et al, 2000), since 
aneuploidy combined with extensive mosaicism had a stronger effect in that study 
resulting in none of the human embryos developing to blastocysts. In Gonzalez- 
Merino et al (2003) it was found that all types of blastocysts (eiher pre-expanded or 
expanded) were all diploid/mosaic with >70% of the cells being diploid and the 
author suggested that this finding might be a normal finding in in-vitro embryos. 
Delhanty et al (1997) observed 19% of human cleavage-stage embryos were diploid 
mosaic, however relatively high amounts of chaotic embryos (26% out of 93 
embryos) were found (Table 3.3). It was proposed that the mechanism of mosaic 
aneuploidy were probably mitotic non-disjunction, which causes a reciprocal loss or 
gain in addition to anaphase lag (Delhanty et al, 1997). Moreover, Delhanty and 
Handyside (1995) suggested that due to the absence of cell-cycle checkpoints mosaic 
aneuploid embryos could form, which may be specific to the cleavage stage of 
development. The latter was also postulated by Harrison et al (2000), which observed 
a mirror-image distribution about the plane of attachment of the signals in each 
sequential hybridisation, indicating premature decondensation during anaphase, which 
is consistent with lack of checkpoint control. The possibility that cell-cycle 
checkpoints do not fully operate during cleavage of the human embryo may also
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explain the relatively high incidence of various nuclear abnormalities which have 
been observed (Winston et al, 1991; Hardy et al, 1993) For example binucleate 
blastomeres are seen in 15% of human embryos, and are frequently associated with 
chromosomal abnormalities and appear to result from failure of cytokinesis (Winston 
et al, 1991; Hardy et al, 1993; Kligman et al, 1996; Staessen and Van Steirteghem, 
1998). Most recently, work on inbred mouse strains with elevated levels of Y 
chromosome nondisjunction has shown that malsegregation in this system is largely 
restricted to the earliest mitotic divisions (Bean et al, 2001). This suggests that 
mammalian embryos are indeed susceptible to mitotic nondisjunction in early 
cleavage stages (Bean et al, 2001; 2002) and fits the lack of checkpoint control model.
Another study which analysed 161 embryos for sex determination using FISH, 
observed examples of three different mechanisms in aneuploid mosaic embryos: (i) 
involvement of an aneuploid gamete which finally lead to an aneuploid mosaic 
embryo; (ii) reciprocal mitotic non-disjunction leading to mosaic embryos with 
monosomic, disomic and trisomic blastomeres for the chromosomes involved; and
(iii) chromosomal loss leading to a combination of monosomic and disomic 
blastomeres (Staessen et al, 1999) confirming the previous reports by Delhanty et al 
(1997)
Veiga et al (1999) revealed a high prevalence of mosaicism in both blastocyst and 
arrested embryos showing 87.5% and 62.5% respectively. Moreover, Ruangvutilert et 
al (2000a) showed that 30% of the day 5 arrested embryos and 21% of the blastocysts 
were aneuploid mosaics, which supports the hypothesis of the selection against 
chromosomal abnormalities through culture to the blastocyst stage proposed by 
Sandalinas and co-workers (2001). Coonen et a l (2004) analysed 295 blastocysts and 
after finding high levels of mosaicism (57%) and chaos (17%) concluded that 
anaphase lagging appeared to be the major mechanism through which human embryos 
acquire a mosaic aneuploid pattern.
1.6.4.2 Ploidy Mosaicsim
Ploidy mosaics have also been frequently reported in cleavage stage embryos, 
blastocysts (Harper et a l, 1995; Delhanty et a l, 1997; Munne et a l, 1997; Staessen et
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al, 1999; Ruangvutilert et al, 2000a; Sandalinas et al, 2001) and those of other animal 
species (Long and Williams, 1982; Murray et al, 1986). Ploidy mosaics may well play 
a role in normal early development particularly when associated with TE lineages 
(Angell et al, 1987) with tetraploid or haploid predominating. It has been proposed 
that probably tetraploid cells may be a normal feature in the development of the 
trophectoderm (Angell et al, 1987). Tetraploid trophectoderm cells may arise as a 
result of endoreduplication or endomitosis and possibly play a role in embryo 
implantation (Drury et a l, 1998). Although other studies have linked mosaic 
tetraploidy to poor quality arrested embryos (Wells and Delhanty, 2000). Laverge et 
al (1997) while studying 97 human cleavage-stage embryos reported that possible 
mechanisms for polyploid mosaics could involve endoreduplication of mononucleated 
blastomeres, or formation of a mitotic spindle during division of a binucleate cell 
which would subsequently form two mononucleate daughter cells with polyploid 
nuclei. The fusion of nuclei in binucleate blastomeres or less frequently blastomere 
fusion may also lead to polyploidy (Balakier et a l, 2000).
Less common mosaicism findings includes haploid and triploid nuclei. The presence 
of a haploid cell in a mosaic embryo is difficult to explain, however the underlying 
mechanism maybe associated with binucleate cell production with a meiotic type of 
segregation (Delhanty et al, 1997) or maybe an incorporation of a polar body into the 
embryo (Staessen et al, 1999). Haploid/diploid mosaics can be found from pronuclear 
zygotes and are believed to arise due to the activation of the oocyte (Staessen and Van 
Steirteghem, 1998). Haploid and triploid cells have been characterised as less viable 
and less actively dividing than tetraploid cells (Ruangvutilert et al, 2000a); with the 
exception of some triploid cells persisting until later in development as in cases of 
mosaic diploid/triploid (Edwards et al, 1994).
The origin of diploid/triploid mosaicism is not clear. The underlying mechanism that 
leads to diploid/triploid mosaics may be due to an incorporation of another gamete or 
its genome into one of the daughter cells derived after the first mitotic division or 
later. The extra gamete might be a polar body (Mueller et al, 1993). Kuo et al (1998) 
also suggested that diploid/triploid mosaicism could result from fusion of a diploid 
zygotic nucleus with an extra sperm nucleus or the extrusion and degeneration of a 
haploid nucleus to produce a diploid cell line in a triploid embryo. In a recent prenatal
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study of four cases of triploid/diploid mosaics, the three different mechanisms of 
origin for these apparent mosaics were detected: i) chimaerism with karyotypes from 
two separate zygotes developing into a single individual, ii) delayed digyny, by 
incorporation of a pronucleus from a 2nd PB into the embryonic blastomere and iii) 
delayed dispermy, similarly by incorporation of a 2nd sperm pronucleus into one 
embryonic blastomere (Daniel et al, 2003).
1.6.4.3 Chaotic Mosaicism
Chaotic embryos have been reported in many studies and involve embryos where all 
nuclei show a different chromosome complement. Chaotic embryos have been found 
in cleavage-stage embryos (Harper et a l, 1995) as well as at the blastocyst stage 
(Evsikov and Verlinsky, 1998). It has been hypothesised that they originate due to 
uncontrolled “chaotic” division, which is possibly related to centriole or spindle 
deficiencies and disturbance of pronuclear syngamy (Klingman et a l, 1996). During 
FISH analysis of human cleavage-stage embryos it was suggested by Delhanty and 
Handyside (1995) that chaotic embryos may result form the absence of cell cycle 
checkpoints leading to chaotic segregation of chromosomes. Furthermore, the 
frequency of chaotic embryos appears to be a patient related phenomenon (Delhanty 
e ta l,  1997).
1.6.4.4 Multinucleation
A normal human embryo should have a single nucleus in each blastomere (only 
visible during interphase when the nuclear membrane is present). The presence of 
multinuclear blastomeres has been reported for both in vivo  (Hertig et al, 1954) and in 
vitro (Winston et al, 1991) developing embryos. Its frequency ranges from 17-69% in 
human embryos (Plachot et al, 1987; Hardy et al, 1993; Munne et al, 1994a) however, 
it might be significantly higher when associated with other morphological 
abnormalities (Munne et al, 1995a). Recently, Meriano et al (2004) found 24% 
mulitnucleation in 770 embryos derived from ICSI. The author suggested -  after time- 
lapse photography -  that multinucleated blastomeres were subject to dissolution of 
their nuclear membrane suggesting an asynchrony the nuclei and a possible 
interruption in proper nuclear and cell division (Meriano et al, 2004). Multinucleation 
first occurs at the 2-cell stage, but it has been shown to occur most frequently at the 8-
125
Chapter 1 -Introduction
cell stage (Hardy et al, 1993). Kligman et al (1996) suggested that if multinucleation 
occurs at the first embryonic division all the embryonic cells might be affected. 
Laverge et al (1997) observed multinucleation in 15 out of 39 normal diploid 
embryos. This is in agreement with Munne and Cohen (1993) who concluded that 
multinucleation occurs frequently in arrested as well as normally developing embryos. 
In a study of 1885 embryos by Balakier and Cadesky (1997) it was observed that 44% 
of patients possessed embryos with at least one multinucleated blastomere (MNB) and 
15% of embryos contained MNB, however, there was no correlation with maternal 
age. It has been proposed that asynchrony between karyokinesis and cytokinesis leads 
to fragmentation and production of multinucleate blastomeres (Lopata et al, 1983; 
Evsikov and Verlinsky, 1998). Furthermore, partial fragmentation of nuclei or 
defective migration of chromosomes during mitotic anaphase have also been linked as 
mechanisms leading to MNB (Tessarik et al, 1987; Wiston et al, 1991; Pickering et 
al, 1995). However, Staessen and co-workers (1998) after analysing 101 3- to 8-cell 
embryos developing from 2-cell embryos (where both blastomeres were bi- or 
multinucleate), reported that the genetic constitution of binucleate and multinucleate 
blastomeres and the daughter cells developing from them are not always abnormal.
1.6.4.5 Mosaicism and Translocations
A study carried out by Iwarsson et al (2000) in preimplantation embryos from 
translocation carriers during PGD cycles revealed a high degree of mosaicism for the 
chromosomes involved in the translocations (65%), compared to control 
chromosomes (35%). However, the degree of mosaicism within each embryo differed 
between the chromosomes involved in the translocation and the control probes. In 
order to explain these relatively high frequency of mosaicism Iwarsson et al (2000) 
proposed three hypothetical explanations: (i) Acrocentric chromosomes (13, 14, 15, 
21 and 22) have a higher tendency to malsegregate during meiosis as well as mitosis;
(ii) The translocation itself may predispose to malsegregation and; (iii) The difference 
between the chromosomes involved in the translocations with the control 
chromosomes could be methodological. Although it was concluded that this last 
hypothesis cannot be regarded as a major cause.
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1.7 Aims of the Study
This study is comprised of three parts employing molecular and cytogenetic 
approaches to the analysis of human chromosomes in human preimplantation 
embryos.
The aim of the first part was to devise novel fluorescent PCR protocols for PGD 
acting as well as attempting to develop a universal-like protocol i.e. methodology 
applicable to different DM patients requiring little optimisation, for PGD for DM. 
Initially, several F-PCR polymorphic markers, linked or unlinked, were investigated 
to assess their efficiency at the single cell level and test whether they are informative 
for two couples. PGD was carried out for both couples using two different single step 
multiplex F-PCR protocols. A third protocol was devised and tested on single cells 
using whole genome amplification in addition to F-PCR. The purpose of employing 
whole genome amplification in this study was primarily to examine whether carrying 
out DOP-PCR on a single cell was able to amplify regions within the genome that 
would match the regions where specific F-PCR polymorphic primers hybridise. As a 
consequence this would eliminate the need for multiplexing and one would be able to 
carry out several single F-PCR procedures with different F-PCR markers using the 
DOP-PCR product as a template. Hence, during a PGD case of a single gene disorder 
such as DM, there would be no need to optimise for a multiplex PCR protocol. If a 
DOP-PCR of the single blastomere was carried out and then separate but 
simultaneous singleplex PCR reactions with different F-PCR markers could be 
performed informative for the parents involved. Also, enough DNA would be 
available to perform CGH analysis which would allow chromosomal examination of 
the blastomere. Therefore, from one blastomere the single gene defect as well as its 
chromosomal status could be identified.
The second part of this study was to develop a reliable FISH-based protocol for the 
analysis of chromosome abnormalities in day 5 human embryos in order to reveal the 
level of chromosomal mosaicism for the five chromosomes studied (1, 11, 18, X and 
Y). Furthermore, it would allow the study of the underlying mechanisms of 
mosaicism and the high rate seen in vitro human preimplantation embryos. 
Optimising conditions and investigating the possibility of different probe
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combinations, therefore allowing the detection of all the possible mechanisms that 
lead to mosaic and chaotic embryos played an intricate role of this study. With the aid 
of two probes per chromosome in sequential rounds of FISH, problems of the FISH 
technique such as FISH artefacts e.g. monosomies, probe overlappings and failure of 
probe hybridisations were overcome. Such artificial findings would be detected and 
thus separated from the true findings enabling the study of the mechanisms of 
mosaicism in human blastomeres. This type of methodology has never been attempted 
before and would allow a innovative approach of investigating the phenomenon of 
mosaicism. Furthermore, the effects of the IVF culture media were examined. 
Interphase FISH was applied to spare/untransferred embryos derived from clinical 
treatment IVF or ICS I cycles
During the last part of this thesis, the use of CGH was investigated as an alternative to 
FISH for investigating the prevalence of mosaicism in day 3 and day 5 embryos. This 
involved assessing the efficiency of CGH, improving the protocol for optimised use 
on single cells, and its application as a research tool on human preimplantation 
embryos. The aim of this study was to assess the full chromosomal status of 1-2 
blastomeres biopsied at day 3, and then confirm whether the abnormality persists until 
day 5 using FISH for the chromosome(s) involved. This study would allow the 
detection of mosaicism in a full karyotype at the cleavage stage and further enquire if 
the mechanisms causing mosaicism continue to exist until day 5.
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Chapter 2 -  Materials and Methods
2.1 Materials
General laboratory chemicals and reagents were obtained from BDH Chemicals UK, 
Sigma UK and were of Analar or biochemical grade unless otherwise stated. The 
materials and stocks that have been used for this study are separated into 4FISH 
Materials ‘PCR M aterials ’ and ‘CGH Materials ’ and are listed below:
2.1.1 FISH Materials
2.1.1.1 Materials for Lymphocyte culture
Cell culture flasks, glass pipettes and microscope slides were obtained from BDH 
whilst all microcapillaries (internal diameters 75-200pm) for embryo, oocyte and 
single cell handling were from Laser (UK). Nunc Nucleon 50x9mm Petri dishes were 
used for single cell isolation and purchased from Gibco BRL (UK). Reagents used for 
media preparation were listed below:
• GPS (Glutamine 200mM, penicillin 300mg/ml, streptomycin 500mg/ml; 
Gibco, UK)
• Iscoves modified Dulbeccos medium (Sigma, UK)
• Phytohaemogglutinin (PHA; Gibco, UK)
• Thymidine (Sigma, UK)
• Deoxycytosine (Sigma, UK)
• Colcemid (Gibco, UK)
2.1.1.2 Materials for Embryo Spreading
• Poly-l-lysine (Sigma, UK)
• Tween-20 (Sigma, UK)
2.1.1.3 Materials for Nick Translation (commercial kit)
• Nick translation enzyme mix (Vysis, UK)
• lOx nick translation buffer (Vysis, UK)
• dATP, dCTP, dGTP and dTTP (0.3mM each; Vysis, UK)
• Nuclease-free water (Vysis, UK)
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• Fluorescent-labelled dUTP’s used with the kit were SpectrumAqua-dUTP 
from
2.1.1.4 Materials for the FISH procedure
• Probes (commercial and non-commercial; Vysis, UK)
• Pepsin (Sigma, UK)
• Hydrochloric Acid (0.0IN; Sigma, UK)
• Paraformaldehyde [37% formaldehyde (Sigma, UK) was saturated with 
NAHCO3 (BDH, UK) and stored in the dark
• Ethanol (99.7%; Sigma, UK)
• Formamide (BDH, UK)
• 20xSSC (Vysis, UK)
• NP-40 (Vysis, UK)
• Vectashield (Vector laboratories, USA)
• 4’,6-diamino-2-phenylindole (DAPI; Sigma, UK)
2.1.2 PCR Materials
2.1.2.1 Materials for Single-cell isolation
• PCR Lysis Buffer [125pg/ml Proteinase K (Sigma, UK), 17pM Sodium 
dodecyl sulphate (SDS; BDH chemicals, UK), Nuclease-Free Water (H2O; 
Promega, UK)]
• Phosphate Buffer Saline (PBS; Sigma, UK)
• Polyvinyl Alcohol (PVA; Sigma, UK)
• Mineral oil (Sigma, UK)
2.1.2.2 Materials for DNA extraction
• TKM1 (low concentration salt buffer): lOmM Tris-HCl pH 8.0, lOmM KC1, 
lOmM MgCl2, 2mM EDTA (BDH, UK)
• TKM2 (high concentration salt buffer): lOmM Tris-HCl pH 8.0, lOmM KC1, 
lOmM MgCl2, 2mM EDTA, 0.4M NaCl (BDH, UK)
• lOxTE buffer: lOmM Tris-HCl pH 8.0, 1M EDTA (BDH, UK)
• Igepal CA-630 (Sigma, USA)
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• SDS (Sigma, UK)
• 6M NaCl (BDH, UK)
• 70% Ethanol (BDH, UK)
2.1.2.3 Materials for PCR procedure
• Primers (Oswel, UK) -  See Table 2.2
• AmpliTaq Gold Polymerase (Applied Biosystems, UK)
• AmpliTaq Buffer (lOx; 1.5mg MgCh; Applied Biosystems, UK)
• dNTP mix (lOmM; Promega, UK)
• Nuclease-Free Water (H2O; Promega, UK)
2.1.2.4 Materials for gel electrophoresis
• Agarose (Sigma, UK)
• Ethidium Bromide (500mg/ml; Sigma, UK)\
• lOxTBE (0.89M Tris Base, 0.89M Boric acid, 2.5M EDTA; Sigma, UK)
• Loading buffer (lOx; 40% sucrose, 0.025% w/v bromophenol blue, 0.025% 
w/v xylene cyanol) (Supplied by Bioline, UK)
• 1 Kb DNA ladder (Bioline, UK)
2.1.2.5 Materials for ABI Prism™ 310 and 3100
• Deionised Formamide (Sigma, UK)
• Size Standard (Genescan 500-TAMRA; Applied Biosystems, UK
• Size Standard (Genescan 500-ROX; Applied Biosystems, UK)
• 0.5ml Sample Tubes (Applied Biosystems, UK)
• Septa for 0.5ml Samples Tubes (Applied Biosystems, UK)
• Plate for 3100 (Applied Biosystems, UK)
• Capillary on array for 310 and 3100 ABI Prism (Applied Biosystems, UK)
• Buffer for 310 and 3100 ABI Prism (Applied Biosystems, UK)
• Polymer for 310 and 3100 ABI Prism (Applied Biosystems, UK)
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2.1.3 CGH Materials
Single buccal cell, single blastomere as well as clump isolation was performed using 
the same materials as in 2.1.5. Furthermore, all genomic DNA from whole blood or 
fibroblasts was carried out using the same material as in 2 .1.6.
2.1.3.1 Materials for DNA Extraction
• Hank’s medium (Sigma, UK)
• DNA extraction lysis buffer (In 100ml 1.2 lg  Tris, 0.19g/100ml EDTA,
0.2gSDS, 1.17g N aC l., lOmg/ml of proteinase K added after autoclaving)
• Isopropanol (BDH, UK)
2.1.3.2 DOP-PCR Materials
• Primer (Oswel, UK) -  See Table 5.3
• SuperTaq Plus (HT Biotechnology, UK)
• SuperTaq Buffer (lOx; lmg MgCL2; HT Biotechnology, UK)
• dNTP mix (lOmM; Promega, UK)
• Nuclease-Free Water (H20 ; Promega, UK)
2.1.3.3 Nick-Translation Materials
• Nick Translation kit (Vysis, UK)
• 0.2mM Spectrum Green or Spectrum Red dUTP’s (Vysis, UK)
• Human Cot-1 DNA (GibCo BRL, UK)
• NaAc (3M; Sigma, UK)
2.1.3.4 CGH Procedure
• Hybridization mix (50% Formamide, 2xSSC, 10%Dextran Sulphate; Sigma, 
UK)
• CGH Metaphase Target Slides (Vysis, UK)
• Triton-X (Sigma, UK)
• Formamide (BDH, UK)
• 20xSSC (Vysis, UK)
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2.1.4 Embryo Materials
2.1.4.1 Ethical Approval
The work on surplus embryos and the clinical application of PGD (Chapter 3) were 
approved by the Research Ethics Committees of the University College London 
Hospital Trusts, and carried out under licence from the Human Fertilisation and 
Embryology Authority (HFEA). The surplus embryos for Chapters 4 and 5 were 
donated from normal patients undergoing routine IVF at the London Fertility Clinic 
which were authorised by the HFEA. Informed written consent was obtained from 
patients for surplus embryos to be used for research purposes
2.1.4.2 Grading Criteria for the Embryos
Preimplantation cleavage stage embryos were graded according to Bolton et al, 
(1989) as follows;
Grade 1 Embryo at the correct stage of in vitro  development with perfect
symmetrical and even-sized blastomeres with no fragmentation.
Grade 1' Embryo at the correct stage of in vitro  development with perfect
symmetrical and even-sized blastomeres with less than 10% 
fragmentation.
Grade 2+ Development with unequally sized blastomeres with less than 20% 
fragmentation
Grade 2 Retarded development with unequally sized blastomeres with 25%-50%
fragmentation.
Grade 3 Retarded development with unequally sized blastomeres with more than
50% fragmentation.
2.1.4.3 Categorisation of Chromosomal Abnormalities in Embryos.
Embryos analysed for the preliminary work and during PGD cycles were categorised 
after Delhanty et al, (1997) into four groups; normal, uniformly abnormal, mosaic 
(diploid mosaic or aneuploid mosaic) and chaotic (Table 1.1). Embryos were 
allocated where possible to each group on the basis of the chromosome constitution of 
the majority of cells present.
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2.1.4.4 Embryo culture
Oocytes were retrieved using Flushing Medium (supplemented with sodium pyruvate, 
HAS, heparin lOIU/ml, penicillin 50,000IU/1, streptomycin 50mg/l, and HEPES; 
Medicult UK Ltd), incubated in 6%C02 in air, at 37°C, inseminated and cultured in 
500pl of IVF Medium (Bicarbonate buffered medium containing human serum 
albumin, penicillin and sodium pyruvate; Vitrolife, Scandinavia). On day 1, oocytes 
were assessed for the number of pronuclei and transferred into 25pi microdroplets of 
Cleavage Medium (Bicarbonate buffered medium containing human serum albumin, 
penicillin-G, EDTA, glucose, inorganic salts and amino acids; G-l, Vitrolife, 
Scandinavia). On day 3, the best embryos were selected for transfer and suitable spare 
embryos were cryopreserved.
The embryos were divided into two groups depending on the culture medium. Group I 
embryos were cultured in standard IVF medium (6.1 Vitrolife, Scandinavia) from day 
0 to day 5 and Group II embryos were cultured in standard IVF medium from day 0-3 
and then in blastocyst medium (6.2 Vitrolife, Scandinavia) from day 3-5. Only 
embryos that arose from a bipronucleate zygote were included in the study.
2.1.4.5 Embryo Freezing
Good quality Day-1 embryos were considered for freezing when two pronuclei and 
two polar bodies were visible 16-18 hours after the oocytes were subjected to sperm 
either by IVF insemination or ICSI. Good quality Day-3 embryos were considered 
when they comprised 6-8 cells and were grade 2 and above.
All embryos (either day-1 or day-3 cell stage) were placed for a five-minute wash in 
Cryo-PBS medium (Vitrolife; Scandinavia) and then taken through consecutive 
washes of embryo freezing solutions 1 and 2 (EFS1 and EFS2; Vitrolife, Scandinavia) 
for ten minutes each at room temperature. The embryos were loaded into the freezing 
straw (maximum two embryos per straw) and placed into a cryobath. The cryobath is 
linked to a computer program which controls temperature until it reached -180°C..
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2.1.4.6 Embryo Thawing
All thawed embryos (either day-1 or day 3-cell stage) were taken through consecutive 
washes of embryo thaw solutions 1, 2, and 3 (ETS1, ETS2 and ETS3; Vitrolife, 
Scandinivia) for five, five and ten minutes respectively at room temperature. A final 
wash was performed through Cryo-PBS medium for five minutes at room temperature 
followed by five minutes on a heated stage (38°C) (Nikon SMZ-U microscope stage).
Pronuclei (PN) stage embryos, after thaw, were initially cultured in G1 medium until 
day 3 (section 4.2.5) and subsequently in G2 medium until blastocyst stage, while day 
3 thawed-embryos were directly cultured in G2 medium.
2.1.4.7 Embryo Spreading
Embryos were spread as described previously (Harper et al, 1994; Ruangvutilert et al, 
2000a; section 2 .2.1.2).
2.1.4.8 Embryo Classification and Scoring of Embryos
The criteria used for classifying the embryos were adopted from Delhanty et al (1997) 
and can be seen in Table 1.1. Whilst classifying an embryo all major cell lines should 
be mentioned e.g. if an embryo has 20 diploid cells, 4 tetraploid cells, 2 trisomy 18 
cells, 1 monosomy 1 cell and 1 triploid cell, it should be classified as 
diploid/polyploid/aneuploid mosaic. Furthermore, if a blastomere displayed 
contradictory results in different rounds of FISH for the same chromosome e.g. one 
signal for lp (1st round) but 2 signals for lhet (2nd round), this was considered as an 
“inconsistent result”. When scoring the fluorescent signals (see section 2.2.1.5.5), 
signals must be a minimum of a signal’s width apart in order to be scored as 2 
individual signals (Hopman et al, 1991).
2.1.4.9 Mosaicism and Events
Diploid mosaic embryos with aneuploid cells were considered to have arisen through 
three different mechanisms: (a) when the embryo contained cells with monosomies, 
then the mechanism was classed as “chromosome loss” (CL), (b) when the embryo 
contained cells with trisomies, then the mechanism was classed as “chromosome
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gain” (CG) and (c) when the embryo had monosomies and trisomies of the same 
chromosome(s) in different cells, this was classified as mitotic non-disjunction 
(MND). Nuclei with multiple abnormalities affecting at least three chromosomes were 
classed as chaotic and not included in the analysis. This included nullisomies and 
tetrasomies. During the last chapter chromosome breakage and partial mosaicism 
mechanisms were revealed, hence all three mechanisms (chromosome loss, 
chromosome gain and mitotic non-disjunction) can occur either partially (p) or in the 
whole (w) chromosome.
2.1.5 Probes and Primers
2.1.5.1 DNA Probes.
Details of DNA probes used in this study along with their sources are summarised in 
Table 2.1. The plasmid DNA clones for chromosome 1 was obtained from resource 
centres as agar stabs. Maxiprep of plasmid and cosmid DNA was carried out with 
Wizard maxiprep kit from Promega. Probe DNA was labelled via nick translation 
supplied in kit form (Nick Translation Kit Vysis UK). Commercially obtained 
labelled a-satellite and locus-specific probes were supplied by Vysis UK. All were 
stored at -20°C and protected from light.
Table 2.1. List of FISH DNA probes used in the FISH and CGH/FISH study
Probe Type Label Source
lp lpter Spectrum Green Vysis, UK
lq lqter Spectrum Orange Vysis, UK
lhet Satellite-II/III Spectrum Aqua Lab-prepared
2q 2qter Spectrum Orange Vysis, UK
2cep a-satellite Spectrum Aqua Lab-prepared
3cep a-satellite 3 Spectrum Orange Vysis, UK
4cep a-satellite 4 Spectrum Aqua Vysis, UK
5p 5pter Spectrum Green Vysis, UK
5p/5q (Cri-du-Chat 
microdeletion probe)
5pl5.2/5q31 Spectrum 
Green /Orange
Vysis, UK
6cep a-satellite 6 Spectrum Green Vysis, UK
7p/7q (Wiliams 
microdeletion probe)
7p31 / 7ql 1.23 Spectrum 
Green/ Orange
Vysis, UK
8q 8qter Spectrum Orange Vysis, UK
8cep a-satellite 8 Spectrum Orange Vysis, UK
9cep a-satellite 9 Spectrum Orange Vysis, UK
lOcep a-satellite 10 Spectrum Green Vysis, UK
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l lq 11 qter Spectrum Orange Vysis, UK
llcep a-satellite 11 Spectrum Green Vysis, UK
llcep a-satellite 11 Spectrum Aqua Vysis, UK
13LSI 13ql 1 Spectrum Green Vysis, UK
14q 14qter Spectrum Orange Vysis, UK
16p 16pter Spectrum Green Vysis, UK
16qter 16qter Spectrum Orange Vysis, UK
16cep a-satellite 16 Spectrum Aqua Vysis, UK
I8q 18qter Spectrum Orange Vysis, UK
18cep a-satellite 18 Spectrum Aqua Vysis, UK
22LSI 22ql 1.2 Spectrum Green Vysis, UK
Xcep a-satellite X Spectrum Green Vysis, UK
Ycep Satellite II/III Spectrum Aqua Vysis, UK
X / Y / 1 8 Probe-cocktail of 
heterochromatic probes
Spectrum Green / 
Orange / Aqua
Vysis, UK
2.1.5.2 PCR Primers
Several STR markers were used in different preliminary work carried out for couples 
undergoing PGD treatment for myotonic dystrophy. These markers were either linked 
or unlinked and varied in their size and fluorescent dyes. All primers for the myotonic 
dystrophy workup can be seen in Table 2.2 below
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Table 2.2. List of PCR primers used in the PCR study
Type of Marker
Marker
(F=forward)
(R=reverse)
Sequence of primers 
(5’-3’)
Chromosome 
location of 
primers
Size of the 
PCR product 
(bp)
Label of primer 
(at 5’ end of 
forward primer)
Reference
STR
(Dinucleotide)
DM (F) 5 ’-cttcccaggcctgcagtttgcccatc-3 ’ 19ql 3.3 128-203 5’-FAM DYE Brooke^/, 1992
DM (R) 5 ’-gaacggggctcgaagggtccttgtagc-3 ’ -
STR
(Dinucleotide)
APOC2 (F) 5 ’-ggctacatagcgagactccatctcc-3 ’ 19ql2 -  
19ql 3.2
134-170 5’-HEX DYE -
APOC2 (R) 5 ’-gggagagggcaaagatcgataaagc-35 -
STR
(Dinucleotide)
D19S207 (F) 5 ’ -tgcggtgtttgaaccctcgctg-3 ’ 118-160 5’-HEX DYE -
D19S207 (R) 5 ’ -actgcactgcagcctgagtgac-3 ’ -
STR
(Dinucleotide)
D19S112(F) 5 ’ -ctgaaagacacgtcacactggt-3 ’ 115-140 5’-HEX DYE Jansen et al, 1992
D19S112 (R) 5 ’ -gccagccattcagtcatttgaag-3 ’ -
STR 
(T etranuclaotide)
D19S393 (F) 5 ’ -gcaatgagccgagatagaa-3 ’ 5’-HEX DYE -
D19S393 (R) 5 ’ -tggctagcccattactcta-3 ’ -
STR 
(T etranucleotide)
D21S11(F) 5 ’ -tatgtgagtcaattccccaagtga-3 ’ 21q21 200-260 5’HEX DYE Sharma and Litt, 
1992D21S11 (R) 5 ’-gttgtattagtcaatgttctccag-3 ’ -
STR 
(T etranucleotide)
D21S1414(F) 5 ’ -aaattagtgtctggcacccagta-3 ’ 21q21 330-370 5’-HEX DYE Sherlock et al, 1998
D21S1414 (R) 5 ’ -caattccccaagtgaattgccttc-3 ’ -
STR 
(T etranucleotide)
D18S535(F) 5 ’ -cagcaaacttcatgtgacaaaagc-3 ’ 18ql2.2 -  
18ql2.3
455-500 5’-HEX DYE Lareu et al, 1998
D18S535 (R) 5 ’ -caatggtaacctactatttacgtc-3 ’ -
STR 
(T etranucleotide)
D13S305 (F) 5 ’ -gcctgtttgaggacctgtcgtta-3 ’ 13ql2.1 -  
12ql4.1
430-465 5’-TET DYE
D13S305 (R) 5 ’ -tggttatagagcagttaaggcac-3 ’ -
DOP
(WGA) DOP-50 5 ’ -ccgactcgagnnnnnnatgtgg-3 ’ Random _
Telenius et al, 1992
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2.1.6 Equipment
2.1.6.1 FISH and CGH Equipment
Dissecting microscopes from Nikon and inverted microscopes from Olympus were 
used for embryo and oocyte handling as well as slide preparation. Fluorescence 
microscopy was carried out with the following microscope systems; Reichert Jung 
Polyvar microscope with single filters for TRITC, FITC and DAPI, Nikon optiphot 
microscope with Omega dual band-pass TRITC/FITC filter and Zeiss Axioskop 
microscope with Chroma multi-band pass TRITC/FITC/DAPI filter and single 
SpectrumAqua filter. Image capture and analysis was carried out using a Zeiss 
Axioskop microscope equipped with a Photometries KAF 1400 cooled CCD (charged 
coupled device) camera controlled by Smartcapture software from Vysis, UK.
2.1.6.2 PCR and CGH Equipment
Three models of thermal cyclers were used for PCR amplification:
1. Hybaid Omnigene was manufactured by Hybaid Middlessex, UK.
2. ABI-9700 PCR System was manufactured and serviced by Applied 
Biosystems, UK.
3. Mastercycler Gradient was from Eppendorf-Netheler-Hinz GmbH, 
Cambridge, UK.
The analysis of fluorescent PCR products was performed on the ABI Prism 310 and 
3100 using GeneScan analysis software (version 2.0.2). A Nikon dissecting 
microscope used for single cell isolation and oocyte spreading and a Nikon phase 
contrast microscope was employed to check slide preparations.
2.2 METHODS
2.2.1 FISH Methods
FISH was used in the mosaicism study (Chapters 4 and 5). FISH consists of:
> Sample (embryo) or control lymphocyte cell suspension
> Probe preparation which consists of: 
o DNA preparation
o Nick Translation or use of commercial probes
> FISH procedure and analysis
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o Slide preparation and pre-treatment
o Probe preparation
o Denaturation conditions
o Post-hybridisation washes
o Analysis (capturing and scoring)
o Sequential FISH procedure
2.2.1.1 Control Lymphocyte Preparation
Male lymphocyte cells were used as control samples to record the efficiency of the 
probe combination employed for each FISH procedure. A sample of blood was 
provided by a male donor and was cultured according to the following procedure. The 
blood sample was collected in a lithium heparin tube. Iscoves modified Dulbeccos 
medium (Sigma, UK), and Fetal calf serum-heat inactivated (FCS) (Gibco, UK), 
were warmed to 37° C. 2 ml of GPS {Glutamin (200 mM), Penicillin (300 mg/ml), 
Streptomycin (500 mg/ml)}, which was stored at -  20°C, was added to the medium in 
order to ensure antibiotic resistance.
Under aseptic conditions, the following were added to a 50 ml culture flask: 17ml 
Iscoves, 2 ml FCS, 200 pi of Phytohaemagglutinin (PHA) (Gibco, UK) which 
stimulates the mitotic process, and 1 ml of blood. These were mixed and incubated at 
37° C for 48 hours or 72 hours. The flasks were gently shaken twice a day to re­
suspend the cells. On day 3 at 4pm, 200 pi of thymidine (30 mg/ml stock) (Sigma, 
UK) was added to achieve synchronisation of mitosis. On day 4 at 10 am, 200 pi of 
deoxycytosine (0.227 mg/ml stock) (Sigma, UK) were added which enforced the 
effect of thymidine on the cell culture in terms of synchronisation of mitosis. Finally, 
at 2 pm, on day 4, 200 pi of colcemid (10 pg/ml stock) (Gibco, UK) was added in 
order to arrest the cells at metaphase prior to harvesting.
2.2.1.1.1 Harvesting
The flasks were shaken, their contents emptied into two 10 ml tubes and centrifuged 
at lOOOrpm for 5 minutes. The supernatant was discarded leaving only a small amount 
for pellet resuspension. An aliquot of 10 ml of 0.075 KC1 was added slowly to each 
tube and left at room temperature for 15-20 minutes, in order for the KC1 to cause the
141
Chapter 2 - Materials and Methods
cells to swell. The tubes were again centrifuged at lOOOrpm for 5 minutes and the 
supernatant was discarded, leaving a small amount to re-suspend the pellet.
Approximately 1-2 drops of the fixative solution (3:1 methanol/ acetic acid), which 
was made fresh, were added to re-suspend the pellet by tapping the tube sharply until 
its contents turned brown and frothy. A few more drops of fix were added slowly, 
whilst the solution was agitated and this was repeated. When the solution stopped 
frothing, a few mis of fix were added at a time until the tube was full (approximately 
10ml). The tubes were centrifuged at 1000 rpm for 5 minutes and the supernatant was 
discarded, leaving a small amount for pellet re-suspension. The fixation process was 
repeated as described above but fix was added a few mis at a time. After the final 
centrifugation the remaining pellet had a pale whitish colour. The lymphocyte 
suspension was stored at -20°C and left overnight before being used for control slide 
preparation.
2.2.1.1.2 Preparation of control lymphocytes
Whenever the FISH procedure was performed, it was of great importance to process a 
control slide as a reference to ensure the efficiency of the procedure. Fixative solution 
(3:1 methanol: acetic acid) and 70% acetic acid were prepared each time. The 
standard cytogenetic preparations of male control lymphocytes which were stored in 
3:1 methanol: acetic acid at -20°C, were centrifuged at 400 g for 5 minutes and re­
suspended in fresh fixative (the volume depended on the pellet size, so as to ensure a 
good concentration of lymphocytes). A microscope slide was cleaned with a tissue 
and breathed on. A small drop of lymphocyte solution was placed on the centre of the 
slide, which was immediately warmed on the back of the hand, to ensure the nuclei 
were spread out. The slide was left to totally dry, while other slides were prepared. 
Subsequently, the slides were flooded with fixative for 10 seconds, which was poured 
off and the slides were left to dry, then they were flooded again with 70% acetic acid 
for 10 seconds. Once the slides were totally dry, they were checked under a phase 
microscope to ensure the presence of nuclei. Finally, they were dehydrated 
successively in 70%, 90%, and 100% ethanol at room temperature for 5 minutes each.
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2.2.1.2 Day-5 Embryo Spreading
Poly-l-lysine coated slides were used to enhance the fixation of nuclei on slides. They 
were prepared by placing glass slides in a mixture of 50ml of 100% methanol and 
0.5ml of IN HC1 for 3-5min. The slides were left to air-dry and subsequently rinsed in 
Poly-l-lysine (Sigma, UK) for 5min. They were left at room temperature overnight 
and stored at 4°C until required.
The embryos were spread as described previously by Harper et al (1994). The embryo 
was washed in a drop of PBS to remove excess culture medium. Then, the embryo 
was transferred to a small drop of spreading solution (0.01N HC1, 0.1% Tween 20) on 
a poly-l-lysine slide. The embryo was constantly observed under an inverted 
microscope. Most of the spreading solution was removed and replaced with fresh 
spreading solution in order to dissolve the zona pellucida and excess cytoplasm. The 
nuclei were further washed by gentle agitation of the spreading solution until clear of 
cytoplasm.
The slides were left to dry completely and washed for 5min in PBS and dehydrated 
through an ethanol series for 3min (70%, 90% and 100% respectively). The nuclei 
were located and mapped using an England Finder (Graticules Ltd, UK) under a phase 
contrast microscope. The slides were left at RT for subsequent FISH. Most of the 
embryos were spread by embryologists in the London Fertility Centre (LFC) after 
being trained by the author on spare IVF human embryos.
2.2.1.3 Plasmid Probe Preparation
The DNA for the laboratory-prepared (lab-prepared) probe for the a-satellite of 
chromosome 1 was isolated from an E. coli strain carrying the pZ20 vector. Initially, 
E. coli cells from stabs were inoculated into 4 ml of 2xTY medium (16g/l 
Bactotryptone, 10g/l Bacto-yeast extract, 5g/l NaCl), also containing 4 pi of 
ampicillin (lOOmg/ml). The culture was left overnight in a shaking incubator at 37°C. 
The following day this culture was re-inoculated into 200 ml of 2xTY medium and 
200 pi ampicillin (100 mg/ml), and was again incubated overnight in a shaking 
incubator at 37°C. The DNA was extracted using a commercial maxiprep kit 
(Promega, UK). The procedure included the following: First the cells were pelleted by
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centrifugation at 4,000 rpm for 10 min. The supernatant was discarded and the cells 
re-suspended into 15 ml of cell re-suspension solution (50 mM Tris-HCL pH 7.5, 10 
mM EDTA, 100 pg/ml, RNase A). Approximately 15ml of cell lysis solution (0.2 
NaOH, 1% SDS) were added and mixed gently but thoroughly, by stirring or 
inverting. When the cellular mixture became clear, 15 ml of neutralization solution 
(1.32M potassium acetate pH 4.8) were added, and immediately mixed by gently 
inverting the centrifuge bottle several times. The suspension was centrifuged at 9,000 
rpm for 15 minutes at 22-25°C in a room temperature rotor.
The supernatant was filtered through blotting paper and transferred into a 100 ml 
graduated cylinder. After its volume was measured, the supernatant was transferred to 
a new centrifuge bottle. Half a volume of isopropanol was added to this supernatant, 
which was mixed by inversion. The suspension was centrifuged at 9,000 rpm for 15 
minutes as above. The supernatant was discarded and the DNA pellet was re­
suspended in 2 ml TE buffer (10 mM Tris-HCL, ImM EDTA pH 7.5). The DNA 
purification was achieved with the use of the Wizard resin and vacuum pump. Finally, 
the concentration of the DNA was measured by a fluorometer, and the latter was 
stored at -20°C.
2.2.1.4 Probe Labelling
The plasmid probes were labelled using a nick translation kit (Vysis, UK). However, 
the labels that this kit contains (spectrum green or spectrum orange direct-labelled 
dUTP) were not used. The label used was diethylaminocoumarin (DEAC)-5-dUTP 
(Perkin Elmer, USA), which emits aqua fluorescence and incorporates into loci- 
specific identifier DNA probes for its use in FISH. Half the amount of the dTTP was 
substituted with labelled dUTP. The latter diluted the label incorporation, and 
increased the DNA Polymerase I efficiency. Hence, the procedure enabled the 
incorporation of about 20% of the fluorescent-labelled nucleotide into the DNA, 
generating in this way a clear bright signal during hybridization. Ethanol precipitation 
removed the unincorporated nucleotides.
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2.2.1.4.1 Nick Translation
Initially a DEAC-5-dUTP (Perkin Elmer, USA) 50nmol concentration was prepared 
at 0.2 mM by adding 10 pi of 0.1 mM dUTP to 40 pi nuclease-free water. dTTP was 
prepared in a concentration of 0.1 mM with the addition of 10 pi of 0.3 mM dTTP to 
20 pi nuclease-free water. A concentration of 0.1 mM dNTP mix was achieved by 
mixing together 10 pi each of 0.3 mM dATP, 0.3 mM dCTP, and 0.3 mM dGTP (all 
three from Vysis, UK).
The nick translation reaction contained the following: 17.5-x nuclease free water 
mixed with 1 pg of DNA (volume x, varied depending on DNA concentration), 2.5 pi 
of 0.2 mM spectrum green and spectrum orange, 5 pi of 0.1 mM dTTP, 10 pi of 
dNTP mix, 5 pi of 10X nick translation buffer, and, 10 pi of nick translation enzyme. 
The latter consisted of DNA polymerase I, DNase I in 50% glycerol, 50 mM Tris- 
HCl, pH 7.2, 10 mM MgSC>4, 0.1 DTT, and 0.5 mg/ml nuclease free BSA.
The Eppendorf tube was briefly centrifuged and vortexed to mix the reaction 
components and incubated for 2 hours at 15°C. This temperature was crucial for probe 
efficiency and the success of the labelling method. The nick translation reaction was 
stopped by the addition of 5 pi of 0.5 mm EDTA pH 8 (BDH, UK). Then, the 
following components were added to the tube: 5 pi of herring sperm DNA (Sigma, 
UK), 6 pi of 3M sodium acetate, and 1 ml of 100% ice cold ethanol. The probe was 
incubated at -70°C for 1 hour, and centrifuged for 10 min at 14,000 rpm. The 
supernatant was removed, and the pellet was air-dried by leaving the tubes open in the 
dark. Finally the probes were re-suspended in 100 pi of hybridisation buffer (2x SSC, 
60% deionized formamide, 10% dextran sulphate), and stored in the dark at -4°C.
2.2.1.5 FISH Procedure
The probes used in this study can be viewed in Table 2.1. All the probes were 
commercial (Vysis, UK) apart from one (lcep in spectrum Aqua), which was lab- 
prepared. The probe combinations during the sequential rounds of FISH for Chapter 4 
are summarised in Table 2.3
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2.2.1.5.1 Slide Pre-treatment
The method of FISH performed was described previously by Harper et al (1994). The 
slides were incubated in 0.0IN HC1 containing lOmg/ml pepsin at 37°C for 20 
minutes, in order for any remaining protein to be removed and to make the nuclei 
accessible to the probes. The slides were briefly washed in bidistilled (FISH) water 
and PBS and incubated for 10 minutes at 4°C in 1% paraformaldehyde in PBS to re- 
fix the nuclei. The slides were then washed in PBS and a further two washes in water. 
The slides were finally dehydrated through an ethanol series (70%, 90% and 100% for 
three minutes each) and left to dry.
2.2.1.5.2 Probe Preparation
A 5 pi probe mix was prepared according to the source and the type of the probe and 
added to the nuclei under a 13mm diameter coverslip. The probe mix consisted of 
different volumes of probes and CEP hybridisation buffer.
2.2.1.5.3 Separate Denaturation
The FISH protocol and embryo analysis was more efficient whilst carrying out 
separate denaturation. Separate denaturation was performed for all three rounds of 
FISH. During separate denaturation both the slide and the probes were treated 
separately. The slide pre-treatment was followed as described above (Section
2.2.1.5.1) until the last dehydration. After the washes with PBS and twice with water, 
lOOpl of denaturation solution (70% formamide in 2xSSC) was added to the slide. 
The slide was immediately denatured at 75°C for 5 min and incubated in 50ml of 70% 
ice-cold ethanol for 5 min to stop the denaturation. Subsequently, the slide was 
dehydrated through an ethanol series (70%, 90% and 100% for 3 min each) and left to 
dry. All probe combinations were sealed with fixo-gum (Qbiogene, UK) and 
incubated overnight in a moist chamber at 37°C.
2.2.1.5.4 Post-Hybridisation Washes
The stringency of probe binding was controlled by the formamide concentration, salt 
concentration and temperature during the post-hybridisation washes. Therefore 
conditions were dependent on probe type. All washes were carried out in 50ml 
volume coplin jars with those containing formamide restricted to a laminar flow
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cabinet and slides were protected from light at all stages. After hybridisation any 
rubber cement was discarded and coverslips were gently removed by immersing 
briefly in the first wash solution. For combinations of probes including locus-specific 
probes, slides were treated at 45°C with 3 x 3  minutes washes in 50% formamide in 
2xSSC and then 3 x 3  minutes washes in 2xSSC followed by a 10 minute wash in 
SSCT [4xSSC; 0.05% Tween 20 (polyoxyethylene sorbitan monolaurate), Sigma, 
UK] at room temperature. When only repetitive probes were used the stringency was 
raised by increasing the formamide concentration to 60% in the 2xSSC solution. All 
other washes were as above.
According to the ‘long washes ’ protocol from Vysis (UK) any unbound probe was 
removed by washing the slides for 10 minutes at 45°C in 70% formamide/2xSSC pH
5.3 (three times), 10 minutes in 2xSSC pH 7.0 at 45°C and then 5 minutes in 0.05% 
2xSSC/ 0.1% NP40 at 45°C.
2.2.1.5.5 Detection, Capturing and Scoring of the Probes
The examination and scoring of the slides was carried out using a fluorescent 
Olympus (BX-40) microscope, which was fitted with a photometries cooled CCD 
camera utilising pathVysion software (Digital Scientific, Cambridge, UK). Two 
hundred interphase nuclei were scored in order to calculate probe efficiency as part of 
the FISH study. All embryonic blastomeres were located using an England Finder. 
FISH probe signals in interphase nuclei were scored following Hopman et al., (1988) 
such that two signals closer than a signals diameter apart were considered a single 
split signal and those further apart were considered as two separate signals.
2.2.1.5.6 Sequential FISH Procedure
After the detection and capturing of the 1st (or 2nd) round probe combination (Table
2.4), co-ordinates of three interphase nuclei and three metaphase spreads were 
recorded in the control lymphocyte slide using an England Finder in order to assess 
the efficiency of the probes in future rounds. The coverslip was removed with care so 
as not to disturb the nuclei. The slide was washed twice in 4xSSC/0.05% Tween 20 
(while shaking) for 10 min each time. The slide was incubated in PBS, washed again
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for 10 min and then dehydrated through a 70, 90, and 100% ethanol series. The probe 
mix was prepared for the second round of FISH.
The probes were separately denatured from the slide (section 2.2.4.3) for 5 min in 
75°C and the slide incubated at 37°C overnight. Any unbound probe was removed by 
washing the slides for 10 minutes at 45°C in 70% formamide/2xSSC pH 5.3 (three 
times), 10 minutes in 2xSSC pH 7.0 at 45°C and then 5 minutes in 0.05% 2xSSC/ 
0.1% NP40 while at 45°C. The slides were left to dry in the dark and mounted in 
Vectarsheild (Vector Laboratories, USA) containing 5pl of 0.2mg/ml 4’,6’- 
diaminidino-2-phenyolindole (DAPI). The DAPI volume was lowered to reduce its 
intensity and thus avoid bleaching the aqua probe signals. The FISH signals were 
analysed as described in section 2.2.1.5.5
2.2.1.6 FISH Protocol for Chapter 4
Initially the study was carried out on control lymphocytes to select and optimise the 
FISH protocol. Subsequently, the study was performed on embryos that were not 
transferred and not suitable for freezing and were donated with written consent from 
patients undergoing routine IVF treatment at the London Fertility Centre.
2.2.1.6.1 FISH Protocol Selection and Optimisation
The FISH protocol was carried out as described by Harper et al (1994) above. 
However, some of the steps were altered in order to obtain high efficiency in all three 
sequential rounds of FISH. Several probe combinations were tested during the initial 
stages of this study (Table 2.3).
Table 2.3. Multi-colour FISH-probe combinations
Chromosome combinations Probes used in the 1st 
round
Probes used in the 2nd 
round
1 dual / 8 dual l h e t / Ip 8ccp / 8q
4 / 1 6  dual & 4 / 11 dual 4eep / 16p / 16q 4cep / 11 cep / 11 q
7 d u a l" /18 & 11 d u a l / 18 7q / 7q / 18eep 11 cep / 1 lq / 18cep
2 / 4 / 5 2q / 4cep / 5p 5p&5q */2cep
1 / 1 1 / 1 8 lp / 1 Iq / 18cep l h e t / l lcep / 18q
X / Y /18 (cocktail) Xcep / Ycep / 18cep Xcep / Ycep / 18cep
# The probe is the 7 (7qll..23 and 7p31) Wiliams microdeletion probe
* The probe is the 5 (5q31 and 5pl5.2) Cri-du-Chat microdeletion probe
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All FISH protocols were tested on lymphocytes and their efficiency was measured on 
200 interphase nuclei for each probe. Once each probe by itself was efficient, all the 
probes were combined and adjustments to salt concentrations, temperature, 
formamide concentration were carried out in various FISH experiments to achieve 
increased efficiency values and clear, sharp, large signals for each probe. The final 
three different combinations of 3-colour FISH in the three rounds were optimised. 
Probe combinations as well as stringency conditions were altered and tailored to 
produce the best possible fluorescent signals for all the chromosomes tested.
2.2.1.6.2 Final FISH Protocol
FISH was performed in three sequential rounds (section 2.2.1.5). The 1st and 2nd 
rounds were performed with probes for chromosomes 1, 11 and 18, whilst the 3rd 
round used probes for the sex chromosomes and chromosome 18 (Table 2.2). All 
probes except one (the probe lstall/III in spectrum aqua) were obtained from Vysis 
(UK) Ltd. The first round included the following probes: lp SpectrumGreen (telomere 
CEB108/T7), which hybridises to the sub-telomere region of the short arm of 
chromosome 1; 11 q SpectrumOrange (telomere VIJyRM2072), which hybridises to 
the sub-telomere region of the long arm of chromosome 11; CEP 18 Spectrum Aqua 
(alpha satellite D18Z1), which hybridises to the centromere region of the chromosome 
18. The second round included the following probes: lhet (satellite II/III), which 
hybridises to the heterochromatic region of chromosome 1 (laboratory-prepared); 
CEP 11 SpectrumGreen (satellite D11Z1), which hybridises to the centromere region 
of the chromosome 11; 18q SpectrumOrange (telomere VIJyRM2050), which 
hybridises to the sub-telomere region of the long arm of chromosome 18. The third 
round included the following probes: repeated use of 18 Spectrum Aqua (as an internal 
control); CEPX SpectrumGreen (alpha satellite DXZ1), which hybridises to the 
centromere region of chromosome X; and CEPY SpectrumOrange (alpha satellite 
DYZ3), which hybridizes to the centromere region of chromosome Y (Table 2.2).
2.2.1.6.3 Stringency Conditions
Each probe combination reacts differently with respect to stringency conditions. The 
telomeric (labelled with a “/?” or a “q”) and locus specific probes (labelled LSI)
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required an LSI buffer solution to hybridise more efficiently onto the DNA. However, 
centromeric probes (labelled “CEP” or “satll/IIF  or “het ’) required a CEP 
hybridisation buffer solution. During the post-hybridisation washes (see section
2.2.5.4) telomeric and locus specific probes needed a lower formamide concentration 
of 50% whereas centromeric probes need a 60% formamide concentration. In all three 
rounds of FISH, CEP buffer and 50% formamide was used. The denaturation 
time/temperature factor was modified since all the telomeric and LSI probes require 
5min at 73°C, whereas CEP probes need 3min at 75°C. Hence, in all three rounds the 
probe combinations were denatured for 5min at 75°C. Also, further optimisation of 
the protocol was carried out whilst working on human embryos. It was found that if 
the denaturation step was carried out in a 75°C waterbath, rather than a 75°C oven, 
higher efficiencies were obtained. The final stringency conditions can be seen in 
Table 2.4. During this study, all the post hybridization washes were carried out 
according to the ‘long washes ’ protocol from Vysis (UK).
Table 2.4. Probe combinations and conditions for all three rounds of sequential FISH
Round of 
FISH
Probe
combination
Volume of 
probe (pi)
Denaturation 
temperature/ time
Hybridisation
time
ip 0.6
Is' Round l lq 0.6 75°C / 5min Overnight
18cep 0.5
CEP buffer 3.3
2nd Round
lhet 1.0
1 lcep 0.5
18q 0.6
CEP buffer 2.8
75°C / 5min Overnight
3rd Round X / Y /  18 2.0 75°C / 5min 2 hours
CEP buffer 2.0
cep = centromeric probe, het = heterochromatic probe
p = sub-telomeric probe for the small arm, q = sub-telomeric probe for the big arm
2.2.2 PCR Methods
PCR was carried out in the CGH (Chapter 5) as well as the PCR-PGD (Chapter 3) 
study. Blood from normal individuals was collected and prepared for PCR to be used 
as control. Specimens for each case (Chapter 3) consisted of maternal and paternal 
blood (as well as relative blood when applicable) collected in ethylene-di-amine-tetra-
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acetic acid (EDTA) blood tubes. Both maternal and paternal bloods were prepared for 
PCR.
2.2.2.1 DNA Extraction from Blood
The method described by Lahiri and Numberger (1991) was employed for DNA 
extraction from blood.
Blood samples of 5ml were collected into Falcon centrifuge tubes (Falcon, UK) 
containing 400mM EDTA. Whole blood was transferred into centrifuge tubes and 5ml 
of low salt buffer TKM1 and 125pl of Igepal CA-630 (Sigma, UK) were added to 
lyse the red blood cells. The mixture was mixed well by inversion and shaking and 
centrifuged at 2,200rpm for 10 minutes. The supernatant was slowly removed and the 
pellet was washed in 5ml of TKM1 and 125pl of Igepal CA-630 as previously. The 
washing and spinning were repeated until redness of the pellet was diminished. The 
pellet was then re-suspended in lOOpl TKM1. A total of 800pl of TKM2 and 50pl of 
10% (w/v) sodium dodecyl sulphate (SDS) were added to the suspended pellet to lyse 
the white blood cells. The solution was mixed thoroughly by pipetting up and down. 
The tube was placed in a 55°C water-bath for >30min until the lumps disappeared 
completely. 300pl of 6M NaCl were added to ensure that all cells had lysed, and the 
tube was centrifuged at 10,000rpm for 10 minutes. The supernatant was transferred to 
a new centrifuge tube and the precipitated protein pellets were discarded. Two 
volumes of 100% ice-cold ethanol were added to the supernatant and the tube was 
inverted until the DNA strands precipitated. The sample was spun at 10,000rpm for 5 
minutes and the supernatant was poured off. The remaining precipitated DNA was 
washed in 1ml of ice-cold 70% ethanol and spun at 10,000rpm for 5 minutes. The 
supernatant was discarded and the DNA pellet was left to dry for 5 minutes. The DNA 
pellet was dissolved in 300pl of lxTE and stored at -20°C until further use.
2.2.2.2 Single Cell Isolation
2.2.2.2.1 Preparation for Single-cell Isolation
All single cell isolations and single cell PCR procedures were carried out in a 
dedicated room (termed single cell room) which was free of PCR amplified samples. 
The ‘single cell’ room was a room with positive pressure which was fitted with a
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Class II Laminar flow hood were all preparations took place which was cleaned 
before and after each use with 100% ethanol. Dedicated bench microfuge, a set of 
Eppendorf pipettes, sterile Eppendorf tips (Eppendorf, UK), sterile gloves and 
laboratory coats were all separate from the main lab. Approximately 3 pi lysis buffer 
consisting of 2pl of 125pg/ml Proteinase K (PK) and lp l of 17mM sodium dodecyl 
sulphate (SDS) was pipetted into each of the microcentrifuge tubes before adding the 
single buccal cells, single human blastomeres and cell clumps (El-Hashemite and 
Delhanty, 1997). Once the single cell was transferred into the lysis buffer, the mixture 
was covered with a drop of light mineral oil to prevent contamination and evaporation 
before closing the lid. The lysis buffer was activated at 37°C for lh, and inactivated 
by incubating at 99°C for 15 min. After lysis, the DNA from the single cells or cell 
clumps was ready for PCR or storage at -80°C.
2.2.2.2.2 Single Buccal Cells
50pl of the concentrated cell suspension was transferred to a 5cm petridish in a 
laminar flow cabinet. Approximately ten 30pl drops of PBS containing 0.1% PVA 
were spotted onto the petridish. A drop of cell suspension (about 500pl) was 
transferred to an adjacent drop of PBS using a pulled glass micropipette, while 
visualising under a dissecting microscope. The transfer of the cells in different 
PBS/0.1% PVA drops was repeated 2-3 times to dilute the cell concentration until the 
isolation of a single cell was achieved. The single cells, once isolated, were 
transferred in and out of at least three fresh PBS drops to wash away any 
contaminants. Then the single cells were transferred into an individual thin-wall 
microcentrifuge tubes ( 0 .2 j l x 1 Eppendorf tubes, Eppendorf, UK) containing lysis 
buffer. A clump of 3-5 cells was taken as a positive control for each PCR. Also, 2pl 
of the last drop was taken as a blank (negative control) for each single cell.
2.2.2.2.3 Isolation and Tubing of Single Human Blastomeres
Blastomeres were used as part of the PGD procedure carried out in Chapter 3 in a 
clinical setting. Furthermore, surplus blastomeres were used for Chapters 5 and 3 for 
research purposes.
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Human blastomeres were provided following informed patient consent, from day 3 or 
day 4 donated spare embryos from standard IVF/ICSI cycles. The blastomeres 
biopsied were selected based on good morphological appearance. The single 
blastomeres derived from biopsy were subsequently washed through several drops of 
PBS/0.1% PVA, to remove excess contaminants such as cumulus cells or sperm, 
before they were transferred into individual thin-wall microcentrifuge tubes (0.2pl 
Eppendorf tubes, Eppendorf, UK) containing 3 pi PCR lysis buffer containing 
proteinase K (2.1.2.1.1). Each tube was checked under the microscope in order to 
visualise the cell within the tube. 2pl of the last wash drop was taken as a blank for 
each single blastomere. The lysed cells were stored at -70°C.
2.2.2.3 PCR Procedure
2.2.2.3.1 DOP-PCR
The procedure for the DOP-PCR was carried out according to Wells et al (1999) 
(Chapters 3 and 5). The DOP50 PCR mixture consisted of 0.2mM deoxynucleoside 
triphosphates (dNTP’s: dATP, dTTP, dCTP and dGTP), 2juM DOP primer (Table 5.2) 
and 2 units of SuperTaq® (HT Biotechnology, UK) DNA polymerase with 
lOxSuperTaq buffer and was made up to a total volume of 50pl with nuclease-free, 
distilled, deionised sterile water (Promega, UK). The reaction mix was added to 200- 
300ng of genomic DNA or extracted DNA from single cells; one extra tube was taken 
as PCR-mix-only negative control for each reaction or blanks from each single cell. 
25pl of lightweight mineral oil was added to prevent contamination and evaporation. 
The PCR was set up on ice, in a laminar flow cabinet using dedicated pipettes and 
sterile filtered tips.
The thermal cycling conditions were as follows: 94°C for 9 min, 30°C for 1 min, 72°C 
for 3 min (eight cycles); 94°C for 1 min, 62°C for 1 min and 72°C for 1.5 min (thirty 
five cycles); 72°C for 8 min.
2.2.2.3.2 Fluorescent PCR
Full details of the oligonucleotides used as primers for the fluorescent PCR can be 
seen in Table 2.2. The annealing (melting) temperature for the oligonucleotide 
primers was estimated by the following ‘the-rule-of-thumb’ calculation:
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Tm = 2x(A+T) + 4x(G+C)
Where A, T, C and G are the nucleotides adenine, thymine, cytosine and guanine 
respectively. The working optimal annealing temperatures were determined 
empirically by experiments using the Mastercycler Gradient® thermal cycler. A 
temperature gradient of ±5°C from the calculated temperature across the block was 
carried out. The temperatures giving the most intense amplified products were 
considered as the optimal annealing temperature.
The PCR procedure was carried out as previously described by Piyamongkol et al 
(2001). The PCR mixture consisted of 0.2pM of each primer, 200pM 
deoxynucleoside triphosphates (dNTP’s: dATP, dTTP, dCTP and dGTP) and 1 unit of 
SuperTaq® (Cambridge Technologies, UK) DNA polymerase with lxSuperTaq 
buffer and was made up to a total volume of 25pi with nuclease-free, distilled, 
deionised sterile water (Promega, UK). The reaction was added to the genomic DNA 
or extracted DNA from single cells; one extra tube was taken as PCR-mix-only 
negative control for each reaction. 25 pi of lightweight mineral oil was added to 
prevent contamination and evaporation. The PCR was set up on ice, in a laminar flow 
cabinet using dedicated pipettes and sterile filtered tips. For single cell PCR, 1.5 units 
of the polymerase enzyme were used in the reaction mixture. When AmpliTaq 
Gold™ polymerase with lxGeneAmp® buffer were used instead of SuperTaq®, the 
primary denaturation step was set to 12 minutes to activate the enzyme. Table 2.5 
reveals the conditions of the thermal cycler for all the cases.
Table 2.5 Conditions for the thermal cycler using different polymerase enzymes
'-^ E n zym e Polymerase 
PCR s t e p s ^ ^ ^ * ^ ^
SuperTaq®
Plus
AmpliTaq
Gold™
Number of cycles
Primary denaturation 94°C 4min 94°C 12min 1
Denaturation 94°C 30sec 94°C 45sec 30 for genomic DNA 
40 for single cellAnnealing 60°C 30sec 60°C 45sec
Extension 72°C 45sec 72°C lmin
Final Extension 72°C lOmin 72°C lOmin 1
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2.2.2.4 PCR Analysis
2.2.2.4.1 Gel Electrophoresis
This type of analysis was only used during the early stages where it was required to 
test the DOP-PCR product as well as the Fluorescent-PCR (F-PCR) product to ensure 
amplification.
A 2% agarose gel containing 0.1 pl/ml ethidium bromide was prepared by mixing 
agarose in lxTBE. The mixture was heated (approx 2min) gently in a microwave until 
the agarose dissolved completely. Ethidium bromide (5 pi) was mixed into the agarose 
mixture and the mixture was poured into a mini-gel tank with an 8 or 16 well- 
forming-comb and left to set at room temperature (approx 20 min).
The comb was removed and the gel was immersed in 50ml of lxTBE. Each PCR 
(8 pi) product was mixed with a one tenth volume of the loading buffer and was 
loaded into each well. One Kb of ladder was used as a reference. Electrophoresis was 
performed for 30-60 min after which the gel was viewed under ultra-violet trans­
illumination.
2.2.2.4.2 Automated laser DNA analyser (ABI Prism™ 310 and 3100)
Fluorescent PCR products were separated and analysed using an automated laser 
DNA analyser (ABI Prism™ 310 or 3100) and the appropriate software (GeneScan 
version 2.0.2; Applied Biosystems, UK). Each F-PCR product (1 pi) was mixed with 
12pl of deionised formamide and 0.5pl of the size standard (Genescan 500-TAMRA 
or Genescan 500-ROX, Applied Biosystem, UK). The mixture was run through a 
capillary (12kVolts, 26 min at 60°C) after 5 min denaturation at 95°C. Each PCR 
product was sized and distinguished illustrated as a peak using the GeneScan 2.0.2 
version analysis software (Applied Biosystems, UK). Each peak represented the allele 
size of the product and the peak height the amount of the product.
2.2.2.4.3 Optimisation of PCR protocol
Each PCR protocol was optimised so the final product showed sharp, high peaks 
when analysed using the GeneScan 2.0.2 version analysis software (Applied 
Biosystems, UK). Efficiency of single cell PCR protocols was carried out by
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calculating the number of single cells which showed amplification of at least one 
correct size allele (either homozygote or heterozygote samples). The allele dropout 
(ADO) rate was calculated only for heterozygote samples. The ADO rate was 
determined from the cells that did show amplification, e.g. if 9/10 cells showed 
amplification, then the ADO rate would be calculated from the 9 cells.
2.2.2.5 PGD
2.2.2.5.1 PGD Consultation
Patients were referred to the UCL centre for PGD. In most cases referral was from 
clinical genetics departments and the patients had already had genetic counselling. 
Prior to commencing treatment all patients were fully informed regarding the 
limitations of PGD. The requirement for IVF treatment, the risk of misdiagnosis, the 
problems caused by mosaicism, the expected implantation and pregnancy rates, were 
all outlined during two thorough IVF/PGD consultations. Before commencement of 
treatment, patients had full gynaecological investigations and the male partners sperm 
was assessed and a specific single cell diagnoses was developed for each couple.
2.2.2.5.2 IVF Treatment and Manipulation of Embryos.
The patients underwent routine IVF procedures as described previously (Ranieri et al, 
2001). Following ovarian stimulation follicles were aspirated and fertilisation was 
evaluated 24h after insemination. Oocytes and embryos were cultured in IVF medium 
(Cook, Australia).
2.2.2.5.3 Embryo Biopsy (UCL)
PGD was performed for two patients ‘G’ and ‘FT. On day 3 embryos were biopsied
I i
by the senior embryologist in Ca Mg -free embryo biopsy medium (Medicult, UK), 
using Research Instrument micromanipulators. Zona drilling was performed using 
acid Tyrode’s solution as described previously (Piyamongkol et al, 2001a). One or 
two blastomeres were aspirated according to the developmental stage and morphology 
of the embryos. In general two cells were biopsied from embryos consisting of 6 or 
more cells. Biopsied cells were washed and tubed for analysis (section 2.2.2.2.3). The 
untransferred (spare) embryos were donated for research with the patient consent for
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confirmatory diagnosis. All the cells from the spare embryos were biopsied and were 
tubed for molecular analysis (section 2.2.2.23).
2.2.2.5.4 Embryo Biopsy (LFC)
The embryo biopsy method carried out for this study was different to that used in 
chapter 3 carried out in the UCL Assisted Conception Unit (section 2.2.2.5.3). The 
embryos were incubated for a 1-2 minutes in Ca+2/Mg+2-free biopsy medium. The 
zona pellucida surrounding the embryo was drilled with a laser system as described 
by Veiga et al (1997). 1-2 cells were removed gently from the embryo and the embryo 
was subsequently washed in IVF medium. The embryos were then placed in 
blastocyst medium (6.2 Vitrolife, Scandinavia) from day 3-5.
2.2.2.6 PGD Strategy for DM Using F-PCR
The diagnosis of a normal embryo was based on the observation of two normal DM 
alleles, one from each parent. The mutant DM expanded allele cannot be detected 
since fragment sizes above 500bp are refractory to PCR, hence an affected embryo 
would only show one normal allele. Different polymorphic markers (STR’s) linked 
and unlinked, were tried for each family to test whether they were informative (Table 
5.2). A linked marker, such as the D19S112 which is located approximately 0.3cM 
upstream to the DMPK, would provide further information about the genetic state of 
the embryo i.e. if the embryo carries the mutation or not. An unlinked marker, such as 
the D2IS 1414, would only allow the detection of contamination (Piyamongkol et al, 
2001a).
2.2.2.6.1 Genomic DNA Workup
Each family was tested for a variety of STR’s from genomic DNA extracted from 
their blood (section 2.2.2.1), which were classed as informative depending on their 
allele size. For example, a tetranucleotide STR would be rendered informative if all 
four alleles from the two parents were of different size and at least one base pair apart 
from each other i.e. 120/130 for the mother and 126/142 for the father. If a family was 
informative for a linked marker, another affected member was asked to produce a 
DNA sample in order to obtain the ‘phase’. Table 2.2 summarises the different STR’s 
tested for all the couples’ extracted genomic DNA (see Tables 3.1-3.10 for results)
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1.2.2.6.2 Single Cell Workup
If a couple had at least one informative linked or unlinked polymorphic marker 
including the DM mutation marker, testing on single cells was initiated for each 
couple individually. Fifty single buccal cells along with 10-20 clumps of buccal cells 
were tested for each multliplex reaction on buccal cells from a normal heterozygous 
individual to test the protocol at the single cell level.
The protocol for family G was the multiplex reaction of DM+D21S1414 (Protocol 1), 
whereas for family H was the multiplex reaction of DM+D19S112 (Protocol 2). 
Subsequently, both protocols were performed on at least 100 single cells isolated from 
each partner of each family as well as spare single human blastomeres for assessing 
the amplification efficiency and ADO rates. The ADO rates were calculated from the 
number of single cells that were amplified, when only one allele was visible as a peak.
For the optimal protocol in both cases, the PCR mixture consisted of 0.1 pM of the 
DM primer and 2.5pM for the D21S1414 primer (Protocol 1) and 3.0pM for the 
D19S112 primer (Protocol 2), 200pM dNTP’s, lOxGeneAmp® Buffer and 1.5U 
AmpliTaq Gold™ and was made up to a final volume of 25pi with double-distilled, 
nuclease-free, de-ionised water. The amplifications were performed with the 
conditions 94°C, 45sec (96°C for the first ten cycles), annealing at 60°C, 45sec for 
family G (Protocol 1) and 61°C 45sec for family H (Protocol 2) and extension of 
72°C, lmin for 42 cycles. These were preceded by denaturation at 94°C for 12 min to 
activate the AmpliTaq Gold™ enzyme.
Each marker was analysed on the 3100ABI Prism™ as wells as backup analysis on 
the 310 ABI Prism™. Since each marker was fluorescently labelled differently (see 
Table 5.2), analysis was possible in different dyes.
2.2.2.6.3 Clinical DM PGD Cases
Following ICSI treatment, one PGD cycle for each family (G and H) was performed. 
The single biopsied blastomeres were analysed using the optimal PGD protocols 1 
and 2. Normal embryos (if any) were chosen for transfer on day 4 post-fertilisation. 
All the cells from the untransferred embryos were biopsied and analysed using the 
same protocols for each family for confirmatory results.
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2 2 .2.1 PGD Strategy for DM Using WGA
A universal protocol for PGD for DM was attempted using DOP-PCR as the method 
of whole genome amplification and then subsequent amplification with five different 
markers. The markers that were selected were DM (mutation marker), D19S112 
(linked polymorphic marker) as well as D13S305, D18S535 and D21S1414 (unlinked 
polymorphic markers) (Table 5.2). These unlinked polymorphic markers were chosen 
as they were on different chromosomes in order to observe the coverage of the 
genome when amplified using DOP-PCR.
2.2.2.7.1 Procedure on Genomic DNA
The DOP-PCR procedure was carried out as described by Wells et al (1999) (section
2.2.2.3.1) initially on genomic DNA. The F-PCR procedure was carried out as 
previously described by Piyamongkol et al (2001) (section 2.2.2.3.2). However, not 
all the primers produced efficient yields when analysed on the automated laser DNA 
analyser (ABI Prism™ 3100). Therefore, the F-PCR protocols were adjusted, at the 
genomic DNA level, in order to generate sufficient quantities of PCR product when 
carried out at the single cell level. Several annealing temperatures were tested using a 
Gradient Thermal Cycler as well as different primer concentrations, to produce an 
efficient PCR protocol. The final annealing temperatures and concentrations of the 
primers can be seen in Table 2.6.
Table 2.6. Annealing temperatures and primer concentrations for the singleplex 
reactions for each polymorphic marker
Type of Marker Marker Annealing
Temperature
(°C)
Primer
Concentration
STR (Dinucleotide) DM 60 °C 0.1 pM
STR (Dinucleotide) D19S112 61 °C 0.6 pM
STR (Tetranucleotide) D21S1414 62 °C 1.0 pM
STR (Tetranucleotide) D18S535 60 °C 0.6 pM
STR (Tetranucleotide) D13S305 56 °C 0.8 pM
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22.2.1.2 Procedure on Single Cells
The single cell DOP-PCR procedure was optimised during the CGH study (section 
4.2.6). Once the singleplex F-PCR protocols were optimised on single cells, two 
individuals were chosen (‘X’ and ‘Z’) from which ten single cells and two clumps 
from each were amplified using DOP-PCR. Subsequently, a 1 .Opl aliquot from each 
single cell DOP-PCR product was used as a template for each singleplex reaction with 
each of the markers (Table 5.2). The final product was run on the 3100ABI Prism™ 
for analysis. Genomic DNA from each individual was amplified to act as positive 
control.
2.22.1.3 CGH on DOP-PCR Amplified Single Cells
From a 50pl DOP-PCR reaction, only lOpl were used. The rest of the DOP-PCR 
product was utilised for CGH analysis. The full CGH protocol can be seen in section 
2.2.3.4, which was performed as described by Wells et al (2002). The optimisation of 
the CGH protocol was performed as part of the study in Chapter 5.
2.2.3 CGH Methods
CGH was used for the study summarised in Chapter 5 (as well as Chapter 3). Some 
sections of the CGH Methods are identical to PCR; hence similar methods will be 
referred to the appropriate sections.
2.2.3.1 DNA Extraction from Frozen Fibroblasts
Several cell pellets (trisomy 13, 18, 21, 22, XXX and normal) were subjected to DNA 
extraction to be subsequently used as positive controls for preliminary studies to 
assess efficiency of the genomic CGH protocol. Cell suspensions were centrifuged at 
lOOOrpm for 5 minutes, and the supernatant containing glycerol was removed. The 
cells were washed with Hank’s medium (Sigma, UK) and centrifuged at 6,000rpm for 
5 minutes. The supernatant was removed and 2.5ml of DNA extraction lysis buffer 
(section 2.1.3.1.2) warmed at 37°C was added and the cells were left at 37°C for 30 
minutes. An equal volume of isopropanol was added in order to precipitate the DNA 
which was “hooked out” and dissolved in water.
For DNA Extraction from Whole Blood refer to section 2.2.2.1.
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2.23.2  Single Cell isolation
Refer to section 2.2.2.2
2.23.3  DOP-PCR
Refer to previous section 2.2.2.3.1
2.2.3.4 CGH Procedure
2.2.3.4.1 Labelling of Probe DNA
The DNA product of DOP-50 was ethanol precipitated, redissolved in water and 
labelled by nick translation. The 50pl reaction contained 5 pi of 10X reaction buffer 
mix, lOpl 0.1 mM dNTP Mix, 5 pi 0.1 mM dTTP mix, 2.5pl of 0.2mM 
Hapten/fluorochrome-dUTP, lOpl DNA Polymerase (lOU/pl) and 17.5 pi of 
Nuclease-free water (Promega, UK). The time for the nick translation was between 
60-120 minutes at 15°C. The reaction was stopped with a 10 minute incubation at 
72°C
2.2.3.4.2 Preparation of Labelled DNA
A 1% agarose gel was run to check the fragment sizes (see section 2.2.2.4.1). Optimal 
sizes for CGH were estimated between 300-2000bp. The reference DNA was labelled 
with Spectrum Red (Vysis, UK) and the test DNA was labelled with spectrum Green 
(Vysis, UK). The appropriate DNA to be hybridised against the single blastomere was 
a group of 3 buccal cells that had undergone the same treatment as the single 
blastomeres and were amplified during the same DOP50-PCR experiment. Labelled 
reference and test DNA were mixed with 30pg Cot-1 DNA and ethanol precipitated 
and washed with 70% ethanol and air-dried. The pellet was resuspended in 6pl 
Hybridisation mix (50% formamide; 2xSSC; 10% dextran dulphate) and dissolved by 
20 minutes incubation at 37°C. The probe was denatured at 75°C for 10 minutes and 
cooled at 37°C by incubation for 2 minutes at room temperature in the dark before 
being applied to the denatured normal chromosome spreads as described below.
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2.2.3.4.3 Denaturation of Metaphase Chromosome Spreads and Probe 
Hybridisation
Denaturation of male lymphocyte slides was performed by a 5 minute incubation of 
the slides in a coplin jar with denaturation solution (70% formamide; 2xSSC pH 7.5) 
pre-warmed at 73°C. Immediately after denaturation the slides were put through an 
ice-cold (chilled at -20°C) ethanol series (70%, 85%, 100%) and dried. The probe was 
applied to the slide and covered with a coverslip sealed with rubber cement and 
hybridised in a moist chamber at 37°C for 72 hours.
2.2.3.4.4 Post-Hybridisation Washing
The post hybridisation washes consisted of 5 minutes in 2x SSC at 72°C, 5 minutes in 
4xSSC at 37°C, 5 minutes in 4xSSC + 0.1% Triton-X (Sigma, UK) at 37°C, 5 
minutes in 4xSSC at 37°C, and 5 minutes in 2xSSC at room temperature followed by 
dipping of the slides in double-distilled water. The slides were put through an ethanol 
series 3 minutes each, air-dried and mounted in anti-fade medium (Vector Labs, 
Peterborough, UK) containing diamidinophenylindole (DAPI) to counterstain the 
chromosomes and nuclei.
2.2.3.4.5 Microscopy and Image Analysis
Metaphase chromosome preparations were captured using a Zeiss Axioscope 
microscope equipped with a Photometries KAFF 1400 cooled CCD camera, and 
SmartCapture software (Vysis Richmond, UK). Image analysis was performed using 
Vysis Quips CGH software. Green:Red fluorescence ratios of >1.2:1 indicated gain of 
genetic material, while ratios of <0.8:1 was indicative of deletions.
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2.2.3.5 CGH Procedure for Chapter 5
This study was performed on frozen embryos which were subsequently thawed 
(frozen-thawed embryos) generated from patients undergoing IVF and ICSI at the 
London Fertility Centre. These embryos were suitable for freezing, hence were 
considered good quality embryos when assessed morphologically. All embryos were 
donated with written consent from patients and the study was licensed by the Human 
Fertilisation and Embryology Authority.
Quality control was performed for every step of this study. Prior to commencing this 
study a preliminary study was performed to ensure the optimal method for analysing 
single blastomeres by CGH. Single cell isolation of 100 buccal cells was carried out. 
Subsequent tubing of the buccal cells was followed by DOP-PCR. The final 
amplified product was run on a 2% agarose gel electrophoresis carried out at 50V for 
30 minutes after which gels were viewed via ultra-violet trans-illumination to assess 
the efficiency of the tubing technique.
2.2.3.5.1 WGA Protocol
DOP-PCR was employed to amplify the whole genome of the cell uniformly as 
described by Wells et al (2002) using the Eppendorf PCR machine (See section 
2 .2 .3 .3)
2.2.3.5.2 Optimisation of WGA Protocol
For the WGA technique, namely DOP-PCR, gel electrophoresis provided the only 
means of assessing whether the PCR conditions were optimal. A non-intense smear 
should be visible for each sample; genomic DNA, clump of buccal cells or single cell. 
Furthermore, in each experiment a negative control was added for the DOP-PCR 
amplification to assess each reaction for contamination. All negative controls were 
tested by gel electrophoresis and by carrying out CGH experiments where the 
negative controls acted as ‘test ’ samples.
Two different thermal cyclers were tested: the Eppendorf and the Hybaid Omnigene 
(see section 2.1.5.2) in order to examine which provided the best amplification results. 
The DOP-PCR products were analysed on a 2% agarose gel
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2.23.5.3 CGH Protocol
The full CGH protocol is detailed in section 2.2.3.4, which was performed as 
described by Wells et al (2002). Each Nick-Translation kit (Vysis, UK) was tested 
before use, since each aliquot of the Nick-translation enzyme (contained in each kit) 
behaved differently and required slightly different times of incubation. Hence, a trial 
Nick-Translation CGH experiment was set up after purchase of a new kit, and it was 
assessed by carrying out DOP on single buccal cells, labelling the sample and testing 
the fragment sizes by gel electrophoresis. The optimal sizes for CGH were estimated 
to be between 300-2000bp (Wells et al, 1999).
Six to twelve metaphases were captured using a Zeiss Axioscope microscope 
equipped with a Photometries KAFF 1400 CCD camera. Each metaphase was 
karyotyped and assessed using Vysis Quips CGH software.
2.2.3.5.4 Optimisation of CGH Protocol
The optimisation of the CGH protocol was achieved by testing initially with high 
quality genomic DNA, which had been extracted ‘in house’, from ‘healthy’ 
individuals. Furthermore, genomic DNA from frozen fibroblast cell lines (cultured in- 
house) with a defined chromosomal abnormality such as trisomy 13, trisomy 18, 
trisomy 21, trisomy 22 and triploidy 69 XXX was employed as a positive control in 
assessing genomic CGH protocol efficiency. Single cell isolation was performed for 
buccal cells and fibroblasts to provide practice, and the positive controls in assessing 
single cell CGH protocol accuracy. A set of embryos were thawed with patient 
consent and were biopsied in order to establish the biopsy technique as well as the 
CGH technique applicable on single blastomeres. This set of embryos were used as a 
learning curve for both biopsy practitioner and the author.
2.2.3.5.5 FISH Protocol
The FISH protocol was carried out as described by Harper et al (1994). However, 
some of the steps were altered in order to obtain high efficiency in all the sequential 
rounds of FISH. All day 5 embryos were subjected to two sequential rounds of FISH 
(section 2.2.1.5). The first round of FISH was always carried out using the probe 
cocktail for chromosomes X, Y and 18, which acted partly as a control for the CGH 
experiment since the sex of the biopsied cells should match the sex of the rest of the
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embryo (unless mosaic). The second round of FISH was a combination of 
9cep/16cep/22LSI if the CGH showed euploid results for the biopsied blastomeres, or 
a combination of probes matching the abnormalities observed by CGH in as many 
chromosomes as possible. Hence, there were a variety of FISH protocols carried out 
for this study. The different combinations can be viewed in Table 2.7.
Table 2.7. FISH probe combinations and stringency conditions.
Chromosomes Probe
Combination
Stringency Conditions
Probe Vol (pi) Denaturation P-Ha washes
X, Y, 18 Xcep/Ycep/18cep 2(j.lb Coc, 75° for 5min 60% FA
9, 16, 22 9cep/16cep/22LSI 0.5|xl/0.5nl/0.7nl Sepd, 75° for 5min Vysis6
3, 11, 13 3cep/l lcep/13LSI 0.5(j.l/0.5(j.l/0.7|j.l Sep, 75° for 5min Vysis6
10, 14 10cep/14q 0.5(j.l/0.6(j.l Co, 75° for 5min 60% FA
1, 16 lp/lq/16cep 0.6pl/0.5pl/0.5pl Sep, 75° for 5min 50% FA
3,6, 18 3cep/6cep/18q 0.5pl/0.5pl/0.6pl Sep, 73° for 5min 60% FA
Y, 4 Ycep/4cep 0.5pl/0.5pl Co, 75° for 5min 60% FA
X, Y, 16 Xcep/Ycep/16q 0.6pl/0.5pl/0.6pl Co, 75° for 3min 50% FA
aPost-Hybridisation washes
bThis was a probe cocktail, where 2pl from the cocktail were added into the probe mixture 
c Co-denaturation
dSeparate Denaturation (section 2.2.1.5.3)
eThe post-hybridisation washes termed ‘long washes’ proposed by Vysis (UK) (section
2.2.1.5.3)
For probe information refer to section 2.1.5.1 in Table 2.1. Most of the probe 
combinations required co-denaturation with the slide. However, there were also probe 
mixtures where diffused signals and cross-hybridisation was observed, therefore 
separate denaturation of the probes and the slide was performed (see section
2.2.1.5.3).
2.2.3.5.6 Optimisation of FISH Protocol
During each FISH experiment on the embryos a control slide of normal male 
lymphocytes was also included to assess the efficiency of the FISH protocol. 50-100 
interphase nuclei were scored and the efficiency of each probe combination was 
examined.
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2.2.3.6 Patient Details for Chapter 3
A total of ten couples were initially referred to our centre for PGD of DM. PGD was 
performed for two couples: G and H (Table 2.8). The rest are awaiting PGD for 
various reasons.
Table 2.8. Patient details for couples undergoing PGD for DM
Family Patient with 
DM expansion
Maternal
Age
Reproductive History
A Mother 42 6 pregnancies, 2 affected sons, 4 spontaneous 
miscarriages
B Mother 39 Infertile (Gave birth to healthy female after PGD)
C Father 38 2 pregnancies, 1 normal birth, 1 affected (TOP)
D Mother 40 4 pregnancies (x2 with IVF), 3 TOP, 1 affected 
son, 1 PGD cycle where all were affected
E Mother 36 1 pregnancy, 1 affected female which died at 
weeks old
F Mother 39 4 pregnancies, 1 normal son, 3 TOP
G Mother 36 1 affected son 
4 affected natural pregnancies
H Mother 41 4 pregnancies, 4 TOP’s
I Mother 40 2 pregnancies, 1 affected son, 1 TOP
J Father 36 3 pregnancies, 1 normal female, 1 affected male, 
1TOP
2.2.3.7 Patient Details for Chapter 4
All patients were healthy individuals that were referred to the London Fertility Centre 
for fertility problems. Patients were either IVF or ICSI patients. Table 2.9 reveals the 
background information of all the patients and their embryos. All patients gave 
consent for their embryos to be used for research. The first three patients’ embryos 
(n=10) were used for preliminary optimisation of the protocol (data not shown).
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Table 2.9. Patient details for Chapter 4
Patient
No.
Age of 
patient
Date of 
treatment
IVF or 
ICSI
No. of eggs 
collected
No. of embryos 
(no. of nuclei)
Embryo
Type
4 40 5/5/02 ICSI 8 2
(4)
Arrested
5 35 17/5/02 IVF 20 5
(65)
Arrested
6 47
(35-O.D.)
17/5/02 ODOR/
IVF
13 1
(22)
Arrested
7 36
(33-O.D.)
28/6/02 ODOR/
ICSI
17 2
(35)
Arrested
8 41 05/07/02 ICSI 9 1
(6)
Arrested
9 27 05/07/02 IVF 11 1
(8)
Arrested
10 41 08/07/02 ICSI 12 1
(5)
Arrested
11 34 09/07/02 IVF 37 1
(1)
Lost
12 35 09/07/02 IVF 34 2
(31)
Arrested
13 37 30/08/02 ICSI 12 3
(110)
Blastocysts
14 19 30/08/02 IVF 13 3
(90)
Blastocysts
15 26 03/10/02 ICSI 19 4
(236)
Expanded
Blastocysts
16 33 04/10/02 ICSI 19 1
(58)
Expanded
Blastocyst
17 31 09/01/03 IVF 11 2
(58)
Arrested
18 38 21/01/03 IVF 7 1
(55)
Hatched
Blastocyst
19 30 31/01/03 ICSI 14 2
(175)
Expanded
Blastocysts
20 32 03/02/03 ICSI 16 1
(43)
Expanded
Blastocyst
21 39 04/02/03 IVF 8 2
(57)
Arrested
22 39 25/03/03 IVF 21 2
(143)
Expanded
Blastocysts
23 49
(20-O.D.)
28/03/03 ODOR/
IVF
23 1
(100)
Hatched
Blastocyst
24 41 04/04/03 ICSI 6 1
(63)
Expanded
Blastocyst
25 36 07/04/03 IVF 11 2
(94)
Expanded
Blastocysts
26 34 14/05/03 IVF 9 2
(61)
Expanded
Blastocysts
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27 46
(33-O.D.)
04/06/03 ODOR/ 
IVF
11 2
(59)
Arrested
IVF = In vitro ferti isation, ICS = Intracytoplasmic sperm injection, ODOR = oocyte
donation cycle, O.D. = oocyte donor
2.2.3.8 Patient Details for Chapter 5
All patients were healthy individuals that were referred to the London Fertility Centre 
for fertility problems. Patients were either IVF or ICSI patients. Table 2.10 below 
reveals the background information of all the frozen embryos. All patients gave 
consent for their embryos to be thawed and used for research.
Tab e 2.10. Patient details regarding their IVF/ICSI cycle and their embryo details
Patient
No.
Age of 
patient
Date of 
Egg
Collection
IVF
or
ICSI
No. of 
eggs
collected
Frozen 
embryos 
donated for 
research
Embryo Type (time of thaw) 
(Grade)
1 2  3 4
1 38 19/03/03 IVF 21 3 7c
(2-3)
6c
(2-3)
6c
(1-2)
2 29 20/04/03 ICSI 30 3 7c
(3)
7c
(2)
5c
(2)
3 35 05/02/97 IVF 16 1 6c
(2)
4 35 23/02/99 ICSI 16 4 5c
(3)
8c
(2)
7c
(2-3)
6c
(2-3)
6 30 18/05/02 IVF 18 3 5c
(2-3)
8c
(1-2)
9c
(1-2)
7 39 06/09/01 IVF 14 3 5c
(2)
10c
(1-2)
7c
(2)
8 31 02/03/03 IVF 19 2 6c
(2-3)
5c
(2)
9 33
(OD)
14/05/02 IVF 22 4 6c
(2-3)
8c
(1-2)
5c
(3)
6c
(2-3)
9 33
(OD)
14/05/02 IVF 22 4 5c
(2-3)
6c
(2)
7c
(2-3)
8c
1-2)
10 32 23/02/01 IVF 12 1 6c
(1-2)
11 35 7/10/02 IVF 15 1 5c
(2)
12 30 19/03/99 IVF 14 3 5c
(2)
8c
(1-2)
7c
(2-3)
13 36 12/10/00 ICSI 24 3 5c
(1-2)
8c
(1-2)
7c
(1-2)
14 28
(OD)
12/06/02 IVF 18 3 6c
(1)
6c
(1)
5c
(1-2)
IVF = In vitro fertilisation, ICSI = Intracytoplasmic sperm injection, OD = oocyte 
donor, OR = oocyte recipient
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Chapter 3 -  Novel approaches for the preimplantation genetic diagnosis o f Myotonic
Dystrophy (DM1)
3.1 Aims
There were two parts to this study. The first was to develop a novel protocol for PGD 
for DM1 for a number of patients using a single, multiplex PCR and the second was 
to determine if WGA followed by a number of singleplex PCRs could be used for 
PGD of DM1 with the potential to also carry out CGH.
PGD for DM1 requires inclusion of highly polymorphic markers, the primary function 
of which is to confirm the affected embryos and reveal when contamination has 
occurred. Several polymorphic markers, linked and unlinked, were tested for a variety 
of families. Two couples underwent PGD for DM1 employing two different 
protocols. The first protocol included the mutation marker and a contamination 
marker whereas the second novel protocol included the mutation marker and a linked 
marker which was able to provide information regarding the mutation as well as 
presence of contamination.
Due to the complexity of developing specific protocols depending on the patients 
being informative for different markers and optimising the multiplex PCR, the second 
part of the project was attempted. A whole genome amplification method, namely 
DOP-PCR, was employed initially on genomic DNA and subsequently on single cells 
to investigate whether specific regions of the genome were amplified. Five different 
markers were tested to see if they were adequately amplified, a mutation marker 
(DM1), a linked marker (D19S112) and three highly polymorphic markers on 
different chromosomes (D21S1414, D18S535 and D13S305). The combination of 
WGA and F-PCR would provide a universal-like protocol able to tackle the time- 
consuming predicament of devising patient-specific single cell multiplex protocols, 
since after DOP-PCR of a single cell, sufficient amounts of DNA would be available 
for many singleplex reactions. Furthermore, the ability to carry out other assays from 
one single cell such as CGH could be performed.
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3.2 Results
3.2.1 Preliminary Work-up of Families
Each family was referred to our centre (UCL Centre for Preimplantation Genetic 
Diagnosis) where bloods were taken from each prospective parent or DNA aliquots 
were sent from cytogenenetic laboratories where original investigations were carried 
out. The extracted DNA (section 2.2.2.1) from both partners was tested with a variety 
of markers to determine for which markers they are informative in order to devise a 
multiplex F-PCR protocol (Tables 3.1-3.10). If a linked marker was informative for 
each patient (i.e. parents share no allele in common), if possible, an affected family 
member was asked to provide a DNA sample in order to obtain the ‘phase’ 
(Underlined allele sizes in Tables 3.1-3.10). Although for some families the same F- 
PCR protocols can be devised and applied e.g. the DM/APOC2 duplex protocol for 
families B, E, F and I; each family was informative for different combinations of 
markers. Furthermore, there were some families where the DM1 primers were semi- 
informative since they share one allele (B, E, F and I), hence the diagnosis could only 
be carried out by multiplexing with a linked marker (Tables 3.2, 3.5, 3.6 and 3.9). For 
family C although there were four informative markers (APOC2, D19S112, 
D2IS 1414 and D21S11) because their allele sizes were very close, stutter peaks can 
create problems during diagnosis (Table 3.3).
Table 3.1. List of polymorphic markers tested on genomic DNA for family A and
their allele sizes
Primer Marker Types Maternal 
allele sizes
Paternal 
allele sizes
Comments
Am A f
DM1 - /1 46 122 (hm) Informative
APOC2 Linked di- 149/151 126/149 Not informative
D19S207 Linked di- 145/145 140/143 Not informative
D19S112 Linked di- 130/132 130/136 Not informative
D19S393 Linked Tetra- 285/285 285/ 285 Not informative
D21S1414 Unlinked tetra- 349/349 345/349 Not informative
D21S11 Unlinked tetra- 227/227) 223/227 Not informative
D18S535 Unlinked tetra- 485/485 481/485 Not informative
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
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Table 3.2. List of polymorphic markers tested on genomic DNA for family B and 
their allele sizes
Primer Marker Types Maternal
allele
sizes
Paternal
allele
sizes
Mother’s 
father 
allele sizes
Comments
Bm B f Bfm
DM1 120/- 120/138 170/- Semi-informative
APOC2 Linked di- 126/153 142/157 150/153 Informative
D19S207 Linked di- 125/141 144/144 125/125 Informative*
D19S112 Linked di- 128/130 116/123 128/130 Informative
D19S393 Linked tetra- 285/296 296/296 289/296 Not informative
D21S1414 Unlinked tetra- 343/348 339/343 335/348 Not informative
D21S11 Unlinked tetra- 223/228 223/229 225/227 Not informative
D18S535 Unlinked tetra- 478/486 478/482 477/490 Not informative
Practically difficult since close allele sizes would cause difficulties in interpretation 
due to stutter peaks
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
Table 3.3. List of polymorphic markers tested on genomic DNA for family C and 
their allele sizes
Primer Marker Types Paternal 
allele sizes
Maternal 
allele sizes
Comments
C f Cm
DM1 146/- 140/149 Informative
APOC2 Linked di- 134/153 149/155 Informative*
D19S207 Linked di- 141/145 144/144 Not informative
D19S112 Linked di- 130/132 124/134 Informative*
D21S1414 Unlinked tetra- 337/355 341/349 Informative
D21S11 Unlinked tetra- 215/233 219/237 Informative
D18S535 Unlinked tetra- 485/485) 477/482 Not informative
due to stutter peaks
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
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Table 3.4. List of polymorphic markers tested on genomic DNA for family D and 
their allele sizes
Primer Marker Types Maternal
allele
sizes
Paternal
allele
sizes
Mother’s 
sister allele 
sizes
Comments
Dm Df Dms
DM1 139/- 146/184 139/- Informative
APOC2 Linked di- 128/150 128/152 135/150 Not informative
D19S207 Linked di- 125/143 142/142 125/143 Not informative
D19S112 Linked di- 123/128 128/132 124/128 Not informative
D19S393 Linked tetra- 281/289 285/289 285/289 Not informative
D21S1414 Unlinked tetra- 337/337 343/348 338/361 Not informative
D18S535 Unlinked tetra- 482/486 478/490 486/490 Informative
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
Table 3.5. List of polymorphic markers tested on genomic DNA for family E and their 
allele sizes
Primer Marker Type
Maternal
allele
sizes
Paternal
allele
sizes
Mother’s 
brother 
allele sizes Comments
Em Ef Emb
DM1 122/- 122/149 122/- Semi-Informative
APOC2 Linked di- 142/156 126/152 152/156 Informative
D19S207 Linked di- 125/143 142 (hm) 127/143 Not Informative
D19S112 Linked di- 132/136 130/136 128/132 Not Informative
D19S393 Linked tetra- 289/297 290/298 - Not Informative
D21S1414 Unlinked tetra- 3441348 344/360 3441369 Not Informative
D21S11 Unlinked tetra- 224/228 224/240 224/228 Not Informative
D18S535 Unlinked tetra- 466/478 482/486 478/490 Informative
D13S305 Unlinked Tetra- 452/452 446/456 - Not Informative
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
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Table 3.6. List of polymorphic markers tested on genomic DNA for family F and their 
allele sizes
Primer Marker Type
Maternal 
allele sizes
Paternal 
allele sizes Comments
Fm Ff
DM11 139/- 122/139 Semi-Informative
APOC2 Linked di- 148/75# 150/152 Informative
D19S112 Linked di- 129/129 127/127 Not Informative
D19S207 Linked di- 127/744 123/141 Informative
D19S393 Linked tetra- 289/293 293/301 Not Informative
D21S1414 Unlinked tetra- 349/363 345/351 Informative
D21S11 Unlinked tetra- 227/242 223/230 Informative
D18S535 Unlinked tetra- 466/486 489/489 Not Informative
D13S305 Unlinked tetra- 443/455 443/455 Not Informative
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
Table 3.7. List of polymorphic markers tested on genomic DNA for family G and 
their allele sizes
Primer Marker Types Maternal
allele
sizes
Paternal 
allele sizes
Affected 
son 
allele sizes
Comments
Gm Gf Gas
DM11 142/- 122/122 122/- Informative
APOC2 Linked di- 152/154 135/150 150/154 Informative*
D19S207 Linked di- 142/142 141/141 142/142 Not informative
D19S112 Linked di- 128/130 128/130 128/130 Not informative
D21S1414 Unlinked tetra- 346/355 335/350 350/354 Informative
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner
&Practically difficult since close allele sizes would cause difficulties in interpretation 
due to stutter peaks
- indicates the affected allele that is refractory to PCR
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Table 3.8. List of polymorphic markers tested on genomic DNA for family H and 
their allele sizes
Primer Marker Types Maternal
allele
sizes
Paternal
allele
sizes
Mother’s 
sister 
allele sizes
Comments
Hm Hf Hms
DM1 146/- 122/143 -/146 Informative
APOC2 Linked di- 155/155 149/155 132/155 Not informative
D19S207 Linked di- 127/142 144/146 127/142 Not informative
D19S112 Linked di- 130/132 117/117 130/134 Informative
D21S1414 Unlinked tetra- 359/359 345/349 340/355 Not informative
D21S11 Unlinked tetra- 244/249 259/259 - Not Informative
D18S535 Unlinked tetra- 478/482 481/481 - Not informative
D13S305 Unlinked tetra- 440/448 438/448 - Not informative
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
Table 3.9. List of polymorphic markers tested on genomic DNA for family I and their 
allele sizes
Primer Marker Type Maternal
allele
sizes
Paternal
allele
sizes
Mother’s 
sister 
allele sizes
Comments
Im If I m f
DM1 122/- 122/145 122/- Semi-informative
APOC2 Linked di- 136/150 127/147 136/150 Informative
D19S207 Linked di- 144/146 141/145 142/144 Not informative
D19S393 Linked tetra- 285/297 289/293 - Informative
D19S112 Linked di- 117/128 117/134 128/132 Not informative
D21S1414 Unlinked tetra- 359/359 345/349 359/359 Not informative
D21S11 Unlinked tetra- 238/359 224/228 238/359 Not informative
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner 
- indicates the affected allele that is refractory to PCR
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Table 3.10. List of polymorphic markers tested on genomic DNA for family J and 
their allele sizes
Primer Marker Type Paternal
allele
sizes
Maternal
allele
sizes
Affected 
fetus allele 
sizes
Comments
J f Jm J a f
DM1 141/- 154/177 -/178 Informative
APOC2 Linked di- 152/154 126/143 143/152 Informative
D19S207 Linked di- 142/142 125/143 125/143 Not informative
D19S112 Linked di- 128/130 126/128 128/130 Not informative
D19S393 Linked tetra- 293/293 289/293 - Not informative
D21S1414 Unlinked tetra- 335/352 339/347 335/339 Informative
D21S11 Unlinked tetra- 220/227 216/232 216/227 Informative
D18S535 Unlinked tetra- 481/481 490/490 481/490 Not informative
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles would be classed as affected 
Patient in italics indicates the affected partner
&Practically difficult since close allele sizes would cause difficulties in interpretation 
due to stutter peaks
- indicates the affected allele that is refractory to PCR
3.2.2 PGD Workup
Workup for a total of ten families was performed during this study (Tables 3.1-3.10). 
PGD was carried out for two families only (families G and H). For family A apart for 
the DM1 marker, no other marker was found to be informative hence further 
investigations of different markers should be carried out. For families B, E, F and I 
the DM1 mutation marker was found to be ‘Semi-informative’ and at least two other 
markers, linked or unlinked, were informative for each couple. The DM1 marker was 
termed ‘Semi-informative’ when the affected partner’s allele that could be sized was 
the same as one of the alleles from the other e.g. for family B, for ‘Bm’ it was (120/-), 
which was the same for ‘B f (120/138). The DM marker could be semi-informative in 
the case where the embryo would show the 120/138 genotype, meaning that the 120 
was inherited from the mother and the 138 from the father. However, it is always 
necessary to perform a multiplex protocol for these families with a linked marker 
since the 120/138 genotype can also arise from paternal contamination. Families C 
and J were awaiting PGD to be performed due to personal reasons, since the protocol 
for both families was ready. For family D, the DM and the D18S535 markers were 
informative, which required optimisation at the single cell DNA level.
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Two families opted to come through for a PGD cycle (families G and H). Two 
different multiplex F-PCR protocols for the detection of DM1 affected embryos were 
devised for this study for the two families. In addition to amplifying the triplet repeat 
region within the DMPK gene, the PGD protocols for DM1 were designed to 
incorporate either an unlinked polymorphic marker on chromosome 21 (Protocol 1) or 
a linked polymorphic marker flanking the DM1 gene (Protocol 2). The CTG repeat 
region of DM1 is also very polymorphic; therefore it was usually possible to 
distinguish both alleles of normal heterozygote subjects on an automated sequencer.
For both protocols the markers could be simultaneously analysed on the 3100ABI 
Prism™ using GeneScan® analysis software. The peak area of the F-PCR analysis 
was indicative of the amount of amplified product, which was similar to the intensity 
of a band when analysing a sample after gel electrophoresis. However, F-PCR allows 
for accurate sizing of fragments and precise quantification of the amount of the PCR 
product. In some instances, the DNA samples revealed large differences between their 
allele sizes (for all three markers) e.g. for Ef (father of family E) the DM1 allele sizes 
were 122/149 indicating a 27bp difference. In those cases, there was significant 
preferential amplification of the smaller allele and also increased incidence ADO of 
the larger allele during single cell amplification. However, this was partly overcome 
by decreasing the temperature by 1-2°C of the annealing temperature. The incidence 
of stutter peaks was also encountered, especially at the single cell level (Figure 3.1). 
Stutter peaks were mostly observed when dinucleotide repeat regions where amplified 
and did not cause diagnostic error since they were always one repeat unit smaller than 
the true allele and relatively under-amplified. However, they were taken into account 
in individuals where their allele sizes differed in size by just one repeat and were 
regarded as practically difficult.
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Figure 3.1. Illustration of preferential amplification, stutter peaks and the +A artefact 
on a dinucleotide repeat region
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The GeneScan® analysis software shows the amplification fragment for each marker 
in different colours (here the AP0C2 is in blue). Below the blue graph there is a table 
which shows the allele size (heading ‘Size’) and the quantification of each fragment 
(heading ‘Peak Height’). Samples 4B and 5B represent single cells from the father 
and mother of family E respectively. Sample 6B is the negative control. In both 
parents the smaller allele shows preferential amplification over the larger allele. For 
example in sample 4B the smaller allele (126) has a peak height of 1344, whereas the 
larger allele (153) has a peak height of 282.
The red circle represents the stutter peak that is caused due to polymerase slippage 
during the PCR extension step. The black square represents the +A effect
Furthermore, the Plus-A (+A) artefact was also encountered during the optimisation 
process of single cell F-PCR. This was due to the addition of a nucleotide, usually 
adenosine, from the DNA polymerase enzyme to the 3’ends of the amplified 
fragments, which lead to PCR products one bp longer than the expected fragment size 
(Figure 3.1). The +A effect would not cause misdiagnosis, however, it may confuse 
the peak area calculation. However, after subsequent optimisation experiments, this 
problem was reduced by omitting the final lOmin extension step typically used in 
PCR protocols.
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3.2.2.1 Analysis of Control Single Cells
Clumps of buccal cells (2-4 cells) were isolated from the author (section 2.2.2.2) to 
test whether the two multiplex protocols were working with a lower starting amount 
of DNA. Protocol 1 was tested on 30 clumps and showed 98% amplification rate for 
both loci with 3% and 5% ADO rate for the DM1 and D2IS 1414 primers respectively 
(Table 3.11). Protocol 2 was tested on 30 clumps revealing 3% amplification failure 
and ADO rates of 4% and 5% for the DM1 and D19S112 primers respectively. Single 
cell analysis was performed initially on 50 single buccal cells from normal 
heterozygote subjects. Amplification of the DM1 and D2 IS 1414 primers (protocol 1) 
showed 96% and 93% amplification efficiency respectively and 9.1% and 10.2% 
ADO rate for the DM1 and D21S1414 respectively in heterozygote individuals. 
Protocol 2 (DM1 and D19S112) revealed similar amplification efficiency of 95% for 
the DM primers and 91% for the D19S112 primers. The ADO rates were 8.8% for the 
DM 12.9% and for the D19S112 primers in heterozygote individuals.
Table 3.11. Results of amplification efficiency and ADO in control clumps and single 
cells
Type of 
cells
Rates Proltocol 1 Prol ocol 2
DM1 D21S1414 DM D19S112
Clumps
(n=30)
Amplification
efficiency
98% 98% 98% 97%
Allele
Dropout
3% 5% 4% 5%
Single
cells
(n=50)
Amplification
efficiency
96% 93% 95% 91%
Allele
Dropout
9.1% 10.2% 8.8% 12.9%
3.2.2.2 Analysis of Patients Single Cells
The single buccal cells used in optimising and testing the PGD protocol were derived 
from members of both families, including 80 cells from each father (‘Gfi and ‘H f ) 
and 80 cells from each mother (‘Gm’ and ‘Hm’) and 50 cells from ‘Hs’ (mother’s 
sister; Table 3.7). The data from all 160 single buccal cells of the members of family 
G displayed an amplification rate of 90.9% and 85.7% and an ADO rate of 14.1% for 
the D21S1414 primer (Table 3.12).
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Table 3.12. DM1 and D21S1414 amplification results on single buccal cells from 
family G (Protocol 1)
Results ‘G f
(n=80)
‘Gm’
(n=80)
Total
(n=160)
DM1
4 Amplification rate 89.8% 92% 90.9%
4  Amplification failure 10.2% 8% 9.1%
±  ADO - - -
4  Contamination 1.2% - 0.6%
D21S1414
4- Amplification rate 84.4% 87% 85.7%
4 Amplification failure 15.6% 13% 14.3%
4- ADO 15% 13.2% 14.1%
4 Contamination *
‘G f= father of G family and ‘Gm’ = mother of G family
The total amplification rate from 210 single buccal cells for family H was 91.3% and 
83.7% for the DM1 and D19S112 respectively, whilst the ADO rate was 7.9% and 
15.6% for the DM1 (from 80 cells for Hf) and D19S112 primers respectively (Table 
3.13 The ADO rates for ‘Hms’ single buccal cells were markedly higher compared to 
those of ‘Hm’ for the D19S112 primer. The underlying reason might be the prolonged 
time from the sample collection until the time of single cell isolation, since the cells 
were sent at room temperature during transit, hence, many cells might have been dead 
or degenerating.
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Table 3.13. DM1 and D19S112 amplification results on single buccal cells from 
family H (Protocol 2)
Results ‘H f
(n=80)
‘Hm’
(n=80)
‘Hms’
(n=50)
Total
(n=210)
DM1
A Amplification rate 92% 92% 90% 91.3%
A Amplification failure 8.1% 8% 10% 8.7%
A ADO 7.9% - - 7.9%
A Contamination 2.5% - 4% 2.9%
D19S112
A  Amplification rate 85.7% 87% 78.3% 83.7%
A Amplification failure 14.3% 13% 21.7% 16.3%
A ADO - 12.8% 23.2% 15.6%
A Contamination 5% 4% 3.8%
‘H f= father of H family, ‘Hm’ = mother of H family and ‘Hms’ = mother’s sister of 
H family
A negative control was included in every ten single buccal cells from the last wash 
drop for both protocols. No contamination was observed in any of the final wash drop 
blanks, lysis-buffer only negative controls or PCR mixture only negative controls. 
During blastomere analysis a wash drop blank was used for every single blastomere. 
All personnel involved in the diagnosis were genotyped to allow detection of 
contamination. No contamination was found by one or more of the personnel.
3.2.3 Clinical PGD Results
The patients underwent routine IVF procedures and ICSI was employed for both 
families to avoid sperm contamination. The embryos were biopsied on day 3 and the 
single blastomeres were prepared for the diagnosis (section 2.2.2.2.3).
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3.2.3.1 Family G
During the PGD cycle for family ‘G’, 7 oocytes were collected from which 5 
underwent ICSI. Five embryos were of sufficient quality for biopsy on day 3 post­
fertilisation; however overall embryonic morphology was not good since from all 
embryos only one cell was biopsied (Table 3.14). Molecular analysis revealed 2 
embryos to be affected, 2 with incomplete results (one of which was suspected to be 
abnormal) and one with no results for either marker. No contamination was detected 
and no allele dropout.
Table 3.14. PGD results of family ‘G’
Embryo
No.
No. of 
cells (time 
of biopsy)^
Grade Cell
No.
Notes DM1 D21S1414 Result
G1 5 2 a - 122/- 335/346 Affected
G2 5-6 2+ a Cell lysing AF 335/355 Incomplete
G3 5 2+ a
Degenerating
embryo 122/- Inconsistent* Affected
G4 5 2- a
No nucleus 
seen AF AF No result
G5 6 2 a - 122/- 346/350 Affected
+ve ctrl
? - - - - 142/- 346/355 -i
+ve ctrl
3 - - - - 122/- 335/350 -
DM=myotonic dystrophy mutation marker; D21S1414=contamination STR marker; 
AF=amplification failure
* Allele sizes that did not correspond to any of the parents nor the people involved in 
the diagnosis
Full information was achieved for embryo G la and embryo G5a (Figure 3.2). In two 
instances (G2a and G4a) the DM1 primer failed to give any kind of results. However, 
cell G2a was lysing during biopsy and some material might have been lost during 
transfer since the contamination marker was able to give a result. Furthermore, in cell 
G4a no nucleus could be seen during biopsy and washing procedures.
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Table 3.15. Confirmatory results from spare embryos after PGD for family ‘G’
Embryo
No.
Cell
No.
DM D21S1414 Result
Gsl A 122/ - 346/351 Affected
B AF AF No Result
Gs2 A 122/ - 335/346 Affected
Gs4
A 122/ - AF Affected
b 122/ - 351/355 Affected
c AF AF No Result
Gs5
a 122/ - AF Affected
b 122/ - /351 ADO Affected
c 122/ - 346/351 Affected
d 122/ - 346/351 Affected
e 122/ - /351 ADO Affected
DM=myotonic dystrophy mutation marker; D21S1414=contamination STR marker; 
AF=amplification failure; ADO=allele dropout
Overall, from 16 blastomeres the DM1 locus revealed a 75% amplification rate 
whereas the D21S1414 showed a 68.75% amplification rate and 12.5% allele dropout.
3.2.3.2 Family H
During the PGD cycle for family ‘H \ 9 oocytes were collected from which 8 
underwent ICSI. Five embryos were of sufficient quality for biopsy on day 3 post­
fertilisation and from all embryos two cells were biopsied (Table 3.16). One embryo 
(embryo H I) was normal and was chosen for embryo transfer. Two embryos were 
considered to be affected and two revealed inconclusive results.
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Table 3.16. PGD results of family ‘H’
Embryo
No.
No. of Grade 
cells (time 
of biopsy)
Cell
No.
Notes DM1 D19S112 Result
HI 8 1- la 122/146 117/132
Normal
lb - -*Vl46 117/ ADO
H2 7 2 2a AF 117/130 Affected
No (incomplete)
2b nucleus AF AF
seen
H3 6 2+ 3a 122/-*2 ADO /132 Inconclusive
3b - 122/-*2 AF
H4 8 1- 4a - 122/- 117/130 Affected
4b - 122/- 117/ADO
H5 8 1- 5a Cell AF AF Affected
lysing
5b - 143/- 117/130
+ve ctrl
Q _ - 146/- 130/132
Hr
+ve ctrl
3 - - - 122/143 117/- (hm) -
* Extreme cases of preferential amplification of the large allele (v.v low amplification 
of the 122 allele), which at the time of diagnosis were considered as allele dropout to 
avoid misdiagnosis.
*2Extreme cases of preferential amplification of the small allele (v.v low 
amplification of the 146 allele), which at the time of diagnosis were considered as 
allele dropout to avoid misdiagnosis
Underlined numbers indicate the phase i.e. those alleles are linked to the mutation 
hence if the embryo carries these alleles it would be classed as affected 
DM=myotonic dystrophy mutation marker; D19S112=linked STR marker; 
AF=amplification failure; ADO=allele dropout; mh=homozygous
In embryo Hlb, there was extreme preferential amplification of the larger allele (122) 
for the DM1 marker (Figure 3.3). However, since the larger allele was the mother’s 
unaffected allele, the whole embryo was considered normal (Figure 3.3). Embryo H2 
was thought to be affected since only the linked marker (D19S112) amplified in one 
of two cells (117/1301 containing the phase allele (130). In embryo H3 the linked 
marker showed inconclusive results and the mutation marker (DM) showed extreme
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preferential amplification of the 146 allele inherited from the mother but it was 
probably normal (Table 3.16). However, to reduce the chance of misdiagnosis it was 
considered as affected at the time of diagnosis.
Figure 3.3. Analysis results for embryo HI (blastomeres H la and Hlb) and the
parents Hm and Hf
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> Embryo 
Hla25202100
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1260
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117 132
146750
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450
300
150
122*
Embryo
Hlb
2S20
2100
1680
1260
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420
117
JU A
146
520
Hm
5880
4200
3360
2520
130
132
122 143
Hf
117
The DM1 (Blue) and D19S112 (Black) genotypes of blastomeres H la and Hlb from
embryos HI can be seen during the clinical case. Furthermore, the prospective 
couples’ DM1 and D19S112 genotypes (Hm=mother and Hf=father) can be seen 
which were used as positive controls. Cell H la showed conclusive results indicating a 
normal cell. Cell Hlb revealed extreme preferential amplification of the smaller allele 
of the DM1 genotype (122) and ADO of the larger allele for the D19S112 marker.
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However, since the mother’s normal allele was inherited, it was concluded that the 
embryo was normal.
The rest of the embryos were donated for confirmation diagnosis. The results from the 
spare embryos revealed that embryo H3 (Hs3 in Table 3.17) was actually normal and 
could have been transferred (Table 3.17). Embryos H2 and H5 (Hs2 and Hs5 in Table 
3.17) were confirmed as affected. In embryo H4 (Hs4 in Table 3.17) no cells could be 
biopsied since it was degenerating and when the whole embryo was collected, 
maternal contamination was detected (Table 3.17). Embryos Hs6, Hs7 and Hs8 were 
not suitable for biopsy during the diagnosis. Embryo Hs6 was degenerating and no 
cells could be biopsied, thus the whole embryo was lysed and amplified, showing 
multiple allele sizes probably due to mosaicism or maternal contamination. For 
embryo Hs8 only one cell could be biopsied and amplified which was normal.
Table 3.17. Confirmatory results from spare embryos after PGD for family ‘H’
Embryo
No.
Cell No. DM1 D19S112 Result
Hs2
a 143/- 117/130
Affectedb 143/- 117/130
c 143/- 117/130
Hs3
a 122/146 117/132
Normalb 122/146 117/132
c 122/146 117/132
Hs4 Whole embryo 122/146 117/130/132 Multiple allele sizes
Hs5
a 122/- 117/130
Affectedb AF 117/ ADO
c 122/- 117/130
Hs6 Whole embryo 122/146 117/130/132 Multiple allele sizes
H8 a 122/146 117/132 Normal
)M=myotonic dystrophy mutation marker; D19S112=linked STR marker; 
AF=amplification failure; ADO=allele dropout
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Overall, from 20 blastomeres the DM1 locus revealed an 80% amplification rate and 
no ADO, 15% of cases showed extreme preferential amplification. The D19S112 
showed an 85% amplification rate and a 15% allele dropout.
3.2.4 DOP-PCR on Genomic DNA
Initially, DOP-PCR was carried out on genomic DNA which was subsequently used 
as template for singleplex reactions of each primer from the mother and father of 
family E as well as individuals X and Z (Table 2.8). However, due to lack of single 
cell material from family E, single cell results were only obtained from individuals X 
and Z. All the F-PCR primers where successfully amplified when genomic DNA 
(100-300ng approximately) was used as template. The amplification rate was 98% for 
all primers except for the D13S305 which was 96%. There was no incidence of allele 
dropout, which was expected due to the nature of the starting template. The similarity 
of amplifications when a singleplex reaction was carried out from genomic DNA 
compared to a singleplex reaction when it was carried out using a DOP-PCR product 
as template is depicted in Figures 3.4, 3.5, 3.6 and 3.7. The peaks in all lanes (except 
the negative control lanes) are high indicating sufficient PCR product, with no ADO 
and little or no stutter effects. However, more importantly the genotypes for both 
primers can be easily interpreted in the amplifications which used the DOP-PCR 
product as starting template (Figures 3.4B, 3.5B, 3.6B and 3.7B).
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Figure 3.4. Analysis results for the DM1 primer for family E using genomic DNA
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A. Results for the DM1 mutation marker when amplified directly from genomic 
DNA. Lanes 1 and 2 show the genotypes of the father and the mother of 
family E respectively (Table 3.5) and lane 3 is the negative control.
B. Results for the DM1 mutation marker when amplified from a DOP-PCR 
product. Lanes 4 and 5 show the genotypes of the father and the mother of 
family E respectively and lane 6 is the negative control.
Each peak represents the alleles of the individual. In both sets of results the peak 
were easily distinguished with no +A artefacts and little or no stutter effects. 
However, there was a slight difference appearance of ‘B’ compared to ‘A’, since 
the latter showed more distinct and sharper peaks.
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Figure 3.5. Analysis results for the D21S1414 primer for family E using gen. DNA
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A. Results for the D2IS 1414 mutation marker when amplified directly from 
genomic DNA. Lanes 1 and 2 show the genotypes of the father and the mother 
of family E respectively (Table 3.5) and lane 3 is the negative control.
B. Results for the D21S1414 mutation marker when amplified from a DOP-PCR 
product. Lanes 4 and 5 show the genotypes of the father and the mother of 
family E respectively and lane 6 is the negative control.
Each peak represents the alleles of the individual. In both sets of results the peak 
was easily distinguished with no +A artefacts and no stutter effects. However, 
there was a slight difference in appearance of 4B’ compared to ‘A’, since the latter 
showed increased peak heights of more than 3600 in comparison to ‘B’ which 
showed peak heights of around 1500. Such results indicated that amplification 
products in ‘B’ were half the amount of ‘A ’.
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Figure 3.6 Analysis results for the D18S535 primer for family E using genomic DNA
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A. Results for the D18S535 unlinked marker when amplified directly from 
genomic DNA. Lanes 1 and 2 show the genotypes of the father and the mother 
of family E respectively (Table 3.5) and lane 3 is the negative control.
B. Results for the D18S535 unlinked marker when amplified from a DOP-PCR 
product. Lanes 4 and 5 show the genotypes of the father and the mother of 
family E respectively and lane 6 is the negative control.
Each peak represents the alleles of the individual. In both sets of results the peak 
were easily distinguished with no +A artefacts and little or no stutter effects. 
However, in 4B’ the peak heights were nearly half the size compared to ‘A’. Such 
results indicated that amplification products in 4B’ were half the amount of ‘A’
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Figure 3.7 Analysis results for the D13S305 primer for family E using genomic DNA
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A. Results for the D13S305 unlinked marker when amplified directly from 
genomic DNA. Lanes 1 and 2 show the genotypes of the father and the mother 
of family E respectively (Table 3.5) and lane 3 is the negative control.
B. Results for the D13S305 unlinked marker when amplified from a DOP-PCR 
product. Lanes 4 and 5 show the genotypes of the father and the mother of 
family E respectively and lane 6 is the negative control.
Each peak represents the alleles of the individual. In both sets of results the peak 
were easily distinguished with no +A artefacts and little or no stutter effects. 
There ass however, slightly increased stutter band effect in ‘B’ which could be 
seen by comparing lanes 1 and 4.
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3.2.5 DOP-PCR on Single Cells
The encouraging results on genomic DNA prompted the amplification on single cells. 
The two individuals that were chosen for their heterozygote genotypes for the DM1 
mutation marker in order to detect ADO rates in the most important marker were X 
and Z. All ten single cells from each individual (100%) were successfully amplified 
with DOP-PCR. Each single cell (including the positive control) were analysed with a 
1% agarose gel (Figures 3.8 and 3.9). The single cells from both individuals were 
fresh and were amplified the same day of collection and isolation to avoid freeze-thaw 
of samples. The amplification of Z was enhanced compared to X and that can be seen 
if the results are evaluated against the genomic DNA amplification. Interestingly 
minor bands were seen only in Z’s amplified products which usually represent 
mitochondrial DNA.
Figure 3.8. DOP-PCR amplification results run on 1% agarose gel of individual X
Ladder XI X2 X3 X4 X5 X6 X7 X8 X9 X10 XCL1 XCL2 X+ve
DOP
The first lane displays the 1Kb ladder. Lines X1-X10 depict each single cell whereas 
XCL1 and XCL2 represent the positive controls from clumps and X+ve DOP shows 
the positive control from genomic DNA. All single cells showed a smear of results 
with no distinct bands except for C4 where the smear was faint and reduced in size. 
The smear from the genomic DNA was more intense and increased in size which 
suggested better amplification of the genome.
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Figure 3.9. DOP-PCR amplification results run on 1% agarose gel of individual Z
Ladder Z1 Z2 Z3 Z4 Z5 Z6 Z7 Z8 Z9 Z10 ZCL1 ZCL2 Z+ve
DOP
The first lane displays the ladder. Lines Z1-Z10 depict each single cell whereas ZCL1 
and ZCL2 represent the positive controls from clumps and Z+ve DOP shows the 
positive control from genomic DNA. All single cells showed a smear of results with 
no distinct bands except for Z10 where the smear was reduced in size, however it was 
very intense.
From the 20 single cells (10 from each individual) the amplification rate was 85%, 
55%, 65%, 60% and 65% for DM, D19S112, D21S1414, D18S535 and D13S305 
respectively (Table 3.18).
Table 3.18. Amplification results for two different individuals
Marker
Individual Z 
(n=10)
Individual X 
(n=10)
Total
AR ADO IG AR ADO IG AR ADO
DM1 90% 0% 0% 80% 20% 0% 85% 10%
D19S112 70% 50% 10% 40% 30% 20% 55% 40%
D21S1414 50% 20% 10% 80% 40% 10% 65% 30%
D18S535 60% 60% 10% 60% - 10% 60% 60%
D13S305 70% - 10% 60% 40% 0% 65% 40%
AR = amplification rate, ADO = allele dropout, IG = incorrect genotype.
Overall, there was a high incidence of ADO for all STR’s ranging from 10-60%. The 
highest allele dropout rates were observed for the D18S535 primers, showing 60% 
ADO (Table 3.18 and 3.9), whilst the DM1 locus displayed the lowest rate of allele
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dropout. This was probably due to the size of the products that the D18S535 primers 
amplify, which is >430bp, whereas the DM1 are considerably lower (Table 3.2 From 
Materials and Methods). Moreover, there was occurrence of incorrect genotype in all 
the markers except for the DM1 (Table 3.18, termed IG). It was rarely observed and 
the differences in allele sizes were of 1-2 base pairs. The D18S535 also revealed high 
ADO rates (60%), however, it showed that ADO affected equally the large and the 
small allele (Figure 3.10).
Figure 3.10. Illustration of allele dropout of the D18S535 locus
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A. Allele dropout of the large allele (482) in a single cell. B. DOP-PCR positive 
control showed amplification of both alleles. C. F-PCR positive control showed 
amplification of both alleles
The D19S112 and D21S1414 showed increased stutter effect as well as random peaks 
outside the region o f the amplified products (Figure 3.11 and 3.12). Furthermore, the 
DM marker showed high +A artefact incidence compared to when they were 
amplified as singleplex reactions from single cell DNA (Figure 3.13).
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igure 3.11. Illustration of allele dropout of the D19S112 locus
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Figure 3.12. Increased occurrence o f ‘stutter effect’ for the D21S1414 locus
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All three single cells showed increased stutter effect of both alleles. However, in 
single cell 2 there was increased stutter effect. Such results were only observed on 
single cells and never at genomic DNA level.
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Figure 3.13. Illustration of the +A artefact affecting the DM1 locus
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All five single buccal cells reveal cases of significant +A effect. This phenomenon 
was especially apparent in single cells 3 and 5 whereby the peak on the right (circled 
in red), which is the +A artefact, was almost a distinct peak and could be difficult to 
interpret which was the true peak representing the allele. In normal single cell F-PCR 
the +A effect was solved by eliminating the final lOmin extension step.
3.2.6 CGH Results on DOP-PCR Products
Each single cell amplified using DOP-PCR yielded 50pl of product. Around lOpl 
were used for the F-PCR reactions. The rest of the product was subjected to CGH 
analysis. All twenty single cells were able to hybridise into target metaphase 
chromosomes; however, 17/20 (85%) produced analysable results (Figure 3.14). All
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analysable cells showed normal chromosome results and the sex was confirmed in all 
samples.
Figure 3.14. CGH results from DOP-PCR amplified single buccal cell of individual X 
against control male DNA.
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For this CGH experiment 11 metaphases were captured, karyotyped, analysed 
individually and then interpreted cumulatively. 1. Capturing of metaphase spread. 2. 
Karyotype of the captured metaphase 3. This shows the cumulative analysis of eleven 
metaphases, which was the basis of the interpretation. There was a shift in 
fluorescence only towards the green in chromosome X and towards the red in 
chromosome Y showing that the test sample was a normal female. Overall, there was 
dynamic hybridisation with little background fluorescence demonstrating that the 
DOP-PCR amplified single cell can be used for PGD of DM as well as further 
chromosomal analysis.
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3.3 Discussion
This study aimed to develop two multiplex PGD F-PCR protocols for DM1 and 
furthermore to determine if WGA could be used for PGD of DM. The PGD protocols 
were developed by exploring informative STR markers for the parents, multiplexing 
them on genomic DNA and finally testing and perfecting the procedure on single 
cells. Two multiplex F-PCR protocols were devised and carried out for clinical PGD 
cases of two families (G and H). In the first protocol a contamination marker was used 
(similar to that used by Piyamongkol et al, 2004). No embryo was transferred. The 
second protocol entailed a linked marker never used before, which enabled both ADO 
and contamination to be tackled. However, this laborious and patient-specific process 
prompted the development of a universal protocol for PGD of DM. Whole genome 
amplification was employed using DOP-PCR, initially on genomic DNA and 
subsequently on single cell DNA. For each DOP-PCR product a lpl aliquot was taken 
in order to carry out a separate singleplex F-PCR procedure able to amplify the 
corresponding locus. Thus, five different polymorphic markers were tested and their 
single cell efficiency and reproducibility was determined. Finally, CGH was 
performed utilising the DOP-PCR product to assess whether chromosomal analysis 
was also feasible along with single gene analysis of DM.
3.3.1 Strategy for PGD
In total 10 families were referred to our centre for PGD for DM. For all families at 
least six polymorphic markers plus the DM1 mutation marker were genotyped for 
each parent. This was carried out in order to find an informative linked marker (STR) 
for the mutation as well as an unlinked marker (STR) for detection of possible 
contamination. All this work was carried out using genomic DNA extracted from 
whole blood from each parent and some relatives. All primers used were fluorescently 
labelled and analysed in an automated sequencer (ABI Prism™ 3100). Once a 
strategy was devised, the protocol was tested and optimised on single buccal cells and 
single blastomeres.
Initially accurate molecular analysis of the DM1 repeat expansion was (and is still) 
performed by Southern Blotting (Brook et al, 1992). However, this method requires a 
high copy number of the DNA template and thus cannot be applied to PGD. The use
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of PCR can provide a fast and efficient means for the molecular diagnosis of DM1. 
However, the interpretation is based on the exclusion principle as the amplification of 
the fragment size larger than 500 bases is inefficient, hence only normal alleles can be 
examined. The first report of PGD for DM DM1 was from Sermon and colleagues 
(1997) who performed traditional PCR and analysis by gel electrophoresis. The DM 
DM1 mutation marker is polymorphic and provides the advantage of identifying the 
presence of both normal alleles in the normal sample (unless homozygous) and in 
some cases contamination. However, in the case of an affected cell or abnormal cell 
with ADO where only one allele is present, the occurrence of contamination may be 
concealed and may lead to misdiagnosis. The first PGD case using F-PCR was also 
performed by the same group (Sermon et al, 1998a), however, a misdiagnosis 
occurred which was attributed to maternal DNA contamination (Vandervors et al, 
2000). This provoked Piyamongkol et al (2001a) to develop a multiplex F-PCR 
protocol able to tackle contamination, which is one of the most significantcan be a 
problems affecting single cell PCR. Hence, the DM DM1 marker was amplified along 
with another polymorphic marker. An addition of a fluorescent polymorphic marker, 
such as the D21S1414, in the F-PCR protocol would eliminate the need for nested 
PCR since the F-PCR technique is sensitive without the need of carrying out two2 sets 
of PCR amplifications and the addition of a contamination marker wouldand would 
provide information on whether a sample is contaminated. The D21S1414 locus is 
unlinked to the DMPK gene, thus providing no information on inheritance of the DM 
DM 1 mutation, although itis able to serves as a very basic form of DNA fingerprint. 
The compound heterozygoscity of the D21S1414 locus is 0.88 (Sherlock et al, 1998). 
During this study, a similar protocol to Piyamongkol et a l (2001a) was employed 
(Protocol 1) for family G. For family H a linked marker was used, namely D19S112, 
in addition to the DM DM1 marker (Protocol 2). The polymorphic characteristic of 
the D19S112 locus offers solution to both contamination and ADO problems 
encountered during single cell PCR. In family H the father was homozygous (117) 
and the mother was heterozygous (130/132) for the D19S112 locus. Hence, the 
parents had different allele sizes between them and were quite far apart rendering the 
marker informative. The mother’s sister gave a samples of blood sample so thatand 
the phase was distinguished. The phase is the allele of the linked locus (here the 
D19S112) which is transmitted with the disease. If that allele (in this case the phase is 
the 130 allele) is present in an embryo it will be considered to be affected. In total, the
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linkage information of the D19S112 marker can predict the presence of the mutant 
DM1 expanded allele in the embryo, which cannot be obtained by direct PCR analysis 
of the DM DM1 gene (due to the over-expanded allele). This allows differentiation 
between the affected embryo and normal embryo whose results are complicated by 
ADO. Therefore, complete diagnosis can be drawn from more normal embryos, 
giving rise to a large number of embryos for transfer and a better chance of 
pregnancy. Moreover, using the DM1/D19S112 multiplex F-PCR protocol reduces 
the case of misdiagnosis since the D19S112 marker acts aslike a safety net for the DM 
DM1 mutation marker (Ao et al, 1998).
The analysis was performed using the automated laser sequencers ABI Prism™ 3100 
and ABI Prism™ 310. The use of F-PCR in comparison to traditional analyses 
provides protocols with further sensitivity since even tiny amounts of amplified 
fluorescent product can be detected as a small peak. The accuracy of the sequencers 
even allows differentiation of single base pair differences making the protocol more 
specific than those using traditional gel analysis (Sermon et al, 1998a). In the context 
of PGD, the most striking advantage of using the automated laser sequencers is time. 
Both the ABI Prism™ 310 and the ABI Prism™ 3100 can analyse up to three genes 
immediately and simultaneously after one multiplex PCR. However, the added 
advantage of the ABI Prism™ 3100 is that it can analyse 4 samples per hour (in 
comparison to one sample per hour for the ABI Prism™ 310), reducing the time of 
the analysis. During the PGD case the ABI Prism™ 310 was used as a backup 
analysis for all the samples.
During optimisation of the PCR protocols the phenomenon of stutter bands and the 
+A artefact was encountered (Figure 5.1). Stutter bands usually cause problems 
during allele scoring of heterozygote individuals whose alleles are close in size 
especially whilst amplifying mono- and dinucleotide repeats. This could be observed 
in many of the families when the allele sizes were different for the parents e.g. for 
family C the APOC2 marker showed 149/155 for the mother and 134/153 for the 
father, however, some of the alleles are only one two base pair apart (155 from the 
mother and 153 from the father) (Table 5.63). Stutter bands are usually one repeat unit 
length shorter than the main allele (Ellegren, 2004), hence during analysis of the 
APOC2 locus for family C the stutter band for the 155 allele would coincide with the
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153 allele. The solution to stutter bands was to choose in our multiplex protocols 
STR’s which displayed alleles between the parents of more than one base pair apart.
The +A artefact was caused by the addition of an extra nucleotide, usually adenosine, 
to the 3’ ends of the amplified fragment during the amplification reaction. The +A 
products are mostly depicted as an extra peak or as a split peak one base pair longer 
than the expected PCR products. Such a problem would confuse the interpretation of 
the results but would not cause misdiagnosis. The split peak pattern can be minimised 
by either encouraging or suppressing the nucleotide addition. During the whole study 
it was decided to minimise the +A artefact by omitting the final extension step.
Both protocols showed high amplification efficiencies in clumps of 98% for both DM 
DM1 and D21S1414 and 97% for D19S112 (Table 5.1411). The ADO rates in clumps 
were also below 5% for both protocols. In the control single cells the ADO rates 
increased as expected to 8.8%-9.1% for the DM1, 10.2% for the D21S1414 and 
12.9% for the D19S112 respectively. These results are within range of previously 
reported rates in studies of different genes (Ray and Handyside, 1996; Piyamongkol et 
al, 2001a). The optimised protocols 1 and 2 were tested in single buccal cells from the 
members of both families (Tables 5.15 12 and 5.1613). The amplification results 
slightly decreased which was expected due to the fact that the samples were not fresh 
and some were frozen. This was exaggerated in the case of ‘Hms’ (mother’s sister of 
H family) which was due to the prolonged time from the sample collection until the 
time of single cell isolation causing the cells to die or degenerate (Table 5.1613). 
However, the amplification efficiencies were high with ADO rates remaining low.
3.3.2 Clinical DM PGD Cases
One cycle for each of the two families was carried out during this study. For family G 
five embryos were suitable for biopsy however, the embryos were of poor quality. 
Hence, only one blastomere was biopsied from each embryo. This was possibly due to 
the advanced maternal age (42 years of age) at the time of egg collection. Three 
embryos were affected and two embryos had either incomplete or no results, therefore 
no embryos were transferred and all were donated for confirmation of diagnosis 
(Table 5.1714). There were no cases of contamination observed in any of the negative
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control samples. The low quality of the embryos was also reflected in the number of 
blastomeres that were biopsied for confirmation of the diagnosis. Embryo no. 3 had 
completely degenerated and no cells could be retrieved. During confirmation analysis, 
all embryos were found to be affected (Table 5.1815). In total the amplification rates 
for the DM DM1 and D21S1414 markers were 75% and 68.75%. The reduced 
amplification rate for both markers when compared to the workup single cell rate has 
been widely reported. Sermon et al (1997) revealed 100% amplification during single 
cell workup which was reduced to 78% whilst performing the clinical cases. In a 
study by Dean and co-workers (2001) a decrease in amplification was also found 
when tested on single lymphocytes (92%) and single blastomeres (84%). No problems 
occurred regarding stutter bands or the +A effect in any of the blastomeres. However, 
in embryo Gs2 there were peaks, outside the region which the D2IS 1414 product 
produces a peak, which were disregarded and were thought to be artefacts.
For family H the DM/D 19S112 (Protocol 2) was also used on five embryos. Three 
embryos were affected, one was normal and one showed incomplete results (Table 
5.1916). The normal embryo was transferred but no pregnancy was achieved. In 
embryo H2 the DM DM1 locus failed to amplify in either of the cells biopsied and the 
D19S112 showed results from one blastomere which was considered affected. 
However, in the case of embryo H3 the results displayed a normal embryo, but, due to 
extreme cases of preferential amplification for both blastomeres regarding the DM 
DM1 allele and ADO of the D19S112 locus it was not considered for transfer to avoid 
misdiagnosis. Carrying out confirmation of the diagnosis in the untransferred (spare) 
embryos revealed that embryo H3 was found to be normal and embryo H2 was 
affected (Table 5.2017). The phenomenon of mosaicism or maternal contamination in 
the spare embryos Hs4 and Hs6 was due to more than one cell being present in the 
tube since some embryos were compacted and could not be either biopsied or 
disaggregated therefore some cumulus cells attached to the ZP might have given such 
results. During the clinical case no incidence of maternal contamination was found in 
any of the 16 blanks (one final wash drop blank for each blastomere; three for lysis- 
buffer-only blanks; and three PCR reaction-mixture-only negative controls). Overall, 
from 20 blastomeres the DM DM1 locus revealed an 80% amplification, no ADO but 
15% of extreme preferential amplification, whereas the D19S112 showed an 85% 
amplification rate and a 15% allele dropout.
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ADO is a major concern of single cell PCR and although no single protocol has 
managed to eliminate ADO completely, the use of F-PCR used in this study can 
increase 1000-fold the sensitivity of PCR (Hattori et al, 1992). Findlay and co­
workers (1995) were able to demonstrate the advantages of F-PCR over conventional 
PCR and concluded that a number of cases of ADO are in fact preferential 
amplification of one of the alleles and that the other weakly amplified product is not 
detected by conventional analysis. Such results were seen during the clinical case for 
family G H when the DM DM1 locus presented in three blastomeres (15%) extreme 
cases of preferential amplification, which at the time of diagnosis were considered as 
ADO. However, upon reanalysis of the data it was observed that the larger allele 
(146) was not able to amplify in the blastomeres biopsied on the day of diagnosis. 
Normal samples with markedly preferential amplification of the father’s DM DM1 
allele can resemble an affected sample. Unless the mother’s unaffected allele was 
present at an analysable level above the base line (peak height = 150) it was not 
considered safe to transfer the embryo. This was the case for embryo H3. It has been 
noted during our experience with single cell F-PCR analysis that it is more common 
for the large allele to be affected by preferential amplification or allele dropout. 
Similar findings were reported from Piyamongkol et al (2003) whilst trying to 
identify the reasons behind allele dropout.
The use of the STR markers on chromosome 21 (D21S1414) and 19 (D19S112) could 
also have the added benefit of providing copy number information for these 
chromosomes in the cells sampled. Sherlock et al (1997) utilised QF-PCR to detect 
small numbers of trisomic fetal cells isolated from the transcervical canal. However, 
when the same group was able to test the D2IS 1414 on single cells the method 
produced precise results for 75% of amplifications (Sherlock et al, 1998). This 
technique was based on the fact that the alleles of a heterozygous STR locus in a 
normal individual should amplify equally as long as the PCR is in the exponential 
phase of amplification (Mansfield, 1993). At an STR locus a trisomic subject has 
three alleles each amplified to the same extent (i.e. three different copies of the 
trisomic chromosome) or alternatively two alleles with one amplified twice as much 
as the other (i.e. two identical copies of the trisomic chromosome and one non­
identical copy). Dean and colleagues (2001) were able to distinguish between an
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embryo being monosomic (or mosaic) for chromosome 19 from an embryo being 
affected from ADO, by including an unlinked STR. During analysis the group 
observed only the affected parent’s normal allele being amplified for the DM DM1 
marker for both biopsied blastomeres, whilst the unlinked STR showed both alleles 
amplified, which was later confirmed from the spare embryos (Dean et al, 2001). 
Therefore, additional STR’s during multiplex analysis can provide further genetic 
information and maximise the number of embryos in which a genotype can be 
assigned.
For both clinical cases the genotypes matched the expected genotypes that were 
known from the workup of control DNA and patient single cells. There was rarely a 
base pair difference (123 instead of 122) in the allele sizes. Apart from the unexpected 
fragments seen in embryo Gs2, there was no other unexplained amplification 
indicating that the results obtained were true genotypes of the embryos and DNA 
contamination was unlikely. Similar observations were observed from Dean et al 
(2000), however, their analysis was performed using an ALF automated sequencer 
(Pharmacia Biotech). Maximising the number of diagnosed embryos is particularly 
important in the case of dominant diseases since only 50% of all generated embryos 
will be expected to be normal and thus available for transfer.
It has been postulated that two cells per embryo should be biopsied in order to reduce 
misdiagnosis (Sermon et al, 1998; Ao et al, 1998; Ray et al, 1998). During this study 
it was appreciated that biopsy of two cells per embryo is a necessity in order to avoid 
misdiagnosis. Two cells are biopsied (in the UCL centre for PGD) from embryos with 
>6 cells. However, for family G only one blastomere was biopsied from each embryo 
due to reduced embryo development. This lead to attaining a complete result from 
only 60% of the embryos which were biopsied. An embryo that does not reach the 7- 
cell stage by 72h of development is less likely to progress to the expanded blastocyst 
stage (8.1% for <6 cells compared to 43.3% for >7 cells) (Shapiro et al, 2000). 
Although, no misdiagnosis occurred, the results for family H were enhanced due to 
the addition of the second cell.
In conclusion a comprehensive PGD protocol for DM DM1 has been developed using 
single step multiplex analysis of the normal DM DM1 triplet region and either a
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polymorphic linked marker (D19S112) or a polymorphic unlinked marker 
(D21S1414). The linked marker will provide backup linkage analysis as well as 
contamination identification and when the linked marker is partially informative for a 
family, the unlinked D21S1414 marker can be used for the detection of 
contamination. In an ideal world triplex analysis would be performed for a PGD 
protocol by employing the mutation marker, a linked marker and an unlinked marker, 
in order to have backup linkage analysis as well as backup contamination exposure.
3.3.3 Universal PGD Protocol for DM
During the second part of this study the development of a PGD protocol for DM1 was 
attempted using a whole genome amplification method, namely DOP-PCR. DOP- 
PCR amplified genomic and single cell DNA was tested for genome coverage through 
amplification of the DM1 mutation marker along with another four polymorphic 
linked (D19S112) and unlinked markers (D21S1414, D18S535 and D13S305). Thus, 
the DOP-PCR coverage would be tested in at least four chromosomes (13, 18, 19 and 
21). Such a protocol would eliminate the time consuming need for multiplexing and 
optimising different F-PCR protocols in single cells for different patients.
3.3.3.1 DOP-PCR on Genomic DNA
To be useful, a whole genome amplification procedure should have the following 
features: generation of long DNA fragments, successful amplification of starting 
DNA template, high amplification fidelity and yield, and good coverage of the 
genome. Due to the increased amount of information gathered from the workup of all 
the families (section 3.2.1) initially genomic DNA was amplified using DOP-PCR 
from family E (mother and father). The genomic DNA was approximately 100-300ng 
and was able to produce very distinct smears when run on agarose gel. All 
microsatellite markers showed similar amplification results when they were amplified 
from genomic DNA or from genomic DNA amplified using DOP-PCR (Figures 3.2, 
3.3, 3.4 and 3.5). When the DOP-amplified DNA was used as a template for the 
further amplification of the five polymorphic markers, there was a slight increase of 
stutter bands especially for the DM1 marker and the D19S112 marker. This was not 
unexpected as mono- and dinucleotide repeats are well known to produce prominent 
stutter bands which might complicate the genotyping analysis (Ellegren, 2004).
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Furthermore, all markers amplified using the DOP-PCR as template showed reduced 
amount of product, especially for the D21S1414 and D18S535 (Figures 3.3 and 3.4 
respectively). However, all DOP-PCR amplified genomic DNA displayed the correct 
genotypes which was in accordance with the findings of Cheung and Nelson (1996) 
which analysed microsatellite repeats of DOP-PCR amplified genomic DNA (lng 
concentration). There was no ADO present, although there were instances of mild 
preferential amplification of the smaller allele. Similar results have been reported 
from Cheung and Nelson (1996) who achieved 100% amplification of the markers 
and correct assignments of genotypes, though it was noticed that there was some 
preferential amplification of the shorter allele. Recently, Struan and colleagues (2002) 
managed to use DOP-PCR to amplify genomic DNA (l-40ng) and subsequently carry 
out single nucleotide polymorphism (SNP) genotyping. In the latter study DOP-PCR 
yielded satisfactory results but, displayed loss in accuracy and quality of the genotype 
assignments. Furthermore, a new method of DOP-PCR (LL-DOP-PCR) has been 
reported which is able to generate long fragments from pg quantities of genomic DNA 
(Kittler et al, 2002). It has been shown that by using LL-DOP-PCR, products of up to 
lOkb can be produced from less than one ng template genomic DNA, thus providing 
better coverage for microsatellite and unique sequences compared to the conventional 
DOP-PCR method. During this study, the overall amplification rate was 98% for all 
primers except for the D13S305 which was 96%.
3.3.3.2 DOP-PCR on Single Cells
Two individuals (X and Z) were chosen to donate 10 single cells each as well as 
genomic DNA. This was due to the fact that they were found to have heterozygous 
alleles for almost all the markers and especially for the DM DM1 mutation marker. 
The underlying reason was to be able to detect any allele dropout present in the most 
important polymorphic markers in this study, since a diagnosis would certainly 
involve this marker as well as the availability of fresh single cells. 100%Hundred 
percent amplification (20/20) was achieved for the DOP-PCR part of the study 
(Figures 5.6 and 5.7). Moreover, the single cells from individual G Z showed better 
amplification results compared to individual X. However, all single cells from both 
individuals were collected, isolated and amplified the same day in order to avoid 
freezing and thawing of the samples which might lead to dead or degenerating cells
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and increase the levels of ADO (Piyamongkol et al, 2003). Only one cell from each 
individual (X4 and Z10) displayed reduced amplification with a smaller and fainter 
smear. This was expected since those particular buccal cells might have been in the 
process of degeneration or the lysis protocol was unable to completely lyse them. 
Furthermore, only in individual G Z the DOP amplified product showed some distinct 
bands in the 450bp region, which has previously been observed from Voullaire et al, 
(2000). For each individual two clumps of buccal cells (3-4 cells) and one sample of 
genomic DNA was also added to observe the differences between the amounts of 
starting DNA and act as a positive control. The negative controls for all single cells 
and of the DOP reaction displayed no amplification and were free of contaminants.
During the DOP-PCR amplified single cell DNA all microsatellite loci revealed 
decreased amplification, increased ADO and the incidence of incorrect genotype of 
about 10% (Table 5.2118). As seen in the DOP results, the genotyping results for the 
microsatellite loci regarding individual G Z showed better overall results. The 
combined amplification efficiency for all markers was 66% which was lower 
compared to the previously reported 85% amplification rate achieved from DOP-PCR 
amplified single cell DNA (Wells et al, 1999). The DM DM1 locus exhibited the 
highest amplification rate of 85% and the most reduced ADO rate of 10%. Overall, 
during this entire study it had been observed that the primer for the DM DM1 locus 
achieves high amplification rates, with minimal ADO and was not affected by the 
presence of other primers (e.g. during multiplex PCR). It was postulated during the 
study by Wells et al (1999), that unique sequences (such as the DM DM1 mutation 
marker) have a higher fidelity for replication compared to microsatellite loci (linked 
and unlinked STR’s), which might account for the higher amplification results. 
However, it was noticed in this study that during amplification of the DM DM1 locus 
using DOP-PCR amplified single cell DNA, there was a greater increase of the +A 
artefact (section 5.4.1; Figure 5.10). The complete elimination of the final ten minute 
extension step and the reduction of the extension step during each cycle of 
amplification from one minute to 30 seconds were not found to improve the fidelity of 
the primer. However, these artefacts would not cause misdiagnosis since the true 
allele was easily distinguishable.
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The linked marker to the DM DM1 mutation, the D19S112, showed the loweeast 
amplification rate (55%) with one of the highest ADO rates (40%). However, this 
result was partly due to the low amplification seen in individual CX. Such reduced 
amplification was in contrast to the amplification seen for the D19S112 marker when 
amplified directly from single cell DNA (78.3%; Table 5.1613). Furthermore, the 
ADO rates nearly tripled compared to direct amplification (15%; Figure 5.8). It has 
been observed in previous studies that microsatellite loci show less reliability for 
replication (Wells et al, 1999) which is in accordance with this study. The D21S1414 
microsatellite locus showed good amplification (65%), but, lower compared with 
direct amplification. A significant number of PCR artefacts were seen to affect the 
D21S1414 and D19S112 repetitive markers particularly small deletions and 
insertions. Allele sizes were increased or decreased by a number of base pairs 
equivalent to one repeat length (Figure 5.9). This phenomenon was locus specific but 
was shown to be present in all the markers though with decreased incidence. Similar 
findings were observed from Wells et al (1999), which suggested that this locus 
specificity is due to variation in factors such as chromatin structure, GC content and 
whether the repeat is perfect or disrupted by other sequences. Focault et al (1996) also 
reported such results when amplifying (CA)n repeats from less than ten single cells 
and concluded that this phenomena are due to replication slippage.
The highest incidence of allele dropout was exhibited from the D18S535 locus (50%; 
Table 5.2118). Allele dropout and preferential amplification was found to affect 60- 
83% of the heterozygous samples when amplified with repetitive microsatellite loci 
(Wells et al, 1999). ADO however, was rarely observed (3-5%) in unique sequences 
such as CFTR AF508 carrier cells in the same study. Preferential amplification was 
not often seen in this study however, it was shown to mainly affect the D18S535 and 
D13S305 loci (data not shown). This might be due to the fact that both microsatellite 
loci produce large products of more than 430bp. Piyamongkol and colleagues (2003) 
have noticed that the larger the amplified product the more prone to preferential 
amplification and ADO it will be. However, both loci showed the best results 
regarding sharp peaks, limited stutter peaks and +A artefact. Such results are in 
accordance with tetranucleotide microsatellite alleles being amplified directly from 
single cells.
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During the analysis of the five markers after whole genome amplification of single 
cells, the incidence of incorrect genotyping was observed (Table 5.2118). Although a 
small number of single cells were tested, it was found that around 10-20% of the loci 
showed incorrect genotypes i.e. l-2bp difference from true allele size and rarely 3-4bp 
difference e.g. for the D18S535 marker the correct genotype was 478/482, but, the 
analysis revealed 473/477. However, more single cells need to be tested and more loci 
investigated.
The poor fidelity of amplification seems to be attributable to the WGA reaction, 
namely the DOP-PCR. Firstly, whilst devising a PGD protocol for DM DM1 using F- 
PCR in the first part of this study, it was found that ADO was present in less than 
20% when directly genotyping microsatellite markers from single cell DNA. This is 
in accordance with other studies that have amplified single cells (Sherlock et al, 1998; 
Sermon et al, 1998). When DOP-PCR amplified single cell DNA was genotyped with 
STR’s, during this study, the overall ADO rate was 35%, suggesting that probably the 
DOP-PCR part was not reliable. Furthermore, different aliquots from the same DOP- 
PCR amplified product showed similar PCR artefacts and the increased failure of 
amplification of the five markers was random during this study. Wells et al (1999) 
noticed similar behaviour. However, when genomic DNA was amplified using DOP- 
PCR, the results were excellent and there were no increase in ADO and PCR artefacts. 
Hence, the success of the DOP-PCR reaction depends on the starting template DNA 
and if it is limited, the DOP-PCR enhances the problems of single cell PCR.
3.3.3.3 CGH and DM
In the final part of this study, the remaining DOP-PCR product was subjected to CGH 
analysis. It has been shown (Chapter 4) that DOP-PCR provides reliable and 
reproducible results for CGH analysis after amplification of single cell DNA. A total 
of 17/20 (85%) DOP-PCR amplified single cell DNA produced dynamic fluorescence 
and specific hybridisation, thus yielding analysable results. Both individuals (C and 
G) were female, hence, their amplified single cells were hybridised against control 
male DNA. In all 17 cells the sex status of the test samples was confirmed (Figure 
3.11). Wells et al (1999) was also able to show reproducible CGH results when using 
as template DOP-PCR amplified single cell DNA. This additional test from the DOP-
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PCR amplified single cells provides the opportunity in the context of PGD of 
investigating a specific single gene disorder as well as the chromosomal status of the 
embryos. Therefore, the phenomenon of mosaicism (Chapter 3) can be explored even 
in single gene analysis and a greater amount of information can be attained from a 
single cell. During a PGD case of myotonic dystrophy the affected embryos as well as 
the overall chromosomal status of the embryo can be distinguished, which will lead to 
better chances of a normal embryo being transferred.
3.3.4 Conclusions and Future Work
It was shown during this study that the development of multiplex F-PCR protocols for 
clinical cases of PGD are efficient and can provide accurate diagnosis. Two protocols 
were used for two families. Protocol 1 has been previously reported (Piyamongkol et 
al, 2001a) however it was found that certain modifications needed to be carried out to 
increase the fidelity of the amplifications. Unfortunately, only 5 embryos were 
biopsied and all were found to be unsuitable for transfer. The multiplex reaction for 
protocol 2 was devised specifically for family H and included a linked marker 
(D19S112), which could detect contamination and ADO. One embryo was found to 
be unaffected and was transferred but no pregnancy was achieved.
An alternative protocol was tested which would allow the detection of DM affected 
embryos as well as any whole chromosome abnormalities with the use of WGA. 
DOP-PCR amplified genomic and single cell DNA were used as templates for 
subsequent F-PCR reactions using five different markers. This would alleviate the 
problem of multiplexing and optimising protocols as well as creating patient-specific 
protocols. DOP-PCR amplified genomic DNA showed excellent results of 
amplifications from four individuals (mother and father of family E and individuals X 
and Z). DOP-PCR amplified single cell DNA showed reduced amplification 
efficiencies and increased ADO rates compared to direct amplification of the five 
markers from single cells. Although it was shown that in addition to single gene 
analysis, whole chromosome analysis using CGH can be carried out.
Future work should include analysis of more single cells (>1000) from more 
individuals, in order to assess the fidelity of amplification. Even though, DOP-PCR
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amplified single cell DNA showed efficient CGH analysis, it did not provide 
acceptable coverage of the genome. Hence, the testing of novel WGA techniques such 
as multiple displacement amplification should be performed (sections 1.3.3.1.3 and 
1.5.3.3).
Recently, the scope of PGD of single gene disorders using micro-arrays has been 
explored. Cystic fibrosis (CF), and specifically the AF508 mutation, has been used as 
a model disease to prove the diagnostic capability of micro-arrays for PGD (Salvado 
et al, 2004). A single micro-array platform was constructed using oligonucleotide 
probes for both the normal and AF508 disease alleles and the target DNA was 
fluorescently labelled which was hybridised to the array and the AF508 genotypes 
assigned from the fluorescence bound to ach allelic probe (Salvado et al, 2004). In a 
mix of samples (homozygous normal, homozygous affected, heterozygous, samples 
from previous PGD case for CF) strong binding of the target DNA to the probes was 
observed and all samples were correctly genotyped (Salvado et al, 2004).
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4.1 Aims
In this study the level of mosaicism was explored using sequential rounds of FISH in 
two groups of day 5 human embryos (mainly blastocysts). The chromosomes studied 
were 1,11 and 18, X and Y. Three rounds of FISH were performed. The aim of this 
study was to develop a FISH protocol that can accurately and precisely determine the 
true level of abnormalities and mosaicism. This unique protocol employed two probes 
for each chromosome at different loci, which were analysed in sequential rounds of 
FISH. Such protocol technique would allow the direct distinction of FISH artefacts, 
failure of hybridisation that can occur during FISH analysis on human embryos. Any 
contradictive results between the two probes for the same chromosome were excluded 
from the analysis therefore revealing the true level of chromosomal abnormalities and 
specifically aneuploidies. So far previous studies have utilised only one probe per 
chromosome and have been hurdled with FISH failure and unexplained findings. 
However, with this novel protocol the FISH procedure is more robust and can aid in 
understanding the extent of mosaicism and most significantly the mechanisms leading 
to mosaicism.
4.2 RESULTS
4.2.1 Preliminary Work
Initial work included developing three FISH probe combinations that would yield 
high efficiencies whilst performing 3-round sequential FISH procedures. The various 
combinations that were attempted and their efficiencies are shown in Table 4.1. Most 
probes were commercially obtained however, probes e.g. lhet and 2cep were 
laboratory grown (Table 2.1). From the combinations, the 1/11/18 chromosome 
combination was picked since it produced high efficiencies and was able to test 3 
chromosomes of different size. A 3rd round of FISH was included using the probe- 
cocktail for chromosomes X, Y and 18. This last round of FISH had a dual purpose. 
First, the probe for chromosome 18 was included in all rounds acting as a control and 
the presence of gonosome abnormalities can be investigated in blastocyst and their 
involvement in mosaic patterns.
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Table 4.1. Various probe combinations that were attempted in order to find the most 
efficient 3-colour FISH in both rounds.
Chromosome
combinations
Probes used in 
1st round
Probe efficiency Probes used in 2nd 
round
Probe efficiency
1 dual / 8 dual lhet / lp 95% / 93% 8cep / 8q 94% / 87%
4 /1 6  dual & 
4 / 11 dual
4cep / 16p / 16q 97% / 95% / 97% 4cep / llcep  / l lq 89% / 94% / 90%
7 dual* / 18 & 
11 dual / 18
7 q /7q /18cep 91% /92% /95% 1 lcep / l l q /  18cep 91% / 89% / 94%
2 / 4 / 5 2q / 4cep / 5p 95% / 98% / 94% 5p&5q */ 
2cep
80%&78% / 
67%&61%
1 /1 1 /1 8 lp  /  l l q  / 18cep 94% / 97% / 96% l h e t / l l c e p / 18q 88% / 89% / 90%
X /Y /1 8
(cocktail)
Xcep / Ycep / 
18cep
96% / 95% / 98% Xcep / Ycep / 18cep 
(3rd Round results)
94% / 90% / 93% 
(3rd Round 
results)
# The probe was the 7 (7ql 1.23 anc 7p31) Wiliams microdeletion probe
* The probe was the 5 (5q31 and 5pl5.2) Cri-du-Chat microdeletion probe 
The colours show the corresponding fluorescent labels i.e. orangi-spectrum red, 
green-spectrum green, blue-spectrum aqua, cep = centromeric or heterochromatic 
probe, p = sub-telomeric probe for the small arm, q = sub-telomeric probe for the big 
arm
The chosen combination was then applied to 10 arrested day 5 human embryos (118 
blastomeres) donated from 3 patients (data not shown). This was performed to assess 
the spreading technique in order to reduce loss of cells and more significantly to 
evaluate the FISH protocol. The preliminary results showed high FISH efficiencies 
with bright and sharp signals in all three rounds of FISH and minimal cell loss. 
Overall, 101 blastomeres were FISHed for all sequential rounds out of 118 
blastomeres counted before spreading (86%). 98/101 blastomeres (97%) produced 
visible and foremost interpretable results for all FISH rounds. The embryos were 
analysed in two separate FISH procedures (five embryos each time). In each of the 
two procedures a control male lymphocyte slide was also included in the FISH
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procedure and 200 interphase nuclei were counted to calculate the probes’ efficiency. 
The yields were 97%, 91% and 88% for the 1st, 2nd and 3rd round respectively.
4.2.2 FISH Study
Twenty-seven couples donated a total of 47 embryos for this research project (Table 
2.9). The overall mean maternal age was 33.7 (range 19-41) years. The mean maternal 
age for Group I embryos was 35.2 (range 27-41) and for Group II was 32.1 (range 19- 
41) years. Five arrested embryos were not included, since the signals were not 
analysable due to loss of most nuclei during sequential rounds of FISH and poor 
quality of the nuclei. Embryos from both groups included nuclei which showed 
contradicting information for the two probes used for each autosome in the different 
rounds of FISH. These cells were classed as inconsistent results and excluded from 
the analysis.
4.2.2.1 FISH Analysis of Controls
Each FISH experiment included a control male lymphocyte slide with mapped nuclei 
in order to assess efficiency of probe hybridisation in the sequential rounds. Overall, 
87.1% (range 78-96) of the control nuclei showed normal signals for all 8 probes 
used. Sub-telomeric probes for chromosomes lp, l lq  and 18q, showed a higher 
incidence of one signal per chromosome per nucleus, 7.8% (range 4-11%), 3.1% 
(range 1.2-4.5%) and 3.9% (range 2-5%) respectively. Heterochromatic region or 
centromeric probes, lhet, 11 CEP and 18CEP (in both 1st and 3rd rounds) displayed a 
lower incidence of one signal per chromosome per nucleus, 6.2% (range 4.4-7.5%), 
2.4% (range 0.9-3.3%) and 2.2% (1.5-3.4%) respectively (Table 4.2). Nuclei with one 
signal for the X chromosome and no signal for chromosome Y and nuclei with three 
or more signals for autosomes comprised less than 1%. Furthermore, all three sub- 
telomeric probes, lp, l lq  and 18q showed the occurrence of split signals (i.e. 
replicated DNA) in 2.2%, 1.4% and 1.9% of nuclei respectively, which was 
considered normal due to the position of the probes. The difference in the efficiency 
of the 18cep probe (used in the 1st and 3rd round of FISH) was not statistically 
significant (p<0.05) and can be attributed to the fact that FISH efficiency decreases 
with sequential rounds of hybridisation due to the DNA being over-processed.
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Table 4.2. Probe efficiencies scored in 200 interphase nuclei of each control slide 
whilst carrying sequential 3-round FISH.
Round 
of FISH
Probe % of missing a signal Split signals
Mean Range Mean Range
1st
ip 7.8 4-11 2.2 1.1-2.8
n q 3.1 1.2-4.5 1.4 0.4-1.9
18cep 2.2 1.5-3.4 0.3 0.1-0.4
2nd
lhet 6.2 4.4-7.5 0.4 0.3-0.7
llcep 2.4 0.9-3.3 - -
18q 3.9 2-5 1.9 0.8-2.4
3rd
Xcep 0.9 0.5-1.1 - -
Ycep 0.5 0.1-0.9 - -
18cep 3.4 2.1-4.3 0.5 0.4-0.8
The results for the probes were calculated during sequential rounds of FISH, hence 
each control slide was subjected to 3 rounds of FISH. The table lists only the 
percentages where a signal was missing, hence 1 signal was seen for the autosomes 
and no signal for the gonosomes. The incidence o f extra and complete lack of signals 
was minute (<0.4%) for all the probes tested.
4.2.2.2 FISH Analysis of Embryos
Twenty-one embryos were analysed for each group. FISH results for Group I and 
Group II embryos are shown in Tables 4.3 and 4.6 respectively. In Group I the total 
number of nuclei analysed was 401/410 (9 lost during sequential rounds of FISH). 
Thus, the mean number of nuclei analysed was 20 (range 4-45). In all, 72% (±20 SD) 
of the nuclei analysed were diploid for the chromosomes tested (Figure 4.1) however 
only a single embryo was uniformly diploid for the tested chromosomes (embryo 9.1). 
One embryo was aneuploid mosaic, and 14 were diploid mosaics (4.3). Three 
embryos contained chaotic complements (embryos 8.1, 12.2 and 17.1) and thus a 
mechanism of mosaicism could not be suggested for those embryos. Since 19/21 
embryos were considered arrested for Group I (<30 cells), four embryos contained 
polyploidy cells and predominantly tetraploidy cells, however, 17.2 had hexaploid and 
octaploid cells. One embryo only (20.1) contained a haploid chromosome 
complement for all five chromosomes tested. Although, this is quite low compared to 
other studies, haploid cells have been characterised as less viable and less actively 
dividing than tetraploid cells (Ruangvutilert et al, 2000a)
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Table 4.3. Results of FISH analysis of Group I embryos after three sequential rounds of hybridisation with probes for chromosomes 1, 11, 18, X
and Y
Embryo
No.
Cells
analysed
Sex Chromosome constitution of cells (number) Diploid
(%)
Classification
4.1 4 F -18 (3) / +18 (1) 0 Mosaic Aneuploid
5.1 9 M Dip (7) / +X, +Y (1)/*(1) 77.8 Mosaic Diploid/Aneuploid
5.2 10 F Dip (6 )/te t (3 )/- I  (1) 60 Mosaic Diploid/Polyploid/Aneuploid
5.3 20 F Dip (15)/ - l  (1) /-X (1) / *(3) 75 Mosaic Diploid/Aneuploid
5.4 22 F Dip (18)/- I  (2 )/+ 1 8 (l) /* ( l) 81.8 Mosaic Diploid/Aneuploid
5.5 4 F Dip (3 )/-1 (1 ) 75 Mosaic Diploid/Aneuploid
6.1 22 M Dip (17)/te t (2)/*(3) 77.2 Mosaic Diploid/Polyploid
7.1 26 F Dip (24)/ - l  (1 )/ - l l  (1) 92 Mosaic Diploid/Aneuploid
7.2 9 M Dip {1)1 A (1) / -1, +X (1) 77.8 Mosaic Diploid/Aneuploid
8.1 6 M Dip (4) / +X, +Y (1) / chaotic (1) 66.7 Mosaic Diploid/Aneuploid/Chaotic
9.1 8 F Dip {1)1 *(1) 87.5 Uniformly Diploid
10.1 5 F Dip (4)/-11 (1) 80 Mosaic Diploid/Aneuploid
12.1 13 M Dip (6) / -18, -Y (3) / -Y (1) / -18, +Y (1) / -18 (1) / -1 (1) / *(1) 46.2 Mosaic Diploid/Aneuploid
12.2 30 F Dip (22)/-11 (1) /-18 (1) / -X (1) / -1, -18 (1) / 
-11 ,-18(1)/chaotic (3)/ *(1)
73.3 Mosaic Diploid/Aneuploid/Chaotic
17.1 45 M Dip (40) / +Y (2) / chaotic (2) / *(1) 88.9 Mosaic Diploid/Aneuploid/Chaotic
17.2 12 F Dip (9) /tet (3) 75 Mosaic Diploid/Polyploid
20.1 43 F Dip (34) / -18 (4) / +11 (4) / hap (1) / *(3) 79 Mosaic Diploid/Aneuploid/Haploid
21.1 27 M Dip (22)/hex (3) / oct (1) / *(1) 81.5 Mosaic Diploid/Polyploid
21.2 29 F Dip (25)/+11 (1)/+1 , +11 (1) / *(2) 86.2 Mosaic Diploid/Aneuploid
27.1 24 M Dip (16) / +Y (2) / +18 (1) / +X (1) / *(4) 66.6 Mosaic Diploid/Aneuploid
27.2 33 M Dip (28) / +Y (1) / *(4) 84.8 Mosaic Diploid/Aneuploid
* Inconsistent results that were observed during scoring, dip = diploid, tet = tetraploid, trip = triploidy, hex = hexaploidy, oct = octaploidy. 
The - indicates loss of chromosome and + indicates gain of chromosome e.g. +18 is trisomy 18 or -1 is monosomy 1.
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Figure 4.1. Results of three sequential rounds of FISH analysis on a single female 
embryonic nucleus from embryo 9.1.
1st Round 2nd Round 3rd Round
1 IQ
l l c e p
Xceo
18CEP
a) Using probes lp, l lq  and 18cep, b) using probes lhet, 1 lcep and 18q and c) using 
probes for Xcep, Ycep and 18cep. In all three rounds the cell appears to be diploid. 
The probe 18CEP is present in rounds 1 and 3 and shows identical results.
In Group I there were 32 post-zygotic errors (16 chromosome losses, 14 chromosome 
gains and 2 instances of mitotic non-disjunction) (Table 4.4). There was no statistical 
significance (p<0.05) between chromosome loss and chromosome gain. For the 
chaotic blastomeres the mechanism causing mosaicism was not included due to the 
nature of chaotic cells. Embryo 12.2 showed the highest incidence of aneuploid 
mosaicism involving 4 chromosomes (chaotic cells not included). The two instances 
of MND were for chromosomes 18 and Y in embryos 4.1 and 12.1.
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Table 4.4. Aneuploidy mosaicism mechanisms for Group I embryos
Embryo
No.
Type of 
embryo
Classification Events Chromosome
4.1 Arrested Mosaic Aneuploid 1 MND 18
5.1 Arrested Mosaic Diploid/Aneuploid 2 CG X, Y
5.2 Arrested Mosaic
Diploid/Polyploid/Aneuploid
1 CL 1
5.3 Arrested Mosaic Diploid/Aneuploid 2 CL i , x
5.4 Arrested Mosaic Diploid/Aneuploid 1 CL 
1 CG
1
18
5.5 Arrested Mosaic Diploid/Aneuploid 1 CL 1
6.1 Arrested Mosaic Diploid/Polyploid - -
7.1 Arrested Mosaic Diploid/Aneuploid 2 CL 1,11
7.2 Arrested Mosaic Diploid/Aneuploid 1 CL 
1 CG
1
X
8.1 Arrested Mosaic 
Diploid/Aneuploid/Chaotic
2 CG X, Y
9.1 Arrested Uniformly Diploid None -
10.1 Arrested Mosaic Diploid/Aneuploid 1 CL 11
12.1 Arrested Mosaic Diploid/Aneuploid 2 CL 
1 MND
1, 18 
Y
12.2 Arrested Mosaic Diploid/Aneuploid 4CL 1, 11, 1 8 , X
17.1 Arrested Mosaic
Diploid/Chaotic/Aneuploid
1 CG Y
17.2 Arrested Mosaic Diploid/Polyploid - -
20.1 Expanded
Blastocyst
Mosaic 
Diploid/Aneuploid/Haploid
1 CL 
1 CG
18
11
21.1 Arrested Mosaic Diploid/Polyploid - -
21.2 Arrested Mosaic Diploid/Aneuploid 2 CG 1,11
27.1 Arrested Mosaic Diploid/Aneuploid 3 CG 18, X, Y
27.2 Arrested Mosaic Diploid/Aneuploid 1 CG Y
Total
21
16 CL 
(50%) 
14 CG 
(44%) 
2 MND 
(6%)
CL = chromosome loss, CG = chromosome gain, MND = mitotic non-disjunction
Table 4.5 summaries the breakdown by chromosome. Chromosome 1 was mostly 
affected by chromosome loss (7 events) whereas the sex chromosomes showed the 
highest incidence of chromosome gain. The Y chromosome did not display any 
chromosome loss events, although it was affected greatly by chromosome gain and
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mitotic non-disjunction. Inconsistent results affected 26/401 (6.5%) nuclei and were 
considered to be FISH artefacts
Table 4.5. Mechanisms of mosaicism ?y chromosome for Group I embryos
Event
Chromosome
Chromosome Loss Chromosome Gain Mitotic Non- 
Disjunction
1 7 1 0
11 3 2 0
18 4 2 1
X 2 4 0
Y 0 5 1
Total 16 14 2
Table 4.6 shows the results of Group II embryos. The total number of nuclei analysed 
was 1143/1171 (28 nuclei lost during sequential rounds of FISH). The mean number 
of nuclei per embryo was 55, ranging from 20-100. 78% (±15 SD) of the nuclei 
analysed were found to be diploid, although only two embryos were found to be 
uniformly diploid (16.1 and 23.1) as tested. The majority (16/21) of embryos were 
found to have some tetraploid cells (confirmed in all rounds), which totalled 
approximately 7% of the abnormal cells analysed (Figure 4.2). Six out of twenty-one 
embryos included a chaotic complement. Those embryos included at least one cell, 
which had more than three abnormalities per cell, including nullisomies and 
tetrasomies. Furthermore, there was one embryo (15.4), which was a 
diploid/aneuploid/haploid/chaotic mosaic. This embryo contained only one cell which 
was haploid, with the results being consistent in all rounds, and three aneuploid cells 
affecting chromosomes 18 and X (Figure 4.3). 20/21 embryos in Group II were 
dividing embryos and only one was arrested (13.1). Ten embryos were male and 
eleven embryos were female, hence no difference was observed in abnormalities 
regarding the sex, although both uniformly diploid (for the chromosomes tested) 
embryos were male.
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Table 4.6. Results of FISH analysis of Group II embryos after three sequential rounds of hybridisation with probes for chromosomes 1, 
11, 18, X and Y
Embryo
No.
Cells
analysed
Sex Chromosome constitution of cells (number) Diploid
(%) Classification
13.1 29 F Dip(13) / trip(7) / tet(5) / -18(1) / +1, +11(1) / chaotic (1) / *(1) 44 Mosaic Diploid/Polyploid/Aneuploid/Chaotic
13.2 38 F Dip(18) / tet(8) / trip(4) / hex(l) / enn(l) / +1, +11(1) / -1(1) / 
chaotic (2) / *(1)
47.4 Mosaic Diploid/Polyploid/Aneuploid/Chaotic
13.3 43 F Dip(33) / tet(6) / trip(l) / chaotic (1) / *(2) 76.7 Mosaic Diploid /Polyploid/Chaotic
14.2 20 F Dip(12) / -X(3) / +X(2) / +11(1) / tet(l) / chaotic (1) 60 Mosaic Diploid/Aneuploid/Polyploid/Chaotic
14.3 43 M Dip(36) / tet(2) / chaotic (3) / *(2) 85.7 Mosaic Diploid/Polyploid/Chaotic
15.1 34 F Dip (31)/te t (3) 91.7 Mosaic Diploid/Polyploid
15.2 100 M Dip(67) /tet(22) / trip(5) / -18(1) / -11, -18(1) / *(4) 67 Mosaic Diploid /Polyploid/Aneuploid
15.3 62 F Dip(57) / tet(l) / trip(l) / +11(1) / *(2) 91.9 Mosaic Diploid /Polyploid/Aneuploid
15.4 33 F Dip(26) / -X(2) / hap(l) / -18(1) / chaotic (1) / *(2) 72.2 Mosaic Diploid/Aneuploid/Haploid/Chaotic
16.1 57 M Diploid (57) 100 Uniformly Normal
18.1 57 M Dip (43) / +X(2) / +Y(2) / -11(2) / -X(l) / -Y(l) / *(6) 75.4 Mosaic Diploid/Aneuploid
19.1 76 F Dip(66) / -X(3) / -18(2) / tet(l) / -11(1) / *(3) 86.8 Mosaic Diploid/Aneuploid/Polyploid
19.2 94 M Dip(81) / tet(5) / trip(l) / +18(2) / -Y(l)/ +X, +Y (1) / *(3) 86.1 Mosaic Diploid/Polyploid/Aneuploid
22.1 75 F Dip(67) / +X(2) / tet(l) / -18(1) / -X(l) / *(3) 89.3 Mosaic Diploid/Aneuploid/Polyploid
22.2 67 F Dip(55) / tet(3) / -X(3) / +1, +X(2) / +11, -18(1)/ +X(1) / *(2) 83.3 Mosaic Diploid/Aneuploid/Polyploid
23.1 100 M Diploid(94) / *(6) 94 Uniformly Normal
24.1 63 M Dip(55) / tet(4) / *(4) 87.3 Mosaic Diploid/Polyploid
25.1 62 F Dip(53) / tet(3) / -18(3) / *(3) 85.5 Mosaic Diploid/Polyploid/Aneuploid
25.2 31 M Dip(24) / +X(2) / tet(l) / -18(1) / -18, -X(l) / *(2) 77.4 Mosaic Diploid/Aneuploid/Polyploid
26.1 30 M Dip(20) / +1, +11(2)/ -1(1)/ +X(1)/ +X, +Y(1)/ chaotic (2)/ *(3) 66.6 Mosaic Diploid/Aneuploid/Chaotic
26.2 31 M Dip(19) / tet(5)/ trip (l)/-11, -18(1)/+X(1)/ chaotic (2)/ *(2) 61.3 Mosaic Diploid/Polyploid/Aneuploid/Chaotic
* Inconsistent results that were observed during scoring, dip = diploid, tet = tetraploid, trip = triploidy, hex = hexaploidy, oct = octaploidy, enn
= enniaploidy. The - indicates loss of chromosome and + indicates gain of chromosome e.g. +18 is trisomy 18 or -1 is monosomy 1.
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Figure 4.2. Results of three sequential rounds of FISH analysis on a single male 
embryonic nucleus from embryo 13.2.
1st Round 2nd Round 3rd Round
a) Using probes lp, 1 lq and 18cep, b) using probes lhet, 1 lcep and 18q and c) using 
probes for Xcep, Ycep and 18cep. This nucleus displayed a tetraploid chromosome 
complement in all three rounds of FISH. In the 3rd round there are 2 signals for X and 
2 signals for Y.
Figure 4.3. Results of three sequential rounds of FISH analysis on a single female 
embryonic nucleus from embryo 15.4.
Round
8CE
2nd Round 3rd Round
I8C.E
a) Using probes lp, 1 lq and 18cep, b) using probes lhet, 1 lcep and 18q and c) using 
probes for Xcep, Ycep and 18cep. This nucleus displayed monosomy 18 in all three 
rounds and XO in the final round of FISH. Therefore, two events o f chromosome loss 
were reported for this nucleus.
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In Group II 37 post-zygotic errors took place, which gave rise to 14 mosaic aneuploid 
embryos (Table 4.7). Some of those embryos also contained polyploid, chaotic and 
haploid cells.
Embryos 22.2 and 26.1 displayed the most chromosomal events affecting four 
chromosomes, sharing between them four chromosome losses, two chromosome gains 
and two mitotic non-disjunctions as mechanisms leading to aneuploid mosaicism.
Table 4.7. Aneuploidy mosaicism mechanisms for Group II embryo
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CL = chromosome loss, CG = chromosome gain, MND = mitotic non-disjunction
Embryo No. Classification Number of Events Chromosome
13.1 Mosaic 1 CL 18
Diploid/Polyploid/Aneuploid/Chaotic 2 CG 1,11
13.2 Mosaic Diploid/Polyploid/Chaotic 1 CG 
1 MND
11
1
13.3 Mosaic 
Diploid /Polyploid/Chaotic
- -
14.2 Mosaic Diploid/Aneuploid/Polyploid 1 CG 
1 MND
11
X
14.3 Mosaic Diploid/Polyploid/Chaotic - -
15.1 Mosaic Diploid/Polyploid - -
15.2 Mosaic Diploid /Polyploid/Aneuploid 2 CL 11, 18
15.3 Mosaic Diploid /Polyploid/Aneuploid 1 CG 11
15.4 Mosaic Diploid/Aneuploid/Haploid/Chaotic 2 CL 18, X
16.1 Uniformly Normal None -
18.1 Mosaic Diploid/Aneuploid 1 CL 
2 MND
11
X, Y
19.1 Mosaic Diploid/Aneuploid/Polyploid 3 CL 11, 18,X
19.2 Mosaic Diploid/Polyploid/Aneuploid 2 CG 
1 MND
18, X 
Y
22.1 Mosaic Diploid/Aneuploid/Polyploid 1 CL 
1 MND
18
X
22.2 Mosaic Diploid/Aneuploid/Polyploid 1 CL
2 CG
1 MND
18
1,11
X
23.1 Uniformly Normal None -
24.1 Mosaic Diploid/Polyploid - -
25.1 Mosaic Diploid/Polyploid/Aneuploid 1 CL 18
25.2 Mosaic Diploid/Aneuploid/Polyploid 1 CL 
1 MND
18
X
26.1 Mosaic 3 CG 11, X, Y
Diploid/Aneuploid/Chaotic 1 MND 1
26.2 Mosaic 2 CL 11, 18
Diploid/Polyploid/Aneuploid/Chaotic 1 CG X
TOTAL 
21 embryos
15 CL (40.5%) 
13 CG (35.1%) 
9 MND (24.4%)
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Moreover, in Group II there were nine MND events, mostly affecting chromosome X, 
occurring in comparison to two in Group I embryos (Table 4.5). Once again, 
chromosome loss was the predominant mechanism leading to mosaic aneuploidy 
(Table 4.8), but in this group it involved mainly chromosome 18, while an additional 
copy of chromosome 11 was the most frequent gain. FISH artefacts (inconsistent 
results) affected 50/1143 (4.4%) of nuclei.
Table 4.8. Mechanisms of mosaicism by chromosome for Group II embryos
Event
Chromosome
Chromosome Loss Chromosome Gain Mitotic Non- 
Disjunction
1 0 2 2
11 4 6 0
18 9 1 0
X 2 3 5
Y 0 1 2
Total 15 13 9
Of the nuclei showing inconsistent results, 34/76 (45%) were due to failure of 
hybridisation of the sub-telomeric probe for chromosome 18 (18q). The probe for the 
satellite II/III region of chromosome 1, exhibited the highest failure rate of the 
centromeric probes (14.5%) (Table 4.9). The underlying reason for the high rate of 
artefacts for the heterochromatic probe for chromosome 1 can be attributed to the fact 
that it was the only laboratory prepared probe. Group II embryos showed increased 
number of FISH artefacts (67%), termed 4inconsistent results' (highlighted in red 
colour in Tables 4.3 and 4.6), compared to Group I (33%). This finding, however, 
might due to the difference in the number of cells analysed for each group.
Table 4.9. Failure rates for each probe in the embryonic nuclei for both Groups.
Probe IP i iq 18q 1HET 11 CEP 18CEP Total
No. of FISH artefacts 12 6 34 11 7 6 76
Percentages 15.8% 7.9% 45% 14.5% 9% 7.9%
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4.3 Discussion
During this study the levels and mechanisms leading to aneuploid mosaicism in 
human embryos were investigated. This was achieved by developing a triple colour 
FISH protocol carried out in three sequential rounds of hybridisation. The use of two 
probes per autosome and the dual use of a chromosome 18 centromere probe allowed 
the distinction between true single cell anomalies and artefacts, which showed up as 
inconsistent results. This study was able to accurately define the true extent of 
chromosomal mosaicism in human embryos without the use o f statistical aids like 
previous studies have done. Of the 42 day 5 embryos, three only were uniformly 
diploid for the tested chromosomes, a single embryo was the product of a meiotic 
error and the remainder were mosaic. Furthermore, it was found that chromosome loss 
was the main mechanism leading to mosaic embryos.
4.3.1 Preliminary Work Assessment
Early work to develop interphase cytogenetics using FISH was hampered in part by 
the lack of access to a reliable panel of locus-specific DNA probes and as such was 
limited in scope (Griffin et al, 1991; Griffin et al, 1992). Methods of screening DNA 
clones for use as FISH probes can be labour intensive and time-consuming as many 
will be chimaeric (large BAC/YAC clones etc), map to another location (cross- 
hybridize) or produce weak FISH signals and so need to be discarded. The plasmid 
clone for the lhet centromeric probe used in this study was found to be suitable, 
producing discrete, easily scored FISH signals in lymphocyte interphase nuclei. 
Fortunately, the increasing availability of a wide range of commercial probes has 
made the method of producing ‘laboratory prepared’ diagnostic probes largely 
redundant. These commercial probes have revolutionised the use of interphase 
cytogenetics particularly in clinical laboratories where FISH is now used routinely to 
complement standard karyotyping for a wide range of pre- and postnatal applications 
(Blennow et al, 1995; Knight and Flint, 2000; Quilter et al, 2001). In addition the 
introduction of multi-probe cocktails specifically designed for polar bodies and 
blastomere analysis have contributed to the increase in the number of groups carrying 
out PGD and related research. Finally, the introduction and subsequent general 
accessibility to subtelomeric probes for all chromosomes has greatly simplified the
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strategies for FISH protocols. The majority of the probes used in this study were 
commercially available.
Whilst carrying out FISH in order to analyse chromosome constitutions several 
difficulties emerge such as scoring errors, cross-hybridisation, background 
fluorescence as well as low quality fluorescent signals (Griffin et al, 1994). Therefore, 
during this study several FISH protocols were carried out using different probe 
combinations and changing the stringency conditions (salt and formamide 
concentration, temperature and pH), on control male blood lymphocytes. The most 
efficient protocol was found to be a sequential FISH protocol involving chromosomes 
1, 11, 18, X and Y. It has been postulated from Bielanska et al (2002b) that similar 
rates of mosaic imbalances can be detected from different probe combinations either 
for three or five chromosomes. The first three chromosomes were examined in both 
the first two rounds, using probes for different loci for each chromosome. Similar 
double loci analysis for just one chromosome was concluded as a preferable method 
of avoiding false monosomies whilst carrying out PGD for aneuploidy (Magli et al, 
2001). Furthermore, the use of two differentially labelled probes to detect a single 
chromosome increased the accuracy of detection, by reducing scoring errors and 
confirming that the mosaicism observed in previous preimplantation diagnosis cycles 
is not a FISH artefact owing to hybridisation failure or overlapping signals, even when 
just one cell differs and no cell resulting from a reciprocal non-disjunction event is 
found (Conn et al, 1999). This study was able to detect any failure of hybridisation or 
FISH artefacts since the three major chromosomes studied (1, 11 and 18) were 
analysed in two sequential rounds using differentially labelled probes at different loci. 
Where differences occurred they were defined as “inconsistent results”. These 
inconsistent results have not been included in the interpretation of the results. Other 
studies have compared levels of aneuploidy present in embryos and only if that 
proportion was higher than the value obtained from the control lymphocytes, its 
presence was considered true (Ruangvutilert et al, 2000b). However, in this study 
such comparison was not needed and the genuine level of aneuploidy and mosaicism 
could be detected due to the safety net provided by the two probes per chromosome 
analysis.
229
Chapter 4 -  Detailed FISH analysis o f  day 5 human embryos reveals the mechanisms
leading to mosaic aneuploidy
As a three sequential round of FISH protocol was used in this study it was possible to 
assess the efficiency of each FISH experiment in each round. A control slide from 
male blood lymphocytes was used that was FISHed at the same time as the embryos 
and scored. 200 interphase nuclei were scored for all probes in all the rounds. This 
step enabled observation of whether the FISH technique worked efficiently without 
the presence of cross-hybridisation and background fluorescence and assessed the 
efficiency of a third-round of hybridisation. All three rounds showed high efficiencies 
when the same slide was FISHed sequentially (Table 4.2). However, the efficiency of 
the 3rd hybridisation decreased by 9% (to 88%) in comparison with the 1st round of 
FISH. This seems to be due to the decrease in the quality of the nuclei DNA and has 
been confirmed by other studies (Ruangvutilert et al, 2000a). Also, the image quality 
of the nuclei and fluorescent signals decreased in intensity during sequential 
hybridisations. Hence, during the denaturation step the slides were incubated in a 
75°C waterbath containing 70% formamide solution instead of incubation on a hot 
plate in an oven. This step showed an increase the intensity of the signals and nuclei 
quality (data not shown).
4.3.2 Distinction between Artefacts and True Results
The use of two probes per autosome allowed this study to detect an error rate of 5% 
per nucleus and to exclude those artefacts from the analysed results. For both Groups 
a true chromosomal error in a total of 76 nuclei would have been missed if only one 
probe per chromosome had been used. Therefore, by adopting our chosen strategy we 
were able to detect the true levels of mosaicism for the three autosomes studied. The 
probe that showed the highest rate of failure of hybridisation on embryonic material 
was the sub-telomere probe for chromosome 18 (Table 4.9). Sub-telomeric probes 
generally have a lower hybridisation efficiency than probes that detect repeat 
sequences, but in this case the situation was possibly exacerbated because the probe 
was used in the second treatment round. However, in the lymphocyte control nuclei, 
the probes for chromosome 1, both for the sub-telomeric (used in the first round) and 
heterochromatic regions, showed the highest failure rates.
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Many of the aneuploidies detected in our study were of a single chromosome and 
confined to a single cell. Other studies would have dismissed these aneuploidies as 
FISH artefacts due to their lack of probe backup. Low level aneuploidy is rarely 
considered to be a mosaicism phenomenon and it is usually classed as normal (Group 
I embryos in Table 1.2 from Munne and Weier, 1996). Bielanska and co-workers 
(2002a) postulated that minor aneuploid cell lines indicated that the aneuploid cells 
did not persist from early cleavage, but were formed at, or shortly before, blastulation, 
and suggest that most cleavage stage embryos with a high degree of mosaic 
aneuploidy do not complete preimplantation development. It is clear from CGH data 
on full analysis of individual blastomeres that single cell anomalies affecting one 
chromosome are a common feature at cleavage stages (Voullaire et al, 2000; Wells 
and Delhanty 2000). In these two small series, nine of the 24 embryos frilly analysed 
showed such single cell anomalies. Furthermore, unlike that which has been observed 
in diploid-tetraploid mouse aggregation chimeras (James and West, 1994), recent 
studies of human blastocysts did not show evidence of preferential allocation of 
aneuploid cells into the trophectoderm lineage (Evsikov and Verlinsky, 1998; Magli 
et al, 2000)
4.3.3 Group I Embryos
The embryos that were left to grow in the basic media showed a decreased rate of 
growth. From the 21 embryos spread, the mean number of blastomeres present was 
20, which was low considering that normal developing day 5 embryos should have 
more than 30-40 cells on day 5 of development. Hence, all embryos, apart from two, 
from Group I were considered arrested (less than 30 cells). The fact that almost all 
embryos were arrested in this group was due to the media they were grown in. Group 
I embryos were left into the medium which contains lactate and pyruvate which are 
considered to be adverse for healthy embryonic development after genome activation 
(Gardner and Sutherland, 1996; section 1.1.3).
The FISH results showed a high prevalence of mosaicism in this group of embryos 
(95%, 20/21 embryos). Veiga et al (1999) observed a lower rate of mosaicism 
(62.5%) in arrested embryos however, most mosaic embryos included a chaotic 
complement. The prevalent type of mosaicism was diploid/aneuploid mosaics (76%)
231
Chapter 4 -  Detailed FISH analysis o f  day 5 human embryos reveals the mechanisms
leading to mosaic aneuploidy
and the predominant mechanism that lead to mosaicism was chromosome loss (50%) 
which is in contrast with other studies (Munne, 2002) that showed that mitotic non­
disjunction was the most common type of mosaicism. This is due to the fact that most 
studies rely on one probe per chromosome in order to analyse the highest number of 
chromosomes simultaneously, thus sacrificing the reliability of their results. 
Monosomies, when carrying out FISH using one probe per chromosome, are 
considered false based on the fact that it was failure of hybridisation or a FISH 
artefact (if they are found at low percentages). However, this diminishes the ability to 
determine the true values from the false ones. This study was able to confirm whether 
a monosomy was false or true and classified as an inconsistent result or as true 
monosomy respectively.
Some mosaic embryos containing aneuploid cell lines arose due to chromosome loss 
and gain such as embryo 5.4, which had a cell monosomic for chromosome 1 and a 
cell trisomic for chromosome 18 (Table 4.4). Therefore, two separate mechanisms 
lead to the occurrence of such mosaic embryos. Diploid/aneuploid mosaic embryos 
resulting from mitotic non-disjunction were only found in two embryos “4.1” and 
“ 12.1” for chromosomes 18 and X respectively (Table 4.4). In mosaic 
diploid/aneuploid embryos arising from MND, there was a reciprocal loss and gain of 
the same chromosome in different embryonic nuclei. Three embryos (14%) were 
classified as diploid/aneuploid/chaotic (8.1, 12.2 and 17.1). There was no apparent 
mechanism that can identify the reason of the chaotic lines. Although, in these 
embryos there was a high percentage of diploid nuclei (67-89%), the remaining cells 
were either aneuploid or chaotic. Veiga et al (1999) described an increased rate of 
chaotic complement of 37.5% in arrested embryos in comparison to the 0% observed 
in blastocysts. This can be partly explained by the ability of chaotic complements in 
embryos to block further development. Sandalinas and co-workers (2001) found that 
some chaotic mosaic embryos developed further but never more than 50 cells and 
were considered to be developmentally compromised. Moreover, it has been 
suggested that there is a strong developmental block at compaction of chromosomally 
abnormal embryos compared to normal embryos (difference was statistically 
significant) (Sandalinas et al, 2001).
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4.3.4 Group II Embryos
None of Group II embryos were considered arrested since they contained more than 
thirty cells per embryo at the time of spreading. 90% (19/21) of the blastocysts 
analysed were mosaic and only 2 embryos were uniformly diploid for the 
chromosomes tested (Table 3.7). Studies where blastocysts were karyotyped also 
found increased levels of mosaicism (Clouston et al, 1997, 2002). Veiga et al (1999) 
also found 7/8 (87.5%) blastocysts analysed to be mosaic and Ruangvutilert et al 
(2000a) reported similar figures of mosaicism to this study in blastocysts (89.5%). 
Evsikov and Verlinsky (1998) also found high levels of mosaicism whilst performing 
FISH on blastocysts (86%), although they did not distinguish between normal and 
diploid mosaics. Ten out of 21 embryos (47%) were diploid/aneuploid mosaics 
(including haploid or polyploidy cell lines). Embryo “14.2” was a 
diploid/aneuploid/polyploid mosaic embryo, which was generated due to three 
different mechanisms, chromosome loss for chromosomes 1 and 18, chromosome 
gain for chromosome 11 and mitotic non-disjunction for chromosome X (Table 4.5).
Group II embryos showed a larger variety of cell lines within each embryo compared 
to Group I, which might have been attributed to the increased number of cells 
analysed (1123 over 401 cells in Group I) or the marked presence of polyploidy cell 
lines. 80% of the embryos analysed contained relatively high levels of tetraploidy 
ranging from 2-22%. This has been also been reported by Verlinsky and Evsikov 
(1998), Veiga et al (1999) and Ruangvutilert et al (2000a). Ruangvutilert et al 
(2000a) suggested that mosaic embryos with a tetraploid cell line might have more 
viability that those with other non-diploid cell lines. The increased number of cells 
present in Group II embryos was expected since embryos in this group were 
transferred to blastocyst medium. The blastocyst medium contains the required 
nutrients that an embryo needs after day 3 of development i.e. glucose.
Compared to studies carried out thus far, a relatively high percentage of triploid cells 
have been found during this study. For 4% (19/458) of the cells scored were found to
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be triploid for the five chromosomes tested. Ruangvutilert et al (2000a) found only
0.3% (4/1272) of triploid cells present in the blastocyst group. However, similar 
findings of haploid cells were observed between this study and other studies of human 
blastocysts, since only 0.2% (1/458) of the cells were haploid. Triploid and haploid 
nuclei have been found more frequently in cleavage stage embryos.
4.3.5 Types of Mosaicism
Aneuploid mosaics arise from post-zygotic mitotic errors. In Group I almost all 
mosaic embryos were diploid/aneuploid mosaics. These embryos arose mostly due to 
post-zygotic chromosome loss, followed by chromosome gain, with only a few 
examples of mitotic non-disjunction. Other studies that found aneuploid mosaic 
embryos suggested that the main mechanism leading to mosaicism was mitotic non­
disjunction (Munne et al, 1998c; 2003a). The basis of this observation lies in the fact 
that those studies did not include two probes (at a different locus) for each 
chromosome, thus accounting monosomy findings as failure of hybridisation or 
signals overlapping, hence, reducing the incidence of aneuploid mosaics due to 
chromosome loss. Although most studies are able to test a higher number of 
chromosomes, they are not able to be positive whether their findings are 100% 
accurate. By using two probes per chromosome at different loci in different rounds of 
FISH can accurately determine the chromosome abnormalities present and suggest a 
mechanism. Magli et al (2001) also came to a similar conclusion, when two probes 
were applied for chromosome 21 on a PGS case so that the misdiagnosis of normal 
embryos as monosomies were reduced. It has been hypothesised that the transition 
from the morula to the blastocyst stage is critical in terms of starting a negative 
selection against aneuploid cells (Evsikov and Verlinsky, 1998), since a high degree 
of mosaicism was observed up until the morula stage in comparison to that of 
blastocysts. However, this hypothesis was not shared with Sandalinas et al (2001), 
which showed that extended culture to blastocyst stage is not a reliable selection tool 
to screen against those chromosomally abnormal embryos that may survive after 
implantation. Monosomies were observed for both groups for all the chromosomes 
tested. Although studies by Sandalinas et al (2001) and Clouston et al (2002) 
retrieved low numbers or were unable to find monosomies respectively, in this study 
monosomies were present, especially in embryos grown in the basic medium. 15%
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(29/188) of the cells scored in Group I were monosomic for all chromosomes tested 
(1, 11, 18 and X), hence, the increased incidence of chromosome loss was a 
mechanism for the aneuploid mosaics. But, in the blastocyst medium group only 3% 
(14/458) of the cells scored included monosomies.
The embryos grown in the blastocyst medium (Group II) showed an increased rate of 
tetraploid cells. It has been suggested that tetraploidy is a normal feature of the 
trophectoderm (Angell et al, 1987) and may be associated with invasion of the 
maternal deciduas (Drury et al, 1998). The significant increase of polyploidy cells, 
and especially tetraploidy, from day 4 to day 6 of development has been suggested to 
be, in human embryos as in other mammalian species, a hallmark of trophoblast 
differentiation (Bielanska et al, 2002a). Harper et al (1995) suggested that the 
underlying mechanism leading to tetraploid cells might be failure of cytokinesis after 
the chromosomes divide. Furthermore, endoreduplication might cause cells to become 
tetraploid by doubling of the chromosomes and failure to divide. Also, tetraploid cells 
might originate from cell fusion (Benkhalifa et al, 1993). Fusion of cells of different 
ploidies, such as 2N plus 4N and 4N plus 4N, may also explain the origins of 6N and 
8N complements found in both Group I and II embryos. Similar findings of 
mixoploidy have been identified in 109 blastocysts analysed with FISH by Bielanska 
et al (2002c). It has been postulated that not all types of mosaicism and the proportion 
of abnormal cells have the same impact on embryo development (Sandalinas et al, 
2001), and a high proportion of tetraploid cells may be detrimental in embryo 
development. In the study by Sandalinas et al (2001) 2n/4n mosaics with <38% 
abnormal cells developed 78% of the time to blastocyst stage compared with only 
33% of those with >38% abnormal cells (the difference was shown to be statistically 
significant).
Slightly higher levels of triploid cells (in comparison to similar studies carried out so 
far) were interestingly observed in the Group II embryos. Seven out of the twenty one 
embryos analysed contained at least one triploid cell line. The origin of 
diploid/triploid cells is not clear, however the presence o f an extra haploid set might 
be derived from an extra gamete, such as a second sperm (in a dispermy event where 
the second sperm remains unincorporated into the formation of the zygote) or a polar 
body (Mueller et al, 1993). Triploid cells were more often seen in cleavage-stage
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embryos (Delhanty et al, 1997), nevertheless, in some instances triploid cells may 
persist until later in development as in cases of mosaic diploid/triploid have been 
reported postnatally (Edwards et al, 1994). Haploid cells were rarely found and it 
seems that they are less viable or less actively dividing in comparison to tetraploid 
cells. Delhanty et al (1997) suggested that they maybe associated with binucleate cell 
production with a meiotic type of segregation. Staessen and co-workers (1999) 
hypothesised that haploid cells might be due to incorporation of a polar body into the 
embryo. In this study only one embryo from each Group revealed a haploid cell line 
displaying an incidence of 0.1%. It has been suggested that IN cells have a 
proliferative disadvantage among 2N cells (Harper et al, 1995; Bahce et al, 1999; 
Bielanska et al, 2002a). In contrast to diploid/triploid mosaics, diploid/haploid 
mosaicism has not been documented in fetal tissues, hence such embryos must 
become eliminated at, or shortly after, implantation.
Chaotic embryos were first described in cleavage-stage embryos (Harper et al, 1995; 
Delhanty et al, 1997). Three embryos were chaotic in Group I and eight in Group II; 
however, all 11/42 embryos included diploid cells as the major cell line. Evsikov and 
Verlinsky (1998) found three chaotic embryos out of 91 in their series, Ruangvutilert 
et al (2000a) observed five chaotic embryos out 40 after FISH analysis whereas Baart 
et al (2004), found only one chaotic embryo out of 22 analysed. Delhanty and 
Handyside (1995) proposed that the absence of cell cycle checkpoints might cause 
such chaotic chromosome constitutions. Cell cycle checkpoints were first identified in 
yeast and would normally protect cells from genetic damage by ensuring that each 
cycle phase is completed before the initiation of the next (Hartwell and Weinert,
1989). In mammalian embryos the absence of cell cycle checkpoints may relate more 
generally to the absence of embryonic gene transcription and dependence on maternal 
products inherited in the oocyte (Delhanty and Handyside, 1995). Hardy et al (1993) 
suggested that the presence of cells with nuclear abnormalities or highly abnormal 
chromosome complements may reflect both lack of co-ordination of the different 
processes o f the cell cycle. Other studies have proposed that chaotic cell lines arise 
from a group of events such as a chromosome misalignment on a disorganised spindle 
in combination with a non-functional metaphase/anaphase checkpoint control 
(LeMarie-Adkins et al, 1997; Harrison et al, 2000). The abnormalities of the mitotic
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spindle could be related to suboptimal in vitro culture environment (Pickering et al,
1990). Munne et al (2004) has suggested that chaotic mosaicism might occur due to 
differences in hormonal stimulation as well as imperfect culture conditions.
4.3.6 Mechanisms of Aneuploidy Mosaicism
Compared to other species, humans display a low fecundity. Of all human 
conceptions, only -30%  progress successfully to delivery (Hassold et al, 1986). To a 
large extent, embryonic death is caused by chromosomal abnormalities that are 
primarily the result of chromosomal errors during female gamete formation. Some 
errors will arise at the time of fertilisation but most are the recently discovered mitotic 
errors which take place during early cleavage division. These errors in cell divisions, 
namely non-disjunction and anaphase lagging lead to mosaicism and chaotic 
imbalances. Kalousek (2000) highlighted the significance of the chromosome 
centromere in the process of cell division. It was suggested that the centromere is 
involved in: i) sister chromatid pairing, ii) mitotic and meiotic spindle attachment, iii) 
chromosome movement, iv) cell cycle control i.e. cell cycle checkpoint control and v) 
marshalling of passenger proteins. This was taken into account in our study and five 
out of the nine probes used were centromeric probes.
In the current study chromosome loss was the predominant mechanism leading to 
mosaicism in both groups of embryos, being responsible for 50% of aneuploid cells in 
Group I and 40.5% in Group II. Chromosome gain followed with 44%, in Group I and 
35.1% in Group II. However only 6% of aneuploid cells occurred due to mitotic non­
disjunction in Group I, while four times this percentage arose by this mechanism in 
Group II. The differential involvement of chromosomes in MND (predominantly 
chromosome X in Group II which was not involved at all in Group I) is interesting but 
may well be due to chance.
Similarly, it is of interest that in Group I embryos, in which growth had slowed or 
arrested, chromosome 1 showed a high incidence of loss but in Group II embryos, 
which had continued dividing, chromosome 1 was not affected by loss at all. This 
might possibly be due to the fact that the presence of cells with monosomies of such a 
large chromosome would have a detrimental effect on development and had been 
selected against in the more rapidly dividing Group II embryos. Trisomy 18 caused by
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chromosome gain was seldom found in either Group, which is a similar finding to that 
reported recently by Coonen et al (2004). The occurrence of monosomy 18 was 
shown to be high (especially in Group II embryos), indicating that chromosome 18 
might be more prone to chromosome loss compared to the other autosomes and 
gonosomes tested.
The current study shows that chromosome loss is the most common mechanism that 
leads to mosaicism detected in human day 5 embryos. This reinforces data on day 3 
embryos obtained earlier by our group using dual locus specific YAC and plasmid 
probe combinations for various autosomes (C. Conn & JDA Delhanty, unpublished 
observations). Chromosome loss is presumed to occur via anaphase lag, in this case 
during mitosis. Coonen et al (2004) concluded in their study on a much larger number 
of blastocysts that anaphase lagging is the major cause of chromosomal mosaicism. 
However, since they were using a single probe for each chromosome they were only 
able to count as valid abnormalities affecting at least two cells. In relation to the 
findings in these two studies, it is of considerable interest that aneuploidy screening of 
cleavage stage embryos has shown that chromosome loss is more common than 
chromosome gain as a cause of constitutional aneuploidy arising during meiosis 
(Munne et al, 2004). This is in contrast with all previous findings from the same 
group which supported that mitotic non-disjunction was the most common type of 
mosaicism mechanism (Munne et al, 1994; 1995a; 1998c; Munne and Cohen 1998, 
Munne, 2002). However, all the studies above were limited to one probe per 
chromosome and were attributing abnormalities confined to low number of cells as 
signal overlap, probe failures, whereas in the recent study by Munne et al (2004) all 
samples were re-analysed with probes binding to a different locus.
In contrast to the chromosomal abnormalities seen in cleavage stage embryos, mosaic 
chromosome patterns observed in blastocysts are derived from mitotic division errors. 
A meiotic division error would render all embryonic cells chromosomally aneuploid. 
In this study only one embryo (from Group I) out of 42 rose due to a meiotic error. 
Embryo 4.1 was aneuploid mosaic and must have originated due to a non-disjunction 
event during meiosis. Coonen and co-workers (2004) also reported only one out of 
299 blastocysts analysed by FISH had occurred from meiotic division errors. Other
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studies have shown no or only a few blastocysts presenting with aneuploid cells only 
(Magli et al, 2000b; Ruangvutilert et al, 2000a; Bielanska et al, 2002a; Baart et al, 
2004)
No difference in embryonic sex ratio between Group I and Group II was observed in 
this series. In Group I there were 12 female and 9 male embryos whereas in Group II 
there were 11 female and 10 male embryos (Tables 4.3 and 4.6). It has been shown in 
a recent study that more male than female babies have been bom after blastocyst 
transfer (Menezzo et al, 1999), which might reflect a greater viability of male 
embryos after implantation. However, no other study has confirmed these results.
During this study the average maternal age was 34 years but still there was a high 
prevalence of mosaicism. The three embryos that were uniformly diploid for the 
tested chromosomes were donated from three women less than 30 years of age. 
Whereas six women whose age was above 38 donated nine embryos, which were 
either diploid/aneuploid mosaic or diploid/aneuploid/chaotic mosaic. While these 
observations may indicate a trend, clearly the numbers in our study are too small to 
enable analysis of a maternal age effect. However, a report of a study of large number 
of cleavage stage embryos from women in an older age group showed a significant 
association of mitotic aneuploidy with advanced maternal age (Munne et al, 2002). 
The association was particularly marked for the MND category. In that study 
chromosome loss was only a third as frequent as MND and consequently mitotic 
anaphase lag failed to show a significant increase with maternal age. The increased 
frequency of MND may be due to the age of the group studied but since only a single 
probe per chromosome was used a cut off point of 10% was used to avoid ‘FISH 
error’. That is, embryos with fewer than 10% abnormal cells were considered 
‘normal’, almost certainly leading to an underestimate of anomalies affecting a single 
cell. Possibly a study of a large number of embryos using two probes per chromosome 
might show a significant association of mitotic anaphase lag with increasing maternal 
age.
4.3.7 Conclusions and Future Work
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In conclusion, during this project it was revealed that three rounds of sequential FISH 
can provide efficient results in human preimplantation embryos in order to study the 
effect of chromosomal mosaicism. High proportion of mosaicism was found during 
this study in both groups of embryos which were mostly affected by aneuploidy. The 
double-loci analysis of each chromosome in different rounds of FISH enabled the 
determination of true level of mosaicism in day 5 human embryos, by detecting the 
FISH artefacts. The major mechanism behind aneuploidy mosaicism for both groups 
of embryos was found to be chromosome loss, which was postulated to be due to 
anaphase lagging. These findings were found to be in agreement with similar studies 
which used different protocols (Coonen et al, 2004; Baart et al, 2004; Munner et al, 
2004). Furthermore, the effects of the two different media used were observed and it 
was found that the nutrients in IVF media are very important to the development of 
human blastocysts.
Examination of a larger cohort of embryos would enable extensive information of the 
chromosomal mosaicism and would further allow statistical analysis to be performed 
in order to find statistical significance, if any, between the mechanisms of mosaicism
i.e. chromosome loss or gain or mitotic non-disjunction. Analysis of all the 
chromosomes o f all the blastomeres would reveal the true extent of mosaicism in day 
5 human embryos. Such task could be carried out using CGH (Wells et al, 1999; 
Voullaire et al, 1999) or using micro-arrays (Schaeffer et al, 2004; Shaffer et al, 
2004). CGH analysis of all the blastomeres on normally developing day 5 embryos or 
blastocysts has not been carried out and might demonstrate results that might explain 
whether mosaicism affects blastocysts more than day 3 embryos. Micro-arrays can 
provide comprehensive (genome-wide), high resolution, amenable to automation, 
rapid and sensitive detection. Moreover, molecular analysis of genes responsible for 
embryo genome activation could be performed on embryos in order to observe the 
effect of IVF media in the development of the embryos.
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Chapter 5 -  Analysis o f  the development o f  chromosome abnormalities in human
embryos from day 3 to day 5 using CGH and FISH
5.1 Aims of the Study
The aim of this study was to assess the level of chromosomal abnormalities in human 
embryos at different times of development. A novel protocol was devised were the 
chromosomal status of the embryos was investigated at the cleavage stage and 
furthermore at the blastocyst stage. Frozen-thawed embryos were biopsied on day 3 
and 1 or 2 cells were extracted for CGH analysis in order to examine the full 
chromosomal status of those blastomeres. The rest of the embryo was left to grow 
until the blastocyst stage (day 5) were it was spread on the whole to carry out 
sequential FISH analysis. The first combination of probes included the X/Y/18 which 
would allow confirmation of the sex when compared to the CGH results from the 
biopsies blastomeres as well as any abnormalities for the corresponding 
chromosomes. However, the second round involved probe combinations according to 
the CGH results i.e. any abnormalities seen in the CGH results would be tested on the 
spread blastomeres using FISH. This would allow the monitoring of abnormalities 
during the different stages of development.
5.2 Results
5.2.1 WGA Optimisation
The efficiency of the tubing technique was found to be 97% (section 2.2.2.2.3). 
Efficient tubing was confirmed by successful amplification, which in turn was 
revealed by a smear on the gel. Bands indicating amplification were observed 
corresponding to a range of fragment sizes of DNA of approximately 1550, 1200, 600 
and 450 bp in length, while the average fragment size was approximately 600 bp in 
length (Figure 5.1). Positive and negative controls were always included in the tubing 
process, to ensure reliability of results. The frequency of amplification in negative 
controls was <5%, while amplification in positive controls was successful with a 
frequency of 98%. During optimisation of the WGA protocol two thermal cyclers 
were tested and the results were run on a 2% agarose gel (Figure 5.2). As shown in 
Figure 5.2B the Omnigene Thermal cycler proved to be superior compared to the 
Eppendorf since the smears from the samples were more intense and more similar to 
the genomic DNA samples revealing a better coverage of the genome. Furthermore,
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the size of the smears was definitely improved when using the Omnigene, since the 
smears were expanded over the 1 Kb Ladder.
Figure 5.1. DOP-PCR amplification results from single cells, clumps of 3-4 buccal 
cells and genomic DNA on an agarose gel.
L I  2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
In lane L the lkb Ladder can be seen. Lanes 1-10 were amplified products from single 
buccal cells. Lanes 11-15 a clump of 3-4 buccal cells were run and in lanes 16-23 
single blastomeres were amplified and analysed. Finally, in lanes 24, 25, 26, 27 and 
28 DNA from frozen fibroblasts of known abnormality (trisomy 13, 18, 21 and 22 and 
triploidy XXX respectively) was run. Lanes 29 and 30 represent amplification results 
from normal genomic DNA.
Figure 5.2. Agarose gel results from (A) Eppendorf and (B) Omnigene thermal cyclers
A. In lanes 2-5 and 7 the amplified products from single buccal cells were run. In 
Lane 6 the amplified product from genomic DNA was analysed and in lane 1 the 
negative control can be viewed. B. Lanes 1, 2, 3 and 5 show the final amplified 
product from single buccal cells. In lanes 4 and 6 the negative control and genomic 
DNA was run. In both Figures, A and B, the lane L represents the lkb ladder.
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5.2.2 CGH Optimisation
CGH analysis o f both control lymphocytes and trisomic cells was carried out to 
optimise the protocol. All control and embryo CGH experiments were carried out on 
control male lymphocyte slides. Figure 5.3 shows an initial CGH experiment carried 
out on DOP-PCR amplified genomic DNA (section 2.2.2.1) between a normal male 
and female individual. The interpretation of 8-12 metaphases was performed for each 
sample. In Figure 4.3 the CGH software was able to distinguish between the male and 
female status of the control (red) and test (green) samples. Five different 
chromosomally abnormal fibroblast cell cultures (trisomy 13, 18, 21, and 22 and 
triploidy XXX) were made available for this study acting as positive controls in the 
identification of aneuploidy in single cells. Figure 5.1 illustrates the DOP-PCR results 
from the amplification of the trisomic and triploidy samples. Aneuploidy was 
correctly identified in single cells with a success rate of 96%, while no false positives 
were recorded. Figures 5.4, 5.5, 5.6, 5.7 and 5.8 show the CGH results which acted as 
positive controls for trisomy 13, 18, 21, 22 and triploidy XXX respectively once the 
CGH protocol was optimised. In all positive control experiments, the CGH 
interpretation was able to distinguish the type of abnormality as well as the sex of 
each trisomic line. However, when the triploid cell line was tested against a single 
male buccal cell, the CGH was not able to distinguish the ploidy status (Figure 5.8). 
This result was expected, since it is known that the CGH technique is not able to 
detect differences in the ploidy status of a tissue (Kallioniemi et al, 1994).
Thirty single cells (including buccal cells and blastomeres) were analysed by CGH 
once the protocol was optimised. 93.3% (28/30) gave analysable results after CGH 
and in 83.3% (25/30) the difference in the sex chromosomes was distinguished. In 
10% (2/30) the fluorescence was of low intensity and with excess of background 
fluorescence indicating that the single cell was either anucleate or degenerating during 
isolation.
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Figure 5.3. Illustration of a control CGH experiment between male genomic DNA 
(red) acting as control against female genomic DNA (green) acting as test
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For each CGH experiment 8-12 metaphases were captured, karyotyped, analysed 
individually and then interpreted cumulatively. A. Capturing of metaphase spread. B. 
In the karyotype of the captured metaphase the X chromosome has a distinct green 
fluorescence indicating excess in the test sample and the Y chromosome shows red 
fluorescence indicating deficiency in the test sample. C. This shows the cumulative 
analysis of ten metaphases, which was the basis of the interpretation. There was a 
shift in fluorescence only towards the green (excess) in chromosome X and towards 
the red (deficiency) in chromosome Y showing that the test sample was a normal 
female
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Figure 5.4. Illustration of a positive control CGH experiment between male single cell 
(red) acting as control against DNA trisomic for 13 (green) acting as test
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For this CGH experiment 9 metaphases were captured, karyotyped, analysed 
individually and then interpreted cumulatively. A. Capturing of a metaphase spread. 
B. In the karyotype of the captured metaphase chromosome 13 has a distinct green 
fluorescence indicating excess in the test sample. C. This shows the cumulative 
analysis of the nine metaphases, which was the basis of the interpretation. There was a 
shift in fluorescence only towards the green in chromosome 13 showing that the test 
sample was male, trisomic for chromosome 13.
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Figure 5.5. Illustration of a positive control CGH experiment between male single 
cell (red) acting as control against DNA trisomic for 18 (green) acting as test
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For this CGH experiment 11 metaphases were captured, karyotyped, analysed 
individually and then interpreted cumulatively. A. Capturing of a metaphase spread. 
B. In the karyotype of the captured metaphase chromosomes 18 and X have a distinct 
green fluorescence indicating excess and red fluorescence in the Y chromosome 
indicating deficiency in the test sample. C. The CGH interpretation successfully 
detected that the test sample was female, trisomic for chromosome 18.
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Figure 5.6. Illustration of a positive control CGH experiment between female single 
cell (red) acting as control against DNA trisomic for 21 (green) acting as test
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For this CGH experiment 11 metaphases were captured, karyotyped, analysed 
individually and then interpreted cumulatively. A. Capturing of a metaphase spread. 
B. In the karyotype of the captured metaphase chromosomes 21 and Y have a distinct 
green fluorescence indicating excess and red fluorescence in the X chromosome 
indicating deficiency in the test sample. C. The CGH interpretation successfully 
detected that the test sample was male, trisomic for chromosome 21.
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Figure 5.7. Illustration of a positive control CGH experiment between male single cell 
(red) acting as control against DNA trisomic for 22 (green) acting as test
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For this CGH experiment 10 metaphases were captured, karyotyped, analysed 
individually and then interpreted cumulatively. A. Capturing of a metaphase spread. 
B. In the karyotype of the captured metaphase chromosomes 22 has a distinct green 
fluorescence indicating excess. C. The CGH interpretation successfully detected that 
the test sample was male, trisomic for chromosome 22.
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Figure 5.8. Illustration of a positive control CGH experiment between male single cell 
DNA (red) acting as control against triploid DNA (green) acting as test
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For this CGH experiment 12 metaphases were captured, karyotyped, analysed 
individually and then interpreted cumulatively. A. Capturing of a metaphase spread.
B. In the karyotype of the captured metaphase chromosome X has a distinct green 
fluorescence indicating excess and red fluorescence on chromosome Y indicating 
deficiency. C. The CGH interpretation successfully detected that the test sample is 
male, however, was unable to detect the triploidy status.
5.2.3 FISH Optimisation
Each FISH experiment included a control male lymphocyte slide with mapped nuclei 
in order to assess efficiency of probe hybridisation in the sequential rounds. Overall,
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90% (range 87-97) of the control nuclei showed normal signals for all 14 probes used 
(Table 5.1). Sub-telomeric probes for chromosomes lp and 16q showed the lowest 
hybridisation efficiencies of 89% and 88% respectively; whilst the a-satellite probes 
for chromosomes 16cep and Ycep demonstrated the highest hybridisation efficiencies 
of 94% and 93% respectively. The difference in the efficiency of the Xcep and Ycep 
probe (used in the 1st and 2nd round of FISH) was not statistically significant (p<0.05) 
and can be attributed to the fact that FISH efficiency decreases with sequential rounds 
of hybridisation due to the degeneration of the DNA. Furthermore, the >5% difference 
between the first round overall efficiency (95%) and the various second round 
efficiencies has been well documented (Conn et al, 1998; Munne et al, 1998; 
Ruanvutilert et al, 2000a and b).
Table 5.1. Probe efficiencies scored in 200 interphase nuclei of each control slide 
whilst carrying 2-round FISH
Probe Combinations Efficiency per probe (%) Overall Efficiency (%)
Xcep/Y cep/18cep 97% / 96% / 97% 95%
9cep/16cep/22 LSI* 92% /94% /91% 90%
10cep/14q* 90% / 90% 88%
3cep/l 1 cep/13LSI 92% / 92% / 89% 90%
lp/lq/16cep* 89% / 90% / 93% 87%
3cep/6cep/18q* 95% /91% /90% 90%
Ycep/4cep* 94% / 92% 90%
Xcep/Ycep/16q* 92% / 93% / 88% 87%
* Carried out in the second round
5.2.4 CGH Analysis of Embryos
Thirteen couples donated a total of 37 embryos for this research project (Appendix 
Table 8.1). The overall mean maternal age was 33.1 (range 28-39) years.
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Graph 5.1. Cumulative results from the 37 embryos that were donated for research
30 embryos
1 embryo
embryos
□  Embryo that failed to 
give any CGH and FISH 
result
■  Embryos that failed to 
give any FISH result
□  Embryos that showed 
results from both CGH 
and FISH
One embryo was not included since it failed to provide any results during either CGH 
or FISH, which was not unexpected due to its low morphology grade (Graph 5.1). A 
total of fifty four blastomeres were biopsied on day 3 for CGH analysis and forty- 
eight (88.9%) provided an interpretable result. There are a variety of factors which 
may account for failure to provide a result. Blastomere 3.1b failed to give 
hybridisation from the test DNA, while the control DNA hybridised successfully. This 
could indicate either an anucleate blastomere (as visibility of the nucleus was not 
possible for all the blastomeres biopsied), or that the cell was mistaken for an anuclear 
fragment. Moreover, a poor slide preparation or premature lysis of the blastomere can 
be responsible. Apart from the non-specific fluorescence and the granular 
hybridisation effect (meaning that although hybridisation was successful it presents 
with a granular effect due to poor chromosome quality, failing to provide analysable 
fluorescence), the strength of the counterstain banding, essential for the identification 
of chromosomes, would also be negatively affected by this factor. These problems 
accounted for lack of analysable results for blastomeres 1.1a, 1.2b, 2.1b, 2.2b and 
7.2b (as well as 3.1b mentioned above).
A total of 48 blastomeres obtained for this study provided good analysable results. 
All embryos were labelled in green and the control male DNA was labelled in red. 
Hybridisation that presented with no granulation, dynamic fluorescence (strength and 
consistency of fluorescent signals) was considered to be of high-quality and good 
chromosome morphology allowed strong counterstain banding essential for the 
analysis. If the sex chromosomes could be determined confidently this provided an
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internal positive control regarding the efficiency and reliability of the CGH technique. 
All biopsied cells from each embryo were consistent with regard to the sex 
chromosome pattern as confirmed by FISH analysis. With regard to the autosomes, 
the literature suggests the exclusion for an analysis of certain regions of the karyotype 
as they have been proven to show variation in the profile, (Kallioniemi et al, 1994) 
and this was also taken into consideration during this study. Moreover, deletions or 
amplifications concerning small subtelomeric regions were found extremely difficult 
to detect and interpret, as reported by other groups (Kallionemi et al, 1994). 
Consequently abnormalities involving distal breakpoints could not be confidently 
detected.
Six out of 36 embryos failed to grow further to day 5 and degenerated, thus no cells 
were available for spreading (4.1, 4.3, 4.4, 13.1, 14.1, 14.3). However, all o f these 
embryos showed, in at least one biopsied cell, analysable CGH results (Table 5.2).
Table 5.2. CGH results from six embryos that did not have blastomeres available on 
day 5 for FISH analysis. The CGH results are presented as excess of GR (green) or 
RD (red) fluorescence in part of the chromosome or in the whole chromosome.
Embryo
No.
No. of cells 
prior
to biopsy
No. of 
cells 
biopsied
CGH Result Interpretation
4.1 5 cells 1 Normal rev ish XY
4.3 7 cells 1 (+ l)a Normal rev ish XY
4.4 6 cells 1 (+ l)a Excess GR in whole of X rev ish XY, 
enh(X)
13.1 5 cells 1 Excess GR: 5pl5.3-ql 1.2 & 5ql4-q34 rev ish XY, 
enh(5)
14.1 6 cells 2
Excess GR: whole of X, 19ql2-q 13.4b 
Excess RD: whole of Y
rev ish XX
Excess GR: whole of 2, 4, X, 9q (whole arm) 
Excess RD: whole of 1, 16, 21 and Y
rev ish XX, 
enh(2,4, 9qter), 
dim(l, 16, 21)
14.3 5 cells 1 Excess GR: whole of X 
Excess RD: whole of Y
rev ish XX
aThe other cell lysed during the biopsy procedure 
b Excluded from analysis since it was considered to be an artefact
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5.2.5 FISH Analysis of Embryos
FISH was able to achieve higher efficiencies of 93% overall (out of the thirty 
embryos), since 343/359 blastomeres from day 5 were analysable. The 7% of 
blastomeres that failed to return a result included blastomeres lost whilst spreading 
and blastomeres which could not provide an analysable result either on the first or 
second round of FISH. The first round of FISH was carried out using the probe 
cocktail for sex determination. This was performed in order to act as an internal 
control between the two techniques. FISH and CGH were in agreement regarding the 
sex in all of the embryos.
5.2.6 Interpretation of CGH and FISH Results
A total of thirty embryos (41 biopsied blastomeres) provided results from both 
techniques (Graph 5.2). Only three embryos (10%) showed normal results from at
i
least one cell after CGH and normal results for all the blastomeres analysed by FISH 
for the chromosomes tested. The rest of the embryos demonstrated various levels of 
abnormality and mosaicism. Table 5.3 displays the embryos with completely normal 
CGH results whilst Table 5.4 shows the embryos where CGH revealed at least one 
cell with an abnormal karyotype.
Graph 5.2. Cumulative analysis results from 30 embryos (41 blastomeres)
3 embryos (3 
blastomeres)
17 embryos (25 
blastomeres)
10 embryos (13 
blastomeres)
□  Embryos that showed 
normal CGH and FISH 
results
■  Embryos that showed 
normal CGH results
□  Embryos that showed at 
least one abnormal CGH 
result
CGH showed normal chromosome complements in thirteen embryos from which 18 
blastomeres were biopsied (termed Group 1) (Table 5.3; Figure 5.9).
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Table 5.3. Results from embryos showing normal CGH findings (Group 1) followed by sequential FISH analysis
Embryo
No.
Cell CGH Result on day 3 FISH Result on day 5b Interpretation
Cells Results (no. of cells)
1.1 a No result 13 Dip (7) / +X,+Y (2) / +22(2) / -18(2) Mosaic Diploid/Aneuploid
b rev ish XY
1.3 a rev ish XY 2 Dip (1) / +X,+Y(1) Mosaic Diploid/Aneuploid
2.1 a rev ish XY 4 Dip (4) Uniformly normal
b No result
6.2 a rev ish XY 5 Dip(3) / -22(2) Mosaic Diploid/Aneuploid
b rev ish XY
7.1 a rev ish XX 8 Dip (3) / -18(2) / +18(1) / -22(1) / -16,-18(1) Mosaic Aneuploid/Diploid
9.1 a rev ish XY, enh(Xpl 1.2-q22)a 7 Dip (7) Uniformly normal
9.2 a rev ish XY, dim(Yql2)a 31 Dip (25)/ -18(1)/ -X(l) / -16,+22( 1 )/chaotic(3) Mosaic Diploid/Aneuploid/Chaotic
9.4 a rev ish XX, dim(l Iq23-q25)a 6 Dip (3) / tet(2) / chaotic(l) Mosaic Diploid/Polyploid/Chaotic
9.5 a rev ish XY 11 Dip(7) / -X(3) / chaotic(l) Mosaic Diploid/Aneuploid/Chaotic
11.1 a rev ish XY, enh(Ypl 1.3-11.2)a 10 Dip (10) Uniformly normal
12.1 a rev ish XX 3 Dip(l) / chaotic(2) Mosaic Diploid/Chaotic
13.2 a rev ish XX, dim(19pl3.3-pl3.2)a 15 Dip(7) / tet(l) / trip(l) / -9,+22(l) / chaotic(5) Mosaic Diploid/Polyploid/Aneuploid/Chaotic
b rev ish XX
13.3 a rev ish XX 35 Dip(28) / trip(2) / +X(2) / chaotic(3) Mosaic Diploid/ Polyploid/Aneuploid/ Chaotic
b rev ish XX
Tiese findings were considered as artefacts, dip = diploid, tet = tetraploid, trip = triploidy. - indicates oss of chromosome and + indicates gain
of chromosome e.g. +18 is trisomy 18 or -1 is monosomy 1.
bThe 1st round of FISH was always performed with the X/Y/18 probe cocktail. The 2nd round was performed with the 9/16/22 probe combination
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Two blastomeres (11%) failed to give interpretable results (1.1a and 2.1b). In the case 
where two cells were available (embryos 6.2, 13.1 and 13.3) for analysis, the sex was 
in agreement between the two cells. Furthermore, in 5 blastomeres (9.1a, 9.2a, 9.4a, 
11.1a and 13.2a) there were some cases of excess of green or red fluorescence in 
small subtelomeric regions, which were considered as artefacts due to their position, 
which is an area characterised by repetitive DNA sequences and has been described as 
difficult to interpret via CGH (Kallioniemi et al, 1994). In three embryos (2.1, 9.1 and 
11.1) the CGH and FISH results were normal and diploid respectively for the 
chromosomes tested (Figure 5.9). Ten embryos were mosaic with various levels of 
abnormalities. The probe combination for all o f these embryos was Xcep/Ycep/18cep 
for the first round and 9cep/16cep/22LSI for the second round. FISH results regarding 
the gonosomes were concordant with the CGH results. Only two embryos were 
considered to be blastocysts (>30 cells) on day 5, whilst the rest were arrested. For the 
embryos that showed a normal karyotype on day 3, on day 5 in total 150 cells were 
spread and 106 (70.6%) were diploid for the chromosomes tested. However, six out of 
the ten mosaic embryos (60%) contained cells with chaotic chromosome complements 
including nullisomies, tetrasomies and cells with more that three abnormalities 
present in different chromosomes. Embryos 9.4, 13.2 and 13.3 contained polyploid 
cells (4% overall), either triploidy or tetraploidy.
256
Chapter 5 -  Analysis o f the development o f chromosome abnormalities in human
embryos from day 3 to day 5 using CGH and FISH
Figure 5.9. Illustration of a control CGH experiment between a male single buccal 
cell (red) acting as control against blastomere 7.1a (in green)
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For each single cell CGH experiment 10 metaphases were captured, karyotyped, 
analysed individually and then interpreted cumulatively. A. Captured metaphase 
spread. B. In the karyotype of the captured metaphase the X chromosome has a 
distinct green fluorescence indicating excess in the test sample and the Y chromosome 
shows red fluorescence indicating deficiency in the test sample. C. This shows the 
cumulative analysis of ten metaphases, which is the basis of interpretation. There was 
a shift in fluorescence only towards the green in chromosome X and towards the red 
in chromosome Y showing that a the test sample (blastomere 7.1a) was a normal 
female
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Table 5.4 displays the embryos which showed an abnormal finding in at least one 
biopsied cell (Group 2). Therefore, the FISH combinations were tailored according to 
the abnormalities the CGH revealed. From these 17 embryos 28 blastomeres were 
biopsied and 3 (10.7%) were not analysable. In four embryos one cell displayed a 
normal karyotype whereas the other was abnormal (4.2a, 7.3b, 8.1a and 9.6b). All 
chromosomes where shown to be affected either by partial or whole duplication or 
deletion. Chromosomes l(x4), 16(x5) and 22(x4) demonstrated the highest incidence 
of chromosome deletion (whole or partial). Chromosomes l(x4), 2(x3) and Y(x5) 
revealed a higher rate of chromosome duplication (whole or partial). Chromosomes 
13 and 15 showed three whole chromosome deletions each, however, no duplication, 
partial or whole, were observed. Interestingly, chromosome 1 was involved in three 
instances of partial chromosome duplication or deletion at the locus of lp36.1 (Figure 
5.10 -  bold letters in legends). This might be due to a fragile site at that specific 
location. Similarly, on chromosome 2 a possible fragile site between the region 2q21- 
q31 was found (Figures 5.10, 4.11 and 4.12 -  bold letters in legends). All embryos 
were mosaic or completely chaotic at the time of spreading on day 5 and only two 
were considered to be blastocysts (4.2 and 7.3). Furthermore, from 183 cells that were 
spread on day 5, only 68 (37.1%) were diploid for the chromosomes tested. In total, 
12/17 (70.5%) embryos contained at least one cell with a chaotic complement, of 
which four embryos (23.5%) were completely chaotic (Table 5.4). Three embryos 
(17.6%) completely lacked cells diploid for the chromosomes tested and all were 
mosaic aneuploid or mosaic aneuploid/chaotic.
In four embryos it was demonstrated that one of two biopsied cells was abnormal 
whereas the other blastomere may carry a normal chromosome complement (4.2, 7.3, 
8.1 and 9.6; Figures 5.12 and 5.13). The FISH results for such embryos varied with 
two embryos showing that diploid cells were the predominant cell line (7.3 and 9.6) 
and two embryos having principally aneuploid cell lines (4.2 and 8.1). In 15 out of the 
17 embryos the abnormality seen in a biopsied cell after CGH was confirmed during 
FISH analysis on day 5 embryos. In embryo 1.2, CGH analysis showed rev ish XY  
dim(22) and the FISH results showed cells with tetrasomy 22 and monosomy 22 
indicating reciprocal loss and gain however, was classed as chaotic due to additional 
complex abnormalities by FISH (Appendix Table 8.1). In embryo 2.2 the CGH result
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was rev ish XY, dim(18) and the FISH results also revealed chromosome loss since 
monosomy and nullisomy 18 were observed. Interestingly, in embryo 8.2 from one 
biopsied cell the karyotype rev ish XX, enh(9 and 16) was seen, whereas during FISH 
analysis the chaotic cells were monosomic and/or nullisomic for chromosome 16 
indicative of reciprocal loss and gain in the embryo (Appendix Table 8.1). In an 
attempt to see whether the phenomenon of chromosome breakage can be observed by 
FISH later in development, in embryo 9.7 where cell 9.7a displayed the following 
karyotype: rev ish XY, enh(lp36.3-q21), dim(lq31-q44), the chosen FISH probe 
combination was lp/lq/16cep (Table 5.4). Two cells showed whole chromosome 1 
loss, one cell revealed partial loss of the Ip  arm and gain for the lq  arm and the one 
other cell showed partial loss of the lq  arm and gain for the lp  arm. It can be argued 
that the numbers are small and FISH artefacts can be affecting the results, however, 
both probes are sub-telomeric locus specific probes and not repetitive. In embryo 12.2 
the CGH results hinted of chromosome breakage at the short arm at chromosome 4 
and FISH was able to detect the partial chromosome loss in 2/12 cells which were 
also classed as chaotic.
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Table 5.4. Results from embryos showing abnormal CGH findings (Group 2) followed by sequential FISH analysis.
Embryo
No.
Cell CGH Result on day 3 FISH Result on day 5b Interpretation
Cells Results (no. of cells)
1.2 a rev ish XY, dim(22) 2 Chaotic(2) Chaotic
2.2 a rev ish XY, dim(18) 3 Chaotic(3) Chaotic
b No result
3.1 a rev ish XY, enh(5pter, 9qter, 17), dim(4,19) 2 Chaotic(2) Chaotic
b No result
4.2 a rev ish XX 33 Dip(9) / -X(8) / -18(5) / -18,-22(2) / -X,-18(2) / 
+18,+16(1) / trip(l) / chaotic(5)
Mosaic Aneuploid/Diploid/ 
Polyploid/Chaoticb rev ish XX, enh( 1, 22), dim( 16pter, 18)
6.3 a rev ish XY, enh(6p25-p21.1 )a 8 Dip(2) / +X(2) / -16,-X(1) / -X,+22(l) / 
-X(l) / -22(1)
Mosaic Aneuploid/Diploid
b rev ish XY, enh(Y)
7.2 a rev ish XYY, enh(lp36.2-36.1, 2q31-p25, 5, 
7, 8, 18, 19, 20, 21 and Y), dim(lp31-q44, 
2q32-q37, 3, 6, 11, 13, 14, 15)
3 3ceD/llceD/13LSIb
Chaotic(3)
Chaotic
b No result
aThese fine ings were considered as artefacts.
bThe 1st round of FISH was always performed with the X/Y/18 probe cocktail. The 2nd round was performed with the 9/16/22 probe combination 
unless stated in bold and underlined combinations.
dip = diploid, tet = tetraploid, trip = triploidy. The - indicates loss o f  chromosome and + indicates gain o f chromosome e.g. +18 is trisomy 18 or
-1 is monosomy 1.
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Embryo
No.
Cell CGH Result on day 3 FISH Result on day 5b Interpretation
Cells Results (no. of cells)
7.3 a rev ish XY, dim(22ql 1.1 -ql 3) 30 Dip(13) / +22(5) / -16,-22(2) / -9(1) / tet(l) / 
chaotic (8)
Mosaic Diploid/Aneuploid/ 
Polyploid/Chaoticb rev ish XY
8.1 a rev ish XX 4 10ceo/14ab
-10(2) / -10,+14qter( 1) / chaotic(l)
Mosaic Aneuploid/Chaotic
b rev ish XX, enh(4, 6qter, 12pl 1.2-q24.3, 
14q21-q32) dim(2q31-q37, 10)
8.2 a rev ish XX, enh(9 and 16) 10 Dip(6) / chaotic(4) Mosaic Diploid/Chaotic
9.3 a rev ish XY, dim(15ql5-q26, 16) 4 Dip(l) / -16, -16(2) / -16,+22(2) Mosaic Aneuploid/Diploid
9.6 a rev ish XX, enh(2q21-q33, 3ql 1.1-q25), 
dim(lp36.1-p31, 16, 19 and 22)
23 Dip(13) / -16,-22(3) / tet(2) / -22(2) / -18(1) / 
+X(1) / chaotic(l)
Mosaic Diploid/Aneuploid/ 
Polyploid/Chaotic
b rev ish XX
9.7 a rev ish XY, enh(lp36.3-q21), dim( 1 q31-q44) 5 ln/la/16ceDb
-lqter,-lpter,+X(l) / +lqter,-lpter,+Y(l) / 
+1 qter,-1 pter( 1) / -16,-X( 1) / chaotic( 1)
Mosaic Aneuploid/Chaotic
b rev ish XY, dim(l)
aThese fine ings were considered as artefacts.
bThe 1st round of FISH was always performed with the X/Y/18 probe cocktail. The 2nd round was performed with the 9/16/22 probe combination 
unless stated in bold and underlined combinations.
dip = diploid, tet = tetraploid, trip = triploidy. The - indicates loss o f chromosome and + indicates gain o f chromosome e.g. +18 is trisomy 18 or
-1 is monosomy 1.
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Embryo
No.
Cell CGH Result FISH Result (day 5)b Interpretation
(day 3) Cells Results
9.8 a rev ish XY, enh(17pl3-ql 1, 18pl 1.3-ql 1.1), 
dim(3p26-pl4)
17 3ceD/6ceo/18ceDb
Dip(l 1) / +6(3) / -6(1) / -18,+Y(1) / -X,+Y(l)
Mosaic Diploid/Aneuploid
b rev ish XY, enh(6)
10.1 a rev ish XX, enh(20) 19 Dip(6) / +X,+X(6) / +X(3) / -X(l) /-22(1) / tet(l) 
/ trip(l) /
Mosaic
Aneuploid/Diploid/Polyploid
12.2 a rev ish XY, enh(Y), dim(4pter) 12 Yceu/4ceD
Dip(6) / -18(2) / -Y(2) / chaotic(2)
Mosaic 
Diploid/Aneuploid/Chaotic
12.3 a rev ish XY, enh(Yql l.l-q l2 ), 
dim(16q21-q24)
2 XceD/YceD/16ab
-16,-18(1)/-16(1)
Mosaic Aneuploid
14.2 a rev ish XX, enh(l, 10, 16qter), 
dim(8, 13,21,22) 6 Dip(l) / -16(1) / -16,-22(1) / +16,+22(1) / 
chaotic(2)
Mosaic
Aneuploid/Diploid/Chaotic
b rev ish XX, enh(2,6), 
dim(9qter,13, 15, 16qter, 17)
aThese findings were considered as artefacts.
bThe 1st round of FISH was always performed with the X/Y/18 probe cocktail. The 2nd round was performed with the 9/16/22 probe combination 
unless stated in bold and underlined combinations.
dip = diploid, tet = tetraploid, trip = triploidy. The - indicates loss o f  chromosome and + indicates gain o f  chromosome e.g. +18 is trisomy 18 or
-1 is monosomy 1.
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Figure 5.10. CGH and FISH analysis results from embryo 7.2
n »  18 
13
n -  18 19
1
n -  18 20
i .  19 
9
s£_3I
n -  >8 21
n  .  2 0  
10
7 35=
iff
n »  18 
16
i IT
R
n m 16 
S
W
n -  15 
12
1
18
I
n *  10
A. Interpretation of CGH experiment showing the cumulative analysis of ten 
metaphases from blastomere 7.2a. The test sample (blastomere 7.2a) is rev ish XYY, 
enh(lp36.2-36.1, 2p25-q31, 5, 7, 8, 18, 19, 20, 21 and Y), dim(lp31-q44, 2q32-q37, 
3, 6, 11, 13, 14, 15). The blue arrow indicates the possible fragile site for chromosome 
1 and the red arrow the fragile site for chromosome 2.
B. Results from the two sequential rounds of FISH in a cell from embryo 7.2. In B1 
the cell was subjected to the X(green) / Y(red) / 18(aqua) probe cocktail where it 
showed female (XX) and monosomy 18. In B2 the cell was subjected to the 3(orange) 
/ 11 (aqua) / 13(green) probe combination which showed monosomy 3, nullisomy 11 
and trisomy 13
Overall, the FISH results confirmed the chromosome loss events for chromosomes 3 
and 11 and revealed reciprocal loss and gain (MND event) for chromosomes 13, 18 
and Y.
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Figure 5.10. CGH and FISH analysis results from embryo 7.2
n -  18
w
® >
l/fCl/
%
n -  16 
3
n- 16
5
I
/ T i
n -  1 7
7
r
n -  16
8
n -  1 9  9 n -  2 0  10 n -  17  It n. 15 12
m
n .  19 
15
:n
n -  18  n -  18
19  2 0
<r
1
n -  16
16
n -  16
n -  17 
17
n -  17 IB
H iIt>>S n
A. Interpretation of CGH experiment showing the cumulative analysis of ten 
metaphases from blastomere 7.2a. The test sample (blastomere 7.2a) is rev ish XYY, 
enh(lp36.2-36.1, 2n25-q31. 5, 7, 8, 18, 19, 20, 21 and Y), dim(lp31-q44. 2q32-q37, 
3, 6, 11, 13, 14, 15). The blue arrow indicates the possible fragile site for chromosome 
1 and the red arrow the fragile site for chromosome 2.
B. Results from the two sequential rounds of FISH in a cell from embryo 7.2. In B1 
the cell was subjected to the X(green) / Y(red) / 18(aqua) probe cocktail where it 
showed female (XX) and monosomy 18. In B2 the cell was subjected to the 3(orange) 
/ 11 (aqua) / 13 (green) probe combination which showed monosomy 3, nullisomy 11 
and trisomy 13
Overall, the FISH results confirmed the chromosome loss events for chromosomes 3 
and 11 and revealed reciprocal loss and gain (MND event) for chromosomes 13, 18 
and Y.
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Figure 5.11. CGH and FISH analysis results from embryo 8.1
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A. Interpretation of CGH experiment showing the cumulative analysis of ten 
metaphases from blastomere 8.1b. The test sample (blastomere 8.1b) was rev ish XX, 
enh(4, 6qter, 12pl 1.2-q24.3, 14q21-q32) dim(2q31-q37. 10). The red arrow indicates 
the possible fragile site for chromosome 2.
B. Results from the two sequential rounds of FISH in a cell from embryo 8.1. In B1 
the cell was subjected to the X(green) / Y(red) / 18(aqua) probe cocktail where it 
showed female (XX) and tetrasomy 18. In B2 the cell was subjected to the lO(green) / 
14(orange) probe combination which showed monosomy 10 and trisomy 14.
Overall, the FISH results confirmed the female status of the embryo, the whole 
chromosome loss event for chromosome 10 and the partial chromosome gain for the 
telomere of chromosome 14 (14qter).
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Figure 5.12. CGH and FISH analysis results from embryo 9.6 (blastomere a)
2
A. Interpretation of CGH experiment showing the cumulative analysis of eight 
metaphases. There is a shift in fluorescence towards the green in chromosome X and 
towards the red in chromosome Y showing that a the test sample (blastomere 9.6a) 
was rev ish XX, enh(2q31-q33, 3p25~p21), dim(lp36.1-p31, 16, 19 and 22). The red 
arrow indicates the possible fragile site for chromosome 2.
B. Results from the two sequential rounds of FISH in a cell from embryo 9.6. In B1 
the cell was subjected to the X(green) / Y(red) / 18(aqua) probe cocktail where it 
showed female (XX) and diploid for chromosome 18. In B2 the cell was subjected to 
the 9(green) / 16(aqua) / 22(orange) probe combination which showed monosomy for 
chromosomes 16 and 22 and diploid for chromosome 9.
Overall, FISH analysis confirmed the sex status of the embryo as well as the presence 
of monosomy for chromosomes 16 and 22.
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Figure 5.13. CGH and FISH analysis results from embryo 9.6 (blastomere b)
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A. Interpretation of CGH experiment showing the cumulative analysis of twelve 
metaphases. There is a shift in fluorescence towards the green in chromosome X and 
towards the red in chromosome Y showing that a the test sample (blastomere 9.6b) 
was rev ish XX. The test sample (blastomere 9.6b) was female with a normal 
chromosome complement.
B. Results from the two sequential rounds of FISH in a cell from embryo 9.6. In B1 
the cell was subjected to the X(green) / Y(red) / 18(aqua) probe cocktail where it 
showed female (XX) and disomy 18. In B2 the cell was subjected to the 9(green) / 
16(aqua) / 22(orange) probe combination which showed disomy 9, 16 and 22.
Overall, the FISH results confirmed the sex status of the embryos and the presence of 
normal (diploid) cells in embryo 9.6
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5.2.6.1 Cytogenetic Events Leading to Mosaicism
In total, only 10% (3/30) of the embryos were uniformly normal. The rest were either 
mosaic 76.7% (23/30) or completely chaotic 13.3% (4/30). The mechanisms were 
either CL, CG or MND. All events involved whole chromosomes for the embryos 
where the CGH results showed normal karyotypes (Group 1). The main mechanism 
leading to mosaicism was whole chromosome loss (50%) (Table 5.5). However, 
whole chromosome gain had also a high incidence with 44.5% (8/18), with MND of 
whole chromosomes in only 5.5% of cases (Table 5.5).
Table 5.5. Mechanisms leading to aneuploid mosaicism detected by FISH analysis for 
the embryos which revealed cells with normal karyotypes after CGH (Group 1).
Embryo Classification Event Chromosome
1.1 Mosaic Diploid/Aneuploid lCL(w) 
3 CG(w)
18
22, X, Y
1.3 Mosaic Diploid/Aneuploid 2CG(w) X, Y
2.1 Uniformly normal - -
6.2 Mosaic Diploid/Aneuploid lCL(w) 22
7.1 Mosaic Aneuploid/Diploid 2CL(w)
lMND(w)
16, 22 
18
9.1 Uniformly normal - -
9.2 Mosaic Diploid/Aneuploid/Chaotic 3CL(w)
lCG(w)
16, 18, X 
22
9.4 Mosaic Diploid/Polyploid/Chaotic - -
9.5 Mosaic Diploid/Aneuploid/Chaotic lCL(w) X
11.1 Uniformly normal - -
12.1 Mosaic Diploid/Chaotic - -
13.2 Mosaic Diploid/Polyploid/Aneuploid/Chaotic lCL(w)
lCG(w)
9
22
13.3 Mosaic Diploid/ Polyploid/Aneuploid/ Chaotic lCG(w) X
Total
13
9CL (50%) 
8CG (44.5%) 
1MND (5.5%)
‘w’ stands for whole chromosome event (either loss, gain or MND) 
‘p ’ stands for partial chromosome event (either loss, gain or MND)
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It must be noted, that taking into account the previous study (Chapter 3), some losses 
can be considered as FISH artefacts when they are confined to just one cell.
In the embryos where there was at least one abnormal karyotype (Group 2) revealed 
during CGH interpretation from 57 events of aneuploid mosaicism, the main 
mechanism was whole CL (37%) followed by whole CG (19%) and whole MND 
(16%) (Table 5.6). In this group of results the incidence of events leading to 
mosaicism involving partial chromosomes was also considerable especially for partial 
chromosome loss which accounted for 14%. Chromosomes involved in partial 
chromosome events included chromosomes 1, 2, 3, 4, 9, 14, 15, 16, 17 and 18. All 
these chromosomes showed breakage in the short (p) or long (q) arms, however, 
chromosome 18 showed partial CG in the region of 18pl 1.3-ql 1.1 during CGH and 
partial CL in the same region in one cell during FISH, thus revealing reciprocal 
aneuploidy due to partial MND for the that region of chromosome 18 (Table 5.4 and 
Table 5.6)
Table 5.6. Mechanisms leading to aneuploid mosaicism for the embryos, which 
revealed a least one cell with abnormal karyotype after CGH (Group 2).
Embryo Classification Event Chromosome
1.2 Chaotic - -
2.2 Chaotic - -
3.1 Chaotic - -
4.2 Mosaic 2CL(w) 22, X
Aneuploid/Diploid/Polyploid/Chaotic lCG(w) 16
lMND(w) 18
6.3 Mosaic Aneuploid/Diploid lCL(w) 16
lCG(w) Y
2MND(w) 22, X
7.2 Chaotic - -
7.3 Mosaic 2CL(w) 9, 16
Diploid/Aneuploid/Polyploid/Chaotic lMND(w) 22
8.1 Mosaic Aneuploid/Chaotic lC L (p)/ lCL(w) 2qter / 10
lC G (p)/ 2CG(w) 14qter / 4, 12
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8.2 Mosaic Diploid/Chaotic - -
9.3 Mosaic Aneuploid/Chaotic lCL(p) / lCL(w) 
lCG(w)
15qter / 16 
22
9.6 Mosaic
Diploid/Aneuploid/Polyploid/Chaotic
lCL(p) / 4CL(w) 
2CG(p) / lCG(w)
3p ter!  16,18,19, 22 
2qter, 3 qter / X
9.7 Mosaic Aneuploid/Chaotic 3CL(w)
lCG(w)
2MND(p)
1, 16,X 
Y
1 pter, \qter
9.8 Mosaic Diploid/Aneuploid lCL(p) / lCL(w)
lCG(p) / lCG(w)
lMND(p) / 
lMND(w)
3pter / X 
1 Ipter! Y 
18 cep / 6
10.1 Mosaic Aneuploid/Diploid/Polyploid lCL(w)
lCG(w)
lMND(w)
22
20
X
12.2 Mosaic Diploid/Aneuploid/Chaotic lCL(p) / lCL(w) 
lMND(w)
4pter / 18 
Y
12.3 Mosaic Aneuploid lCL(p) / lCL(w) 
lCG(w)
16qter / 18 
Y
14.2 Mosaic Aneuploid/Diploid/Chaotic 2CL(p) / 3CL(w) 
2CG(w) 
2MND(w)
9qter,\6qter /13,15,17 
2 ,6  
16, 22
Total
17
8CL(p) (14%) 
21CL(w) (37%) 
5CG(p) (9%) 
llCG (w ) (19%) 
3MND(p) (5%) 
9MND(w) (16%)
‘w’ stands for whole chromosome event (either loss, gain or MND) 
‘p’ stands for partial chromosome event (either loss, gain or MND)
5.3 Discussion
This study was aimed at assessing the CGH technique and examining its suitability as 
a research tool on human preimplantation embryos. Each step of the technique was
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optimised for single cell use. Furthermore, CGH was tested against FISH in order to 
investigate whether by obtaining a full karyotype on 1-2 cells on day 3 of embryo 
development can reveal any surplus information about the mechanisms of mosaicism 
on day 5 of embryo development when the whole embryo was analysed by FISH.
5.3.1 WGA Optimisation
Initial work included assessing the handling of single buccal cells and tubing and 
amplifying each single cell. Amplification efficiency reached 97% (from 100 single 
cells) after DOP-PCR. DOP was selected as the preferred method of whole genome 
amplification since it has been postulated that it produces sufficient quantities of 
amplified product and provides sufficient coverage of the genome from a single cell 
(Wells et al, 1999; Voullaire et al, 1999). All DOP-PCR products were analysed using 
gel electrophoresis where contamination in the negative controls was present in less 
than 5% (Figure 5.1). All single buccal cells and blastomeres yielded a smear that 
contained a single distinct band at 450bp (Figure 5.1). Such bands have previously 
been suggested to be mitochondrial DNA, which is amplified by DOP-PCR although 
this does not interfere with the CGH profile, as it does not hybridise to the template 
chromosomes (Voullaire et al, 2000). It was essential to maintain stringent 
precautions against contamination throughout single cell isolation, lysis and 
amplification. The incidence of contamination was assessed regularly using numerous 
control blanks containing PCR reaction mixture but no DNA. A non-intensive smear 
in the single cell amplified products was visible thus displaying sufficient coverage of 
the whole genome. Such heterogeneous mixture of fragments generated by DOP-PCR 
and visualised as a smear has also been reported by Wells et al (1999). During 
amplification of single cells using DOP-PCR, two different thermal cyclers were 
assessed, the Omnigene™ and Eppendorf Master Gradient®. In each thermal cycler 
20 single cells were amplified and their results were analysed on 1-2% agarose gel 
stained with ethidium bromide (Figure 5.2). During analysis it was observed that the 
Omnigene™ thermal cycler displayed a larger smear thus showing enhanced 
amplification of the genome. This considerable difference in smears between thermal 
cyclers was later reduced by adjusting the ‘ramp’ speed of the Eppendorf Master
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Gradient®, however, the Omnigene™ remained the preferred choice of thermal 
cyclers during DOP-PCR amplification.
5.3.2 CGH Optimisation
Preliminary work on genomic DNA extracted ‘in house’ was utilised to optimise the 
CGH technique in order to be able to produce reliable results in single cells. Normal 
male genomic DNA (labelled in red which acted as the ‘control’ sample) against 
normal female DNA (labelled in green which acted as the ‘test’ sample) was 
amplified and analysed using CGH. CGH was able to detect the sex chromosomes in 
the samples with shift of fluorescence towards the green for the X chromosome 
indicating excess and towards the red for the Y chromosome indicating deficiency in 
the ‘test’ sample (Figure 5.3). The determination of the sex chromosome CGH pattern 
was a criterion for the reliability of the procedure. However, it must be taken into 
consideration that the euchromatic region of the Y chromosome is at the limit of size 
resolution for which aneuploidy can be detected by CGH (Voullaire et al, 1999). 
Subsequently CGH was performed on clumps of buccal cells from normal male and 
female individuals, which was successful. Thus, the remaining single cell DOP-PCR 
products (section 5.2.1) were put through CGH to assess its efficiency at the single 
cell level. The CGH efficiency on control single cell samples was 93.3%, with only 
two cells producing non-interpretable results. Furthermore, in a study of single 
fibroblasts the DOP-PCR amplification allowed reliable detection of trisomies 13, 18, 
21 and 22 (Figures 5.4-5.7). The hybridisation of DOP-PCR products to normal 
metaphase chromosomes produced strong even signals with no obvious sites of 
amplification deficiency or excess. The fluorescence shifts on the trisomic 
chromosomes were later used as reference for shifts displayed by day 3 blastomeres. 
Similar results on single fibroblasts of trisomic samples have been shown by Wells et 
al (1999). Furthermore, the fluorescence intensity observed on the Y chromosome of 
the female ‘test’ samples revealed the extent of background fluorescence could be 
used ‘roughly’ as a reference to distinguish between monosomic and nullisomic 
samples. During the whole of this study homo-hybridisation (the hybridisation of 
samples containing similar amounts of DNA, each amplified and labelled using the 
same methods) was performed for all blastomeres, since it has been suggested that
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hetero-hybridisation of DOP-PCR CGH displays high background, uneven 
hybridisation and is also associated with false deletions or amplifications (Huang et 
al, 2000)
CGH sensitivity is usually considered to be low in terms of the minimum size of 
detectable over/underrepresented chromosome fragments. Studies using CGH in a 
variety of samples have reported a resolution limit o f 10-40Mbp (Kallioniemi et al, 
1994; Daniely et al, 1998; Voullaire et al, 1999; Lestou et al, 2000; Malmgrem et al, 
2002). However, Kirchhoff et al (1999; 2000; 2001) managed to develop the 
technique further to increase the sensitivity as well as the specificity in order to detect 
chromosomal aberrations as small as 3Mbp. Their modification was termed high 
resolution CGH (HR-CGH). During this study the CGH technique was not designed 
to detect small deletions such as the study which aimed and accomplished the 
detection of Prader Will/Angelman deletions (Kirchhoff et al, 1998), which are 
thought to be approximately 4Mbp (Christian et al, 1998) and thus are likely to be 
undetected by normal G-banding. However, during CGH interpretation of the 
captured images in some cases the presence of hybridisation artefacts was observed 
for the heterochromatic regions, and both the short and long arm telomeres of certain 
chromosomes, including 1, 9, 16, and Y and the satellite regions of the acrocentric 
chromosomes. These were caused due to the extreme suppression of these regions by 
the Cot-1 DNA and any low level fluorescence at these sites was attributable to 
background. Consequently, these regions were not considered during interpretation. In 
addition, in cases where abnormal results were obtained for chromosomes 19 and 22, 
they were interpreted with caution, due to the fact that these chromosomes are also 
known to be prone to labelling artefacts. Other similar observations regarding such 
artefacts on these chromosome regions have been reported from various studies in the 
literature (Tabet et al, 2001; Wilton et al, 2001).
5.3.3 CGH and FISH on Human Embryos
CGH is a technique with several difficulties due to the complexities of its nature. All 
cells from each embryo were consistent for the determination of the sex chromosomes 
and all were in agreement with the respective FISH results. However, it should be
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noted that a possible case of mosaicism for a sex chromosome abnormality would 
negate this suggestion of an ‘internal control’. In addition, the chromosomes present 
in a normal diploid copy number can be used as an internal negative control for 
assessment of efficiency of hybridisation (Malmgren et al, 2002). It has been 
reported that small deletions or amplifications of the telomeric regions are difficult to 
interpret by CGH analysis and might be missed (Malmgren et al, 2002).
A total of 54 blastomeres were biopsied on day 3 and 48 (88.9%) produced 
interpretable results. Failure of the CGH could indicate either an anucleate blastomere 
(as visibility of the nucleus was not possible for all the blastomeres biopsied), or that 
the cell was mistaken for an anuclear fragment which is a common finding in day 
three embryos (Voullaire et al, 2000). It has been shown that 5% of good quality 
embryos and 12% of poor quality embryos contain anucleated blastomeres (Hardy et 
al, 1993). Another explanation accounting for failure of results could be premature 
cell lysis or loss of a cell during transfer to the PCR tube. A cytoplasmic metaphase 
preparation of poor chromosome morphology would present a major obstacle to the 
successful hybridisation of both control and test DNA.
The efficiency o f single blastomere CGH for this study was 88.9%, which is exactly 
the same as the single buccal cell rates. Wells and Delhanty, (2000) reported a CGH 
efficiency o f 88% whilst Voullaire et al, (2000) revealed a slightly higher efficiency 
of 89%. Similarly to this study, both studies employed IVF embryos of good quality. 
However, during this study the embryos were ffozen-thawed and not fresh which may 
explain the minor difference in efficiency. The efficiency of the study performed by 
Malmgren et al, (2002) using spare embryos from PGD cases was 70%, considerably 
lower than the one reported in this project. The fact that Malmgren et al, (2000) used 
a different type of WGA than the one used by Voullaire et al, (2000), Wells and 
Delhanty (2000) and this study could account for the lower efficiency seen in their 
study. The protocol used, based on linker-adapter mediated PCR, might be less 
reliable or amplify DNA less efficiently leading to their poorer results (D. Wells, 
personal communication). The FISH efficiency on embryos was higher than CGH 
with 343/354 (93%) producing analysable results. The FISH probe efficiency was
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88.6% (range 81-97) for the 14 probes used, which was calculated on 200 interphase 
nuclei from a normal male lymphocyte slide.
Thirteen couples donated a total of 37 embryos for this research project with a mean 
maternal age of 33.1 (range 28-39) years. One embryo was not included since it failed 
to provide any kind of results during either CGH or FISH, which was expected due to 
their low morphology grade. A further six embryos failed to grow to day 5 and 
degenerated thus no cells could be spread. However, from all these embryos at least 
one cell was biopsied and the CGH results showed 3/7 blastomeres being of a normal 
karyotype, 2/7 were aneuploid and one was chaotic. Overall, from the thirty embryos 
where analysis was possible with both techniques the mean number of nuclei 
investigated on day 5 was 12. The low number of nuclei which was available for 
FISH analysis on day 5, where the embryos should have been blastocysts (at least 30 
cells per embryo) can be attributed to several factors. Firstly, the culture media at the 
time might have been problematic hence, blastocyst formation was not promoted. 
Furthermore, the biopsy procedure was performed with a laser and might have had an 
adverse effect on the embryos. However, similar pregnancy rates have been obtained 
from studies comparing the laser biopsy technique to the widely used acid Tyrodes 
technique (De Vos and Van Steirteghem, 2001). It has been postulated that blastomere 
excision on day 3 could risk embryonic death by reducing the number of cells 
available for differentiation or by the excision of blastomeres essential to form a 
particular cell line (De Vos and Van Steirteghem, 2001). Technical expertise is 
required for a successful biopsy procedure and the person performing the technique 
was training and so was not adequately experienced. It has been suggested that the 
biopsy procedure can cause a strain on the embryo by disturbing tight junctions either
I <m\ | o
by incubating the embryos in Ca /Mg -free medium prior to operating or by forceful 
aspiration (Munne and Cohen, 1998). Dumoulin and co-workers (1998) evaluated the 
embryo viability and implantation after exposing embryos for 45min to Ca+2/Mg+2- 
free medium and concluded that subsequent development to the blastocyst was not 
affected. Overall it has been shown from untransferred biopsied embryos in PGD 
cycles for sexing or aneuploidy screening that less than 30% show blastocyst 
formation after cleavage stage biopsy (Veiga et al, 1999; Magli et al, 2000; 
Sandalinas et al, 2000). A more recent study by Baart et al (2004) showed that around 
50% of the embryos formed into blastocysts after biopsy of two blastomeres on day 3. 
Another factor that may have affected the blastocyst formation is the freeze-thaw
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procedure, which might have rendered the embryos more fragile. It has been broadly 
suggested that the formation to blastocyst stage and consequent implantation potential 
of ffozen-thawed embryos is probably compromised (Levran et al, 1990; Van 
Steirteghem et al, 1992; Van der Elst et al, 1995). Therefore, addition of the biopsy 
procedure on ffozen-thawed embryos might have influenced the low numbers of 
blastomeres present during day 5 of spreading.
A total of thirty embryos provided results from both techniques. Only three embryos 
(10%) showed normal results both after CGH and for all the blastomeres analysed by 
FISH for the chromosomes tested. Compared to other studies the normality rate for 
this study is quite low since Wells and Delhanty (2000), Voullaire et al (2000) and 
Trussler et al (2004) showed rates of 25%, 25% and 42.5% respectively. In all three 
studies good quality fresh embryos were analysed of a grade 3-4/4 with grade 4 being 
the best quality embryos. Whereas in the present study though the embryos were 
considered of good quality, they had been ffozen-thawed thus they might have been 
compromised. Laverge et al (1998) after analysing 63 ffozen-thawed embryos by 
FISH concluded that embryos which do not grow further after freezing and thawing 
carry chromosomal abnormalities. Malmgrem et al (2002) found 0% normal embryos 
however the embryos used in that study were previously diagnosed as unbalanced and 
were considered not fit for transfer hence the higher degree of mosaicism. IVF culture 
conditions could also be responsible for the high frequency of mosaicism in this 
study. An example is a sudden decrease in temperature that could in turn affect 
cytokinesis, leading to the generation of diploid/polyploid embryos (Munne and 
Cohen, 1998). In addition, it has been suggested that embryos produced by different 
stimulation protocols and cultured under different conditions have very diverse 
mosaicism rates (Munne et al, 1997).
5.3.3.1 Group 1 Embryos
CGH showed a normal chromosome complement in thirteen embryos (Group 1). 
FISH analysis confirmed the sex of the embryo in all thirteen embryos. However, in 
five blastomeres (Table 5.3) there were sites on the sub-telomeric regions of 
chromosomes 19, X and Y that showed enhanced or diminished fluorescence. This set
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of results was considered as artefacts. The underlying reason was that certain regions 
of the karyotype such as centromeres and sub-telomeric segments show variation in 
the profile and these regions are normally excluded from CGH (Kallionemi et al, 
1994). Moreover, certain chromosomes (lp, 17, 19, 22 and Y) are prone to show 
frequent enhancement of the test signal and are also excluded from the analysis 
(Moore et al, 1997). Other chromosomes that have been reported to be prone to 
artefactual results in placental tissues include chromosomes 4, 13, and 18 (Lestou et 
al, 2000) however, these chromosomes did not present similar results in the current 
study. Embryo 13.2 displayed the only blastomere which was affected by an 
abnormality involving chromosome 9 after FISH analysis, whereas all other embryos 
had mixed aneuploid cells of monosomies or trisomies for chromosomes 16, 18, 22, X 
and Y, with aneuploidies for chromosomes 22 and X showing the highest incidence. 
Trisomy of the small autosomes and monosomy for the X chromosome, such as 
embryo 9.5 (Table 5.3) are the most common abnormalities detected in human 
pregnancy (Boue et al, 1985). Furthermore, embryos 13.2 and 13.3 displayed triploid 
cells the origin of which is unclear in the literature. The underlying mechanism that 
could lead to diploid/triploid mosaics may be due to an incorporation of another 
gamete or its genome into one of the daughter cells derived after the first mitotic 
division or later. The extra gamete might be a polar body (Mueller et al, 1993). It has 
also been suggested that diploid/triploid mosaicism could result from fusion of a 
diploid zygotic nucleus with an extra sperm nucleus or the extrusion and degeneration 
of a haploid nucleus to produce a diploid cell line in a triploid embryo (Kuo et al, 
1998). Embryo 13.3 displayed mosaicism involving the sex chromosomes as well as 
triploidy. It has been postulated that delayed IVF might also cause triploid cells 
(Plachot et al, 1988) and more interestingly the embryo came from a couple which 
had ICSI treatment. Although this is an isolated phenomenon an increase of sex 
chromosome abnormality has been reported in children conceived using ICSI 
affecting at least 1% (Martin, 1996). Similar observations have been reported in a 
CGH study o f human day 3 embryos where 2/12 embryos displayed mosaicism 
involving only sex chromosomes which were thought to have arisen from 47, XXX 
zygotes after ICSI treatment (Wells and Delhanty, 2000). Chaotic complements were 
also present in this group of embryos, which revealed normal CGH karyotypes from 
the biopsied blastomeres, in 6 embryos. Chaos has been reported in almost all the 
studies in embryos using either FISH or CGH.
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5.3.3.2 Group 2 Embryos
In 17 embryos at least one cell showed an abnormal karyotype when analysed by 
CGH. Ultimately, all 17 embryos were classified as mosaic or chaotic (Group 2). Four 
embryos (23.5%) were completely chaotic containing cells with three or more 
abnormalities in different chromosomes. All four embryos when analysed by FISH on 
day 5 were arrested consisting of only 2-3 blastomeres each, which is consistent with 
suggestions that chaos is associated with impaired development (Delhanty and 
Handyside, 1995; Delhanty et al, 1997). All four embryos displayed abnormalities 
such as nullisomies, tetrasomies and completely abnormal gonosome karyotypes.
Except for embryo 4.2 all embryos were arrested (<30 blastomeres) and all embryos 
had a decreased number of blastomeres with a diploid cell line compared to Group 1. 
It has been implied from blastocyst studies that embryos with a lower proportion of 
diploid cell line (therefore higher degree of mosaicism) have a low developmental 
potential (Ruangvutilert et al, 2000a). However, this selection against embryos with a 
high degree o f mosaicism does not operate perfectly.
Most of the evidence for different chromosome susceptibilities to aneuploidy has been 
obtained from clinically recognised pregnancies. Major studies reported that although 
trisomy 16 accounts for 20-35% of all trisomies, acrocentrics and chromosome 2 
account for 5-10% each (Hassold et al, 1984; Warburton et al, 1986). In Group 2 
embryos all chromosomes were involved in abnormal karyotypes either due to 
duplications or deletions (partial or whole). Chromosome 1 was shown to be most 
affected with four incidences of chromosome duplication (whole or partial) and four 
incidences of chromosome deletion (whole or partial). Similar data were obtained 
during our FISH study on day 5 embryos for the group of embryos (Group I), which 
were arrested (Chapter 3). However, in the case of these set of results it must be 
highlighted that some confined chromosome losses can be attributed to FISH artefacts 
since there was not two-loci per chromosome analysis during the current study. 
Therefore, FISH failure could not be detected and excluded from the results. Wells 
and Delhanty (2000) also found an increased incidence of chromosome 1 deletion 
however chromosome 2 was shown to be affected by chromosome deletion (partial or 
whole) on six different occasions. Baart et al (2004) also found chromosome 1
277
Chapter 5 -  Analysis of the development of chromosome abnormalities in human
embryos from day 3 to day 5 using CGH and FISH
affecting 9/29 (31%) embryos when analysed by FISH. In our study chromosome 2 
was mostly involved in chromosome duplications (partial or whole). In a recent CGH 
study nine instances of trisomy 22 were found (Trussler et al, 2004), which is in 
accordance with a FISH study investigating differences in chromosome susceptibility 
to aneuploidy that concluded that trisomy 22 is the most common aneuploidy (Munne 
et al, 2003b). In this study aneuploidy of chromosome 22 was also increased however, 
chromosome 22 deletions were more prominent than duplications.
In two embryos, 7.2 and 14.2, a total of 16 and 13 chromosomes were shown to be 
affected respectively. Embryo 7.2 displayed a complete breakdown of normal 
chromosome complement (Figure 5.10). The embryo was classed as chaotic and the 
FISH results were able to confirm the CGH abnormalities in six chromosomes. 
Different aneuploidies were seen including nullisomy for chromosomes 11, 13, 14 
and 15, trisomy for chromosomes 3, 4, 5, 17, 18 and 19 as well as abnormalities in the 
sex chromosomes revealing karyotypes of XXYY, XXXO and XXXXXYY. Similar 
complete aneuploidy and embryos with random allocation of chromosomes to 
daughter cells have been previously observed by Wells and Delhanty (2000) in 2/12 
embryos and by Trussler et al (2004) in 3/40 embryos. There is no pattern to the 
aneuploidy seen; chromosome losses and gains occur with similar frequency and there 
is no evidence of that any particular chromosome is involved more often than any 
other (Wells and Delhanty, 2000). Evsikov and Verlinsky (1998) postulated that 
embryos with chaotic chromosome segregation do survive to the blastocyst stage but 
will not progress further and would fail to implant.
FISH analysis was able to confirm the sex status of all seventeen embryos shown by 
CGH. Analysis of the CGH and FISH data demonstrated results ‘in agreement’ in 
15/17 embryos (in the other two embryos there were no FISH probes available for the 
specific chromosome). The ‘agreeing results’ showed a similar abnormality on the 
chromosome in question or revealed a reciprocal abnormality for that chromosome. 
For example in embryo 8.1 CGH analysis revealed deletion of chromosome 10 and 
duplication of the 14qter. On day 5, the FISH protocol showed 4/4 cells with 
monosomy 10 and 2/4 cells with trisomy for the 14qter chromosome segment.
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Furthermore, the CGH results in embryo 4.2 displayed duplication of chromosome 22 
and deletion in chromosomes 16pter and 18. FISH analyses demonstrated two 
blastomeres with monosomy 22, nine blastomeres with monosomy 18 and one 
blastomere with trisomy 16 and 18 therefore revealing, overall, reciprocal loss and 
gain for chromosomes 16, 18 and 22.
The use of CGH to study human preimplantation embryos has enabled the detection 
of a specific type of error involving structural alteration of chromosomes, namely 
chromosome breakage. Embryos 7.2, 8.1, 9.6 and 9.7 displayed possible breakage in 
chromosomes 1 and 2. In embryo 9.7 the FISH protocol was chosen so that it can 
detect whether the breakage was an experimental artefact by having one sub-telomeric 
probe for each arm (‘p’ and ‘q’). FISH analysis revealed 2/5 blastomeres showing 
reciprocal products of the breakage and 2/5 blastomeres displaying similar products of 
the breakage. In embryos 7.2 and 8.1 chromosome breakage was noted at the region 
of 2q31-2q37 where the acentric fragment was lost. Interestingly, in embryo 7.2 the 
remaining centric chromosome fragment (2p25-q31) was shown to be duplicated. 
Partial aneuploidy due to chromosome breakage is likely to result in an unstable 
karyotype through the formation of acentric and dicentric chromosomes (Voullaire et 
al, 2002).
5.3.4 Mosaicism and Chaos
Overall, 23/30 (76.6%) of the embryos analysed were mosaic, from which 14/23 and 
9/23 were diploid as the major cell line and the aneuploid line respectively. In Group 
1 embryos FISH results on 150 blastomeres showed 70.6% being diploid whereas 
from 183 cells analysed by FISH in Group 2 embryos only 37.1% were diploid for the 
chromosomes tested. The significant drop of the diploid cells was expected since 
Group 1 embryos would have been diagnosed as normal in a PGD setting due to their 
normal CGH results. All errors leading to aneuploid mosaic embryos were post- 
zygotic with no meiotic error present. A meiotic division error would render all 
embryonic cells chromosomally aneuploid. This is an interesting finding which is in 
accordance with a similar study performed by Baart et al (2004) which analysed two 
blastomeres by FISH on day 3 and re-analysed the whole embryos by FISH, using the
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same probe combination on day 5. Their aim was to clarify whether it is more 
informative and less prone to misdiagnosis to carry out PGD for aneuploidy screening 
on day 3 or on day 5. However, in all embryo CGH studies a low percentage of 
meiotic errors (7.5-8.3%) has been reported (Wells and Delhanty, 2000; Voullaire et 
al, 2000; Trussler et al, 2004).
Furthermore, it was disturbing that in 18/30 (60%) embryos at least one cell was 
chaotic in its chromosome complement. Chaotic embryos are thought to arise due to 
absence of cell cycle checkpoints. A study performed on mouse oocytes demonstrated 
the absence of the metaphase-anaphase checkpoint (Le Maire-Adkins et al, 1997). 
This checkpoint is responsible for the correct alignment of chromosomes onto the 
mitotic spindle, and the situation could be similar for human oocytes. The 
abnormalities of the mitotic spindle could be related to the sub-optimal in vitro culture 
environment (Pickering et al, 1990). Moreover, maternal genome support could result 
in the survival of embryos with multiple aneuploidies up until the blastocyst stage. 
Elimination of maternal mRNAs could lead to the arrest that is frequently observed 
prior to blastocyst formation for highly abnormal embryos (Wells and Delhanty,
2000). Wilding and co-workers (2003) recently published data stating that if poor 
vascularization of follicles is the underlying cause for the loss of mitochondrial 
activity in maturing oocytes this would lead to chaotic development.
5.3.5 Mechanisms of Aneuploidy Mosaicism
Embryonic death is caused by chromosomal abnormalities that are primarily the result 
of chromosomal errors during female gamete formation. However, there are some 
errors that will arise during early cleavage divisions as a consequence of mitotic 
errors. These errors in cell divisions, namely mitotic non-disjunction and anaphase lag 
lead to mosaicism and chaotic imbalances.
In Group 1 embryos only whole chromosome mosaicism mechanisms were seen from 
which the predominant was chromosome loss (CL) (50%), followed by chromosome 
gain (CG) (44.5%) and just one instance of mitotic non-disjunction (MND) (5.5%).
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These results are very similar to the ‘Group I embryos’ in our FISH study on day 5 
embryos (Chapter 4 Table 4.3). All errors were post-zygotic for Group 1 embryos. In 
the group of embryos that the CGH analysis displayed at least one cell with an 
abnormal karyotype (Group 2) there was an increased incidence of partial 
chromosome errors (28% in total). The predominant mechanism of mosaicism was 
whole chromosome loss (37%). Whole CG gave rise to 19% of the aneuploid mosaic 
embryos and whole MND to 16%. In comparison to Group 1, in Group 2 embryos the 
incidence of whole CG was halved whereas the rate of whole MND was tripled. 
Chromosome 22 was mostly affected by reciprocal loss and gain of material. 
Anaphase lagging is the causative agent behind whole CL and CG. Anaphase lagging 
leads to mosaicism and chaotic chromosome distribution, most probably reflecting 
asynchrony between karyokinesis and cytokinesis. Coonen et al (2004) recently 
reported that anaphase lag is the main cause chromosomal mosaicism in embryos. 
This was in accordance with our findings in the FISH study (Chapter 3). Similarly by 
employing CGH and FISH it has been shown that chromosome loss and gain are the 
main causes o f mosaicism which occur probably due to anaphase lag.
In the partial chromosome mechanisms, again, partial CL was found to be 14%, 
followed by partial CG (9%) and partial MND (5%). This is the first study that 
recognises partial chromosome mechanisms as an underlying reason causing 
chromosomal aneuploidy. It has been postulated that chromosome breakage and 
whole chromosome aneuploidy could be caused by different factors (Wells and 
Delhanty, 2000). In a recent study, 6% of the embryos analysed by CGH were found 
to be affected solely by partial aneuploidy (Voullaire et al, 2002). Wells and Delhanty
(2000) have proposed that acentric fragments would not be stably transmitted to 
daughter cells and the resultant loss of material would leave the embryo with a 
potentially lethal monosomy for that chromosome region. Furthermore, both initial 
studies of embryos using CGH observed chromosome breakage at the point of 2q31 
(Wells and Delhanty, 2000; Voullaire et al, 2000) which is similar to this study 
(Figures 5.10, 5.11 and 5.12) along with the breakpoint in chromosome 1 (lp31). 
Both sets of breakpoints map to defined chromosomal fragile sites (Sutherland, 2003), 
which are prone to chromosome breakage. Fragile sites are non-randomly located 
gaps or breaks in chromosomes that are induced to appear by specific culture
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conditions (Sutherland, 1979) and are frequently involved in de-novo chromosome 
rearrangements (Warburton, 1991). They are classified according to their chemistry 
and of induction and by their frequency in the population (Richards, 2001). Rare (or 
heritable) fragile sites are found on the chromosomes of less than 5% of individuals, 
whereas common (or constitute) fragile sites are found in all individuals (Sutherland 
and Baker, 2000). The most common ‘fragile’ site in the genome is FRA3B at 3pl4.2 
which has occurred once in this study in embryo 9.8 where that part of the 
chromosome 3 region (3pl4-p26) was lost. A fragile site is a region of chromatin that 
fails to compact normally for mitosis (Sutherland, 2003). Therefore, during this study 
CGH has demonstrated that chromosome breakage in human preimplantation 
embryos can be considered as a possible mechanism of aneuploidy. FISH can only 
reveals information about a small area of each chromosome to which they hybridise, 
thus rearrangements affecting chromosomal regions rather than whole chromosomes, 
are not detected. During this study, this FISH limitation was used to our advantage in 
order to establish chromosome breakage rather than regard it as a CGH artefact.
5.3.6 Conclusions
Throughout this study all three techniques used i.e. whole genome amplification, 
FISH and CGH were optimised through a series of control experiments in order to 
achieve high amplification rates and hybridisation rates respectively. After FISH and 
CGH analysis it was found that only 10% of the day 5 embryos were uniformly 
diploid, while the rest were mosaic or completely chaotic. The major mechanism of 
mosaicism leading to aneuploid cells was found to be chromosome loss from Group 1 
and Group 2 embryos. However, the difference between chromosome loss with 
chromosome gain and mitotic non-disjunction was not statistically significant. Similar 
results were obtained in Chapter 4, adding to the conclusion that chromosome loss, 
which probably arises due to anaphase lag, is mostly responsible for the high level of 
mosaicism present in embryos.
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5.3.7 Future Work
CGH and FISH were employed during this study and assessed as techniques. Each 
technique offered information on the process of understanding the mechanisms that 
lead to chromosomal mosaicism and chaos in human preimplantation embryos.
Initially the CGH technique should be made less laborious and more reliable in order 
to be used in a clinical setting e.g. for PGD of chromosomal abnormalities. This can 
be achieved by reducing the time of hybridisation from 72 hours to less than 24. Wells 
and co-workers (2002) were able to reduce the time to 30 hours during a PGD case for 
aneuploidy screening, however, the CGH was applied to polar bodies.
The use of DNA microarrays to act as hybridisation templates, instead of the target 
metaphase chromosomes that have been used so far could further reduce the period of 
hybridisation, and improve the analysis of the obtained results, increasing the 
simplicity of interpretation by avoiding the need to karyotype metaphase 
chromosomes. During CGH-array analysis, patient DNA and normal reference DNA 
are hybridised to arrays of genomic clones in order to detect unbalanced gains or 
losses of genetic material across the genome (Shaffer et al, 2004). In a recent study by 
Schaffer et al (2004) where production-of-conception samples were analysed with G- 
banding and CGH-array technology. It was found that the array technology detected 
all abnormalities as reported by G-banding analysis and revealed -10% new 
abnormalities. Bermudez et al (2004) carried out microarray CGH to analyse 5 human 
oocytes and were able to identify 1361 transcripts expressed in oocytes. Chan et al
(2002) designed a DNA disc chip array, based on comparative genomic hybridisation 
in order to study sperm and concluded that the technique was reliable however it was 
still prone to manual processing involving the fluorescent microscope and computer. 
In recent study carried out on single lymphocytes, Hu et al (2004), described the 
application of array-CGH for normal and trisomic (13, 15, 18) single cell 
lymphocytes. During that study the slides were arrayed with chromosome-specific 
DNA libraries and the expected karyotypes of all cells was analysed and confirmed 
whilst hybridisation took place for 30hrs (Hu et al, 2004). These results prompted the 
author to suggest the use of this technique for PGS (Hu et al, 2004).
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The whole genome amplification procedure could be replaced and use MDA as an 
alternative method of WGA. This method uses a (p29 DNA polymerase and random 
exonuclease-resistant primers, whilst DNA amplification takes place at 30°C (Dean et 
al., 2002). It has been shown that MDA provides a highly uniform representation of 
the genome, with the amplification bias being less than 3-fold among eight 
chromosomal loci, compared to the 4-6-fold observed with the application of the 
DOP-PCR (Dean et al, 2002). Spits et al (2006) developed a protocol using MDA and 
were able to amplify 22 loci in 60 single cells and concluded that it can be used for 
PGD for single gene disorders.
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6.1 Final Thoughts
The constant evolution of molecular, cytogenetic and combinatorial techniques aims 
to facilitate and enrich the study of human preimplantation embryos and the 
subsequent application of PGD. During this study new methods and protocols for 
different techniques were devised and tested.
The phenomenon of mosaicism was explored in human preimplantation embryos with 
a novel protocol using multi-colour FISH. Mosaicism can be explained by the 
presence of two or more cell line present in one embryo. Mosaicism has been the 
‘culprit’ causing misdiagnosis during PGD using either FISH or PCR. Therefore, the 
need of biopsying two cells per embryo whilst carrying out PGD has been put 
forward. The decision as to whether one or two cells should be removed is 
controversial; removing two cells reduces the cellular mass and could potentially 
reduce its developmental capacity (Braude et al, 2002). Early studies to measure the 
effect of biopsy on human embryonic development showed that two cells could be 
removed from 8-cell embryos on day three post-insemination without reducing the 
number blastulating or disturbing cleavage rates (Hardy et al, 1990). Furthermore, 
two-cell biopsy procedures should only be carried out on day three post-insemination 
at the 6-8 cell stage, when up to a quarter of the blastomeres can be removed without 
disturbing subsequent development (Handyside et al, 1989; Handyside, 1991; Hardy 
et al, 1990), as the biopsied cells are still undifferentiated (Harper et al, 1996). The 
debate over whether taking two cells rather than one is detrimental to the embryo, is 
ongoing (De Vos and Van Steirteghem, 2001). However, it has been shown that the 
accuracy of the diagnosis is likely to be enhanced if embryos are replaced when 
results from both cells are concordant (Van de Velde et al, 2000).
Therefore, it is necessary to determine the level of mosaicism. Many studies have 
been carried out in search of the levels of mosaicism using FISH both in cleavage 
stage (Delhanty et al, 1993; Munne et al, 1994b; Harper et al, 1995; Delhanty et al, 
1997; Laverge et al, 1997; Iwarsson et al, 1999; Magli et al, 2000; Coonen et al, 
2004) as well as blastocysts (Evsikov and Verlinksy, 1998; Veiga et al, 1999; 
Ruangvutilert et al, 2000a). All of these studies tried to assess the level of mosaicism 
using probes for as many chromosomes as possible. However, all previous studies
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conclude that the FISH efficiency ranges from 60-95% depending on the type of 
probe, the number of probes used simultaneously and the number of sequential 
rounds. Hence, up to 40% of abnormalities can be missed whilst studying mosaicism 
and its effects. The protocol devised in this study was based on the detection of 
mosaicism of three main chromosomes (1, 11 and 18) as well as the degree of 
mosaicism in the sex chromosomes (due to the near perfect efficiency results of the 
probes). The three main chromosomes were investigated during two sequential rounds 
of FISH by employing a different probe and at a different site for each chromosome 
e.g. a centromere and a sub-telomere for each chromosome. This allowed the 
detection of any FISH artefacts and any FISH failure that might occur, providing the 
true level of abnormality for the chromosomes investigated. A total of 76 abnormal 
results would have been missed unless the two probes per chromosome protocol was 
carried out.
One of the main aims of this study was to explore the mechanisms that give rise to 
aneuploid mosaic embryos in order to understand the high levels in in vitro human 
preimplantation embryos. It has been suggested that the high level of embryonic death 
is mainly due to chromosomal abnormalities (Wells and Delhanty, 2000). 
Chromosomal abnormalities and especially aneuploidy has been found to be 
extremely high after as >60% of spontaneous abortions at <12 weeks are aneuploid 
(Hassold et al, 1980). In our study chromosome loss was found to be the mechanism 
affecting most aneuploid lines. Chromosome loss probably occurs due to anaphase 
lagging. Other studies have found that mitotic non-disjunction was the main 
mechanism affecting mosaicism. This may be due to the fact that the FISH protocols 
used by other groups regard low level monosomy findings as FISH failure or artefacts 
since they are using one probe per chromosome. In a very recent study, it was 
suggested that anaphase lagging is the major mechanism behind aneuploid mosaic 
embryos (Coonen et al, 2004).
The two different groups of embryos analysed were distinguished based on the type of 
IVF medium that they were grown. Group I embryos were cultured until day 5 in non­
sequential medium, which is considered sub-optimal (Jones et al, 1998), whereas 
Group II embryos were grown in sequential medium. Their main difference was the 
number of nuclei available on days which was ~20 cells per embryo for Group I and
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-55 cells per embryo for Group II signifying the limited growth in Group I. Both 
Groups revealed chromosomal loss as the main mechanism behind aneuploid mosaic 
embryos, however, in Group II there was an increased number of tetraploid cells 
present compared to Group I. This can be explained by the findings of multiple 
studies, which have proposed that probably tetraploid cells may be a normal feature in 
the development of the trophectoderm. This would add more support to the 
presumption of limited growth for Group I embryos.
In order to achieve definitive proof of the underlying mechanisms of mosaicism more 
embryos need to be analysed as well as analysis of all the chromosomes. Although, 
the current study was performed on spare, not fit for transfer embryos, therefore 
morphologically the embryos were compromised, still the data obtained were useful. 
A larger cohort of embryos which are morphologically sound should be analysed with 
means that can provide information regarding all the chromosomes. Novel techniques 
such as interphase conversion allowing the entire karyotype to be screened in one step 
have been developed in the recent years and have found clinical application. Their 
principle involves fusion of polar bodies or blastomeres with enucleated human or 
bovine oocytes to induce mitosis (Verlinsky and Evsikov, 1999a; Willadsen et al,
1999). Interphase conversion methods for inducing metaphase in biopsied blastomeres 
have been successfully applied in a number of translocation cases to date with 
subsequent analysis by standard chromosome painting (Verlinsky and Evsikov, 
1999a; Evsikov et al, 2000) or SKY FISH (Willadsen et al, 1999). For both these 
methods however there remains the difficulty inherent in working with single 
metaphase spreads of limiting artefactual chromosome loss.
Therefore, in an attempt to assess the level of mosaicism in all the chromosomes, by 
avoiding the problems encountered by FISH i.e. FISH failure and artefacts, CGH was 
used in the second part of this study. One or two cells were biopsied on day 3 in order 
to carry out CGH and the rest of the embryo was left to grow until day 5, when it was 
spread and FISHed. CGH has been found to be able to diagnose 25-38% more 
abnormalities during PGS in comparison to five- and nine-probe FISH protocols 
(Voullaire et al, 2002). Therefore, by employing CGH in embryos to investigate the 
whole genome, the entire level of mosaicism would be revealed. The set of embryos 
used for this study were frozen-thawed embryos of good quality, which at the time of
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freezing were considered to be fit for transfer. Thus, good quality embryos 
(morphologically assessed) would be analysed using CGH. However, CGH has been 
considered to be laborious and not able to detect small deletions or insertions 
(Mamgrem et al, 2002), as well as responsible for artefacts regarding chromosomes 
19, 22 and Y (Kallioniemi et al, 1994; Tabet et al, 2001; Wilton et al, 2001). Hence, 
FISH was carried out on day 5 to act as a safety net for CGH as well as provide 
confirmation results regarding the abnormalities present on day 3 and whether these 
abnormalities persist until day 5. CGH and FISH results were found to be in 
agreement by scoring the sex chromosomes, where it was found that both techniques 
showed the sex chromosome complement. Overall, CGH was found to be an efficient 
technique whilst analysing single embryonic blastomeres (83.3%). During CGH 
analysis it was found that on day 3 when 1-2 cells were biopsied, 13 embryos were 
found to be normal, however, when left to grow and spread until day 5 and FISHed 
with probes for six chromosomes (9, 16, 18, 22, X and Y), only three were uniformly 
normal. Overall, only 10% (3/30) of the embryos analysed were normal, whilst the 
rest were either mosaic or chaotic. This high level of mosaicism was also observed in 
the 1st study and has been reported from other CGH and FISH studies (Tables 3.3 and 
4.1). Sandalinas and colleagues (2001) found similar percentages of chromosomal 
mosaicism (85%) during FISH analysis of human blastocysts. However, Baart and co­
workers (2004) analysed embryos using FISH on day 3 (by 2-cell biopsy) and day 5 
(whole embryos spreading) and found significantly decreased levels of abnormality 
and mosaicism (55%). However, the latter study was carried out as part of the PGS 
programme and was aiming to distinguish whether day 3 analysis of two biopsied 
cells is able to provide a reliable estimate of chromosomal mosaicism (Baart et al, 
2004).
Similar to the 1st study, chromosome loss was found to be the most common 
mechanism of mosaicism leading to mosaic aneuploid cell lines. However, due to the 
CGH involvement, partial aneuploid events were also exposed with an incidence of 
28% of events producing partial aneuploidy results. Partial chromosome loss was 
found to be the predominant mechanism leading to partial aneuploidy (14%). The 
phenomenon of partial aneuploidy has not been well documented during studies 
carried out on human preimplantation embryos. This is partly due to the fact that 
FISH is unable to distinguish between whole and partial aneuploidy since each FISH
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probe span is relatively small and can only cover a limited stretch of the chromosome. 
For example, when one or three signals are observed during a FISH study employing 
the locus-specific probe for chromosome 21, whole monosomy or trisomy 
respectively is assumed rather than loss or gain of that specific part. However, studies 
on embryos employing CGH (Wells and Delhanty, 2000; Voullaire et al, 2000; 
Voullaire et al, 2002; Malmgrem et al, 2002; Trussler et al, 2004), have all 
documented chromosome breakage. It has been postulated that chromosome breakage 
and whole chromosome aneuploidy are caused by different factors (Wells and 
Delhanty, 2000). In our study, chromosome breakage was observed and documented 
and two chromosome sites were mostly affected, namely 1 p31 and 2q31. Both 
locations have been found to be fragile sites within the chromosomes (Richards,
2001). Where possible the FISH protocol was devised in order to detect and confirm 
chromosome breakage by employing two probes per chromosome (embryo 9.7 Table 
4.7). Therefore, during this study CGH has demonstrated that chromosome breakage 
in human preimplantation embryos can be considered as a possible mechanism of 
aneuploidy and mosaicism.
During the two studies on preimplantation embryos and especially at the blastocyst 
stage more than 80 embryos and >2200 cells were analysed either by CGH or FISH 
for at least five chromosomes. Overall, it was shown that chromosome loss, either 
whole or partial was the main mechanism leading to mosaic aneuploid cell lines. Both 
studies were developed to produce accurate and reliable results, either by employing a 
second probe for the same chromosome to confirm the status of the cell (Chapter 3) or 
by utilising two techniques to confirm the results. It has been shown that CGH can 
provide reliable analysis on single cells as well as blastomeres. However, it still 
remains laborious and time-consuming and will probably not be used for clinical 
purposes in this form. Initially the CGH technique should be made less laborious and 
more reliable in order to be used in a clinical setting e.g. for PGD of chromosomal 
abnormalities. This can be achieved by reducing the time of hybridisation from 72 
hours to less than 24. Wells and co-workers (2002) were able to reduce the time to 30 
hours during a PGD case for aneuploidy screening, however, the CGH was applied to 
polar bodies. The use of DNA microarrays to act as hybridisation templates, instead 
of the target metaphase chromosomes that have been used so far could further reduce 
the period of hybridisation, and improve the analysis of the obtained results,
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increasing the simplicity of interpretation by avoiding the need to karyotype 
metaphase chromosomes. DNA microarray or microarray CGH (M-CGH) analysis is 
a rapid evolving method of molecular analysis that could find several potential uses in 
PGD (Maughan et al, 2001; Clarke et al, 2001). Following in the steps of CGH, 
microarrays could replace the metaphase spreads that are used now to assess 
chromosomal imbalance in CGH. It is likely that their versatility will make them an 
attractive option for PGD. However, at present, technical imitations such as paucity of 
material available for hybridisation, sensitivity and reliability of the data, and the cost 
of producing appropriate microarrays are likely to hinder their application in PGD for 
some time (Braude et al, 2002). Chan et al (2002) designed a DNA disc chip array, 
based on comparative genomic hybridisation in order to study sperm and concluded 
that the technique was reliable but it, was still prone to manual processing involving 
the fluorescent microscope and computer. Furthermore, the whole genome 
amplification procedure could be replaced and MDA can be tested as an alternative 
method of WGA. This method uses a cp29 DNA polymerase and random exonuclease- 
resistant primers, whilst DNA amplification takes place at 30°C (Dean et al, 2002). It 
has been shown that MDA provides a highly uniform representation of the genome, 
with the amplification bias being less than 3-fold among eight chromosomal loci, 
compared to the 4-6-fold observed with the application of DOP-PCR (Dean et al, 
2002).
In the last part, two protocols were devised for carrying out PGD for a single gene 
disorder, namely myotonic dystrophy. These protocols were tested and carried out 
during clinical cases. Furthermore, a novel universal protocol was developed and 
tested on single cells for future application of clinical PGD cases for myotonic 
dystrophy. During the whole PGD protocol workup fluorescent PCR was utilised to 
provide the most sensitive and accurate results. An array of fluorescent polymorphic 
markers was tested initially for 10 different families at the genomic DNA level to 
observe which markers were informative for each family. Two different F-PCR 
protocols were tested and analysis on more than 700 single cells in order to optimise 
the protocols. Protocol 1 had been recently published for its efficiency (Piyamongkol 
et al, 2001a), because it employs a duplex method of detectionof the affected embryos 
as well as a contamination marker (D21S1414). Contamination is the most significant
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problem during single cell PCR. Contamination can be caused by cumulus cells of 
maternal origin, sperm, culture media and the PCR products present in the laboratory 
environment (Delhanty, 1998; section 1.6.3.4.1). Protocol 2 was devised for family H 
and was clinically applied for the first time during this study. The novel side of 
Protocol 2 entails the use of a single-step multiplex F-PCR protocol including the DM 
mutation marker and the polymorphic marker D19S112. This protocol was able to 
detect the presence of contamination as well as the presence of ADO. ADO is the 
amplification of only one of the two parental alleles present in the single cell and can 
lead to misdiagnosis especially during PGD of a dominant genetic disease (Handyside 
et al, 1997; section 16.3.4.2). The D19S112 marker has a polymorphic nature 
therefore contamination can be detected in a sample specific fashion. An additional 
aspect of the D19S112 marker is that it is linked to the DM locus, and so can provide 
back-up diagnostic information for example when ADO has been detected for the DM 
locus. The use of linked markers for the adenomatous polyposis disease during 
clinical PGD has been reported previously (Ao et al, 1998). However, clinical 
application of a duplex F-PCR protocol for PGD of DM using the D19S112 linked 
marker was carried out only during this study. Unfortunately, no pregnancy was 
achieved in either of the PGD cycles performed.
Due to the extensive work in devising a patient-specific PGD protocol for the 
diagnosis of DM, the development of a universal-like protocol for the diagnosis of 
DM was tested initially in genomic DNA and subsequently in single cell DNA. The 
protocol was based on our previous experience with whole genome amplification 
procedures such as DOP-PCR and the use of fluorescent PCR markers. The protocol 
entailed amplification of DNA using WGA and then subsequent amplification of the 
DOP-PCR amplified DNA with the DM mutation marker (DM) as well as linked 
(D19S112) and unlinked polymorphic markers (D13S305, D18S535, D21S1414) for 
the DM disease. Initial testing a the genomic DNA level produced excellent results of 
amplification of the mutation and polymorphic markers (96-98%). Such amplification 
results prompted testing at the single cell DNA level. Twenty single cells from two 
heterozygote individuals were amplified using DOP-PCR and at least ten subsequent 
reactions (2 reactions per marker) were performed for each single cell. A decreased 
amplification rate and increased ADO rate was observed for the amplification (even 
during testing on various single cell DNA where results were not shown) of single
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cells. The DM marker only showed acceptable amplification and an ADO rate of 85% 
and 10%. Respectively, CGH analysis was performed on the DOP-PCR amplified 
single cells and proved successful (85%). Hence, it can be concluded that the idea of a 
universal-like protocol for the PGD of DM is feasible however, requires refinement of 
the whole genome amplification protocol which may be achieved by changing the 
protocol to MDA (above) which offers a more reliable representation of genome. 
Further work should include purification of the whole genome amplified product 
which might enhance the amplification fidelity of the polymorphic markers. Overall, 
it was shown that this protocol can be used for low quantities of DNA, however, 
certain alterations and further optimisation should be carried out to improve the 
reliability in the minute quantities present in single cells.
6.2 Ethical Considerations towards PGD
The wide media coverage regarding advances in ART is the source of most of the 
ethical concerns raised today concerning what could become possible in the future. 
Cloning, prenatal diagnosis, and gene therapy (Fletcher, 1978; Fiddler and Pergament, 
1995; Fiddler et al, 1999) are research fields mainly linked with fear of excessive 
embryo and fetal experimentation. Consequently most countries where this 
technology exists now have in place, or are in the process of defining, ethical 
guidelines or legislation to regulate human embryo research.
The philosophy of PGD is to provide couples at risk of transmitting an inherited 
disorder with the option and assurance of selectively having an unaffected child, in 
cases of an unacceptably high risk for a defective child. The great advantage from the 
ethical point of view that PGD provides is that it avoids implantation of defective 
embryos, and this process of selection eliminates the need for future TOP. Couples at 
high risk are offered the opportunity to overcome the worrisome burden of a possible 
abortion, as affected embryos are detected in vitro and only healthy embryos are 
implanted (Raeburn, 1995). Furthermore, PGD is able to prevent disabling inherited 
disorders prior to embryonic development (Viville et al, 1998). By applying PGD in 
countries where abortions are illegal, the number of terminations due to genetic 
factors can be reduced (Viville et al, 1998). PGD avoids the heated debate of selective 
abortion in society and in individual cases (Fasouliotis and Schenker, 1998). The goal
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of avoiding the birth of offspring with severe genetic handicaps is part of the 
procreative liberty and parental decision (Kanavakis and Synodinos, 2002). However, 
the selection of embryos on genetic grounds is not yet ethically acceptable by all 
countries.
Attitudes to embryo research vary widely from country to country, which has raised 
great debate towards the diagnosis of embryos at the preimplantation stage. Most 
concerns have been pointed to the fact that PGD can and will be used for eugenic 
purposes i.e. the possibility that embryos could be analysed for characteristics not 
related to health issues (Wells and Delhanty, 2001). PGD has been referred to as a 
vehicle of eugenics more powerful than any of its predecessors (Fasouliotis and 
Schenker, 1998). Therefore, in the UK centres that offer PGD are controlled by the 
Human Fertilisation and Embryology Authority (HFEA) (Harper and Delhanty,
2000). The Human Fertilisation and Embryology Act 1990 permits embryo research 
due to the following reasons: (1) promoting advances in the treatment of infertility, 
(2) Increasing knowledge about the causes of congenital disease, (3) Increasing 
knowledge about the causes of miscarriage, (4) Developing more effective techniques 
of contraception and (5) Developing methods for detecting the presence of gene or 
chromosome abnormalities in embryos before implantation. However, prohibited are 
reproductive cloning, inter-species fertilisation or transfer of human embryos into 
other species and gene therapy in the pre-embryo.
“Designer babies” and PGD raise real ethical dilemmas in certain unusual cases 
(Braude et al, 1998; Braude et al, 2001). A dilemma might occur with inherited 
deafness. In a recent case a non-hearing child was deliberately conceived to be deaf 
like its lesbian parents (Savulescu et al, 2002). Sex selection referred to as “family 
balancing” remains controversial (Gleincher and Karande, 2002) and many consider it 
not to be a legitimate use of PGD (Robertson, 2002). Finally, the attempt to save the 
life of a sibling by having another child provide a suitable tissue match can be 
rationalised and commended however, this process has met with great controversy 
(Boyle and Savulescu, 2002). In addition, further problems that PGD faces is the 
possibility of misdiagnosis (Harper et al, 1999; Harper and Delhanty, 2000; Wells, 
2004).
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Chapter 8 Appendix
Table 8.1. Analytical CGH and FISH results from each cell for chapter 4
Pt No.
(age)
EMB
No.
Cell CGH Result
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no)
1
(38)
1.1
a
No result X, Y, 18,18(1,5,6,7,8,9,10,11,13) 
X, Y, 18(2,12)
X, X, Y, Y, 18,18 (3,4)
9, 9, 16, 16, 22, 22 (1,2,3,4,5,6,9,10,11, 
12,13)
9, 9, 16,16, 22, 22, 22 (7,8)
b
rev ish XY
1.2
a
rev ish XY, dim(22) X, 18(1)
X,X,X,X,X,X,X, 18,18,18,18,18,18,18 
(2)
9, 9, 22 (1)
9,9,9,9,9, 16,16,16,16,16, 22,22,22,22 (2)
b No result
1.3 a
rev ish XY X, X, Y, Y, 18,18, 18, 18(1) 
X, Y, 18,18(2)
9, 9,16,16, 22, 22(1,2)
2
(29)
2.1
a
rev ish XY X, Y, 18,18 (1,2,3,4) 9, 9,16,16, 22, 22(1,2,3,4)
b
No result
353
Pt No.
(age)
EMB
No.
Cell CGH Result
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
2
(29) 2.2
a
rev ish XY, dim(18) Nullisomy for all chromosomes (1) 
X, Y, 18 (2)
18(3)
9, 22(1,3) 
9, 9, 16(2
b
No result
3
(35)
3.1
a
rev ish XY, 
enh(5pter, 9qter, 17), 
dim(4,19)
Y, 18,18,18 (1,2) 16, 22(1)
9, 9, 16, 22 (2)
b No result
4
(35)
4.1 a rev ish XY No cells to FISH No cells to FISH
4.2
a rev ish XX
X, X, 18, 18 (10,12,16,17,19,20,22, 
26,32)
X, 18, 18 (4,9,13,23,24,27,30,31) 
X, X, 18(2,6,8,14,28)
X, 18(11,15,18,29)
18, 18(5,7,21)
X, X, 18, 18, 18 (25,33)
X, X, 18, 18, 18, 18(1)
X, X, X, 18, 18, 18(3)
9, 9, 16, 16, 22, 22 (2,4,6, 12,14,16,21, 
22,23,24,25,26,27, 
29,30,31,32,33)
9, 9, 16, 16, 22 (7,8,9, 15)
9, 9, 16, 22(10,11,13)
9, 9, 16, 22, 22(17, 18, 19)
9, 9,16, 22 (3)
9, 9,16(1,5,28)
b
rev ish XX, 
enh(l, 22), 
dim(16pter, 18)
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Pt No. 
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
4
(35)
4.3 a rev ish XY No cells to FISH No cells to FISH
4.4 a rev ish XY, enh(X) No cells to FISH No cells to FISH
6
(30)
6.1 a No result No cells to FISH No cells to FISH
6.2
a rev ish XY
X, X, 18,18(1,2,3,4,5) 9, 9,16,16, 22, 22(1,3,4) 
9, 9, 16, 16, 22 (2,5)
b rev ish XY
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Pt No. 
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
a
rev ish XY, enh(6p25-p21.1)* X, X, Y, 18, 18(1,2) 
X, 18, 18(3,4,7,8)
X, Y, 18, 18(5,6)
9, 9, 16, 16, 22, 22(1,2,5,6,7) 
9, 9, 16, 22, 22 (3)
9, 9, 16, 16, 22, 22, 22 (4)
6
(30)
6.3
b rev ish XY, enh(Y)
9, 9, 16, 16, 22 (8)
7.1 a rev ish XX
X, X, 18, 18(3,6,7,8) 
X, X, 18(1,2,4)
X, X, 18, 18, 18(5)
9, 9 ,16,16, 22, 22(1,2,3,5,7,8) 
9, 9, 16, 22, 22 (4)
9, 9, 16, 16, 22 (6)
7
7.2
a
rev ish XYY, 
enh( 1 p36.2-36.1, 2q31 -p25, 5, 
7, 8, 18, 19, 20,21 and Y), 
dim(lp31-q44, 2q32-q37, 3, 6, 
11, 13, 14, 15)
X, X, X, 18, 18, 18(1,3)
X, X, X, X, X, Y, Y, 18,18, 18(2)
3c/llc/13LSI
3 ,13 ,13(1 )
3(2)
3 ,3 ,3 , 13(3)
(39)
b
No result
7.3
a
rev ish XY, dim(22ql 1.1 -ql 3)
X, X, 18, 18(3,5,6,7,9,10,11,12, 
13, 14,15,17,18,19, 
20,21,22,23,24,25, 
26,27,28,29,30)
9, 9, 16, 16, 22, 22 (6,13,15,23,24)
9, 9, 16, 16,22,22,22 (7,14,18,19,26) 
9, 9, 16, 22(12,22)
9,9(17,20)
b rev ish XY
X, 18, 18(4,8)
X, X, X, X, 18, 18(1,2)
X, X, X, X, 18, 18, 18, 18(16) 
X, X, 18(24)
22 (3,8)
9, 9, 22 (4,11)
9, 16, 16, 22(1)
9, 9, 9, 16, 22 (2)
9, 16, 16, 22, 22 (5)
9,9,9,9, 16,16,16,16, 22,22,22,22 (16)
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Pt No.
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result(day 5) 
9c/16c/22LSI (cell no.)
8
(31)
8.1
a
rev ish XX
X, X, 18, 18(1,2,3)
X, X, 18, 18, 18, 18(4)
10c / 14a
10, 14q, 14q (1,2)
10, 14q, 14q, 14q (3,4)
b
rev ish XX, 
enh(4, 12pll.2-q24.3, 14q21-q32) 
dim(2q31-q37, 10)
8.2 a rev ish XX, enh(9 and 16) X, X,18,18 (1,2,3,4,5,6,7,8,9,10)
9, 9, 16, 16, 22, 22 (2,3,4,6,7,10) 
22, 22(1,8,9)
9, 22, 22 (5)
9
(33)
9.1
a rev ish XY, enh(Xpl 1.2-q22)* X, Y, 18, 18(1,2,3,4,5,6,7) 9, 9, 16, 16, 22, 22(1,2,3,4,5,6,7)
9.2 a rev ish XY, dim(Yql2)*
X, Y, 18, 18(2,3,4,5,7,8,9,10,11, 
12,1516,17,18,19,20 
21,22,23,24,2526,27 
28,29,30,31)
X, Y, 18(1,13,14)
Y, 18, 18(6)
9, 9, 16, 16, 22, 22 (2,3,4,5,6,7,8,9, 
10,11,12,14,15, 
16,17,18,19,20, 
21,22,23,24,25, 
26,27,29,31)
9, 9, 16, 22, 22, 22(1,30)
9, 9, 9, 16, 22, 22, 22(13)
9, 9, 16, 16, 22, 22, 22, 22 (28)
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Pt No.
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
9.3
a rev ish XY, dim(15ql5-q26, 16) X, Y, 18, 18(1,2,3,4) 9, 9, 16, 16, 22, 22(1,4) 
9, 9, 16, 22, 22, 22 (2,3)
9
9.4 a
rev ish XX, dim(l Iq23-q25)*
X, X, 18, 18(1,3,5)
X, X, X, X, 18, 18, 18, 18(2,6) 
X, X (4)
9, 9 ,16,16, 22, 22(1,3,4,5)
9,9,9,9, 16,16,16,16, 22,22,22,22
(2,6)
(33)
9.5 a rev ish XY
X, Y, 18, 18(1,3,4,5,7,8,9) 
Y, 18, 18(2,6,10)
18(11)
9, 9, 16, 16, 22, 22(1,2,3,4,5,6,7, 
8,9,10)
9, 16, 22, 22(11)
a
rev ish XX,
enh(2q21-q33, 3qll.l-q25), 
dim(lp36.1-p33, 16, 19 and 22)
X, X, 18, 18 (1,2,3,4,5,6,7,8,9,12,13 
14,15,16,18,19,20,22)
X, X, 18(10)
X, X, X, X, 18, 18, 18, 18(11,17)
9, 9, 16, 16, 22, 22 (2,3,4,5,7,8, 
9,10,13,16, 
17,19,20,21 
22,23)
9.6
b rev ish XX
X, X, X, 18, 18(22) 9, 9, 16, 22 (6,14,15)
9,9,9,9, 16,16,16,16, 22,22,22,22
(11,17)
9, 9, 16, 16, 22(12,18)
9, 9, 16, 22, 22, 22, 22(1)
358
Pt No.
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
9
(33)
9.7
a
rev ish XY, 
enh(lp36.3-q21), 
dim(lq31-q44) X, Y, 18, 18(3,5) 
X, X, Y, 18, 18(1) 
X, Y,Y, 18, 18(2) 
Y, 18, 18(4)
In / la  / 16cen
lp, lq, 16, 16(1) 
lp, lq, lq, lq, 16, 16(2,5) 
lp, lp, lp, 16, 16(3) 
lp, lp, lq, lq, 16(4)b rev ish XY, dim(l)
9.8
a
rev ish XY,
enh(17pl3-ql 1, 18pl 1.3-ql 1.1), 
dim(3p26-pl4) X, Y, 18, 18 (1,2,3,4,5,6,7,8,9,10,12, 
13,15,16,17)
X, Y,Y Y, 18, 18(11)
Y, Y, 18, 18(14)
3cen/6cen/18ceD
3, 3 ,6 , 6, 18, 18(1,2,3,5,6,7,8,12, 
13,16,17)
3 .3 .6 , 6, 6, 18, 18(4,9,10)
3 .3 .6 , 18, 18(15)
3, 3, 6, 6, 18(11)
b rev ish XY, enh(6)
10
(32)
10.1 a
rev ish XX, enh(20)
X, X, 18, 18(4,8,12,13,16,17,18)
X, X, X, X, 18, 18(1,2,3,5,6,11,14) 
X, X, X, 18, 18(7,15,19)
X, X, X, 18, 18, 18(9)
X, 18(10)
X, X, X, X, X, X, 18, 18, 18, 18(17)
9, 9, 16, 16, 22, 22(1,2,3,4,5,6,7, 
8,10,11,12,13, 
15,16,17,18,19 
9, 9, 16, 16, 16, 22, 22, 22 (9)
9, 9, 16, 16, 22(14)
9, 9, 9, 9, 16, 16, 16, 16, 22, 22, 
22, 22(17)
11
(35)
11.1 a rev ish XY, enh(Ypl 1.3-11.2)* X, Y, 18, 18(1,2,3,4,5,6,7,8,9,10) 9, 9, 16, 16, 22, 22(1,2,3,4,5,6,7, 
8,9,10)
359
Pt No. 
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
12.1 a rev ish XX
X, X, 18, 18(1,3) 
X, X, 18(2)
9, 9, 16, 16, 22, 22(1)
9, 9, 16, 22, 22, 22, 22 (2) 
9, 22, 22 (3)
12
(30) 12.2 a
rev ish XY, 
enh(Y), 
dim(4pter)
X, Y, 18, 18(1,2,3,4,5,11) 
X, Y, 18(8,10)
X, 18, 18(6,7)
18(9)
Y, Y, 18, 18(12)
4cep/Y cep
4,4 , Y (1,2,3,4,5,8,10,11) 
4, 4 (6,7)
Nullisomy 4 and Y (9)
4, Y, Y (12)
12.3
a
rev ish XY, 
enh(Y qll.l-ql2), 
dim(16q21-q24)
X, Y, 18(1)
X, Y, 18, 18(2)
Xc/Yc/16a
X, Y, 16q (1,2)
13
(36)
13.1 a rev ish XY, enh(5) No cells to FISH No cells to FISH
360
Pt No.
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
13
(36)
13.2
a
rev ish XX, dim(19pl3.3- 
pl3.2)*
X, X, 18, 18(1,2,3,4,7,9,12,14) 
18, 18(5)
X, X, X, X, 18,18(6)
X, X, X, 18, 18, 18(8)
X, X, X, 18(10)
X, 18, 18, 18(11)
X, X, 18(13)
X, X, X, X, 18, 18, 18, 18(15)
9, 9, 16, 16, 22, 22(1,2,3,7,9,12,14)
9, 16, 16, 22, 22, 22 (4)
16, 22, 22, 22, 22 (5)
22, 22 (6)
9, 9, 9 ,16,16,16, 22, 22, 22 (8)
9, 9, 16, 16, 22, 22, 22(10)
9, 9, 16, 16, 22(11)
9, 9, 9, 16, 16, 22, 22, 22(13)
9, 9, 9, 9, 16, 16, 16, 16, 22, 22, 22, 22 (15)
b
rev ish XX
13.3
a
rev ish XX X, X, 18, 18 (1,2,3,4,5,6,8,9,10,12,15,16 
17,20,22,23,24,25,26,27, 
28,29,30,31,32,33,34,35) 
X, X, X, 18, 18, 18(13,14)
X, X, X, 18(11,21)
X, X, X, X, X, X, 18, 18, 18 18, 18 (7) 
X, X, 18, 18, 18, 18, 18(18)
X, X, 18, 18, 18(19)
9, 9, 16, 16, 22, 22(1,2,3,4,5,6,8,9,10,11, 
12,15,16,17,18,20,21, 
22,23,24,25,26,27,28, 
29,30,31,32,33,34,35) 
9, 9, 9, 16, 16, 16, 22, 22, 22(13,14)
9, 9, 9, 16, 16, 22, 22, 22, 22 (7)
9, 16, 22, 22(19)
b
rev ish XX
14
(28)
14.1
a rev ish XX
No cells to FISH No cells to FISH
b rev ish XX, 
enh(2,4, 9qter), 
dim(l, 16, 21)
361
Pt No.
(age)
EMB
No.
Cell CGH Result 
(day 3)
FISH Result (day 5) 
X/Y/18 (cell no.)
Re-FISH Result (day 5) 
9c/16c/22LSI (cell no.)
14.2
a
rev ish XX, 
enh(l, 10, 16qter), 
dim(8, 13,21,22)
X, X, 18, 18(1,2,5,6) 
X, X (3)
X, 18 (4)
9, 9, 16, 16, 22, 22(1)
9, 9, 16, 22, 22 (2)
9, 9,16, 22 (3,5)
9, 9, 16, 16, 16, 22, 22, 22 (4,6)
14
(28)
b
rev ish XX, 
enh(2,6), 
dim(9qter,13, 15, 16qter, 17)
14.3 a rev ish XX No cells to FISH No cells to FISH
'XfT)
